Datasets:

YupengCao

/

validation_set_task2_llama3_8b

like 0

edtsum6

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN DIEGO, California, July 28, 2020 /PRNewswire/ -- Geek+, a global AMR leader, announced a beginning of a new distribution partnership with Kuecker Logistics Group (KLG), a material handling systems integrator, to provide smart logistics solutions to customers across North America. With an already extensive portfolio of successful cases across industries and a wide variety of AI-driven robotics solutions, Geek+ is partnering up with KLG, enabling an upgrade of the system integrators already broad range of services provided, from supply chain management and industrial automation to life cycle services and more. Rick DeFiesta, Director of Business Development and Partnership at Geek+, said: "We are happy to be partnering up with an experienced integrator whose customer-first mentality has earned them a good reputation throughout North America, and are confident that the customized smart robotics solutions of Geek+ will leverage KLG's know-how in the material handling industry." Jim Kuecker, Vice President of Systems at KLG, said: "We look forward to working together to offer our customers a flexible and robust portfolio of technologically advanced robotics solutions for logistics, and recognize the ability of Geek+ to design and build systems that, not only bring advantages of increased throughput and storage capacity, but reduces the overall reliance on labor, mitigating against various warehousing costs and logistics bottlenecks." The distribution agreement allows KLG to offer Geek+ robotics solutions so as to improve efficiency, provide flexibility, and reduce costs associated with warehouse and logistics operations, especially in regard to fast-growing industries, such as e-commerce and online retail, often subject to an overall need for solutions that can enable businesses to meet higher customer expectations, flexibly scale operations and meet fluctuations in demand. About Geek+ Geek+ is global technology company leading the intelligent logistics revolution. We apply advanced robotics and AI technologies to realize flexible, reliable and highly efficient solutions for warehouses and supply chain management. Geek+ counts 300 global customers and has deployed more than 10,000 robots worldwide. Founded in 2015, Geek+ has over 800 employees and is headquartered in Beijing, with offices in Germany, the UK, the US, Japan, Hong Kong and Singapore. For more information, please visit https://www.geekplus.com/ About Kuecker Logistics Group Since 1980, Kuecker Logistics Group has been an MHE integrator that has grown into an end-to-end provider of Supply Chain Solutions that range from Engineering Services, Systems Integration, to Life Cycle Services. They are a family-owned private company. Kuecker Logistics Group was founded with a customer-first focus and although they are growing, their focus remains the same. Kuecker Logistics Group is working with a wide portfolio of companies on their Distribution and Fulfillment Center needs. For more information, please visit https://www.kuecker.com/ SOURCE Geek+ Related Links geekplus.com.cn Answer:

Geek+ and Kuecker Logistics Group Announce Distribution Agreement Geek+ and Kuecker Logistics Group enter a distribution partnership to provide smart logistics robotics solutions to customers across North America

SAN DIEGO, California, July 28, 2020 /PRNewswire/ -- Geek+, a global AMR leader, announced a beginning of a new distribution partnership with Kuecker Logistics Group (KLG), a material handling systems integrator, to provide smart logistics solutions to customers across North America. With an already extensive portfolio of successful cases across industries and a wide variety of AI-driven robotics solutions, Geek+ is partnering up with KLG, enabling an upgrade of the system integrators already broad range of services provided, from supply chain management and industrial automation to life cycle services and more. Rick DeFiesta, Director of Business Development and Partnership at Geek+, said: "We are happy to be partnering up with an experienced integrator whose customer-first mentality has earned them a good reputation throughout North America, and are confident that the customized smart robotics solutions of Geek+ will leverage KLG's know-how in the material handling industry." Jim Kuecker, Vice President of Systems at KLG, said: "We look forward to working together to offer our customers a flexible and robust portfolio of technologically advanced robotics solutions for logistics, and recognize the ability of Geek+ to design and build systems that, not only bring advantages of increased throughput and storage capacity, but reduces the overall reliance on labor, mitigating against various warehousing costs and logistics bottlenecks." The distribution agreement allows KLG to offer Geek+ robotics solutions so as to improve efficiency, provide flexibility, and reduce costs associated with warehouse and logistics operations, especially in regard to fast-growing industries, such as e-commerce and online retail, often subject to an overall need for solutions that can enable businesses to meet higher customer expectations, flexibly scale operations and meet fluctuations in demand. About Geek+ Geek+ is global technology company leading the intelligent logistics revolution. We apply advanced robotics and AI technologies to realize flexible, reliable and highly efficient solutions for warehouses and supply chain management. Geek+ counts 300 global customers and has deployed more than 10,000 robots worldwide. Founded in 2015, Geek+ has over 800 employees and is headquartered in Beijing, with offices in Germany, the UK, the US, Japan, Hong Kong and Singapore. For more information, please visit https://www.geekplus.com/ About Kuecker Logistics Group Since 1980, Kuecker Logistics Group has been an MHE integrator that has grown into an end-to-end provider of Supply Chain Solutions that range from Engineering Services, Systems Integration, to Life Cycle Services. They are a family-owned private company. Kuecker Logistics Group was founded with a customer-first focus and although they are growing, their focus remains the same. Kuecker Logistics Group is working with a wide portfolio of companies on their Distribution and Fulfillment Center needs. For more information, please visit https://www.kuecker.com/ SOURCE Geek+ Related Links geekplus.com.cn

edtsum10

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PALO ALTO, Calif.--(BUSINESS WIRE)--Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) (SCH, and after the Domestication as described below, Clover Health) today announced the pending transfer of the listing of its Class A ordinary shares, par value $0.0001 per share (the SCH Class A ordinary shares) and redeemable warrants (the SCH warrants) from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market (Nasdaq) related to its pending business combination with Clover Health Investments, Corp. (Clover). Prior to the consummation of the business combination, SCH will domesticate as a Delaware corporation (the Domestication), and in connection with the business combination, SCH will change its name to Clover Health Investments, Corp. As part of the Domestication, (1) each of the then issued and outstanding SCH Class A ordinary shares, will convert automatically, on a one-for-one basis, into a share of Class A common stock, par value $0.0001 per share, of Clover Health (the Clover Health Class A common stock); (2) each of the then issued and outstanding SCH warrants will convert automatically into a redeemable warrant to acquire one share of Clover Health Class A common stock (the Clover Health warrants); and (3) each of the then issued and outstanding units of SCH that have not been previously separated into the underlying SCH Class A ordinary shares and underlying SCH warrants upon the request of the holder thereof (the SCH units) will be cancelled and will entitle the holder thereof to one share of Clover Health Class A common stock and one-third of one Clover Health warrant. Trading is expected to begin on Nasdaq on January 8, 2021 under the new ticker symbol CLOV for the Clover Health Class A common stock and CLOVW for the Clover Health warrants. Until the Domestication and transfer is complete, the SCH ordinary shares, warrants and units will continue to trade under the ticker symbols IPOC, IPOC.WS and IPOC.U, respectively, on NYSE. The last day of trading on the NYSE is expected to be on January 7, 2021, following the consummation of SCH's pending transaction with Clover, which is currently expected to occur on January 7, 2021, subject to final shareholder approval at SCH's extraordinary general meeting on January 6, 2021, and satisfaction of other customary closing conditions. No action is required by existing SCH shareholders with respect to the ticker symbol or exchange listing change. About Social Capital Hedosophia Holdings Corp. III Social Capital Hedosophia Holdings Corp. III is a partnership between the investment firms of Social Capital and Hedosophia. Social Capital Hedosophia Holdings Corp. III unites technologists, entrepreneurs and technology-oriented investors around a shared vision of identifying and investing in innovative and agile technology companies. To learn more about Social Capital Hedosophia Holdings Corp. III, visit www.socialcapitalhedosophiaholdings.com. Additional Information and Where to Find It This press release relates to a proposed transaction between Clover and SCH. This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. In connection with the proposed transaction, SCH has filed a registration statement on Form S-4 (as amended, the Registration Statement) with the U.S. Securities and Exchange Commission (the SEC) (File No. 333-249558), which includes a proxy statement/prospectus, that is both the proxy statement which has been distributed to SCHs shareholders in connection with SCHs solicitation of proxies for the vote by SCHs shareholders with respect to the proposed transaction as described in the Registration Statement as well as the prospectus relating to the offer of the securities to be issued to SCHs security holders in connection with SCHs proposed domestication as a Delaware corporation in connection with the proposed transaction as described in the Registration Statement. SCH has mailed a definitive proxy statement/prospectus and other relevant documents to its shareholders of record as of November 17, 2020, the record date established for the extraordinary general meeting of stockholders relating to the business combination. SHAREHOLDERS AND OTHER SECURITY HOLDERS OF SCH ARE ADVISED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders are able to obtain free copies of the Registration Statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by SCH (when available) through the website maintained by the SEC at https://www.sec.gov. The documents filed by SCH with the SEC also may be obtained free of charge at SCHs website at http://www.socialcapitalhedosophiaholdings.com/docsc.html or upon written request to 317 University Ave, Suite 200, Palo Alto, California 94301. Cautionary Statement Regarding Forward Looking Statements This press release contains certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Clover and SCH, including statements regarding SCHs and Clovers expectations with respect to the listing of shares of the post-combination company on Nasdaq. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of SCHs securities, (ii) the risk that the transaction may not be completed by SCHs business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by SCH, (iii) the failure to satisfy the conditions to the consummation of the transaction, including the adoption of the Agreement and Plan of Merger (as amended, the Merger Agreement), dated as of October 5, 2020, by and among SCH, Asclepius Merger Sub Inc. and Clover, by the shareholders of SCH, the satisfaction of the minimum trust account amount following redemptions by SCHs public shareholders and the receipt of certain governmental and regulatory approvals, (iv) the lack of a third-party valuation in determining whether or not to pursue the transaction, (v) the inability to complete the PIPE investment in connection with the transaction, (vi) the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement, (vii) the effect of the announcement or pendency of the transaction on Clovers business relationships, operating results and business generally, (viii) risks that the proposed transaction disrupts current plans and operations of Clover and potential difficulties in Clover employee retention as a result of the transaction, (ix) the outcome of any legal proceedings that may be instituted against Clover or against SCH related to the Merger Agreement or the transaction, (x) the ability to maintain the listing of SCHs securities on a national securities exchange, (xi) the price of SCHs securities may be volatile due to a variety of factors, including changes in the competitive and highly regulated industries in which SCH plans to operate or Clover operates, variations in operating performance across competitors, changes in laws and regulations affecting SCHs or Clovers business and changes in the combined capital structure, (xii) the ability to implement business plans, forecasts, and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities, and (xiii) the risk of downturns and a changing regulatory landscape in the highly competitive healthcare industry. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Risk Factors section of the definitive proxy statement/prospectus discussed above and other documents filed by SCH from time to time with the U.S. Securities and Exchange Commission (the SEC). These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Clover and SCH assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither Clover nor SCH gives any assurance that either Clover or SCH, or the combined company, will achieve its expectations. Answer:

Social Capital Hedosophia Holdings Corp. III to Trade on Nasdaq in Connection with its Proposed Business Combination with Clover Health

PALO ALTO, Calif.--(BUSINESS WIRE)--Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) (SCH, and after the Domestication as described below, Clover Health) today announced the pending transfer of the listing of its Class A ordinary shares, par value $0.0001 per share (the SCH Class A ordinary shares) and redeemable warrants (the SCH warrants) from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market (Nasdaq) related to its pending business combination with Clover Health Investments, Corp. (Clover). Prior to the consummation of the business combination, SCH will domesticate as a Delaware corporation (the Domestication), and in connection with the business combination, SCH will change its name to Clover Health Investments, Corp. As part of the Domestication, (1) each of the then issued and outstanding SCH Class A ordinary shares, will convert automatically, on a one-for-one basis, into a share of Class A common stock, par value $0.0001 per share, of Clover Health (the Clover Health Class A common stock); (2) each of the then issued and outstanding SCH warrants will convert automatically into a redeemable warrant to acquire one share of Clover Health Class A common stock (the Clover Health warrants); and (3) each of the then issued and outstanding units of SCH that have not been previously separated into the underlying SCH Class A ordinary shares and underlying SCH warrants upon the request of the holder thereof (the SCH units) will be cancelled and will entitle the holder thereof to one share of Clover Health Class A common stock and one-third of one Clover Health warrant. Trading is expected to begin on Nasdaq on January 8, 2021 under the new ticker symbol CLOV for the Clover Health Class A common stock and CLOVW for the Clover Health warrants. Until the Domestication and transfer is complete, the SCH ordinary shares, warrants and units will continue to trade under the ticker symbols IPOC, IPOC.WS and IPOC.U, respectively, on NYSE. The last day of trading on the NYSE is expected to be on January 7, 2021, following the consummation of SCH's pending transaction with Clover, which is currently expected to occur on January 7, 2021, subject to final shareholder approval at SCH's extraordinary general meeting on January 6, 2021, and satisfaction of other customary closing conditions. No action is required by existing SCH shareholders with respect to the ticker symbol or exchange listing change. About Social Capital Hedosophia Holdings Corp. III Social Capital Hedosophia Holdings Corp. III is a partnership between the investment firms of Social Capital and Hedosophia. Social Capital Hedosophia Holdings Corp. III unites technologists, entrepreneurs and technology-oriented investors around a shared vision of identifying and investing in innovative and agile technology companies. To learn more about Social Capital Hedosophia Holdings Corp. III, visit www.socialcapitalhedosophiaholdings.com. Additional Information and Where to Find It This press release relates to a proposed transaction between Clover and SCH. This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. In connection with the proposed transaction, SCH has filed a registration statement on Form S-4 (as amended, the Registration Statement) with the U.S. Securities and Exchange Commission (the SEC) (File No. 333-249558), which includes a proxy statement/prospectus, that is both the proxy statement which has been distributed to SCHs shareholders in connection with SCHs solicitation of proxies for the vote by SCHs shareholders with respect to the proposed transaction as described in the Registration Statement as well as the prospectus relating to the offer of the securities to be issued to SCHs security holders in connection with SCHs proposed domestication as a Delaware corporation in connection with the proposed transaction as described in the Registration Statement. SCH has mailed a definitive proxy statement/prospectus and other relevant documents to its shareholders of record as of November 17, 2020, the record date established for the extraordinary general meeting of stockholders relating to the business combination. SHAREHOLDERS AND OTHER SECURITY HOLDERS OF SCH ARE ADVISED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders are able to obtain free copies of the Registration Statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by SCH (when available) through the website maintained by the SEC at https://www.sec.gov. The documents filed by SCH with the SEC also may be obtained free of charge at SCHs website at http://www.socialcapitalhedosophiaholdings.com/docsc.html or upon written request to 317 University Ave, Suite 200, Palo Alto, California 94301. Cautionary Statement Regarding Forward Looking Statements This press release contains certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Clover and SCH, including statements regarding SCHs and Clovers expectations with respect to the listing of shares of the post-combination company on Nasdaq. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of SCHs securities, (ii) the risk that the transaction may not be completed by SCHs business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by SCH, (iii) the failure to satisfy the conditions to the consummation of the transaction, including the adoption of the Agreement and Plan of Merger (as amended, the Merger Agreement), dated as of October 5, 2020, by and among SCH, Asclepius Merger Sub Inc. and Clover, by the shareholders of SCH, the satisfaction of the minimum trust account amount following redemptions by SCHs public shareholders and the receipt of certain governmental and regulatory approvals, (iv) the lack of a third-party valuation in determining whether or not to pursue the transaction, (v) the inability to complete the PIPE investment in connection with the transaction, (vi) the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement, (vii) the effect of the announcement or pendency of the transaction on Clovers business relationships, operating results and business generally, (viii) risks that the proposed transaction disrupts current plans and operations of Clover and potential difficulties in Clover employee retention as a result of the transaction, (ix) the outcome of any legal proceedings that may be instituted against Clover or against SCH related to the Merger Agreement or the transaction, (x) the ability to maintain the listing of SCHs securities on a national securities exchange, (xi) the price of SCHs securities may be volatile due to a variety of factors, including changes in the competitive and highly regulated industries in which SCH plans to operate or Clover operates, variations in operating performance across competitors, changes in laws and regulations affecting SCHs or Clovers business and changes in the combined capital structure, (xii) the ability to implement business plans, forecasts, and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities, and (xiii) the risk of downturns and a changing regulatory landscape in the highly competitive healthcare industry. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the Risk Factors section of the definitive proxy statement/prospectus discussed above and other documents filed by SCH from time to time with the U.S. Securities and Exchange Commission (the SEC). These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Clover and SCH assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither Clover nor SCH gives any assurance that either Clover or SCH, or the combined company, will achieve its expectations.

edtsum31

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: CINCINNATI--(BUSINESS WIRE)--More than 380,000 babies1 in 10are born preterm in the U.S.i and many of these littlest fighters require extra help from the start. In honor of World Prematurity Day, Pampers is partnering with March of Dimes to bring 40,000 books and educational resources to NICUs across the country, as part of its ongoing commitment to care for the happy, healthy development of every baby. As a continuation of the Pampers Bright Beginnings Reading initiative announced last month, Pampers will provide more than 65 March of Dimes NICU Family Support programs with books and helpful reading tips to bring awareness of the developmental benefits of reading to babies from the very beginning. Through their longstanding partnership, Pampers and March of Dimes will work together to reach more than 35,000 families annually. "March of Dimes NICU Family Support is thrilled to be partnering with Pampers Bright Beginnings to bring the joy of reading into NICUs across the nation," said Heather Reimer, Senior Director, NICU Initiatives, March of Dimes. "We know how vital early reading is for our littlest fighters, so being able to provide NICU babies and their families with a way to help create a moment of bonding and development is such a privilege. We look forward to continuing our longstanding partnership with Pampers and making a difference in the lives of thousands of families together." Studies show that infants admitted to the NICU are at an increased risk for neurodevelopmental deficits due to prematurity or illness, poor language exposure as well as impaired parent-infant bonding. Reading aloud to babies, beginning from birth, can mitigate this issue. Dr. Viral G Jain, MD, FAAP, a physician-scientist, neonatologist and Assistant Professor in Pediatrics at the University of Alabama at Birmingham, and a member of Pampers Bright Beginnings Advisory Council, recently conducted a large-scale studyii to support this notion. He found that when parents were shown by a healthcare professional how to read with their baby, it doubled the number of parents reading to their babies while in the NICU. Benefits were especially strong among parents who did not themselves enjoy reading aloud, who are at high risk for lower reading frequency and quality, and in turn lower language exposure. These parents were five times more likely to read in the NICU and three times more likely to continue reading aloud at home. These improvements in reading behaviors were likely mediated by reduced parental stress, enhanced bonding between parent and baby and positive parent-infant interactions. Reading to baby for even fifteen minutes a day can make a lasting impact on their brain development, especially during the first few months of life when babies are developing key areas of the brain, said Sarah Pasquinucci, Senior Communications Director, P&G North America Baby Care and mother of two. Reading to a baby from birth is not only vital to their development, but its also a meaningful activity that promotes quality time and bonding between baby and parent. Thats why were honored to be partnering with March of Dimes to bring books and educational resources directly to NICU families, so they can experience the joys of reading with baby from the very beginning. Pampers and March of Dimes continue to evolve their partnership to find new ways to support the healthy, happy development of babies. Earlier this year, March of Dimes assisted Pampers during the review process after Pampers announced it would be donating $400,000 in NICU Connectivity Grants to select hospitals throughout North America to help keep families connected when it matters most. Due to the COVID-19 pandemic, many hospitals were forced to restructure their family presence protocols, resulting in a reduction of in-person time for many families and their loved ones in the NICU. With the help of Pampers donation, select eligible hospitals across North America have been able to acquire the resources and capabilities they need to keep families and babies connected when it matters most. The addition of these resources, including technology like cameras and tablets, has allowed parents to talk, read, sing and stay connected to their baby every day, even when they cannot be physically together. The use of this technology has made a world of difference for our families who have had to be separated during this COVID pandemic, said Kristin Chipoco, Nurse Manager at White Plains Hospital, a selected grant recipient. During the height of the pandemic one of our babies was separated from both of their parents due to the parents testing positive for COVID. Over the course of the next two weeks these parents were able to see and interact with their babies using Facetime. In addition, the parents were able to virtually see and meet the nurses who were caring for their baby each and every day.This technology allowed a bond to grow and foster between both these parents and their babies and the nursing staff involved, even though the parents were never allowed to set foot in the NICU.This technology helped ease some of the fear and anxiety of these brand new parents who had a baby admitted to NICU during such an already stressful period. Pampers believes a babys earliest days are essential towards shaping a bright beginning and is committed to supporting their happy, healthy development from the start. Through the Bright Beginnings initiative, Pampers is proud to continue to serve babies and their families by removing barriers that hinder early success and development and enhancing access to tools and resources to ensure the success of generations to come. To learn more about Pampers Bright Beginnings and its upcoming initiatives or how you can get involved, please download the Pampers App or visit Pampers.com. About Bright Beginnings At Pampers, caring for babies is more than just our purpose, its in our DNA. We believe a babys earliest days are essential toward shaping a bright beginning, and are committed to supporting their happy, healthy development right from the start. Through the Pampers Bright Beginnings program, we serve babies and their families by removing barriers that hinder early success and development, and enhancing access to resources, tools and support. For more information on the Pampers Bright Beginnings program, visit Pampers.com About Pampers For more than 50 years, parents have trusted Pampers to care for their babies. Pampers is a part of The Procter & Gamble Company (NYSE:PG) and is the #1-selling diaper worldwide. Every day, more than 25 million babies in 100 countries around the world wear Pampers. Pampers offers a complete range of diapers, wipes and training pants designed to provide protection and comfort for every stage of babys development. Visit www.pampers.com to learn more about Pampers products, join the Pampers Club program, and find ideas and information to help you and your baby love the change together. About Procter & Gamble P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always, Ambi Pur, Ariel, Bounty, Charmin, Crest, Dawn, Downy, Fairy, Febreze, Gain, Gillette, Head & Shoulders, Lenor, Olay, Oral-B, Pampers, Pantene, SK-II, Tide, Vicks, and Whisper. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands. i March of Dimes Report Card marchofdimes.org/reportcard ii Jain et al. A city-wide structured book sharing program enhances reading behavior in high-risk NICU infants. EPAS2020. 2245.1 Answer:

Pampers Bright Beginnings Brings the Joy of Reading to NICUs Through a New Program with March of Dimes A fresh chapter in Pampers legacy of caring for premature infants, more than 40,000 books will be provided to March of Dimes NICU Family Support programs across the U.S.

CINCINNATI--(BUSINESS WIRE)--More than 380,000 babies1 in 10are born preterm in the U.S.i and many of these littlest fighters require extra help from the start. In honor of World Prematurity Day, Pampers is partnering with March of Dimes to bring 40,000 books and educational resources to NICUs across the country, as part of its ongoing commitment to care for the happy, healthy development of every baby. As a continuation of the Pampers Bright Beginnings Reading initiative announced last month, Pampers will provide more than 65 March of Dimes NICU Family Support programs with books and helpful reading tips to bring awareness of the developmental benefits of reading to babies from the very beginning. Through their longstanding partnership, Pampers and March of Dimes will work together to reach more than 35,000 families annually. "March of Dimes NICU Family Support is thrilled to be partnering with Pampers Bright Beginnings to bring the joy of reading into NICUs across the nation," said Heather Reimer, Senior Director, NICU Initiatives, March of Dimes. "We know how vital early reading is for our littlest fighters, so being able to provide NICU babies and their families with a way to help create a moment of bonding and development is such a privilege. We look forward to continuing our longstanding partnership with Pampers and making a difference in the lives of thousands of families together." Studies show that infants admitted to the NICU are at an increased risk for neurodevelopmental deficits due to prematurity or illness, poor language exposure as well as impaired parent-infant bonding. Reading aloud to babies, beginning from birth, can mitigate this issue. Dr. Viral G Jain, MD, FAAP, a physician-scientist, neonatologist and Assistant Professor in Pediatrics at the University of Alabama at Birmingham, and a member of Pampers Bright Beginnings Advisory Council, recently conducted a large-scale studyii to support this notion. He found that when parents were shown by a healthcare professional how to read with their baby, it doubled the number of parents reading to their babies while in the NICU. Benefits were especially strong among parents who did not themselves enjoy reading aloud, who are at high risk for lower reading frequency and quality, and in turn lower language exposure. These parents were five times more likely to read in the NICU and three times more likely to continue reading aloud at home. These improvements in reading behaviors were likely mediated by reduced parental stress, enhanced bonding between parent and baby and positive parent-infant interactions. Reading to baby for even fifteen minutes a day can make a lasting impact on their brain development, especially during the first few months of life when babies are developing key areas of the brain, said Sarah Pasquinucci, Senior Communications Director, P&G North America Baby Care and mother of two. Reading to a baby from birth is not only vital to their development, but its also a meaningful activity that promotes quality time and bonding between baby and parent. Thats why were honored to be partnering with March of Dimes to bring books and educational resources directly to NICU families, so they can experience the joys of reading with baby from the very beginning. Pampers and March of Dimes continue to evolve their partnership to find new ways to support the healthy, happy development of babies. Earlier this year, March of Dimes assisted Pampers during the review process after Pampers announced it would be donating $400,000 in NICU Connectivity Grants to select hospitals throughout North America to help keep families connected when it matters most. Due to the COVID-19 pandemic, many hospitals were forced to restructure their family presence protocols, resulting in a reduction of in-person time for many families and their loved ones in the NICU. With the help of Pampers donation, select eligible hospitals across North America have been able to acquire the resources and capabilities they need to keep families and babies connected when it matters most. The addition of these resources, including technology like cameras and tablets, has allowed parents to talk, read, sing and stay connected to their baby every day, even when they cannot be physically together. The use of this technology has made a world of difference for our families who have had to be separated during this COVID pandemic, said Kristin Chipoco, Nurse Manager at White Plains Hospital, a selected grant recipient. During the height of the pandemic one of our babies was separated from both of their parents due to the parents testing positive for COVID. Over the course of the next two weeks these parents were able to see and interact with their babies using Facetime. In addition, the parents were able to virtually see and meet the nurses who were caring for their baby each and every day.This technology allowed a bond to grow and foster between both these parents and their babies and the nursing staff involved, even though the parents were never allowed to set foot in the NICU.This technology helped ease some of the fear and anxiety of these brand new parents who had a baby admitted to NICU during such an already stressful period. Pampers believes a babys earliest days are essential towards shaping a bright beginning and is committed to supporting their happy, healthy development from the start. Through the Bright Beginnings initiative, Pampers is proud to continue to serve babies and their families by removing barriers that hinder early success and development and enhancing access to tools and resources to ensure the success of generations to come. To learn more about Pampers Bright Beginnings and its upcoming initiatives or how you can get involved, please download the Pampers App or visit Pampers.com. About Bright Beginnings At Pampers, caring for babies is more than just our purpose, its in our DNA. We believe a babys earliest days are essential toward shaping a bright beginning, and are committed to supporting their happy, healthy development right from the start. Through the Pampers Bright Beginnings program, we serve babies and their families by removing barriers that hinder early success and development, and enhancing access to resources, tools and support. For more information on the Pampers Bright Beginnings program, visit Pampers.com About Pampers For more than 50 years, parents have trusted Pampers to care for their babies. Pampers is a part of The Procter & Gamble Company (NYSE:PG) and is the #1-selling diaper worldwide. Every day, more than 25 million babies in 100 countries around the world wear Pampers. Pampers offers a complete range of diapers, wipes and training pants designed to provide protection and comfort for every stage of babys development. Visit www.pampers.com to learn more about Pampers products, join the Pampers Club program, and find ideas and information to help you and your baby love the change together. About Procter & Gamble P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always, Ambi Pur, Ariel, Bounty, Charmin, Crest, Dawn, Downy, Fairy, Febreze, Gain, Gillette, Head & Shoulders, Lenor, Olay, Oral-B, Pampers, Pantene, SK-II, Tide, Vicks, and Whisper. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands. i March of Dimes Report Card marchofdimes.org/reportcard ii Jain et al. A city-wide structured book sharing program enhances reading behavior in high-risk NICU infants. EPAS2020. 2245.1

edtsum33

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON--(BUSINESS WIRE)--Technavio has been monitoring the automotive digital key market and it is poised to grow by 1.45 mn units during 2020-2024, progressing at a CAGR of over 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts Frequently Asked Questions: The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. BMW AG, Continental AG, Daimler AG, DENSO Corp., Hyundai Motor Co., Robert Bosch GmbH, Samsung Electronics Co. Ltd., Tesla Inc., Valeo SA, and Volkswagen AG are some of the major market participants. The vulnerability in existing keyless entry systems will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Automotive Digital Key Market 2020-2024: Segmentation Automotive Digital Key Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43684 Automotive Digital Key Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The automotive digital key market report covers the following areas: This study identifies demand for car-sharing and car rental services as one of the prime reasons driving the automotive digital key market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Automotive Digital Key Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Answer:

Automotive Digital Key Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Vulnerability In Existing Keyless Entry Systems to Boost the Market Growth | Technavio

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the automotive digital key market and it is poised to grow by 1.45 mn units during 2020-2024, progressing at a CAGR of over 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts Frequently Asked Questions: The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. BMW AG, Continental AG, Daimler AG, DENSO Corp., Hyundai Motor Co., Robert Bosch GmbH, Samsung Electronics Co. Ltd., Tesla Inc., Valeo SA, and Volkswagen AG are some of the major market participants. The vulnerability in existing keyless entry systems will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Automotive Digital Key Market 2020-2024: Segmentation Automotive Digital Key Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43684 Automotive Digital Key Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The automotive digital key market report covers the following areas: This study identifies demand for car-sharing and car rental services as one of the prime reasons driving the automotive digital key market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Automotive Digital Key Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

edtsum35

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK--(BUSINESS WIRE)--Awarding winning shareholder rights law firm Labaton Sucahrow reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation filed on behalf of investors who purchased or otherwise acquired common stock of Splunk Inc. ("Splunk" or the "Company") (NASDAQ: SPLK) between October 21, 2020 and December 2, 2020, inclusive (the "Class Period"). If you purchased or otherwise acquired Splunk common stock or options during the Class Period, you may move the Court for appointment as lead plaintiff by no later than February 2, 2021. Splunk investors who wish to learn more about the litigation and/or how to seek appointment as lead plaintiff should contact David J. Schwartz of Labaton Sucharow using the toll-free number (800) 321-0476 or via email at dschwartz@labaton.com Background on the Splunk Securities Class Litigation Splunk, incorporated in Delaware and headquartered in San Francisco, California, is a software company specializing in web-based products for searching, monitoring, and analyzing machine-generated data at an organizational level. The action alleges that, during the Class Period, defendants misrepresented and/or failed to disclose that: (1) Splunk was failing to close deals with most of its biggest customers in the fiscal third quarter 2021; (2) Splunk was not achieving the financial targets it had previously announced; and (3) as a result, defendants' public statements were at all relevant times materially false and misleading. On December 2, 2020, after markets closed, Splunk announced disappointing results for the fiscal third quarter 2021, including a decrease of approximately 11% in total revenues, missing analyst estimates by almost $60 million. On the subsequent earnings call, Company executives disclosed for the first time that Splunk had failed to close most of its largest deals during the quarter. On this news, the price of Splunk stock dropped $47.88 per share, or 23.25%, from its closing price of $205.91 on December 2, 2020, to close at $158.03 per share on December 3, 2020, on extremely heavy trading volume. About the Firm Labaton Sucharow LLP is one of the worlds leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at http://www.labaton.com. Answer:

IMPORTANT FILING DEADLINE: February 2, 2021 Important Filing Deadline in Splunk Investor Class Action - Contact Labaton Sucharow LLP

NEW YORK--(BUSINESS WIRE)--Awarding winning shareholder rights law firm Labaton Sucahrow reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation filed on behalf of investors who purchased or otherwise acquired common stock of Splunk Inc. ("Splunk" or the "Company") (NASDAQ: SPLK) between October 21, 2020 and December 2, 2020, inclusive (the "Class Period"). If you purchased or otherwise acquired Splunk common stock or options during the Class Period, you may move the Court for appointment as lead plaintiff by no later than February 2, 2021. Splunk investors who wish to learn more about the litigation and/or how to seek appointment as lead plaintiff should contact David J. Schwartz of Labaton Sucharow using the toll-free number (800) 321-0476 or via email at dschwartz@labaton.com Background on the Splunk Securities Class Litigation Splunk, incorporated in Delaware and headquartered in San Francisco, California, is a software company specializing in web-based products for searching, monitoring, and analyzing machine-generated data at an organizational level. The action alleges that, during the Class Period, defendants misrepresented and/or failed to disclose that: (1) Splunk was failing to close deals with most of its biggest customers in the fiscal third quarter 2021; (2) Splunk was not achieving the financial targets it had previously announced; and (3) as a result, defendants' public statements were at all relevant times materially false and misleading. On December 2, 2020, after markets closed, Splunk announced disappointing results for the fiscal third quarter 2021, including a decrease of approximately 11% in total revenues, missing analyst estimates by almost $60 million. On the subsequent earnings call, Company executives disclosed for the first time that Splunk had failed to close most of its largest deals during the quarter. On this news, the price of Splunk stock dropped $47.88 per share, or 23.25%, from its closing price of $205.91 on December 2, 2020, to close at $158.03 per share on December 3, 2020, on extremely heavy trading volume. About the Firm Labaton Sucharow LLP is one of the worlds leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at http://www.labaton.com.

edtsum37

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Honeycomb Core Materials - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Honeycomb Core Materials market accounted for $2.22 billion in 2019 and is expected to reach $5.19 billion by 2027 growing at a CAGR of 11.2% during the forecast period. Increasing demand for lightweight materials for fuel efficiency is driving the growth of the market. However, significant cost of the products is likely to inhibit market growth. Honeycomb core are used to manufacture composite sandwich structures. It provides stiffness to the structure with minimal weight gain. Honeycombs utilize far less material than a solid panel but still provide exceptional strength, making it a highly economical option for many applications. In addition, the strength of the honeycomb increases with its thickness, meaning it is well suited to structures needing considerable core materials. Lightweight honeycomb solutions are used in a wide range of industries, including the aerospace, marine, military, construction and automotive markets. Based on the product type, the nomex segment is estimated to have a lucrative growth due to its outstanding strength-to-weight ratio. The rigid and thin Nomex sheet structures are used to build sturdy yet lightweight honeycomb sandwich composite panels. These panels are used in aircraft parts such as flooring panels, internal walls, engine nacelles, helicopter blades, and tail booms. Nomex honeycomb composites are also used in the manufacture of boats to help provide buoyancy that enhances speed. By geography, North America is going to have a lucrative growth during the forecast period due to the high demand from aerospace & defense and marine industries. Companies Mentioned What the report offers: Key Topics Covered: 1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Product Analysis 3.7 Application Analysis 3.8 End User Analysis 3.9 Emerging Markets 3.10 Impact of Covid-19 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Honeycomb Core Materials Market, By Product Type 5.1 Introduction 5.2 Paper 5.3 Fiberglass 5.4 Nomex 5.5 Thermoplastics 5.6 Aluminum 5.7 Kevlar 5.8 Aramid Fiber 5.9 Other Product Types 5.9.1 Polypropylene 5.9.2 Stainless Steel 5.9.3 Carbon 6 Global Honeycomb Core Materials Market, By Application 6.1 Introduction 6.2 Composite 6.3 Non-composite 7 Global Honeycomb Core Materials Market, By End User 7.1 Introduction 7.2 Defense 7.3 Marine 7.4 Aerospace 7.5 Packaging 7.6 Automotive & Transportation 7.7 Automobiles 7.8 Other End Users 7.8.1 Furniture 7.8.2 Building & Construction 7.8.3 Sporting Goods 7.8.4 Industrial 8 Global Honeycomb Core Materials Market, By Geography 8.1 Introduction 8.2 North America 8.2.1 US 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 UK 8.3.3 Italy 8.3.4 France 8.3.5 Spain 8.3.6 Rest of Europe 8.4 Asia Pacific 8.4.1 Japan 8.4.2 China 8.4.3 India 8.4.4 Australia 8.4.5 New Zealand 8.4.6 South Korea 8.4.7 Rest of Asia Pacific 8.5 South America 8.5.1 Argentina 8.5.2 Brazil 8.5.3 Chile 8.5.4 Rest of South America 8.6 Middle East & Africa 8.6.1 Saudi Arabia 8.6.2 UAE 8.6.3 Qatar 8.6.4 South Africa 8.6.5 Rest of Middle East & Africa 9 Key Developments 9.1 Agreements, Partnerships, Collaborations and Joint Ventures 9.2 Acquisitions & Mergers 9.3 New Product Launch 9.4 Expansions 9.5 Other Key Strategies 10 Company Profiling 10.1 Koninklijke Ten Cate BV 10.2 Tubus Baer GmbH 10.3 Packaging Corporation of America 10.4 Argosy International 10.5 Axxion Group 10.6 The Gill Corporation 10.7 Corinth Group 10.8 Samia Canada 10.9 Dufaylite Developments 10.10 Thermhex Waben GmbH 10.11 Euro-Composites 10.12 Hexcel Corporation 10.13 Grigeo 10.14 Honeycomb Cellpack 10.15 Thermhex Waben GmbH 10.16 Honicel For more information about this report visit https://www.researchandmarkets.com/r/eg98g9. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Answer:

Global Honeycomb Core Materials Market Outlook to 2027 - Strategic Recommendations for New Entrants - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Honeycomb Core Materials - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Honeycomb Core Materials market accounted for $2.22 billion in 2019 and is expected to reach $5.19 billion by 2027 growing at a CAGR of 11.2% during the forecast period. Increasing demand for lightweight materials for fuel efficiency is driving the growth of the market. However, significant cost of the products is likely to inhibit market growth. Honeycomb core are used to manufacture composite sandwich structures. It provides stiffness to the structure with minimal weight gain. Honeycombs utilize far less material than a solid panel but still provide exceptional strength, making it a highly economical option for many applications. In addition, the strength of the honeycomb increases with its thickness, meaning it is well suited to structures needing considerable core materials. Lightweight honeycomb solutions are used in a wide range of industries, including the aerospace, marine, military, construction and automotive markets. Based on the product type, the nomex segment is estimated to have a lucrative growth due to its outstanding strength-to-weight ratio. The rigid and thin Nomex sheet structures are used to build sturdy yet lightweight honeycomb sandwich composite panels. These panels are used in aircraft parts such as flooring panels, internal walls, engine nacelles, helicopter blades, and tail booms. Nomex honeycomb composites are also used in the manufacture of boats to help provide buoyancy that enhances speed. By geography, North America is going to have a lucrative growth during the forecast period due to the high demand from aerospace & defense and marine industries. Companies Mentioned What the report offers: Key Topics Covered: 1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Product Analysis 3.7 Application Analysis 3.8 End User Analysis 3.9 Emerging Markets 3.10 Impact of Covid-19 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Honeycomb Core Materials Market, By Product Type 5.1 Introduction 5.2 Paper 5.3 Fiberglass 5.4 Nomex 5.5 Thermoplastics 5.6 Aluminum 5.7 Kevlar 5.8 Aramid Fiber 5.9 Other Product Types 5.9.1 Polypropylene 5.9.2 Stainless Steel 5.9.3 Carbon 6 Global Honeycomb Core Materials Market, By Application 6.1 Introduction 6.2 Composite 6.3 Non-composite 7 Global Honeycomb Core Materials Market, By End User 7.1 Introduction 7.2 Defense 7.3 Marine 7.4 Aerospace 7.5 Packaging 7.6 Automotive & Transportation 7.7 Automobiles 7.8 Other End Users 7.8.1 Furniture 7.8.2 Building & Construction 7.8.3 Sporting Goods 7.8.4 Industrial 8 Global Honeycomb Core Materials Market, By Geography 8.1 Introduction 8.2 North America 8.2.1 US 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 UK 8.3.3 Italy 8.3.4 France 8.3.5 Spain 8.3.6 Rest of Europe 8.4 Asia Pacific 8.4.1 Japan 8.4.2 China 8.4.3 India 8.4.4 Australia 8.4.5 New Zealand 8.4.6 South Korea 8.4.7 Rest of Asia Pacific 8.5 South America 8.5.1 Argentina 8.5.2 Brazil 8.5.3 Chile 8.5.4 Rest of South America 8.6 Middle East & Africa 8.6.1 Saudi Arabia 8.6.2 UAE 8.6.3 Qatar 8.6.4 South Africa 8.6.5 Rest of Middle East & Africa 9 Key Developments 9.1 Agreements, Partnerships, Collaborations and Joint Ventures 9.2 Acquisitions & Mergers 9.3 New Product Launch 9.4 Expansions 9.5 Other Key Strategies 10 Company Profiling 10.1 Koninklijke Ten Cate BV 10.2 Tubus Baer GmbH 10.3 Packaging Corporation of America 10.4 Argosy International 10.5 Axxion Group 10.6 The Gill Corporation 10.7 Corinth Group 10.8 Samia Canada 10.9 Dufaylite Developments 10.10 Thermhex Waben GmbH 10.11 Euro-Composites 10.12 Hexcel Corporation 10.13 Grigeo 10.14 Honeycomb Cellpack 10.15 Thermhex Waben GmbH 10.16 Honicel For more information about this report visit https://www.researchandmarkets.com/r/eg98g9. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

edtsum41

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ANAHEIM, Calif.--(BUSINESS WIRE)--EACO Corporation (OTCQB:EACO) today reported the results for three months ended November 30, 2020. Net sales, net income and earnings per share were as follows for the three months ended November 30, 2020 (dollars in thousands, except per share information): Three Months Ended November 30, % 2020 2019 Change (unaudited) (unaudited) Net sales $53,403 $56,040 (4.7)% Net income $851 $1,917 (55.6)% Basic and diluted earnings per common share $0.17 $0.39 (56.4)% The Company had 373 sales employees at November 30, 2020, an increase of 24 or 6.4% from the prior year quarter. The Companys sales force is divided into Sales focus teams (SFTs). The Company had 101 SFTs as of November 30, 2020, an increase of 2 from the prior year quarter. Management anticipates continued growth in both our headcount and SFTs in fiscal year 2021. The Company believes it continues to gain market share through its local presence business model. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in this news release that are not entirely historical and factual in nature, including without limitation, statements related to our headcount expansion and future growth are forward-looking statements. These forward-looking statements are based on our current expectations and are inherently subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. The potential risks and uncertainties include, but are not limited to, our ability to hire and retain additional qualified employees, our ability to open additional sales offices, and to gain market acceptance for our products, the pricing and availability of our products, the success of our sales and marketing programs, the impact of products offered by our competitors from time to time, and the impact of the Covid-19 pandemic. In addition to these factors and any other factors mentioned elsewhere in this news release, the reader should refer as well to the factors, uncertainties or risks identified in EACOs most recent Form 10-K and all subsequent Form 10-Q reports filed by us with the SEC. The forward-looking statements included in this release speak only as of the date hereof, and EACO does not undertake any obligation to update these forward-looking statements to reflect subsequent events or circumstances. EACO Corporation and Subsidiaries Condensed Consolidated Balance Sheets (in thousands, except share information) (unaudited) November 30, August 31, 2020 2020* ASSETS Current Assets: Cash and cash equivalents $ 6,665 $ 6,079 Restricted cash 3,202 2,916 Trade accounts receivable, net 28,033 29,667 Inventory, net 39,616 39,545 Marketable securities, trading 791 1,368 Prepaid expenses and other current assets 4,388 5,094 Total current assets 82,695 84,669 Non-current Assets: Property, equipment and leasehold improvements, net 8,650 8,848 Other assets: Operating lease right-of-use assets 12,393 12,810 Other assets, net 1,414 1,424 Total assets $ 105,152 $ 107,751 LIABILITIES AND SHAREHOLDERS EQUITY Current Liabilities: Trade accounts payable $ 16,334 $ 16,535 Accrued expenses and other current liabilities 5,909 6,632 Liability for short sales of trading securities 3,202 2,916 Current portion of operating lease liabilities 2,585 2,653 Current portion of long-term debt 2,939 5,100 Total current liabilities 30,969 33,836 Non-current Liabilities: Long-term debt 4,781 4,807 Operating lease liabilities 9,833 10,289 Total liabilities 45,583 48,932 Commitments and Contingencies Shareholders Equity: Convertible preferred stock, $0.01 par value per share; 10,000,000 shares authorized; 36,000 shares outstanding (liquidation value $900) 1 1 Common stock, $0.01 par value per share; 8,000,000 shares authorized; 4,861,590 shares outstanding 49 49 Additional paid-in capital 12,378 12,378 Accumulated other comprehensive income 706 788 Retained earnings 46,435 45,603 Total shareholders equity 59,569 58,819 Total liabilities and shareholders equity $ 105,152 $ 107,751 * Derived from the Companys audited financial statements included in its Form 10-K for the year ended August 31, 2020 filed with the U.S. Securities and Exchange Commission on November 30, 2020. Condensed Consolidated Statements of Income (in thousands, except for share and per share information) (unaudited) Three Months Ended November 30, 2020 2019 Net sales $ 53,403 $ 56,040 Cost of sales 38,951 40,144 Gross margin 14,452 15,896 Operating expenses: Selling, general and administrative expenses 12,681 12,602 Income from operations 1,771 3,294 Other (expense): Net loss on trading securities (553) (80) Loss on sale of real property (102) Interest and other expense, net (69) (119) Other (expense), net (622) (301) Income before income taxes 1,149 2,993 Provision for income taxes 298 1,076 Net income 851 1,917 Cumulative preferred stock dividend (19) (19) Net income attributable to common shareholders $ 832 $ 1,898 Basic and diluted earnings per common share: $ 0.17 $ 0.39 Basic and diluted weighted average common shares outstanding 4,861,590 4,861,590 EACO Corporation and Subsidiaries Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited) Three Months Ended November 30, 2020 2019 Operating activities: Net income $ 851 $ 1,917 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization 377 259 Bad debt expense 3 Loss on sale of property 102 Net loss on trading securities 553 80 (Increase) decrease in: Trade accounts receivable 1,634 2,175 Inventory (71) (2,472) Prepaid expenses and other assets 716 (729) Operating lease right-of-use assets 417 Increase (decrease) in: Trade accounts payable 666 (2,266) Accrued expenses and other current liabilities (723) (737) Operating lease liabilities (524) Net cash provided by (used in) operating activities 3,896 (1,668) Investing activities: Additions to property, equipment, and leasehold improvements (179) (2,393) Proceeds from sale of property 7,075 Sale of marketable securities, trading 24 1,388 Net change in liabilities for short sales of trading securities 286 2,167 Net cash provided by investing activities 131 8,237 Financing activities: (Payments) borrowings on revolving credit facility, net (2,187) 513 Borrowings on Construction Loan 1,701 Repayments on long-term debt (5,125) Preferred stock dividend (19) (19) Bank overdraft (867) 104 Net cash used in financing activities (3,073) (2,826) Effect of foreign currency exchange rate changes on cash and cash equivalents (82) (212) Net increase in cash, cash equivalents, and restricted cash 872 3,531 Cash, cash equivalents, and restricted cash - beginning of period 8,995 5,347 Cash, cash equivalents, and restricted cash - end of period $ 9,867 $ 8,878 Supplemental disclosures of cash flow information: Cash paid for interest $ 48 $ 122 Cash paid for income taxes $ $ Answer:

EACO Corporation Reports 1st Quarter Net Sales and Net Income

ANAHEIM, Calif.--(BUSINESS WIRE)--EACO Corporation (OTCQB:EACO) today reported the results for three months ended November 30, 2020. Net sales, net income and earnings per share were as follows for the three months ended November 30, 2020 (dollars in thousands, except per share information): Three Months Ended November 30, % 2020 2019 Change (unaudited) (unaudited) Net sales $53,403 $56,040 (4.7)% Net income $851 $1,917 (55.6)% Basic and diluted earnings per common share $0.17 $0.39 (56.4)% The Company had 373 sales employees at November 30, 2020, an increase of 24 or 6.4% from the prior year quarter. The Companys sales force is divided into Sales focus teams (SFTs). The Company had 101 SFTs as of November 30, 2020, an increase of 2 from the prior year quarter. Management anticipates continued growth in both our headcount and SFTs in fiscal year 2021. The Company believes it continues to gain market share through its local presence business model. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in this news release that are not entirely historical and factual in nature, including without limitation, statements related to our headcount expansion and future growth are forward-looking statements. These forward-looking statements are based on our current expectations and are inherently subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. The potential risks and uncertainties include, but are not limited to, our ability to hire and retain additional qualified employees, our ability to open additional sales offices, and to gain market acceptance for our products, the pricing and availability of our products, the success of our sales and marketing programs, the impact of products offered by our competitors from time to time, and the impact of the Covid-19 pandemic. In addition to these factors and any other factors mentioned elsewhere in this news release, the reader should refer as well to the factors, uncertainties or risks identified in EACOs most recent Form 10-K and all subsequent Form 10-Q reports filed by us with the SEC. The forward-looking statements included in this release speak only as of the date hereof, and EACO does not undertake any obligation to update these forward-looking statements to reflect subsequent events or circumstances. EACO Corporation and Subsidiaries Condensed Consolidated Balance Sheets (in thousands, except share information) (unaudited) November 30, August 31, 2020 2020* ASSETS Current Assets: Cash and cash equivalents $ 6,665 $ 6,079 Restricted cash 3,202 2,916 Trade accounts receivable, net 28,033 29,667 Inventory, net 39,616 39,545 Marketable securities, trading 791 1,368 Prepaid expenses and other current assets 4,388 5,094 Total current assets 82,695 84,669 Non-current Assets: Property, equipment and leasehold improvements, net 8,650 8,848 Other assets: Operating lease right-of-use assets 12,393 12,810 Other assets, net 1,414 1,424 Total assets $ 105,152 $ 107,751 LIABILITIES AND SHAREHOLDERS EQUITY Current Liabilities: Trade accounts payable $ 16,334 $ 16,535 Accrued expenses and other current liabilities 5,909 6,632 Liability for short sales of trading securities 3,202 2,916 Current portion of operating lease liabilities 2,585 2,653 Current portion of long-term debt 2,939 5,100 Total current liabilities 30,969 33,836 Non-current Liabilities: Long-term debt 4,781 4,807 Operating lease liabilities 9,833 10,289 Total liabilities 45,583 48,932 Commitments and Contingencies Shareholders Equity: Convertible preferred stock, $0.01 par value per share; 10,000,000 shares authorized; 36,000 shares outstanding (liquidation value $900) 1 1 Common stock, $0.01 par value per share; 8,000,000 shares authorized; 4,861,590 shares outstanding 49 49 Additional paid-in capital 12,378 12,378 Accumulated other comprehensive income 706 788 Retained earnings 46,435 45,603 Total shareholders equity 59,569 58,819 Total liabilities and shareholders equity $ 105,152 $ 107,751 * Derived from the Companys audited financial statements included in its Form 10-K for the year ended August 31, 2020 filed with the U.S. Securities and Exchange Commission on November 30, 2020. Condensed Consolidated Statements of Income (in thousands, except for share and per share information) (unaudited) Three Months Ended November 30, 2020 2019 Net sales $ 53,403 $ 56,040 Cost of sales 38,951 40,144 Gross margin 14,452 15,896 Operating expenses: Selling, general and administrative expenses 12,681 12,602 Income from operations 1,771 3,294 Other (expense): Net loss on trading securities (553) (80) Loss on sale of real property (102) Interest and other expense, net (69) (119) Other (expense), net (622) (301) Income before income taxes 1,149 2,993 Provision for income taxes 298 1,076 Net income 851 1,917 Cumulative preferred stock dividend (19) (19) Net income attributable to common shareholders $ 832 $ 1,898 Basic and diluted earnings per common share: $ 0.17 $ 0.39 Basic and diluted weighted average common shares outstanding 4,861,590 4,861,590 EACO Corporation and Subsidiaries Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited) Three Months Ended November 30, 2020 2019 Operating activities: Net income $ 851 $ 1,917 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization 377 259 Bad debt expense 3 Loss on sale of property 102 Net loss on trading securities 553 80 (Increase) decrease in: Trade accounts receivable 1,634 2,175 Inventory (71) (2,472) Prepaid expenses and other assets 716 (729) Operating lease right-of-use assets 417 Increase (decrease) in: Trade accounts payable 666 (2,266) Accrued expenses and other current liabilities (723) (737) Operating lease liabilities (524) Net cash provided by (used in) operating activities 3,896 (1,668) Investing activities: Additions to property, equipment, and leasehold improvements (179) (2,393) Proceeds from sale of property 7,075 Sale of marketable securities, trading 24 1,388 Net change in liabilities for short sales of trading securities 286 2,167 Net cash provided by investing activities 131 8,237 Financing activities: (Payments) borrowings on revolving credit facility, net (2,187) 513 Borrowings on Construction Loan 1,701 Repayments on long-term debt (5,125) Preferred stock dividend (19) (19) Bank overdraft (867) 104 Net cash used in financing activities (3,073) (2,826) Effect of foreign currency exchange rate changes on cash and cash equivalents (82) (212) Net increase in cash, cash equivalents, and restricted cash 872 3,531 Cash, cash equivalents, and restricted cash - beginning of period 8,995 5,347 Cash, cash equivalents, and restricted cash - end of period $ 9,867 $ 8,878 Supplemental disclosures of cash flow information: Cash paid for interest $ 48 $ 122 Cash paid for income taxes $ $

edtsum44

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WORCESTER, Mass., March 1, 2021 /PRNewswire/ --The Hanover Insurance Group, Inc. (NYSE: THG) today announced J. Paul Condrin III has been elected to the company's board of directors, effective Friday, Feb. 26. (PRNewsfoto/The Hanover Insurance Group, Inc.) Condrin is a seasoned executive with expansive knowledge of the property and casualty insurance industry, having served in various executive leadership roles at Liberty Mutual for nearly 30 years. Most recently, he served as executive vice president and president of commercial insurance, from 2012 until his retirement in 2018. In this capacity, he oversaw the company's $10 billion commercial operation and led transformational and profitable change in the organization. During his time at Liberty Mutual, Condrin also served as president and chief executive officer of Liberty Mutual Agency, president of commercial markets, president of personal markets, corporate chief financial officer and corporate comptroller. "Paul is a highly experienced, proven and respected industry leader with a deep understanding of our business and an impressive track record," said Cynthia L. Egan, chair of the board of directors at The Hanover. "We are delighted to welcome Paul to our board. We look forward to his active involvement and contributions as we continue to enhance our distinctive competitive position in our dynamic and rapidly changing business, delivering even greater value for our shareholders and other stakeholders." "We are thrilled to have Paul join our board," said John C. Roche, president and chief executive officer at The Hanover. "Paul is a very successful senior leader in our industry who brings valuable insight and perspective as we continue to navigate evolving market conditions and provide high-quality insurance solutions to our agent partners and customers."Condrin received a bachelor's degree from Bentley University and began his career as an auditor in KPMG's Boston office. He joined Bentley's board of trustees in 2013 and he currently serves as chair of that board, as well as interim president of the university. In addition, he serves as chair of the board of directors of Wide Horizons for Children, Inc., an international adoption and humanitarian aid organization. About The HanoverThe Hanover Insurance Group, Inc. is the holding company for several property and casualty insurance companies, which together constitute one of the largest insurance businesses in the United States. The company provides exceptional insurance solutions through a select group of independent agents and brokers. Together with its agent partners, The Hanover offers standard and specialized insurance protection for small and mid-sized businesses, as well as for homes, automobiles, and other personal items. For more information, please visithanover.com. CONTACTS: Investors: Media: Oksana Lukasheva Emily P. Trevallion Abby M. Clark [emailprotected] [emailprotected] [emailprotected] 508-525-6081 508-855-3263 508-855-3549 SOURCE The Hanover Insurance Group, Inc. Related Links www.hanover.com Answer:

The Hanover Insurance Group, Inc. Elects J. Paul Condrin III to Board of Directors

WORCESTER, Mass., March 1, 2021 /PRNewswire/ --The Hanover Insurance Group, Inc. (NYSE: THG) today announced J. Paul Condrin III has been elected to the company's board of directors, effective Friday, Feb. 26. (PRNewsfoto/The Hanover Insurance Group, Inc.) Condrin is a seasoned executive with expansive knowledge of the property and casualty insurance industry, having served in various executive leadership roles at Liberty Mutual for nearly 30 years. Most recently, he served as executive vice president and president of commercial insurance, from 2012 until his retirement in 2018. In this capacity, he oversaw the company's $10 billion commercial operation and led transformational and profitable change in the organization. During his time at Liberty Mutual, Condrin also served as president and chief executive officer of Liberty Mutual Agency, president of commercial markets, president of personal markets, corporate chief financial officer and corporate comptroller. "Paul is a highly experienced, proven and respected industry leader with a deep understanding of our business and an impressive track record," said Cynthia L. Egan, chair of the board of directors at The Hanover. "We are delighted to welcome Paul to our board. We look forward to his active involvement and contributions as we continue to enhance our distinctive competitive position in our dynamic and rapidly changing business, delivering even greater value for our shareholders and other stakeholders." "We are thrilled to have Paul join our board," said John C. Roche, president and chief executive officer at The Hanover. "Paul is a very successful senior leader in our industry who brings valuable insight and perspective as we continue to navigate evolving market conditions and provide high-quality insurance solutions to our agent partners and customers."Condrin received a bachelor's degree from Bentley University and began his career as an auditor in KPMG's Boston office. He joined Bentley's board of trustees in 2013 and he currently serves as chair of that board, as well as interim president of the university. In addition, he serves as chair of the board of directors of Wide Horizons for Children, Inc., an international adoption and humanitarian aid organization. About The HanoverThe Hanover Insurance Group, Inc. is the holding company for several property and casualty insurance companies, which together constitute one of the largest insurance businesses in the United States. The company provides exceptional insurance solutions through a select group of independent agents and brokers. Together with its agent partners, The Hanover offers standard and specialized insurance protection for small and mid-sized businesses, as well as for homes, automobiles, and other personal items. For more information, please visithanover.com. CONTACTS: Investors: Media: Oksana Lukasheva Emily P. Trevallion Abby M. Clark [emailprotected] [emailprotected] [emailprotected] 508-525-6081 508-855-3263 508-855-3549 SOURCE The Hanover Insurance Group, Inc. Related Links www.hanover.com

edtsum49

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced the pricing of the underwritten public offering of 2,197,803 of its ordinary shares for gross proceeds of approximately $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Galmed. The offering is expected to close on or about February 18, 2021, subject to customary closing conditions. In addition, Galmed has granted the underwriter for the offering, a 30-day option to purchase up to an additional 329,670 of its ordinary shares. Cantor Fitzgerald & Co. is acting as the sole book-running manager of the offering. The underwriter may offer the shares from time to time for sale in one or more transactions on the Nasdaq Capital Market, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. On February 12, 2021, the last sale price of the shares as reported on the Nasdaq Capital Market was $5.03 per share. During February 2021, Galmed sold approximately $8.4 million in ordinary shares under its at-the-market equity offering. Galmed intends to use the net proceeds of this offering and that of its at-the-market offering for continued development of its pipeline products, as well as the advancement of new programs, business development activities, and general corporate purposes. The offering is being made pursuant to a "shelf" registration statement on Form F-3 (File No. 333-223923) previously filed by Galmed with the Securities and Exchange Commission (the "SEC") on March 26, 2018 and declared effective by the SEC on April 2, 2018. The offering is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A preliminary prospectus supplement describing the terms of the offering and the accompanying prospectus have been filed with the SEC. Before you invest, you should read the registration statement, the preliminary prospectus, the documents that Galmed has filed with the SEC that are incorporated by reference into the registration statement, and the other documents Galmed has filed with the SEC for more complete information about Galmed and the offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the final prospectus and the accompanying prospectus relating to the offering can be obtained, when available, from Cantor Fitzgerald & Co., Attn: Capital Markets, 499 Park Avenue, 6th floor, New York, NY 10022; Email: [emailprotected]. The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study during the first quarter of 2021. Forward-Looking Statements This press release may include forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to Galmed's objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that Galmed intends, expects, projects, believes or anticipates will or may occur in the future, including statements relating to the offering, including as to the consummation of the offering described above, the expected proceeds from the offering, the intended use of proceeds and the timing of the closing of the offering. These statements are often characterized by terminology such as "believes," "hopes," "may," "anticipates," "should," "intends," "plans," "will," "expects," "estimates," "projects," "positioned," "strategy" and similar expressions and are based on assumptions and assessments made in light of management's experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Many factors could cause Galmed's actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the following: market and other conditions; the timing and cost of Galmed's pivotal Phase 3 ARMOR trial, or the ARMOR Study or any other pre-clinical or clinical trials; completion and receiving favorable results of the ARMOR Study for Aramchol or any other pre-clinical or clinical trial; the impact of the COVID-19 pandemic; regulatory action with respect to Aramchol or any other product candidate by the FDA or the EMA; the commercial launch and future sales of Aramchol or any other future products or product candidates; Galmed's ability to comply with all applicable post-market regulatory requirements for Aramchol or any other product candidate in the countries in which it seeks to market the product; Galmed's ability to achieve favorable pricing for Aramchol or any other product candidate; Galmed's expectations regarding the commercial market for NASH patients or any other indication; third-party payor reimbursement for Aramchol or any other product candidate; Galmed's estimates regarding anticipated capital requirements and Galmed's needs for additional financing; market adoption of Aramchol or any other product candidate by physicians and patients; the timing, cost or other aspects of the commercial launch of Aramchol or any other product candidate; the development and approval of the use of Aramchol or any other product candidate for additional indications or in combination therapy; and Galmed's expectations regarding licensing, acquisitions and strategic operations. More detailed information about the risks and uncertainties affecting Galmed is contained under the heading "Risk Factors" included in Galmed's most recent Annual Report on Form 20-F filed with the SEC on March 12, 2020, the Preliminary Prospectus filed with the SEC on February 16, 2021, the Report on Form 6-K filed with the SEC on February 16, 2021 and in other filings that Galmed has made and may make with the SEC in the future. The forward-looking statements contained in this press release are made as of the date of this press release and reflect Galmed's current views with respect to future events, and Galmed does not undertake and specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. SOURCE Galmed Pharmaceuticals Ltd. Answer:

Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares USA - English USA - English

TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced the pricing of the underwritten public offering of 2,197,803 of its ordinary shares for gross proceeds of approximately $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Galmed. The offering is expected to close on or about February 18, 2021, subject to customary closing conditions. In addition, Galmed has granted the underwriter for the offering, a 30-day option to purchase up to an additional 329,670 of its ordinary shares. Cantor Fitzgerald & Co. is acting as the sole book-running manager of the offering. The underwriter may offer the shares from time to time for sale in one or more transactions on the Nasdaq Capital Market, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. On February 12, 2021, the last sale price of the shares as reported on the Nasdaq Capital Market was $5.03 per share. During February 2021, Galmed sold approximately $8.4 million in ordinary shares under its at-the-market equity offering. Galmed intends to use the net proceeds of this offering and that of its at-the-market offering for continued development of its pipeline products, as well as the advancement of new programs, business development activities, and general corporate purposes. The offering is being made pursuant to a "shelf" registration statement on Form F-3 (File No. 333-223923) previously filed by Galmed with the Securities and Exchange Commission (the "SEC") on March 26, 2018 and declared effective by the SEC on April 2, 2018. The offering is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A preliminary prospectus supplement describing the terms of the offering and the accompanying prospectus have been filed with the SEC. Before you invest, you should read the registration statement, the preliminary prospectus, the documents that Galmed has filed with the SEC that are incorporated by reference into the registration statement, and the other documents Galmed has filed with the SEC for more complete information about Galmed and the offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the final prospectus and the accompanying prospectus relating to the offering can be obtained, when available, from Cantor Fitzgerald & Co., Attn: Capital Markets, 499 Park Avenue, 6th floor, New York, NY 10022; Email: [emailprotected]. The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study during the first quarter of 2021. Forward-Looking Statements This press release may include forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to Galmed's objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that Galmed intends, expects, projects, believes or anticipates will or may occur in the future, including statements relating to the offering, including as to the consummation of the offering described above, the expected proceeds from the offering, the intended use of proceeds and the timing of the closing of the offering. These statements are often characterized by terminology such as "believes," "hopes," "may," "anticipates," "should," "intends," "plans," "will," "expects," "estimates," "projects," "positioned," "strategy" and similar expressions and are based on assumptions and assessments made in light of management's experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Many factors could cause Galmed's actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the following: market and other conditions; the timing and cost of Galmed's pivotal Phase 3 ARMOR trial, or the ARMOR Study or any other pre-clinical or clinical trials; completion and receiving favorable results of the ARMOR Study for Aramchol or any other pre-clinical or clinical trial; the impact of the COVID-19 pandemic; regulatory action with respect to Aramchol or any other product candidate by the FDA or the EMA; the commercial launch and future sales of Aramchol or any other future products or product candidates; Galmed's ability to comply with all applicable post-market regulatory requirements for Aramchol or any other product candidate in the countries in which it seeks to market the product; Galmed's ability to achieve favorable pricing for Aramchol or any other product candidate; Galmed's expectations regarding the commercial market for NASH patients or any other indication; third-party payor reimbursement for Aramchol or any other product candidate; Galmed's estimates regarding anticipated capital requirements and Galmed's needs for additional financing; market adoption of Aramchol or any other product candidate by physicians and patients; the timing, cost or other aspects of the commercial launch of Aramchol or any other product candidate; the development and approval of the use of Aramchol or any other product candidate for additional indications or in combination therapy; and Galmed's expectations regarding licensing, acquisitions and strategic operations. More detailed information about the risks and uncertainties affecting Galmed is contained under the heading "Risk Factors" included in Galmed's most recent Annual Report on Form 20-F filed with the SEC on March 12, 2020, the Preliminary Prospectus filed with the SEC on February 16, 2021, the Report on Form 6-K filed with the SEC on February 16, 2021 and in other filings that Galmed has made and may make with the SEC in the future. The forward-looking statements contained in this press release are made as of the date of this press release and reflect Galmed's current views with respect to future events, and Galmed does not undertake and specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. SOURCE Galmed Pharmaceuticals Ltd.

edtsum51

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN MATEO, Calif.--(BUSINESS WIRE)--Roblox, a global online platform bringing millions of people together through play, announced today the acquisition of Loom.ai, a privately-held company specializing in real-time facial animation technology for 3D avatars, using deep learning, computer vision, and VFX. We believe as people share experiences virtually, their avatars should have the ability to express a full range of emotions, said David Baszucki, CEO of Roblox. Loom.ai will accelerate making human co-experiences more immersive and personal, adding world-class facial animation technology as part of Robloxs efforts to provide expressive emotive actions to avatars that will enable deeper connections for our community. With the team and technology behind Loom.ai, Roblox will accelerate the development of next-generation avatars. Loom.ais technology enables immersive social experiences, allowing players to show their emotions and facial expressions in life-like ways. Roblox players can imagine watching their favorite music artist singing with facial expressions during a virtual concert or communicating with friends in a life-like, interactive way when playing together on the platform. From our very first meeting with David Baszucki, it was clear we share a vision where art and engineering meet to create an exciting range of personalized avatars and characters, said Kiran Bhat, co-founder of Loom.ai. We will continue our work on that vision to bring real-time and real-life emotions to every Roblox avatar. Were thrilled to join forces with Roblox to bring real-time facial expressions to the 36 million Roblox avatars playing every day in the metaverse, said Mahesh Ramasubramanian, co-founder of Loom.ai. Roblox has created an incredible community, and we see a perfect fit for Loom.ais advanced 3D avatar technologies to bring shared experiences to the next level. About Roblox Robloxs mission is to build a human co-experience platform that enables shared experiences among billions of users. Every day, more than 36 million people around the world have fun with friends as they explore millions of immersive digital experiences. All of these experiences are built by the Roblox community, made up of over five million creators. We believe in building a safe, civil, and diverse communityone that inspires and fosters creativity and positive relationships between people around the world. For more information, please visit corp.roblox.com. Answer:

Roblox Acquires Loom.ai, Accelerating Development of Avatar Realism and Emotions

SAN MATEO, Calif.--(BUSINESS WIRE)--Roblox, a global online platform bringing millions of people together through play, announced today the acquisition of Loom.ai, a privately-held company specializing in real-time facial animation technology for 3D avatars, using deep learning, computer vision, and VFX. We believe as people share experiences virtually, their avatars should have the ability to express a full range of emotions, said David Baszucki, CEO of Roblox. Loom.ai will accelerate making human co-experiences more immersive and personal, adding world-class facial animation technology as part of Robloxs efforts to provide expressive emotive actions to avatars that will enable deeper connections for our community. With the team and technology behind Loom.ai, Roblox will accelerate the development of next-generation avatars. Loom.ais technology enables immersive social experiences, allowing players to show their emotions and facial expressions in life-like ways. Roblox players can imagine watching their favorite music artist singing with facial expressions during a virtual concert or communicating with friends in a life-like, interactive way when playing together on the platform. From our very first meeting with David Baszucki, it was clear we share a vision where art and engineering meet to create an exciting range of personalized avatars and characters, said Kiran Bhat, co-founder of Loom.ai. We will continue our work on that vision to bring real-time and real-life emotions to every Roblox avatar. Were thrilled to join forces with Roblox to bring real-time facial expressions to the 36 million Roblox avatars playing every day in the metaverse, said Mahesh Ramasubramanian, co-founder of Loom.ai. Roblox has created an incredible community, and we see a perfect fit for Loom.ais advanced 3D avatar technologies to bring shared experiences to the next level. About Roblox Robloxs mission is to build a human co-experience platform that enables shared experiences among billions of users. Every day, more than 36 million people around the world have fun with friends as they explore millions of immersive digital experiences. All of these experiences are built by the Roblox community, made up of over five million creators. We believe in building a safe, civil, and diverse communityone that inspires and fosters creativity and positive relationships between people around the world. For more information, please visit corp.roblox.com.

edtsum56

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: MADRID, Nov. 16, 2020 /PRNewswire/ --Bitergia, the software development analytics company, announced today that it is proud that the open source GrimoireLab tool is now used in The Linux Foundation's new LFX Insights platform. LFX Insights is the largest platform to have ever been built on top of the GrimoireLab tool, highlighting the open source success story of GrimoireLab. GrimoireLab, as part of LFX Insights: Transfers 15+ years' experience with open source community metrics Serves 1,000+ enterprise companies Analyzes 69 Linux Foundation projects History of GrimoireLab Bitergia initially developed GrimoireLab to better serve customers with metric strategy because existing tools lacked critical features for analyzing open source communities. In 2017, Bitergia donated GrimoireLab to the newly formed Linux Foundation project: CHAOSS Community Health Analytics Open Source Software. From there, GrimoireLab grew brand recognition, adoption, and new contributors. "GrimoireLab's goal is to be the standard for open source community metrics." Bitergia CEO, Manrique Lopez. Other platforms built with GrimoireLab CROSSMINER is a European Commission funded research project to support the evidence-based selection of open source projects. Cauldron.io is a research project funded by the European Regional Development Fund and the Spanish State Research Agency to build a SaaS platform for users who want quick metrics about their open source communities. "Cauldron.io builds on GrimoireLab and is free for everyone to analyze open source communities," says Jesus M. Gonzalez-Barahona, Professor at the Universidad Rey Juan Carlos. "We tremendously improved the usability of GrimoireLab through Cauldron.io." Why GrimoireLab is popular GrimoireLab provides a holistic picture of an open source community by collecting data from 30+ different data sources, such as GitHub, GitLab, Discourse, mailing lists, Slack, Twitter and StackOverflow. A core feature of GrimoireLab allows connecting contributions to organizations and managing contributors' information who use different emails and usernames. These features make GrimoireLab the default option for open source community metrics. About Bitergia Bitergia is the market leader in open source community metrics and software development analytics with 15+ years' experience of helping companies and organizations to understand the software development projects that matter to them by developing effective metric strategies. Website: https://bitergia.com The Linux Foundation has registered trademarks that it uses, including CHAOSS and GrimoireLab. For a list of trademarks held by The Linux Foundation, please see its trademark usage page: www.linuxfoundation.org/trademark-usage. Media Contact Ana Jimenez SantamariaBitergia[emailprotected] SOURCE Bitergia Answer:

GrimoireLab grows up to power The Linux Foundation's LFX Insights platform USA - English France - Franais Deutschland - Deutsch

MADRID, Nov. 16, 2020 /PRNewswire/ --Bitergia, the software development analytics company, announced today that it is proud that the open source GrimoireLab tool is now used in The Linux Foundation's new LFX Insights platform. LFX Insights is the largest platform to have ever been built on top of the GrimoireLab tool, highlighting the open source success story of GrimoireLab. GrimoireLab, as part of LFX Insights: Transfers 15+ years' experience with open source community metrics Serves 1,000+ enterprise companies Analyzes 69 Linux Foundation projects History of GrimoireLab Bitergia initially developed GrimoireLab to better serve customers with metric strategy because existing tools lacked critical features for analyzing open source communities. In 2017, Bitergia donated GrimoireLab to the newly formed Linux Foundation project: CHAOSS Community Health Analytics Open Source Software. From there, GrimoireLab grew brand recognition, adoption, and new contributors. "GrimoireLab's goal is to be the standard for open source community metrics." Bitergia CEO, Manrique Lopez. Other platforms built with GrimoireLab CROSSMINER is a European Commission funded research project to support the evidence-based selection of open source projects. Cauldron.io is a research project funded by the European Regional Development Fund and the Spanish State Research Agency to build a SaaS platform for users who want quick metrics about their open source communities. "Cauldron.io builds on GrimoireLab and is free for everyone to analyze open source communities," says Jesus M. Gonzalez-Barahona, Professor at the Universidad Rey Juan Carlos. "We tremendously improved the usability of GrimoireLab through Cauldron.io." Why GrimoireLab is popular GrimoireLab provides a holistic picture of an open source community by collecting data from 30+ different data sources, such as GitHub, GitLab, Discourse, mailing lists, Slack, Twitter and StackOverflow. A core feature of GrimoireLab allows connecting contributions to organizations and managing contributors' information who use different emails and usernames. These features make GrimoireLab the default option for open source community metrics. About Bitergia Bitergia is the market leader in open source community metrics and software development analytics with 15+ years' experience of helping companies and organizations to understand the software development projects that matter to them by developing effective metric strategies. Website: https://bitergia.com The Linux Foundation has registered trademarks that it uses, including CHAOSS and GrimoireLab. For a list of trademarks held by The Linux Foundation, please see its trademark usage page: www.linuxfoundation.org/trademark-usage. Media Contact Ana Jimenez SantamariaBitergia[emailprotected] SOURCE Bitergia

edtsum59

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: CARLSBAD, Calif., Aug. 7, 2020 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) reported financial resultsfor the second quarter ended June 30, 2020. "The negative impact of the COVID-19 pandemic on our customers was abrupt and substantial, and it had a ripple-effect on our business. As a result, we took action to significantly reduce our operating costs," saidAllen Wolff, CEO. "We have been focused on cash management and exploring and evaluating strategic alternatives." Financial Results For the second quarter 2020, total revenues were $754,000, compared to $5.2 million for the second quarter of 2019. The decrease reflects reduced site count and the impact of the COVID-19 pandemic on the company's business as a substantial number of the bars and restaurants that subscribe to the company's network suspended their subscriptions for at least a portion of the current year period. Through corporate restructuring and cost reductions, second quarter 2020 operating expense decreased to $2.4 million, from $5.2 million for the second quarter of 2019. Second quarter 2020 net loss attributable to common shareholders was $2.0 million, including $100,000 in capitalized software impairments, or $0.69 per share, compared to $98,000, or $0.03 per share, for the prior year quarter. Liquidity Cash, cash equivalents and unrestricted cash was $2.2 million at June 30, 2020, compared to $2.2 million at March 31, 2020 and $3.2 million at December 31, 2019.In April 2020, the company received $1.6 million under the Paycheck Protection Program of the CARES Act. At June 30, 2020, the principal balance of the company's term loan with its primary lender was $1.6 million, and working capital was $894,000. For additional information regarding the company's liquidity and capital resources, please see the company's quarterly report on Form 10-Q expected to be filed with the SEC today. The company will not be hosting an earnings call for the recently completed quarter. The company's limited resources are being directed toward managing operations and liquidity in light of the substantial impact of the COVID-19 pandemic on its business and on exploring and evaluating strategic alternatives. No assurance are, or can be given, that a definitive agreement for a strategic transaction will result from the company's strategic process, or that even if such agreement is entered into, that the potential transaction will be consummated. Forward-looking StatementsThis release may contain forward-looking statements that reflect management's current views of future events and operations, including challenges that we and our customers will face related to the COVID-19 pandemic and the potential meaningfulness of our product platform to our customers as they or if they re-open their businesses. Among the factors that could cause or contribute to material differences between our actual results and the expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: (1) our ability to raise substantial capital in the very near-term to allow us to maintain operations and sustain the negative impact of the COVID-19 pandemic on our business and financial condition, and if we are able to sustain such impact, our ability to recover from the impact; (2) our ability to successfully manage our liquidity and our working capital deficit by managing the timing of payments to our third parties; (3) our ability to comply with our financial covenants in our loan and security agreement with Avidbank and its right to declare a default if we do not, which could lead to all payment obligations becoming immediately due and payable and which could lead to a foreclosure on our assets; (4) when, and the extent to which, the negative impact of the pandemic will improve, including when restaurants will be permitted to offer on-site dining or when bars will be permitted to re-open and to what degree, when our customers will re-open, or if they will subscribe to our service if and when they do; (5) the negative impact that measures we implemented and may implement to reduce our operating expenses and planned capital expenses (including investments in our business) may have on our ability to effectively manage and operate our business; (6) our ability to maintain or grow our revenue; (7) with respect to our strategic process, the risk that we may not enter into a definitive agreement for a potential transaction or, if we do, that the potential transaction will not be completed; (8) our ability to compete effectively within the highly competitive interactive games, entertainment and marketing services industries, including our ability to successfully commercially launch attractive product offerings, and the impact of new products and technological change, especially in the mobile and wireless markets, on our operations and competitiveness; (9) our ability to adequately protect our proprietary rights and intellectual property ; and (10) the other risks and uncertainties described in Part I, Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and described in other documents we filed or file from time to time with the Securities and Exchange Commission thereafter, including in our Current Reports on Form 8-K filed with the SEC on March 30, 2020 and April 21, 2020, and our Quarterly Reports on Form 10-Q for each of the quarters ended March 31, 2020 and June 30, 2020. Please see our filings with the SEC for information about these and other risks that may affect us. All forward-looking statements included in this release are based on information available to us on the date hereof. These statements speak only as of the date hereof and NTN Buzztime, Inc. does not undertake to publicly update or revise any of its forward-looking statements, even if experience or future changes show that the indicated results or events will not be realized. About Buzztime:Buzztime (NYSE American: NTN) delivers interactive entertainment and innovative technology that helps its customers acquire, engage and retain its patrons. Most frequently used in bars and restaurants in North America, the Buzztime tablets, mobile app and technology offer engaging solutions to establishments that have guests who experience dwell time, such as casinos, senior living, and more. Casual dining venues license Buzztime's customizable solution to differentiate themselves via competitive fun by offering guests trivia, card, sports and arcade games. Buzztime's platform creates connections among the players and venues and amplifies guests' positive experiences. Buzztime's in-venue TV network creates one of the largest digital out of home ad audiences in the US and Canada. Buzztime hardware solutions leverages the company's experience manufacturing durable tablets and charging systems, enabling a diverse group of businesses including corrections, point-of-sale and loyalty with product implementation. Buzztime games have also been recently licensed by other businesses serving other markets. For more information, please visithttp://www.buzztime.com. IR AGENCY CONTACT: Kirsten Chapman, LHA Investor Relations, [emailprotected] 415-433-3777 NTN BUZZTIME, INC. AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except par value amount) ASSETS June 30,2020 December 31,2019 Current Assets: (unaudited) Cash and cash equivalents $ 2,234 $ 3,209 Restricted cash 201 50 Accounts receivable, net 186 1,195 Site equipment to be installed 1,132 1,090 Prepaid expenses and other current assets 336 526 Total current assets 4,089 6,070 Restricted cash, long-term -- 150 Operating lease right-of-use assets 44 2,101 Fixed assets, net 928 2,822 Software development costs, net 1,515 1,915 Deferred costs 152 274 Goodwill -- 696 Other assets 62 97 Total assets $ 6,790 $ 14,125 LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities: Accounts payable $ 397 $ 835 Accrued compensation 116 588 Accrued expenses 385 490 Sales taxes payable -- 131 Income taxes payable 15 3 Current portion of long-term debt 1,620 2,739 Current portion of obligations under operating leases 28 409 Current portion of obligations under financing leases 24 21 Current portion of deferred revenue 377 460 Other current liabilities 233 419 Total current liabilities 3,195 6,095 Long-term debt 1,625 -- Obligations under operating leases 18 2,891 Obligations under financing leases 9 20 Deferred revenue 1 2 Other liabilities 11 26 Total liabilities 4,859 9,034 Commitments and contingencies Shareholders' equity: Series A 10% cumulative convertible preferred stock, $0.005 par value, $156 liquidation preference, 156 shares authorized; 156 shares issued and outstanding at June 30, 2020 and December 31, 2019 1 1 Common stock, $0.005 par value, 15,000 shares authorized at June 30, 2020 and December 31, 2019; 2,938 and 2,901 shares issued at June, 2020 and December 31, 2019, respectively 15 14 Treasury stock, at cost, 10 shares at June 30, 2020 and December 31, 2019 (456) (456) Additional paid-in capital 136,837 136,721 Accumulated deficit (134,706) (131,457) Accumulated other comprehensive income 240 268 Total shareholders' equity 1,931 5,091 Total liabilities and shareholders' equity $ 6,790 $ 14,125 NTN BUZZTIME, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) (In thousands, except per share data) Three months endedJune 30, Six months endedJune 30, 2020 2019 2020 2019 Revenues Subscription revenue $ 727 $ 3,800 $ 2,726 $ 7,633 Hardware revenue 26 595 42 800 Other revenue 1 831 380 1,625 Total revenues 754 5,226 3,148 10,058 Operating expenses: Direct operating costs (includes depreciation and amortization) 613 1,717 1,563 3,201 Selling, general and administrative 1,595 3,422 4,675 6,891 Impairment of capitalized software 100 -- 238 1 Impairment of goodwill -- -- 662 -- Depreciation and amortization (excluding depreciation and amortization included in direct costs 78 89 163 185 Total operating expenses 2,386 5,228 7,301 10,277 Operating loss (1,632) (2) (4,153) (219) Other (expense) income, net (376) (88) 908 (173) Loss before income taxes (2,008) (90) (3,245) (392) Income tax (provision) benefit (15) -- 4 (11) Net loss (2,023) (90) (3,241) (403) Series A preferred stock dividend (8) (8) (8) (8) Net loss attributable to common shareholders $ (2,031) $ (98) $ (3,249) $ (411) Net loss per common share basic and diluted $ (0.69) $ (0.03) $ (1.12) $ (0.14) Weighted average shares outstanding basic and diluted 2,925 2,870 2,913 2,868 Comprehensive loss: Net loss $ (2,023) $ (98) $ (3,241) $ (403) Foreign currency translations adjustment 76 32 (28) 65 Total comprehensive loss $ (1,947) $ (58) $ (3,269) $ (338) NTN BUZZTIME, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (In thousands) Six months endedJune 30, 2020 2019 Cash flows (used in) provided by operating activities: Net loss $ (3,241) $ (403) Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation and amortization 1,058 1,454 Provision for doubtful accounts 133 27 Amortization of operating lease right-of-use assets 146 144 Common stock issued for compensation in lieu of cash payment 61 -- Transfer of fixed assets to sales-type lease -- 6 Stock-based compensation 82 109 Gain from the asset sale of Stump! Trivia and OpinioNation (1,265) -- Gain from the termination of operating lease $ (8) -- Loss from the disposition or sale of assets 502 19 Loss from impairment of capitalized software 238 1 Loss from impairment of goodwill 662 -- Amortization of debt issuance costs 9 5 Changes in assets and liabilities: Accounts receivable 975 384 Site equipment to be installed (286) 465 Operating lease liabilities (120) (58) Prepaid expenses and other liabilities 190 12 Accounts payable and accrued expenses (1,436) (20) Income taxes 13 (10) Deferred costs 122 47 Deferred revenue (84) (866) Other liabilities (201) 23 Net cash (used in) provided by operating activities (2,450) 1,339 Cash flows used in investing activities: Capital expenditures (20) (79) Capitalized software development expenditures (130) (639) Net cash used in investing activities (150) (718) Cash flows provided by (used in) financing activities: Net proceeds from the sale of Stump! Trivia and OpinoNation 1,166 -- Proceeds on long-term debt 1,625 -- Payment on long-term debt (1,125) (417) Debt issuance costs on long-term debt (3) -- Principal payments on financing leases (8) (30) Payment of preferred stockholder dividends (8) (8) Payroll taxes remitted on net share settlement of equity awards (27) (13) Net cash provided by (used in) financing activities 1,620 (468) Effect of exchange rate on cash 6 39 Net (decrease) increase in cash and cash equivalents (974) 192 Cash, cash equivalents and restricted cash at beginning of period 3,409 2,786 Cash, cash equivalents and restricted cash at end of period 2,435 2,978 SOURCE NTN Buzztime, Inc. Related Links http://www.buzztime.com Answer:

NTN Buzztime, Inc. Reports Second Quarter 2020 Results

CARLSBAD, Calif., Aug. 7, 2020 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) reported financial resultsfor the second quarter ended June 30, 2020. "The negative impact of the COVID-19 pandemic on our customers was abrupt and substantial, and it had a ripple-effect on our business. As a result, we took action to significantly reduce our operating costs," saidAllen Wolff, CEO. "We have been focused on cash management and exploring and evaluating strategic alternatives." Financial Results For the second quarter 2020, total revenues were $754,000, compared to $5.2 million for the second quarter of 2019. The decrease reflects reduced site count and the impact of the COVID-19 pandemic on the company's business as a substantial number of the bars and restaurants that subscribe to the company's network suspended their subscriptions for at least a portion of the current year period. Through corporate restructuring and cost reductions, second quarter 2020 operating expense decreased to $2.4 million, from $5.2 million for the second quarter of 2019. Second quarter 2020 net loss attributable to common shareholders was $2.0 million, including $100,000 in capitalized software impairments, or $0.69 per share, compared to $98,000, or $0.03 per share, for the prior year quarter. Liquidity Cash, cash equivalents and unrestricted cash was $2.2 million at June 30, 2020, compared to $2.2 million at March 31, 2020 and $3.2 million at December 31, 2019.In April 2020, the company received $1.6 million under the Paycheck Protection Program of the CARES Act. At June 30, 2020, the principal balance of the company's term loan with its primary lender was $1.6 million, and working capital was $894,000. For additional information regarding the company's liquidity and capital resources, please see the company's quarterly report on Form 10-Q expected to be filed with the SEC today. The company will not be hosting an earnings call for the recently completed quarter. The company's limited resources are being directed toward managing operations and liquidity in light of the substantial impact of the COVID-19 pandemic on its business and on exploring and evaluating strategic alternatives. No assurance are, or can be given, that a definitive agreement for a strategic transaction will result from the company's strategic process, or that even if such agreement is entered into, that the potential transaction will be consummated. Forward-looking StatementsThis release may contain forward-looking statements that reflect management's current views of future events and operations, including challenges that we and our customers will face related to the COVID-19 pandemic and the potential meaningfulness of our product platform to our customers as they or if they re-open their businesses. Among the factors that could cause or contribute to material differences between our actual results and the expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: (1) our ability to raise substantial capital in the very near-term to allow us to maintain operations and sustain the negative impact of the COVID-19 pandemic on our business and financial condition, and if we are able to sustain such impact, our ability to recover from the impact; (2) our ability to successfully manage our liquidity and our working capital deficit by managing the timing of payments to our third parties; (3) our ability to comply with our financial covenants in our loan and security agreement with Avidbank and its right to declare a default if we do not, which could lead to all payment obligations becoming immediately due and payable and which could lead to a foreclosure on our assets; (4) when, and the extent to which, the negative impact of the pandemic will improve, including when restaurants will be permitted to offer on-site dining or when bars will be permitted to re-open and to what degree, when our customers will re-open, or if they will subscribe to our service if and when they do; (5) the negative impact that measures we implemented and may implement to reduce our operating expenses and planned capital expenses (including investments in our business) may have on our ability to effectively manage and operate our business; (6) our ability to maintain or grow our revenue; (7) with respect to our strategic process, the risk that we may not enter into a definitive agreement for a potential transaction or, if we do, that the potential transaction will not be completed; (8) our ability to compete effectively within the highly competitive interactive games, entertainment and marketing services industries, including our ability to successfully commercially launch attractive product offerings, and the impact of new products and technological change, especially in the mobile and wireless markets, on our operations and competitiveness; (9) our ability to adequately protect our proprietary rights and intellectual property ; and (10) the other risks and uncertainties described in Part I, Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and described in other documents we filed or file from time to time with the Securities and Exchange Commission thereafter, including in our Current Reports on Form 8-K filed with the SEC on March 30, 2020 and April 21, 2020, and our Quarterly Reports on Form 10-Q for each of the quarters ended March 31, 2020 and June 30, 2020. Please see our filings with the SEC for information about these and other risks that may affect us. All forward-looking statements included in this release are based on information available to us on the date hereof. These statements speak only as of the date hereof and NTN Buzztime, Inc. does not undertake to publicly update or revise any of its forward-looking statements, even if experience or future changes show that the indicated results or events will not be realized. About Buzztime:Buzztime (NYSE American: NTN) delivers interactive entertainment and innovative technology that helps its customers acquire, engage and retain its patrons. Most frequently used in bars and restaurants in North America, the Buzztime tablets, mobile app and technology offer engaging solutions to establishments that have guests who experience dwell time, such as casinos, senior living, and more. Casual dining venues license Buzztime's customizable solution to differentiate themselves via competitive fun by offering guests trivia, card, sports and arcade games. Buzztime's platform creates connections among the players and venues and amplifies guests' positive experiences. Buzztime's in-venue TV network creates one of the largest digital out of home ad audiences in the US and Canada. Buzztime hardware solutions leverages the company's experience manufacturing durable tablets and charging systems, enabling a diverse group of businesses including corrections, point-of-sale and loyalty with product implementation. Buzztime games have also been recently licensed by other businesses serving other markets. For more information, please visithttp://www.buzztime.com. IR AGENCY CONTACT: Kirsten Chapman, LHA Investor Relations, [emailprotected] 415-433-3777 NTN BUZZTIME, INC. AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except par value amount) ASSETS June 30,2020 December 31,2019 Current Assets: (unaudited) Cash and cash equivalents $ 2,234 $ 3,209 Restricted cash 201 50 Accounts receivable, net 186 1,195 Site equipment to be installed 1,132 1,090 Prepaid expenses and other current assets 336 526 Total current assets 4,089 6,070 Restricted cash, long-term -- 150 Operating lease right-of-use assets 44 2,101 Fixed assets, net 928 2,822 Software development costs, net 1,515 1,915 Deferred costs 152 274 Goodwill -- 696 Other assets 62 97 Total assets $ 6,790 $ 14,125 LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities: Accounts payable $ 397 $ 835 Accrued compensation 116 588 Accrued expenses 385 490 Sales taxes payable -- 131 Income taxes payable 15 3 Current portion of long-term debt 1,620 2,739 Current portion of obligations under operating leases 28 409 Current portion of obligations under financing leases 24 21 Current portion of deferred revenue 377 460 Other current liabilities 233 419 Total current liabilities 3,195 6,095 Long-term debt 1,625 -- Obligations under operating leases 18 2,891 Obligations under financing leases 9 20 Deferred revenue 1 2 Other liabilities 11 26 Total liabilities 4,859 9,034 Commitments and contingencies Shareholders' equity: Series A 10% cumulative convertible preferred stock, $0.005 par value, $156 liquidation preference, 156 shares authorized; 156 shares issued and outstanding at June 30, 2020 and December 31, 2019 1 1 Common stock, $0.005 par value, 15,000 shares authorized at June 30, 2020 and December 31, 2019; 2,938 and 2,901 shares issued at June, 2020 and December 31, 2019, respectively 15 14 Treasury stock, at cost, 10 shares at June 30, 2020 and December 31, 2019 (456) (456) Additional paid-in capital 136,837 136,721 Accumulated deficit (134,706) (131,457) Accumulated other comprehensive income 240 268 Total shareholders' equity 1,931 5,091 Total liabilities and shareholders' equity $ 6,790 $ 14,125 NTN BUZZTIME, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) (In thousands, except per share data) Three months endedJune 30, Six months endedJune 30, 2020 2019 2020 2019 Revenues Subscription revenue $ 727 $ 3,800 $ 2,726 $ 7,633 Hardware revenue 26 595 42 800 Other revenue 1 831 380 1,625 Total revenues 754 5,226 3,148 10,058 Operating expenses: Direct operating costs (includes depreciation and amortization) 613 1,717 1,563 3,201 Selling, general and administrative 1,595 3,422 4,675 6,891 Impairment of capitalized software 100 -- 238 1 Impairment of goodwill -- -- 662 -- Depreciation and amortization (excluding depreciation and amortization included in direct costs 78 89 163 185 Total operating expenses 2,386 5,228 7,301 10,277 Operating loss (1,632) (2) (4,153) (219) Other (expense) income, net (376) (88) 908 (173) Loss before income taxes (2,008) (90) (3,245) (392) Income tax (provision) benefit (15) -- 4 (11) Net loss (2,023) (90) (3,241) (403) Series A preferred stock dividend (8) (8) (8) (8) Net loss attributable to common shareholders $ (2,031) $ (98) $ (3,249) $ (411) Net loss per common share basic and diluted $ (0.69) $ (0.03) $ (1.12) $ (0.14) Weighted average shares outstanding basic and diluted 2,925 2,870 2,913 2,868 Comprehensive loss: Net loss $ (2,023) $ (98) $ (3,241) $ (403) Foreign currency translations adjustment 76 32 (28) 65 Total comprehensive loss $ (1,947) $ (58) $ (3,269) $ (338) NTN BUZZTIME, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (In thousands) Six months endedJune 30, 2020 2019 Cash flows (used in) provided by operating activities: Net loss $ (3,241) $ (403) Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation and amortization 1,058 1,454 Provision for doubtful accounts 133 27 Amortization of operating lease right-of-use assets 146 144 Common stock issued for compensation in lieu of cash payment 61 -- Transfer of fixed assets to sales-type lease -- 6 Stock-based compensation 82 109 Gain from the asset sale of Stump! Trivia and OpinioNation (1,265) -- Gain from the termination of operating lease $ (8) -- Loss from the disposition or sale of assets 502 19 Loss from impairment of capitalized software 238 1 Loss from impairment of goodwill 662 -- Amortization of debt issuance costs 9 5 Changes in assets and liabilities: Accounts receivable 975 384 Site equipment to be installed (286) 465 Operating lease liabilities (120) (58) Prepaid expenses and other liabilities 190 12 Accounts payable and accrued expenses (1,436) (20) Income taxes 13 (10) Deferred costs 122 47 Deferred revenue (84) (866) Other liabilities (201) 23 Net cash (used in) provided by operating activities (2,450) 1,339 Cash flows used in investing activities: Capital expenditures (20) (79) Capitalized software development expenditures (130) (639) Net cash used in investing activities (150) (718) Cash flows provided by (used in) financing activities: Net proceeds from the sale of Stump! Trivia and OpinoNation 1,166 -- Proceeds on long-term debt 1,625 -- Payment on long-term debt (1,125) (417) Debt issuance costs on long-term debt (3) -- Principal payments on financing leases (8) (30) Payment of preferred stockholder dividends (8) (8) Payroll taxes remitted on net share settlement of equity awards (27) (13) Net cash provided by (used in) financing activities 1,620 (468) Effect of exchange rate on cash 6 39 Net (decrease) increase in cash and cash equivalents (974) 192 Cash, cash equivalents and restricted cash at beginning of period 3,409 2,786 Cash, cash equivalents and restricted cash at end of period 2,435 2,978 SOURCE NTN Buzztime, Inc. Related Links http://www.buzztime.com

edtsum60

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN DIEGO--(BUSINESS WIRE)--Applied Data Finance, LLC (ADF), a leading technology-enabled lender and asset manager, announced today that it has closed a $14.2 million capital raise led by existing investors. The capital was raised through the issuance of convertible notes that, at the purchasers election, can be converted into preferred stock of the company. The notes mature in July 2023. Through its Personify Financial online lending platform, ADF provides unsecured personal loans to consumers often overlooked by traditional financial institutions. This new capital will drive ADFs continued growth and allow the company to serve more underbanked individuals in need of straightforward, affordable loans. Finalizing this capital deal in a difficult economic environment demonstrates the strength of the platform and positions ADF to be successful in 2021 and beyond, said Krishna Gopinathan, Co-Founder and Chief Executive Officer of ADF. Our ability to select economically resilient consumers has enabled the creation of a solid loan book built to grow profitably in virtually any economy. Founded in 2014, ADF and its partner bank have together lent over $560 million to 160,000 consumers and has grown to almost 300 employees with offices in San Diego and Chennai, India. Earlier this year, ADF ranked #8 on The Financial Times The Americas Fastest Growing Companies 2020 list and second overall in the Fintech category. Inc. Magazine also ranked ADF #345 on its annual Inc. 5000 list. These lists are considered the premier recognition of the most successful independent small businesses. About Applied Data Finance ADF, through its Personify Financial brand, is the trusted financial partner for thousands of underestimated under-banked consumers. Combining state-of-the-art technology and world-class application of advanced data science and machine learning, ADF is setting a new standard for assessing non-prime borrower credit and fraud risk. Learn more at www.applieddatafinance.com and www.personifyfinancial.com. Answer:

Applied Data Finance Closes $14.2 Million Capital Raise

SAN DIEGO--(BUSINESS WIRE)--Applied Data Finance, LLC (ADF), a leading technology-enabled lender and asset manager, announced today that it has closed a $14.2 million capital raise led by existing investors. The capital was raised through the issuance of convertible notes that, at the purchasers election, can be converted into preferred stock of the company. The notes mature in July 2023. Through its Personify Financial online lending platform, ADF provides unsecured personal loans to consumers often overlooked by traditional financial institutions. This new capital will drive ADFs continued growth and allow the company to serve more underbanked individuals in need of straightforward, affordable loans. Finalizing this capital deal in a difficult economic environment demonstrates the strength of the platform and positions ADF to be successful in 2021 and beyond, said Krishna Gopinathan, Co-Founder and Chief Executive Officer of ADF. Our ability to select economically resilient consumers has enabled the creation of a solid loan book built to grow profitably in virtually any economy. Founded in 2014, ADF and its partner bank have together lent over $560 million to 160,000 consumers and has grown to almost 300 employees with offices in San Diego and Chennai, India. Earlier this year, ADF ranked #8 on The Financial Times The Americas Fastest Growing Companies 2020 list and second overall in the Fintech category. Inc. Magazine also ranked ADF #345 on its annual Inc. 5000 list. These lists are considered the premier recognition of the most successful independent small businesses. About Applied Data Finance ADF, through its Personify Financial brand, is the trusted financial partner for thousands of underestimated under-banked consumers. Combining state-of-the-art technology and world-class application of advanced data science and machine learning, ADF is setting a new standard for assessing non-prime borrower credit and fraud risk. Learn more at www.applieddatafinance.com and www.personifyfinancial.com.

edtsum61

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PALO ALTO, Calif.--(BUSINESS WIRE)--NTT Research, Inc., a division of NTT (TYO:9432), today announced that its Cryptography and Information Security (CIS) Lab has reached a joint research agreement with Stanford University. The four-year agreement with Stanford covers basic and fundamental research topics of cryptography and blockchain. The principal investigator will be Dr. Dan Boneh, professor of computer science and electrical engineering and co-director of the Stanford Computer Security Lab at Stanford University. One of three divisions at NTT Research, the CIS Lab is engaged in basic research of cryptography with the potential for long-term impact. Directed by NTT Fellow Tatsuaki Okamoto, the CIS Lab is focused on foundational research problems in cryptography and blockchain. NTT Research Distinguished Scientist Brent Waters, who heads the CIS Labs cryptography research group, as well as NTT Research Senior Scientist Hoeteck Wee, will be involved in the cryptography research with Stanford. Dr. Shinichiro Matsuo, a research professor at Georgetown University who heads the CIS Labs blockchain group at NTT Research, will be involved in the joint research with Stanford on blockchain. Professor Boneh, who also heads the applied cryptography group at Stanford, focuses his research on applications of cryptography to computer security. His work includes cryptosystems with novel properties, security for mobile devices, web security and cryptoanalysis. He is the author of more than 150 publications in the field and a recipient of the 2014 Association for Computing Machinery (ACM) prize (for ground-breaking contributions to the development of pairing-based cryptography and its application in identity-based encryption), the 2013 Godel prize, the RSA award in mathematics, and six best paper awards. In 2016, Dr. Boneh was elected to the National Academy of Engineering. The NTT Research CIS Lab is tremendously fortunate to be engaging with some of the worlds leading academics, as we continue to focus on foundational research problems, said CIS Lab Director Okamoto. We are looking forward to seeing the collaboration between Professor Boneh and his counterparts in the CIS Lab. The scope of work for the four-year agreement with Stanford includes several important areas of basic research in cryptography and blockchain. This is a great opportunity to collaborate with a skilled group of computer scientists and a team that is willing to address questions that have yet to be answered, said Professor Boneh. We are eager to get started. NTT Research actively explores opportunities to work with experts in its three fields of study. Earlier this year, it announced a collaboration with Stanford Universitys Department of Applied Physics on a National Science Foundation (NSF)-funded initiative into Coherent Ising Machines (CIMs). In addition, last fall NTT Research entered an Industrial Partnership between its CIS Lab and the Simons Institute for the Theory of Computing at UC Berkeley; reached joint research agreements between its CIS Lab and UCLA and Georgetown; set up joint research agreements between its Physics and Informatics (PHI) Lab and six universities (CalTech, Cornell, Michigan, MIT, Stanford and Swinburne), one US Federal Agency (NASAs Ames Research Center) and one private quantum computing software company (1QBit); and reached a joint research agreement between its Medical and Informatics (MEI) Lab and the Technical University of Munich (TUM). About NTT Research NTT Research opened its Palo Alto offices in July 2019 as a new Silicon Valley startup to conduct basic research and advance technologies that promote positive change for humankind. Currently, three labs are housed at NTT Research: the Physics and Informatics (PHI) Lab, the Cryptography and Information Security (CIS) Lab, and the Medical and Health Informatics (MEI) Lab. The organization aims to upgrade reality in three areas: 1) quantum information, neuro-science and photonics; 2) cryptographic and information security; and 3) medical and health informatics. NTT Research is part of NTT, a global technology and business solutions provider with an annual R&D budget of $3.6 billion. NTT and the NTT logo are registered trademarks or trademarks of NIPPON TELEGRAPH AND TELEPHONE CORPORATION and/or its affiliates. All other referenced product names are trademarks of their respective owners. 2020 NIPPON TELEGRAPH AND TELEPHONE CORPORATION Answer:

NTT Research Collaboration Advances Cryptography and Blockchain Research NTT Research CIS Lab Focused on Information Security Announces Joint Research Agreement

PALO ALTO, Calif.--(BUSINESS WIRE)--NTT Research, Inc., a division of NTT (TYO:9432), today announced that its Cryptography and Information Security (CIS) Lab has reached a joint research agreement with Stanford University. The four-year agreement with Stanford covers basic and fundamental research topics of cryptography and blockchain. The principal investigator will be Dr. Dan Boneh, professor of computer science and electrical engineering and co-director of the Stanford Computer Security Lab at Stanford University. One of three divisions at NTT Research, the CIS Lab is engaged in basic research of cryptography with the potential for long-term impact. Directed by NTT Fellow Tatsuaki Okamoto, the CIS Lab is focused on foundational research problems in cryptography and blockchain. NTT Research Distinguished Scientist Brent Waters, who heads the CIS Labs cryptography research group, as well as NTT Research Senior Scientist Hoeteck Wee, will be involved in the cryptography research with Stanford. Dr. Shinichiro Matsuo, a research professor at Georgetown University who heads the CIS Labs blockchain group at NTT Research, will be involved in the joint research with Stanford on blockchain. Professor Boneh, who also heads the applied cryptography group at Stanford, focuses his research on applications of cryptography to computer security. His work includes cryptosystems with novel properties, security for mobile devices, web security and cryptoanalysis. He is the author of more than 150 publications in the field and a recipient of the 2014 Association for Computing Machinery (ACM) prize (for ground-breaking contributions to the development of pairing-based cryptography and its application in identity-based encryption), the 2013 Godel prize, the RSA award in mathematics, and six best paper awards. In 2016, Dr. Boneh was elected to the National Academy of Engineering. The NTT Research CIS Lab is tremendously fortunate to be engaging with some of the worlds leading academics, as we continue to focus on foundational research problems, said CIS Lab Director Okamoto. We are looking forward to seeing the collaboration between Professor Boneh and his counterparts in the CIS Lab. The scope of work for the four-year agreement with Stanford includes several important areas of basic research in cryptography and blockchain. This is a great opportunity to collaborate with a skilled group of computer scientists and a team that is willing to address questions that have yet to be answered, said Professor Boneh. We are eager to get started. NTT Research actively explores opportunities to work with experts in its three fields of study. Earlier this year, it announced a collaboration with Stanford Universitys Department of Applied Physics on a National Science Foundation (NSF)-funded initiative into Coherent Ising Machines (CIMs). In addition, last fall NTT Research entered an Industrial Partnership between its CIS Lab and the Simons Institute for the Theory of Computing at UC Berkeley; reached joint research agreements between its CIS Lab and UCLA and Georgetown; set up joint research agreements between its Physics and Informatics (PHI) Lab and six universities (CalTech, Cornell, Michigan, MIT, Stanford and Swinburne), one US Federal Agency (NASAs Ames Research Center) and one private quantum computing software company (1QBit); and reached a joint research agreement between its Medical and Informatics (MEI) Lab and the Technical University of Munich (TUM). About NTT Research NTT Research opened its Palo Alto offices in July 2019 as a new Silicon Valley startup to conduct basic research and advance technologies that promote positive change for humankind. Currently, three labs are housed at NTT Research: the Physics and Informatics (PHI) Lab, the Cryptography and Information Security (CIS) Lab, and the Medical and Health Informatics (MEI) Lab. The organization aims to upgrade reality in three areas: 1) quantum information, neuro-science and photonics; 2) cryptographic and information security; and 3) medical and health informatics. NTT Research is part of NTT, a global technology and business solutions provider with an annual R&D budget of $3.6 billion. NTT and the NTT logo are registered trademarks or trademarks of NIPPON TELEGRAPH AND TELEPHONE CORPORATION and/or its affiliates. All other referenced product names are trademarks of their respective owners. 2020 NIPPON TELEGRAPH AND TELEPHONE CORPORATION

edtsum65

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against QuantumScape Corporation ("QuantumScape" or "the Company") f/k/a Kensington Capital Acquisition Corp. (NYSE: QS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired QuantumScape securities between November 27, 2020 and December 31, 2020, inclusive (the Class Period). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/qs. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the class period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) that the Companys purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects were materially misleading and/or lacked a reasonable basis. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/qs or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in QuantumScape you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Answer:

QS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies QuantumScape Corporation Shareholders With Losses Exceeding $100K of Class Action and Encourages Shareholders to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against QuantumScape Corporation ("QuantumScape" or "the Company") f/k/a Kensington Capital Acquisition Corp. (NYSE: QS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired QuantumScape securities between November 27, 2020 and December 31, 2020, inclusive (the Class Period). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/qs. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the class period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) that the Companys purported success related to its solid-state battery power, battery life, and energy density were significantly overstated; (2) that the Company is unlikely to be able to scale its technology to the multi-layer cell necessary to power electric vehicles; and (3) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects were materially misleading and/or lacked a reasonable basis. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/qs or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in QuantumScape you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

edtsum68

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ALEXANDRIA, Va., Feb. 11, 2021 /PRNewswire/ --Burke & Herbert Bank invites northern Virginia high school seniors to register for Bank Day 2021. Participating seniors can win up to $7,500 from the Virginia Bankers Association (VBA) by submitting an essay about banking, financial services, and the vital role that banks play in the community. Bank Day is a statewide program sponsored by the VBA Education Foundation. Bank Day began when the third Tuesday in March was declared Bank Day by the Virginia General Assembly in 1991. The purpose is to provide an opportunity for high school seniors to learn about banks and their role. Due to the pandemic, Bank Day will be virtual. Students will have access to an online Bank Day resource from March 15-April 2, 2021. Registrants selecting Burke & Herbert Bank as their host will receive additional resources, including a virtual opportunity to learn from our bankers and get answers to their specific questions. A total of $29,000 will be awarded to twelve students across the Commonwealth, to include six regional and six honorable mention winners. One of the regional ($2,500) winners will be named the statewide runner-up winner, earning an extra $3,000 and one of the regional winners will also be named the statewide winner, earning an extra $5,000 for a total scholarship of $7,500. Burke & Herbert Bank's prior Bank Day participants have done quite well. Four seniors in the last four years have won awards, including two regional winners, and one grand prize winner. Interested students must register online by March 5th through the VBA registration link. Additional details and the link can be found at burkeandherbertbank.com. Registrants should indicate "Burke & Herbert Bank" as their "host" bank on the registration form for access to additional resources. Burke & Herbert Bank & Trust Company, established in 1852, is the oldest bank in the Commonwealth of Virginia and the oldest continuously operating bank in the Washington DC area. The Bank offers a full range of personal and business banking products and services designed to meet customers' banking, borrowing, and investing needs. Burke & Herbert Bank & Trust Company is headquartered in Alexandria and operates more than 20 branches in Northern Virginia. Member FDIC CONTACT:Jane Petty703-216-5491 SOURCE Burke & Herbert Bank Answer:

Burke & Herbert Bank Announces 2021 Bank Day Scholarship Program High School Seniors Can Win Up to $7,500 from the Virginia Bankers Association

ALEXANDRIA, Va., Feb. 11, 2021 /PRNewswire/ --Burke & Herbert Bank invites northern Virginia high school seniors to register for Bank Day 2021. Participating seniors can win up to $7,500 from the Virginia Bankers Association (VBA) by submitting an essay about banking, financial services, and the vital role that banks play in the community. Bank Day is a statewide program sponsored by the VBA Education Foundation. Bank Day began when the third Tuesday in March was declared Bank Day by the Virginia General Assembly in 1991. The purpose is to provide an opportunity for high school seniors to learn about banks and their role. Due to the pandemic, Bank Day will be virtual. Students will have access to an online Bank Day resource from March 15-April 2, 2021. Registrants selecting Burke & Herbert Bank as their host will receive additional resources, including a virtual opportunity to learn from our bankers and get answers to their specific questions. A total of $29,000 will be awarded to twelve students across the Commonwealth, to include six regional and six honorable mention winners. One of the regional ($2,500) winners will be named the statewide runner-up winner, earning an extra $3,000 and one of the regional winners will also be named the statewide winner, earning an extra $5,000 for a total scholarship of $7,500. Burke & Herbert Bank's prior Bank Day participants have done quite well. Four seniors in the last four years have won awards, including two regional winners, and one grand prize winner. Interested students must register online by March 5th through the VBA registration link. Additional details and the link can be found at burkeandherbertbank.com. Registrants should indicate "Burke & Herbert Bank" as their "host" bank on the registration form for access to additional resources. Burke & Herbert Bank & Trust Company, established in 1852, is the oldest bank in the Commonwealth of Virginia and the oldest continuously operating bank in the Washington DC area. The Bank offers a full range of personal and business banking products and services designed to meet customers' banking, borrowing, and investing needs. Burke & Herbert Bank & Trust Company is headquartered in Alexandria and operates more than 20 branches in Northern Virginia. Member FDIC CONTACT:Jane Petty703-216-5491 SOURCE Burke & Herbert Bank

edtsum70

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN FRANCISCO--(BUSINESS WIRE)--Eaze, Californias largest marketplace for legal cannabis, has entered the chat. Today, Eaze launches its first non-fungible token (NFT) to put its signature moonman image in the hands of the - ahem - highest bidder in celebration of 4/20s golden anniversary. The NFT, which features NBA champion and nationally-recognized cannabis advocate Matt Barnes, is for sale on OpenSea. All proceeds from the sale will go to National Expungement Week (N.E.W.), a POC-powered organization that provides access to relief, equity, and opportunity in communities affected by the War on Drugs. 2021 is the 50th anniversary of 4/20 and theres no better way to commemorate this milestone than supporting social equity, said Sheena Shiravi, vice president of marketing at Eaze. Like cannabis, NFTs are changing how we all think about commerce and culture, so this made a ton of sense to us. And who doesnt want Matt Barnes as a digital moonman? The one-of-a-kind NFT features one of Eazes signature creative assets: the smokin hot moonman, juxtaposed with Matt Barnes and a special message to celebrate cannabis highest holiday. Eazes moonman is featured prominently in its award-winning advertising, which was recognized with a Clio Cannabis Award. Bidding starts today at .1715 WETH (~$420) and closes on 4/20 at 11:59pm PT. "On behalf of the N.E.W. leadership team, we are elated at the opportunity to form a relationship with EAZE and deeply appreciative for the kind donation to our organization, said Torie Marshall, founder of N.E.W. These funds will help to support and uplift the expungement work that N.E.W. provides 365 days a year." This project builds on Eazes commitment to delivering good with the goods. Eazes annual Momentum business accelerator provides $50,000 grants and a 12-week business development curriculum to under-represented and social equity founders. To-date, BIPOC-owned brands have sold over $4 million in products on Eazes Social Equity Menu. Eazes other social impact work includes a partnership with Code for America to help clear 250,000 low-level criminal offenses; a permanent 25% discount for U.S. veterans; and partnerships with Success Centers SF and the San Francisco AIDS project, among others. Barnes serves as a senior advisor to Eazes Board of Directors on cannabis policy, social impact, and industry relations. NFTs are buzzy and now, making them a creative way to raise awareness for groups doing important equity work, said Jennifer Lujan, director of social impact at Eaze. People love to be part of something new and exciting, and even better if it also fights the racist War on Drugs. Visit OpenSea to access Eazes NFT now. About Eaze Eaze delivers good with the goods. As Californias largest legal cannabis marketplace, we bring enjoyment and convenience to our customers, break down barriers to access, and cultivate community in everything we do. With over seven million cannabis deliveries to-date, we are committed to creating a more diverse and sustainable industry through our Momentum business accelerator and Social Equity Partners Program. www.eaze.com. Answer:

Get It While Its Smokin Hot! Eaze Releases NFT Featuring NBA Champion Matt Barnes to Fund National Expungement Week And Celebrate 4/20s 50th Anniversary Proceeds from sale of one-of-a-kind digital artwork will benefit social equity organization

SAN FRANCISCO--(BUSINESS WIRE)--Eaze, Californias largest marketplace for legal cannabis, has entered the chat. Today, Eaze launches its first non-fungible token (NFT) to put its signature moonman image in the hands of the - ahem - highest bidder in celebration of 4/20s golden anniversary. The NFT, which features NBA champion and nationally-recognized cannabis advocate Matt Barnes, is for sale on OpenSea. All proceeds from the sale will go to National Expungement Week (N.E.W.), a POC-powered organization that provides access to relief, equity, and opportunity in communities affected by the War on Drugs. 2021 is the 50th anniversary of 4/20 and theres no better way to commemorate this milestone than supporting social equity, said Sheena Shiravi, vice president of marketing at Eaze. Like cannabis, NFTs are changing how we all think about commerce and culture, so this made a ton of sense to us. And who doesnt want Matt Barnes as a digital moonman? The one-of-a-kind NFT features one of Eazes signature creative assets: the smokin hot moonman, juxtaposed with Matt Barnes and a special message to celebrate cannabis highest holiday. Eazes moonman is featured prominently in its award-winning advertising, which was recognized with a Clio Cannabis Award. Bidding starts today at .1715 WETH (~$420) and closes on 4/20 at 11:59pm PT. "On behalf of the N.E.W. leadership team, we are elated at the opportunity to form a relationship with EAZE and deeply appreciative for the kind donation to our organization, said Torie Marshall, founder of N.E.W. These funds will help to support and uplift the expungement work that N.E.W. provides 365 days a year." This project builds on Eazes commitment to delivering good with the goods. Eazes annual Momentum business accelerator provides $50,000 grants and a 12-week business development curriculum to under-represented and social equity founders. To-date, BIPOC-owned brands have sold over $4 million in products on Eazes Social Equity Menu. Eazes other social impact work includes a partnership with Code for America to help clear 250,000 low-level criminal offenses; a permanent 25% discount for U.S. veterans; and partnerships with Success Centers SF and the San Francisco AIDS project, among others. Barnes serves as a senior advisor to Eazes Board of Directors on cannabis policy, social impact, and industry relations. NFTs are buzzy and now, making them a creative way to raise awareness for groups doing important equity work, said Jennifer Lujan, director of social impact at Eaze. People love to be part of something new and exciting, and even better if it also fights the racist War on Drugs. Visit OpenSea to access Eazes NFT now. About Eaze Eaze delivers good with the goods. As Californias largest legal cannabis marketplace, we bring enjoyment and convenience to our customers, break down barriers to access, and cultivate community in everything we do. With over seven million cannabis deliveries to-date, we are committed to creating a more diverse and sustainable industry through our Momentum business accelerator and Social Equity Partners Program. www.eaze.com.

edtsum84

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Nov. 24, 2020 /PRNewswire/ --This press release provides shareholders of Cohen&Steers Limited Duration Preferred and Income Fund, Inc. (NYSE: LDP) (the "Fund") with information regarding the sources of the distribution to be paid on November 30, 2020 and cumulative distributions paid fiscal year-to-date. In December 2016, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term capital gains throughout the year and to distribute those gains on a regular monthly basis to shareholders. The Board of Directors of the Fund may amend, terminate or suspend the managed distribution policy at any time, which could have an adverse effect on the market price of the Fund's shares. The Fund's monthly distributions may include long-term capital gains, short-term capital gains, net investment income and/or return of capital for federal income tax purposes. Return of capital includes distributions paid by the Fund in excess of its net investment income and net realized capital gains and such excess is distributed from the Fund's assets. A return of capital is not taxable; rather, it reduces a shareholder's tax basis in his or her shares of the Fund. The amount of monthly distributions may vary depending on a number of factors, including changes in portfolio and market conditions. At the time of each monthly distribution, information will be posted to cohenandsteers.com and mailed to shareholders in a concurrent notice. However, this information may change at the end of the year because the final tax characteristics of the Fund's distributions cannot be determined with certainty until after the end of the calendar year. Final tax characteristics of all of the Fund's distributions will be provided on Form 1099-DIV, which is mailed after the close of the calendar year. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year-to-date from the sources indicated. All amounts are expressed per common share. DISTRIBUTION ESTIMATES November 2020 YEAR-TO-DATE (YTD) November 30, 2020* Source Per ShareAmount % of CurrentDistribution Per ShareAmount % of 2020Distributions Net Investment Income $0.1125 78.67% $1.2748 77.21% Net Realized Short-Term Capital Gains $0.0000 0.00% $0.0000 0.00% Net Realized Long-Term Capital Gains $0.0000 0.00% $0.0000 0.00% Return of Capital (or other Capital Source) $0.0305 21.33% $0.3762 22.79% Total Current Distribution $0.1430 100.00% $1.6510 100.00% You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's managed distribution policy. The Fund estimates that it has distributed more than its income and capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with 'yield' or 'income'. The amounts and sources of distributions reported in this Notice are only estimates, are likely to change over time, and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The amounts and sources of distributions year-to-date may be subject to additional adjustments. *THE FUND WILL SEND YOU A FORM 1099-DIV FOR THE CALENDAR YEAR THAT WILL TELL YOU HOW TO REPORT THESE DISTRIBUTIONS FOR FEDERAL INCOME TAX PURPOSES The Fund's Year-to-date Cumulative Total Return for fiscal year 2020 (January 1, 2020 through October 31, 2020) is set forth below. Shareholders should take note of the relationship between the Year-to-date Cumulative Total Return with the Fund's Cumulative Distribution Rate for 2020. In addition, the Fund's Average Annual Total Return for the five-year period ending October 31, 2020 is set forth below. Shareholders should note the relationship between the Average Annual Total Return with the Fund's Current Annualized Distribution Rate for 2020. The performance and distribution rate information disclosed in the table is based on the Fund's net asset value per share (NAV). The Fund's NAV is calculated as the total market value of all the securities and other assets held by the Fund minus the total liabilities, divided by the total number of shares outstanding. While NAV performance may be indicative of the Fund's investment performance, it does not measure the value of a shareholder's individual investment in the Fund. The value of a shareholder's investment in the Fund is determined by the Fund's market price, which is based on the supply and demand for the Fund's shares in the open market. Fund Performance and Distribution Rate Information: Year-to-date January 1, 2020 to October 31, 2020 Year-to-date Cumulative Total Return1 -0.87% Cumulative Distribution Rate2 6.71% Five-year period ending October 31, 2020 Average Annual Total Return3 7.33% Current Annualized Distribution Rate4 6.98% 1. Year-to-date Cumulative Total Return is the percentage change in the Fund's NAV over the year-to-date time period including distributions paid and assuming reinvestment of those distributions. 2. Cumulative Distribution Rate for the Fund's current fiscal period (January 1, 2020 through November 30, 2020) measured on the dollar value of distributions in the year-to-date period as a percentage of the Fund's NAV as of October 31, 2020. 3. Average Annual Total Return represents the compound average of the Annual NAV Total Returns of the Fund for the five-year period ending October 31, 2020. Annual NAV Total Return is the percentage change in the Fund's NAV over a year including distributions paid and assuming reinvestment of those distributions. 4. The Current Annualized Distribution Rate is the current fiscal period's distribution rate annualized as a percentage of the Fund's NAV as of October 31, 2020. Investors should consider the investment objectives, risks, charges and expense of the Fund carefully before investing. You can obtain the Fund's most recent periodic reports, when available, and other regulatory filings by contacting your financial advisor or visiting cohenandsteers.com. These reports and other filings can be found on the Securities and Exchange Commission's EDGAR Database. You should read these reports and other filings carefully before investing. Shareholders should not use the information provided here in preparing their tax returns. Shareholders will receive a Form 1099-DIV for the calendar year indicating how to report Fund distributions for federal income tax purposes. Website: https://www.cohenandsteers.comSymbol: (NYSE: CNS) About Cohen & Steers. Cohen & Steers is a global investment manager specializing in liquid real assets, including real estate securities, listed infrastructure, commodities and natural resource equities, as well as preferred securities and other income solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, and Tokyo. Forward-Looking StatementsThis press release and other statements that Cohen & Steers may make may contain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which reflect the company's current views with respect to, among other things, its operations and financial performance. You can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "seeks," "approximately," "predicts," "intends," "plans," "estimates," "anticipates," or the negative versions of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. The company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. SOURCE Cohen & Steers Related Links http://www.cohenandsteers.com Answer:

Cohen & Steers Limited Duration Preferred and Income Fund, Inc. (LDP) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, Nov. 24, 2020 /PRNewswire/ --This press release provides shareholders of Cohen&Steers Limited Duration Preferred and Income Fund, Inc. (NYSE: LDP) (the "Fund") with information regarding the sources of the distribution to be paid on November 30, 2020 and cumulative distributions paid fiscal year-to-date. In December 2016, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission. The managed distribution policy seeks to deliver the Fund's long-term total return potential through regular monthly distributions declared at a fixed rate per common share. The policy gives the Fund greater flexibility to realize long-term capital gains throughout the year and to distribute those gains on a regular monthly basis to shareholders. The Board of Directors of the Fund may amend, terminate or suspend the managed distribution policy at any time, which could have an adverse effect on the market price of the Fund's shares. The Fund's monthly distributions may include long-term capital gains, short-term capital gains, net investment income and/or return of capital for federal income tax purposes. Return of capital includes distributions paid by the Fund in excess of its net investment income and net realized capital gains and such excess is distributed from the Fund's assets. A return of capital is not taxable; rather, it reduces a shareholder's tax basis in his or her shares of the Fund. The amount of monthly distributions may vary depending on a number of factors, including changes in portfolio and market conditions. At the time of each monthly distribution, information will be posted to cohenandsteers.com and mailed to shareholders in a concurrent notice. However, this information may change at the end of the year because the final tax characteristics of the Fund's distributions cannot be determined with certainty until after the end of the calendar year. Final tax characteristics of all of the Fund's distributions will be provided on Form 1099-DIV, which is mailed after the close of the calendar year. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year-to-date from the sources indicated. All amounts are expressed per common share. DISTRIBUTION ESTIMATES November 2020 YEAR-TO-DATE (YTD) November 30, 2020* Source Per ShareAmount % of CurrentDistribution Per ShareAmount % of 2020Distributions Net Investment Income $0.1125 78.67% $1.2748 77.21% Net Realized Short-Term Capital Gains $0.0000 0.00% $0.0000 0.00% Net Realized Long-Term Capital Gains $0.0000 0.00% $0.0000 0.00% Return of Capital (or other Capital Source) $0.0305 21.33% $0.3762 22.79% Total Current Distribution $0.1430 100.00% $1.6510 100.00% You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's managed distribution policy. The Fund estimates that it has distributed more than its income and capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with 'yield' or 'income'. The amounts and sources of distributions reported in this Notice are only estimates, are likely to change over time, and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The amounts and sources of distributions year-to-date may be subject to additional adjustments. *THE FUND WILL SEND YOU A FORM 1099-DIV FOR THE CALENDAR YEAR THAT WILL TELL YOU HOW TO REPORT THESE DISTRIBUTIONS FOR FEDERAL INCOME TAX PURPOSES The Fund's Year-to-date Cumulative Total Return for fiscal year 2020 (January 1, 2020 through October 31, 2020) is set forth below. Shareholders should take note of the relationship between the Year-to-date Cumulative Total Return with the Fund's Cumulative Distribution Rate for 2020. In addition, the Fund's Average Annual Total Return for the five-year period ending October 31, 2020 is set forth below. Shareholders should note the relationship between the Average Annual Total Return with the Fund's Current Annualized Distribution Rate for 2020. The performance and distribution rate information disclosed in the table is based on the Fund's net asset value per share (NAV). The Fund's NAV is calculated as the total market value of all the securities and other assets held by the Fund minus the total liabilities, divided by the total number of shares outstanding. While NAV performance may be indicative of the Fund's investment performance, it does not measure the value of a shareholder's individual investment in the Fund. The value of a shareholder's investment in the Fund is determined by the Fund's market price, which is based on the supply and demand for the Fund's shares in the open market. Fund Performance and Distribution Rate Information: Year-to-date January 1, 2020 to October 31, 2020 Year-to-date Cumulative Total Return1 -0.87% Cumulative Distribution Rate2 6.71% Five-year period ending October 31, 2020 Average Annual Total Return3 7.33% Current Annualized Distribution Rate4 6.98% 1. Year-to-date Cumulative Total Return is the percentage change in the Fund's NAV over the year-to-date time period including distributions paid and assuming reinvestment of those distributions. 2. Cumulative Distribution Rate for the Fund's current fiscal period (January 1, 2020 through November 30, 2020) measured on the dollar value of distributions in the year-to-date period as a percentage of the Fund's NAV as of October 31, 2020. 3. Average Annual Total Return represents the compound average of the Annual NAV Total Returns of the Fund for the five-year period ending October 31, 2020. Annual NAV Total Return is the percentage change in the Fund's NAV over a year including distributions paid and assuming reinvestment of those distributions. 4. The Current Annualized Distribution Rate is the current fiscal period's distribution rate annualized as a percentage of the Fund's NAV as of October 31, 2020. Investors should consider the investment objectives, risks, charges and expense of the Fund carefully before investing. You can obtain the Fund's most recent periodic reports, when available, and other regulatory filings by contacting your financial advisor or visiting cohenandsteers.com. These reports and other filings can be found on the Securities and Exchange Commission's EDGAR Database. You should read these reports and other filings carefully before investing. Shareholders should not use the information provided here in preparing their tax returns. Shareholders will receive a Form 1099-DIV for the calendar year indicating how to report Fund distributions for federal income tax purposes. Website: https://www.cohenandsteers.comSymbol: (NYSE: CNS) About Cohen & Steers. Cohen & Steers is a global investment manager specializing in liquid real assets, including real estate securities, listed infrastructure, commodities and natural resource equities, as well as preferred securities and other income solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, and Tokyo. Forward-Looking StatementsThis press release and other statements that Cohen & Steers may make may contain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which reflect the company's current views with respect to, among other things, its operations and financial performance. You can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "seeks," "approximately," "predicts," "intends," "plans," "estimates," "anticipates," or the negative versions of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. The company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. SOURCE Cohen & Steers Related Links http://www.cohenandsteers.com

edtsum85

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company has granted non-statutory stock options for the purchase of up to an aggregate of 61,500 shares of the companys common stock to five new employees as inducement awards under the companys 2019 Inducement Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options were granted as inducements material to the new employees acceptance of employment with the company and were approved by the Compensation Committee of the companys Board of Directors. The stock options were granted on Mar. 1, 2021, with an exercise price of $11.45 per share, representing the closing price of AVROBIOs common stock as reported by Nasdaq on the grant date. The stock option awards have a 10-year term and vest over four years, with 25 percent of the original number of shares vesting on the first anniversary of the employees new hire date and the remainder vesting in equal monthly installments over the following three years. Vesting of the option awards is subject to continued service with AVROBIO by the employee through the applicable vesting dates. About AVROBIO Our vision is to bring personalized gene therapy to the world. We aim to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone. Our ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. AVROBIO is powered by our industry leading plato gene therapy platform, our foundation designed to deliver gene therapy worldwide. We are headquartered in Cambridge, Mass., with an office in Toronto, Ontario. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn. Forward-Looking Statements This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words and phrases such as aims, anticipates, believes, could, designed to, estimates, expects, forecasts, goal, intends, may, plans, possible, potential, seeks, will, and variations of these words and phrases or similar expressions that are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements regarding our business strategy for and the potential therapeutic benefits of our prospective product candidates, the design, commencement, enrollment and timing of ongoing or planned clinical trials, clinical trial results, product approvals and regulatory pathways, anticipated benefits of our gene therapy platform including potential impact on our commercialization activities, timing and likelihood of success, the expected benefits and results of our implementation of the plato platform in our clinical trials and gene therapy programs and the expected safety profile of our investigational gene therapies. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Results in preclinical or early-stage clinical trials may not be indicative of results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements, or the scientific data presented. Any forward-looking statements in this press release are based on AVROBIOs current expectations, estimates and projections about our industry as well as managements current beliefs and expectations of future events only as of today and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that any one or more of AVROBIOs product candidates will not be successfully developed or commercialized, the risk of cessation or delay of any ongoing or planned clinical trials of AVROBIO or our collaborators, the risk that AVROBIO may not successfully recruit or enroll a sufficient number of patients for our clinical trials, the risk that AVROBIO may not realize the intended benefits of our gene therapy platform, including the features of our plato platform, the risk that our product candidates or procedures in connection with the administration thereof will not have the safety or efficacy profile that we anticipate, the risk that prior results, such as signals of safety, activity or durability of effect, observed from preclinical or clinical trials, will not be replicated or will not continue in ongoing or future studies or trials involving AVROBIOs product candidates, the risk that we will be unable to obtain and maintain regulatory approval for our product candidates, the risk that the size and growth potential of the market for our product candidates will not materialize as expected, risks associated with our dependence on third-party suppliers and manufacturers, risks regarding the accuracy of our estimates of expenses and future revenue, risks relating to our capital requirements and needs for additional financing, risks relating to clinical trial and business interruptions resulting from the COVID-19 outbreak or similar public health crises, including that such interruptions may materially delay our development timeline and/or increase our development costs or that data collection efforts may be impaired or otherwise impacted by such crises, and risks relating to our ability to obtain and maintain intellectual property protection for our product candidates. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause AVROBIOs actual results to differ materially and adversely from those contained in the forward-looking statements, see the section entitled Risk Factors in AVROBIOs most recent Annual or Quarterly Report, as well as discussions of potential risks, uncertainties and other important factors in AVROBIOs subsequent filings with the Securities and Exchange Commission. AVROBIO explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law. Answer:

AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company has granted non-statutory stock options for the purchase of up to an aggregate of 61,500 shares of the companys common stock to five new employees as inducement awards under the companys 2019 Inducement Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options were granted as inducements material to the new employees acceptance of employment with the company and were approved by the Compensation Committee of the companys Board of Directors. The stock options were granted on Mar. 1, 2021, with an exercise price of $11.45 per share, representing the closing price of AVROBIOs common stock as reported by Nasdaq on the grant date. The stock option awards have a 10-year term and vest over four years, with 25 percent of the original number of shares vesting on the first anniversary of the employees new hire date and the remainder vesting in equal monthly installments over the following three years. Vesting of the option awards is subject to continued service with AVROBIO by the employee through the applicable vesting dates. About AVROBIO Our vision is to bring personalized gene therapy to the world. We aim to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone. Our ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. AVROBIO is powered by our industry leading plato gene therapy platform, our foundation designed to deliver gene therapy worldwide. We are headquartered in Cambridge, Mass., with an office in Toronto, Ontario. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn. Forward-Looking Statements This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words and phrases such as aims, anticipates, believes, could, designed to, estimates, expects, forecasts, goal, intends, may, plans, possible, potential, seeks, will, and variations of these words and phrases or similar expressions that are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements regarding our business strategy for and the potential therapeutic benefits of our prospective product candidates, the design, commencement, enrollment and timing of ongoing or planned clinical trials, clinical trial results, product approvals and regulatory pathways, anticipated benefits of our gene therapy platform including potential impact on our commercialization activities, timing and likelihood of success, the expected benefits and results of our implementation of the plato platform in our clinical trials and gene therapy programs and the expected safety profile of our investigational gene therapies. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Results in preclinical or early-stage clinical trials may not be indicative of results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements, or the scientific data presented. Any forward-looking statements in this press release are based on AVROBIOs current expectations, estimates and projections about our industry as well as managements current beliefs and expectations of future events only as of today and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that any one or more of AVROBIOs product candidates will not be successfully developed or commercialized, the risk of cessation or delay of any ongoing or planned clinical trials of AVROBIO or our collaborators, the risk that AVROBIO may not successfully recruit or enroll a sufficient number of patients for our clinical trials, the risk that AVROBIO may not realize the intended benefits of our gene therapy platform, including the features of our plato platform, the risk that our product candidates or procedures in connection with the administration thereof will not have the safety or efficacy profile that we anticipate, the risk that prior results, such as signals of safety, activity or durability of effect, observed from preclinical or clinical trials, will not be replicated or will not continue in ongoing or future studies or trials involving AVROBIOs product candidates, the risk that we will be unable to obtain and maintain regulatory approval for our product candidates, the risk that the size and growth potential of the market for our product candidates will not materialize as expected, risks associated with our dependence on third-party suppliers and manufacturers, risks regarding the accuracy of our estimates of expenses and future revenue, risks relating to our capital requirements and needs for additional financing, risks relating to clinical trial and business interruptions resulting from the COVID-19 outbreak or similar public health crises, including that such interruptions may materially delay our development timeline and/or increase our development costs or that data collection efforts may be impaired or otherwise impacted by such crises, and risks relating to our ability to obtain and maintain intellectual property protection for our product candidates. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause AVROBIOs actual results to differ materially and adversely from those contained in the forward-looking statements, see the section entitled Risk Factors in AVROBIOs most recent Annual or Quarterly Report, as well as discussions of potential risks, uncertainties and other important factors in AVROBIOs subsequent filings with the Securities and Exchange Commission. AVROBIO explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

edtsum87

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: TYSONS CORNER, Va.--(BUSINESS WIRE)--MicroStrategy (Nasdaq: MSTR), the largest independent publicly-traded business intelligence company, today announced it will report its financial results for the first quarter of 2021 after the U.S. financial markets close on Thursday, April 29, 2021. MicroStrategy will host a live Video Webinar on Thursday, April 29, 2021 at 5:00 p.m. Eastern Time to discuss the companys first quarter 2021 financial results. A live Video Webinar of the event can be accessed under the Events and Presentations section of MicroStrategys investor relations website at https://www.microstrategy.com/en/investor-relations. The Video Webinar will be conducted on the Zoom platform and questions will only be taken from Video Webinar participants. Log-in instructions will be available after registering for the event. An archived replay of the event will be available beginning approximately two hours after the call concludes. About MicroStrategy Incorporated MicroStrategy (Nasdaq: MSTR) is the largest independent publicly-traded business intelligence company, with the leading enterprise analytics platform. Our vision is to enable Intelligence Everywhere. MicroStrategy provides modern analytics on an open, comprehensive enterprise platform used by many of the worlds most admired brands in the Fortune Global 500. Optimized for cloud and on-premises deployments, the platform features HyperIntelligence, a breakthrough technology that overlays actionable enterprise data on popular business applications to help users make smarter, faster decisions. For more information about MicroStrategy, visit www.microstrategy.com. MicroStrategy and HyperIntelligence are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners. MSTR-F Answer:

MicroStrategy Announces Earnings Release Date and Live Video Webinar for First Quarter 2021 Financial Results

TYSONS CORNER, Va.--(BUSINESS WIRE)--MicroStrategy (Nasdaq: MSTR), the largest independent publicly-traded business intelligence company, today announced it will report its financial results for the first quarter of 2021 after the U.S. financial markets close on Thursday, April 29, 2021. MicroStrategy will host a live Video Webinar on Thursday, April 29, 2021 at 5:00 p.m. Eastern Time to discuss the companys first quarter 2021 financial results. A live Video Webinar of the event can be accessed under the Events and Presentations section of MicroStrategys investor relations website at https://www.microstrategy.com/en/investor-relations. The Video Webinar will be conducted on the Zoom platform and questions will only be taken from Video Webinar participants. Log-in instructions will be available after registering for the event. An archived replay of the event will be available beginning approximately two hours after the call concludes. About MicroStrategy Incorporated MicroStrategy (Nasdaq: MSTR) is the largest independent publicly-traded business intelligence company, with the leading enterprise analytics platform. Our vision is to enable Intelligence Everywhere. MicroStrategy provides modern analytics on an open, comprehensive enterprise platform used by many of the worlds most admired brands in the Fortune Global 500. Optimized for cloud and on-premises deployments, the platform features HyperIntelligence, a breakthrough technology that overlays actionable enterprise data on popular business applications to help users make smarter, faster decisions. For more information about MicroStrategy, visit www.microstrategy.com. MicroStrategy and HyperIntelligence are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners. MSTR-F

edtsum88

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN FRANCISCO, June 2, 2020 /PRNewswire/ --Global Dental Drug Market is estimated to expand at a substantial CAGR in the forecast period as the scope, product types, and its applications are increasing across the globe. There are essentially two categories of the product in the market: Prescription Drug Products and OTC Drug Products. The OTC type is responsible for the biggest share and will have speedy development percentage. There are a numeral diverse medicines that dentist may possibly recommend, contingent on the condition of the patient. More or less medicines are suggested to fight definite illnesses of oral, to stop or treat contagions, or else to control discomfort and release unease. The prescribed amount of the medications and directions on by what method to take them will vary from patient to patient, dependent on what the drug is being utilized for, weight and age of the patient and the additional parameters. Drivers Increasing frequency of dental caries and additional periodontal illnesses, augmented endodontic circumstances, increasing alertness of the people regarding the oral cleanliness and dental care, growth in elderly inhabitants, and progression in diagnostic and treatment technologies of dental illness are the most important features motivating the global market. Furthermore, growing per head earnings in emerging nations is a most important issue boosting up the market for dental drug. Pleaseclick here to download the sample pdfand find more details on "Global Dental Drug Market"Report 2028. Restraints On the other hand, greater prices and availability of inadequate compensation for the treatment, issue of reasonable pricing faced by the important manufacturers and the scarcity of expert dental specialists are the most important restraints of the market. Classification The global market of dental drug can be classified by Sales Network, Mode of Administration, Type of Drug, Type of Product and Region. By Sales Network, it can be classified as Online Supplies, Retail Pharmacies, Hospital Pharmacies, and Medicine Stores. By Mode of Administration, it can be classified as Spray, Injectable and Oral. By Type of Drug, it can be classified as Saliva Alternatives, Fluorides, Antifungal, Anesthetics, Benzodiazepines, Antiseptics, Antibiotics and Analgesic. By Type of Product, it can be classified as Prescription Drug Product and OTC Drug Product. Regional Lookout By Region the global market of dental drug can be classified as North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. Owing to growing number of circumstances of tooth ache and dental caries between the children having preferences for sweets and junk foods, the North America ruled the global market for dental drug. Greater alertness between adults and employed professionals regarding cleanliness of mouth is additional factor, boosting the market within the state. North America responsible for a considerably big share of the dental drug industry. It is tracked by Europe and augmented demand for these drugs in industrialized nation state in Europe for example France, the U.K., and Germany. Growing demand for the dental drug in the nation states for example Japan, China and India is likely to increase the scope of the market in Asia Pacific. On the other hand, affordability and absence of technology performances such as the most important limitations to the market for dental drug in underdeveloped areas for example Latin America and Middle East & Africa. The scope in these provinces is estimated to grow which will be motivated by the emerging nations similar to South Africa and Brazil. Companies The scope and share of the market for dental drug is increasing by a speedy step. By means of growth in technical improvement, competition and M&A actions within the business, several native and provincial companies are proposing their products for particular application for diverse end users. The fresh competitors, entering in this field are finding it difficult to contest with the transnational companies on the basis of novelties in technology, quality and dependability. Some of the important companies for Dental Drug Market are: Sirona Dental Systems Inc., Danaher Corporation, Colgate-Palmolive, 3M, J&J, Merck, Kavo Dental GmbH, Den Mat, Sun star, GSK, Bayer. Additional notable companies are: Mediwin Pharmaceuticals, Acteon, Hutchison China MediTech, Roche, Valeant Pharmaceuticals, Xttrium Laboratorie, Xiuzheng Pharmaceutical, PerioChip, Septodont, and Showa Yakuhin Kako. Access 118 page research report with TOC on "Global Dental Drug Market" available with Radiant Insights, Inc. @: https://www.radiantinsights.com/research/2013-2028-report-on-global-dental-drug-market This report provides detailed historical analysis of global market for Dental Drug from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dental Drug market. Market Segmentation: Leading players of Dental Drug including: Merck Bayer J&J GSK 3M Sunstar Colgate-Palmolive DenMat Showa Yakuhin Kako Valeant Pharmaceuticals Septodont Roche PerioChip Hutchison China MediTech Xiuzheng Pharmaceutical Acteon Xttrium Laboratorie Mediwin Pharmaceuticals Market split by Type, can be divided into: OTC Prescription Product Market split by Application, can be divided into: Hospitals Dental Clinics Drugstores Market split by Sales Channel, can be divided into: Direct Channel Distribution Channel Market segment by Region/Country including: North America (United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Spain etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) South America Brazil, Argentina, Colombia and Chile etc.) Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) Browse Latest Market Research Reports available with Radiant Insights, Inc.: Chondroitin Sulfate Market Ursodeoxycholic Acid Market Glycine Market Sugar Coated Tablets Market About Radiant Insights, Inc.: At Radiant Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact:Michelle Thoras.Corporate Sales SpecialistRadiant Insights, Inc.Phone: +1-415-349-0054Toll Free: 1-888-928-9744Email: [emailprotected] Web: https://www.radiantinsights.com Blog: https://radiantinsightsinc.blogspot.com/ SOURCE Radiant Insights, Inc. Answer:

Dental Drug Market Analysis and Industry Insights Report, 2028 | Market Growth to be Motivated by Increasing Alertness Towards Oral Cleanliness and Dental Care: Radiant Insights, Inc.

SAN FRANCISCO, June 2, 2020 /PRNewswire/ --Global Dental Drug Market is estimated to expand at a substantial CAGR in the forecast period as the scope, product types, and its applications are increasing across the globe. There are essentially two categories of the product in the market: Prescription Drug Products and OTC Drug Products. The OTC type is responsible for the biggest share and will have speedy development percentage. There are a numeral diverse medicines that dentist may possibly recommend, contingent on the condition of the patient. More or less medicines are suggested to fight definite illnesses of oral, to stop or treat contagions, or else to control discomfort and release unease. The prescribed amount of the medications and directions on by what method to take them will vary from patient to patient, dependent on what the drug is being utilized for, weight and age of the patient and the additional parameters. Drivers Increasing frequency of dental caries and additional periodontal illnesses, augmented endodontic circumstances, increasing alertness of the people regarding the oral cleanliness and dental care, growth in elderly inhabitants, and progression in diagnostic and treatment technologies of dental illness are the most important features motivating the global market. Furthermore, growing per head earnings in emerging nations is a most important issue boosting up the market for dental drug. Pleaseclick here to download the sample pdfand find more details on "Global Dental Drug Market"Report 2028. Restraints On the other hand, greater prices and availability of inadequate compensation for the treatment, issue of reasonable pricing faced by the important manufacturers and the scarcity of expert dental specialists are the most important restraints of the market. Classification The global market of dental drug can be classified by Sales Network, Mode of Administration, Type of Drug, Type of Product and Region. By Sales Network, it can be classified as Online Supplies, Retail Pharmacies, Hospital Pharmacies, and Medicine Stores. By Mode of Administration, it can be classified as Spray, Injectable and Oral. By Type of Drug, it can be classified as Saliva Alternatives, Fluorides, Antifungal, Anesthetics, Benzodiazepines, Antiseptics, Antibiotics and Analgesic. By Type of Product, it can be classified as Prescription Drug Product and OTC Drug Product. Regional Lookout By Region the global market of dental drug can be classified as North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. Owing to growing number of circumstances of tooth ache and dental caries between the children having preferences for sweets and junk foods, the North America ruled the global market for dental drug. Greater alertness between adults and employed professionals regarding cleanliness of mouth is additional factor, boosting the market within the state. North America responsible for a considerably big share of the dental drug industry. It is tracked by Europe and augmented demand for these drugs in industrialized nation state in Europe for example France, the U.K., and Germany. Growing demand for the dental drug in the nation states for example Japan, China and India is likely to increase the scope of the market in Asia Pacific. On the other hand, affordability and absence of technology performances such as the most important limitations to the market for dental drug in underdeveloped areas for example Latin America and Middle East & Africa. The scope in these provinces is estimated to grow which will be motivated by the emerging nations similar to South Africa and Brazil. Companies The scope and share of the market for dental drug is increasing by a speedy step. By means of growth in technical improvement, competition and M&A actions within the business, several native and provincial companies are proposing their products for particular application for diverse end users. The fresh competitors, entering in this field are finding it difficult to contest with the transnational companies on the basis of novelties in technology, quality and dependability. Some of the important companies for Dental Drug Market are: Sirona Dental Systems Inc., Danaher Corporation, Colgate-Palmolive, 3M, J&J, Merck, Kavo Dental GmbH, Den Mat, Sun star, GSK, Bayer. Additional notable companies are: Mediwin Pharmaceuticals, Acteon, Hutchison China MediTech, Roche, Valeant Pharmaceuticals, Xttrium Laboratorie, Xiuzheng Pharmaceutical, PerioChip, Septodont, and Showa Yakuhin Kako. Access 118 page research report with TOC on "Global Dental Drug Market" available with Radiant Insights, Inc. @: https://www.radiantinsights.com/research/2013-2028-report-on-global-dental-drug-market This report provides detailed historical analysis of global market for Dental Drug from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dental Drug market. Market Segmentation: Leading players of Dental Drug including: Merck Bayer J&J GSK 3M Sunstar Colgate-Palmolive DenMat Showa Yakuhin Kako Valeant Pharmaceuticals Septodont Roche PerioChip Hutchison China MediTech Xiuzheng Pharmaceutical Acteon Xttrium Laboratorie Mediwin Pharmaceuticals Market split by Type, can be divided into: OTC Prescription Product Market split by Application, can be divided into: Hospitals Dental Clinics Drugstores Market split by Sales Channel, can be divided into: Direct Channel Distribution Channel Market segment by Region/Country including: North America (United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Spain etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) South America Brazil, Argentina, Colombia and Chile etc.) Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) Browse Latest Market Research Reports available with Radiant Insights, Inc.: Chondroitin Sulfate Market Ursodeoxycholic Acid Market Glycine Market Sugar Coated Tablets Market About Radiant Insights, Inc.: At Radiant Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact:Michelle Thoras.Corporate Sales SpecialistRadiant Insights, Inc.Phone: +1-415-349-0054Toll Free: 1-888-928-9744Email: [emailprotected] Web: https://www.radiantinsights.com Blog: https://radiantinsightsinc.blogspot.com/ SOURCE Radiant Insights, Inc.

edtsum90

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Aug. 18, 2020 /PRNewswire/ --Online travel and accommodations firm Travala.com has integrated STP Network into its platform, allowing for payments to be made in native STPT. Travala.com recently partnered with hotel booking giant Expedia, expanding its hotel and accommodations offerings to a total of over 2 million in 230 countries.Travala.com's partnership with STP Network enhances the utility of STPT by enabling it to be used for purchasing travel services. Continue Reading STP Network "Travala.com has solidified itself as the leader in accommodation booking platforms that offer users more convenient payment alternatives especially with their partnerships with giants like Expedia and Booking.com. We are very excited about this integration, which adds greater utility for the STPT token and will help promote strong collaboration between both communities," said Minhui Chen, STP Network CEO. Backed by industry-giant Binance, Travala.com is building one of the biggest online travel agencies, standing out from its competitors by directly integrating cryptocurrency payments, loyalty programs, crypto debit cards & other advantages inherent to blockchain technology.The Travala.com platform has experienced a surge in demand even in recent times, demonstrating consumer appetite for innovative solutions and modern payment options, which will further the exposure of the STP ecosystem to an actively growing user base."The overhead associated with integrating new blockchains into our platforms makes us very selective about how we expand the available options so that we do so in a meaningful way. STP Network's ecosystem and community will help strengthen our global presence and will be a key partner for us in Asia,"said Juan Otero, Travala.com CEO.About Travala.comFounded in 2017, Travala.com is the leading cryptocurrency-friendly travel booking service with 2,200,000+ hotels and homes in 230 countries and 600 airlines globally. Backed by industry-giant Binance, Travala.com is a champion of cryptocurrency adoption, accepting over 30 leading cryptocurrencies in addition to traditional payment methods. The Travala.com value proposition is bolstered by AVA. As the native cryptocurrency of the platform, AVA can be used for payments, receiving loyalty rewards, discounts and bonuses, among several other use cases. For more information, visit: www.travala.comAbout STP NetworkSTP Network is a decentralized blockchain-powered network that allows for the tokenization of any asset. All assets tokenized via STP Network are compliant across global jurisdictions and transferable across any blockchain platform. The protocol's on-chain validator verifies the compliance with jurisdictional and user-specific requirements of tokens built on top of the STP standard. To learn more about STP Network, visit https://stp.network.Related Imagesimage1.png SOURCE STP Network Answer:

Leading Blockchain-Based Travel Booking Platform Travala.com Integrates STPT as Payment

NEW YORK, Aug. 18, 2020 /PRNewswire/ --Online travel and accommodations firm Travala.com has integrated STP Network into its platform, allowing for payments to be made in native STPT. Travala.com recently partnered with hotel booking giant Expedia, expanding its hotel and accommodations offerings to a total of over 2 million in 230 countries.Travala.com's partnership with STP Network enhances the utility of STPT by enabling it to be used for purchasing travel services. Continue Reading STP Network "Travala.com has solidified itself as the leader in accommodation booking platforms that offer users more convenient payment alternatives especially with their partnerships with giants like Expedia and Booking.com. We are very excited about this integration, which adds greater utility for the STPT token and will help promote strong collaboration between both communities," said Minhui Chen, STP Network CEO. Backed by industry-giant Binance, Travala.com is building one of the biggest online travel agencies, standing out from its competitors by directly integrating cryptocurrency payments, loyalty programs, crypto debit cards & other advantages inherent to blockchain technology.The Travala.com platform has experienced a surge in demand even in recent times, demonstrating consumer appetite for innovative solutions and modern payment options, which will further the exposure of the STP ecosystem to an actively growing user base."The overhead associated with integrating new blockchains into our platforms makes us very selective about how we expand the available options so that we do so in a meaningful way. STP Network's ecosystem and community will help strengthen our global presence and will be a key partner for us in Asia,"said Juan Otero, Travala.com CEO.About Travala.comFounded in 2017, Travala.com is the leading cryptocurrency-friendly travel booking service with 2,200,000+ hotels and homes in 230 countries and 600 airlines globally. Backed by industry-giant Binance, Travala.com is a champion of cryptocurrency adoption, accepting over 30 leading cryptocurrencies in addition to traditional payment methods. The Travala.com value proposition is bolstered by AVA. As the native cryptocurrency of the platform, AVA can be used for payments, receiving loyalty rewards, discounts and bonuses, among several other use cases. For more information, visit: www.travala.comAbout STP NetworkSTP Network is a decentralized blockchain-powered network that allows for the tokenization of any asset. All assets tokenized via STP Network are compliant across global jurisdictions and transferable across any blockchain platform. The protocol's on-chain validator verifies the compliance with jurisdictional and user-specific requirements of tokens built on top of the STP standard. To learn more about STP Network, visit https://stp.network.Related Imagesimage1.png SOURCE STP Network

edtsum95

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Turbo Generator Market by Type, Cooling System, and End-User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global turbo generator market was valued at $10. 4 billion in 2019, and is projected to reach $12. 6 billion by 2027, growing at a CAGR of 3. 1% from 2020 to 2027. Turbo generator is a system in which turbine is connected to generator and converts mechanical energy of steam, water, natural gas into electricity. Turbo generator is also called as turbine generator. Turbine generator has normal speed of 1,500 or 3,000 rpm depending on number of poles at 50 HZ. It can be used as standby, emergency, standalone, and peak shaving unit. Cooling systems used in the turbo generators depending on the applications include air-cooled, water-cooled, and hydrogen-cooled generators. It is utilized in the generation of power in nuclear, gas, hydro, thermal and other power plants. Rapid growth in the installation of gas power plants is a key factor driving the growth of the turbo generator market. In addition, increase in demand for continuous and stable power supply contribute toward the growth of the global turbo generator market in the upcoming years. However, increase in developments in the renewable energy sector and stringent governmental regulations toward greenhouse gases emissions hampers the growth of the market, globally. Conversely, increase in investment toward the electrification of rural and remote areas is expected to create potential growth opportunity for key player operating in this market. The global turbo generator market is segmented into type, cooling system, end-user, and region. Depending on type, the market is categorized into gas turbine generator, steam turbine generator, and water turbine generator. As per cooling system, it is classified into air-cooled, water-cooled, and hydrogen-cooled. By end-user, the market is fragmented into coal power plants, gas power plants, nuclear power plants and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Key Benefits Market Dynamics Drivers Restraints Opportunity Key Market Players For more information about this report visit https://www.researchandmarkets.com/r/kh8kqa Answer:

Insights on the Turbo Generator Global Market to 2027 - Opportunity Analysis and Industry Forecast - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Turbo Generator Market by Type, Cooling System, and End-User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global turbo generator market was valued at $10. 4 billion in 2019, and is projected to reach $12. 6 billion by 2027, growing at a CAGR of 3. 1% from 2020 to 2027. Turbo generator is a system in which turbine is connected to generator and converts mechanical energy of steam, water, natural gas into electricity. Turbo generator is also called as turbine generator. Turbine generator has normal speed of 1,500 or 3,000 rpm depending on number of poles at 50 HZ. It can be used as standby, emergency, standalone, and peak shaving unit. Cooling systems used in the turbo generators depending on the applications include air-cooled, water-cooled, and hydrogen-cooled generators. It is utilized in the generation of power in nuclear, gas, hydro, thermal and other power plants. Rapid growth in the installation of gas power plants is a key factor driving the growth of the turbo generator market. In addition, increase in demand for continuous and stable power supply contribute toward the growth of the global turbo generator market in the upcoming years. However, increase in developments in the renewable energy sector and stringent governmental regulations toward greenhouse gases emissions hampers the growth of the market, globally. Conversely, increase in investment toward the electrification of rural and remote areas is expected to create potential growth opportunity for key player operating in this market. The global turbo generator market is segmented into type, cooling system, end-user, and region. Depending on type, the market is categorized into gas turbine generator, steam turbine generator, and water turbine generator. As per cooling system, it is classified into air-cooled, water-cooled, and hydrogen-cooled. By end-user, the market is fragmented into coal power plants, gas power plants, nuclear power plants and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Key Benefits Market Dynamics Drivers Restraints Opportunity Key Market Players For more information about this report visit https://www.researchandmarkets.com/r/kh8kqa

edtsum96

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: MIAMI, March 17, 2020 /PRNewswire/ --Cool Holdings, Inc. (OTCQB: AWSM) (the "Company" or "Cool Holdings"), the parent company of Simply Mac, Inc., the largest Apple Premier Partner in the U.S. ("Simply Mac"), and GameStop Corp. ("GameStop"), have completed a restructuring of the debt owed to GameStop by the Company. On September 25, 2019, Cool Holdings purchased all of the outstanding stock of Simply Mac from GameStop. A portion of the consideration for the purchase included a 12% Secured Promissory Note for $7,858,000 (the "Note") that was due in quarterly installments beginning December 25, 2019. The Company anticipated that it would be able to raise sufficient equity capital to pay the quarterly Note installments. However, that did not occur, and the Company was unable to make the first installment payment. Consequently, on January 15, 2020, the Company received a notice of default from GameStop of its obligations under the Note (the "Default"). The Company announced today that on March 11, 2020 it closed the restructuring of the Note and related agreements in a settlement that resulted in a curing of the Default and the following: Cool Holdings made an immediate payment of $250,000 to GameStop; $345,000 held in escrow to secure the indemnity obligations of GameStop in connection with the Simply Mac sale to Cool Holdings was released to GameStop; The original Note was amended so that the principal amount was adjusted downward to $1,250,000, the Note became unsecured and all Company assets formerly secured were released, the interest rate is set at 6% and all principal and interest accrued from March 11, 2020 will be due upon maturity on February 17, 2024. About Cool Holdings, Inc.Cool Holdings is a Miami-based company currently comprised of Simply Mac and OneClick, two chains of retail stores and an authorized reseller under the Apple Premier Partner, APR (Apple Premium Reseller) and AAR MB (Apple Authorized Reseller Mono-Brand) programs and Cooltech Distribution, an authorized distributor to the OneClick stores and other resellers of Apple products and other high-profile consumer electronic brands. Additional information can be found on its website at www.coolholdings.com. Forward-looking and cautionary statementsForward-looking statements in this press release and all other statements that are not historical facts are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements, including actions by third parties. A list and description of various risk factors related to Cool Holdings, Inc. can be found and reviewed in the Company's Annual Report on Form10-K for the year ended December 31, 2018 and the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, both of which can be accessed under the Company's profile at www.sec.gov. These forward-looking statements speak only as of the date of this release and we undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release, except as required by law. All product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement. SOURCE Cool Holdings, Inc. Related Links http://www.coolholdings.com Answer:

Cool Holdings Cures Default and Extinguishes $6.6 Million of Debt After Restructuring Agreement with GameStop

MIAMI, March 17, 2020 /PRNewswire/ --Cool Holdings, Inc. (OTCQB: AWSM) (the "Company" or "Cool Holdings"), the parent company of Simply Mac, Inc., the largest Apple Premier Partner in the U.S. ("Simply Mac"), and GameStop Corp. ("GameStop"), have completed a restructuring of the debt owed to GameStop by the Company. On September 25, 2019, Cool Holdings purchased all of the outstanding stock of Simply Mac from GameStop. A portion of the consideration for the purchase included a 12% Secured Promissory Note for $7,858,000 (the "Note") that was due in quarterly installments beginning December 25, 2019. The Company anticipated that it would be able to raise sufficient equity capital to pay the quarterly Note installments. However, that did not occur, and the Company was unable to make the first installment payment. Consequently, on January 15, 2020, the Company received a notice of default from GameStop of its obligations under the Note (the "Default"). The Company announced today that on March 11, 2020 it closed the restructuring of the Note and related agreements in a settlement that resulted in a curing of the Default and the following: Cool Holdings made an immediate payment of $250,000 to GameStop; $345,000 held in escrow to secure the indemnity obligations of GameStop in connection with the Simply Mac sale to Cool Holdings was released to GameStop; The original Note was amended so that the principal amount was adjusted downward to $1,250,000, the Note became unsecured and all Company assets formerly secured were released, the interest rate is set at 6% and all principal and interest accrued from March 11, 2020 will be due upon maturity on February 17, 2024. About Cool Holdings, Inc.Cool Holdings is a Miami-based company currently comprised of Simply Mac and OneClick, two chains of retail stores and an authorized reseller under the Apple Premier Partner, APR (Apple Premium Reseller) and AAR MB (Apple Authorized Reseller Mono-Brand) programs and Cooltech Distribution, an authorized distributor to the OneClick stores and other resellers of Apple products and other high-profile consumer electronic brands. Additional information can be found on its website at www.coolholdings.com. Forward-looking and cautionary statementsForward-looking statements in this press release and all other statements that are not historical facts are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements, including actions by third parties. A list and description of various risk factors related to Cool Holdings, Inc. can be found and reviewed in the Company's Annual Report on Form10-K for the year ended December 31, 2018 and the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, both of which can be accessed under the Company's profile at www.sec.gov. These forward-looking statements speak only as of the date of this release and we undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release, except as required by law. All product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement. SOURCE Cool Holdings, Inc. Related Links http://www.coolholdings.com

edtsum99

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN DIEGO, Dec. 17, 2020 /PRNewswire/ -- International Land Alliance, Inc. (OTCQB: ILAL), is pleased to announce its joint venture partner has completed site preparation and will officially break ground next week to develop a commercial hemp operation on 40 acres of the Company's Southern California property. The Company announced the signing of the joint venture onOctober 12, 2020. The first phase of the development includes plans for 1,350 square feet of indoor operations slated for growing, germination, processing and storageand 3 acres of outdoor. Indoor grows can have nearly perpetual harvests if the growing conditions are right and a good cultivation team is in place.Outdoor plants are usually larger and contain more buds in many cases, but with multiple harvests, the yield for indoor plants can be much larger depending on the number of plants, as well as the other factors that can impact output. "It is impressive to see how quickly this project is getting off the ground and we are grateful for the collaboration with our strategic business partner. We are proud to share our first of what will be many updates to our shareholders," saidJason Sunstein, Vice President of International Land Alliance. As previously announced, the Company entered into a joint venture, which will be owned 50% by the Company and 50% by Grower. The Company's contribution to the Joint Venture will be the use of the 40 acres of land and existing indoor commercial space. Grower will contribute all required capital, consulting services, cultivation equipment, agricultural infrastructure and ability to scale hemp operations. The Company acquired this property in Q1 2019 for $1,100,000, which included three vacant 20-acre parcels, and one 20-acre parcel with an existing 8,000 square foot event venue currently generating revenue. In Q3 2019, the Company sold one vacant 20-acre parcel for $630,000. After careful due diligence, the Company has determined that this Joint Venture is the best use and return on investment for the remaining two vacant 20-acre parcels without the Company expending additional capital. About International Land Alliance, Inc.: International Land Alliance, Inc. (OTCQB:ILAL) is an international land investment and development firm based in San Diego, California. As its' core mission, the Company has embraced technology for sustainable and socially responsible solutions, in addition to using proptech and construction tech advanced applications to meet these goals. The Company is focused on acquiring attractive raw land primarily in Northern Baja California, often within driving distance from Southern California. The Company serves its shareholders by devoting considerable time and resources to seeking out the finest sites available and obtaining the necessary development permits to build a compelling portfolio of properties, which provide a diversity of investment and living options. Please visit: www.ila.company. Safe Harbor Statement The press release may include certain statements that are not descriptions of historical facts but are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements may include the description of our plans and objectives for future operations, assumptions underlying such plans and objectives, and other forward-looking terminology such as "may," "expects," "believes," "anticipates," "intends," "projects," or similar terms, variations of such terms or the negative of such terms. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements made herein. Such information is based upon various assumptions made by, and expectations of, our management that were reasonable when made but may prove to be incorrect. All of such assumptions are inherently subject to significant economic and competitive uncertainties and contingencies beyond our control and upon assumptions with respect to the future business decisions which are subject to change. Accordingly, there can be no assurance that actual results will meet expectation and actual results may vary (perhaps materially) from certain of the results anticipated herein. SOURCE International Land Alliance, Inc. Answer:

International Land Alliance Announces Site Preparation for CBD Hemp Joint Venture

SAN DIEGO, Dec. 17, 2020 /PRNewswire/ -- International Land Alliance, Inc. (OTCQB: ILAL), is pleased to announce its joint venture partner has completed site preparation and will officially break ground next week to develop a commercial hemp operation on 40 acres of the Company's Southern California property. The Company announced the signing of the joint venture onOctober 12, 2020. The first phase of the development includes plans for 1,350 square feet of indoor operations slated for growing, germination, processing and storageand 3 acres of outdoor. Indoor grows can have nearly perpetual harvests if the growing conditions are right and a good cultivation team is in place.Outdoor plants are usually larger and contain more buds in many cases, but with multiple harvests, the yield for indoor plants can be much larger depending on the number of plants, as well as the other factors that can impact output. "It is impressive to see how quickly this project is getting off the ground and we are grateful for the collaboration with our strategic business partner. We are proud to share our first of what will be many updates to our shareholders," saidJason Sunstein, Vice President of International Land Alliance. As previously announced, the Company entered into a joint venture, which will be owned 50% by the Company and 50% by Grower. The Company's contribution to the Joint Venture will be the use of the 40 acres of land and existing indoor commercial space. Grower will contribute all required capital, consulting services, cultivation equipment, agricultural infrastructure and ability to scale hemp operations. The Company acquired this property in Q1 2019 for $1,100,000, which included three vacant 20-acre parcels, and one 20-acre parcel with an existing 8,000 square foot event venue currently generating revenue. In Q3 2019, the Company sold one vacant 20-acre parcel for $630,000. After careful due diligence, the Company has determined that this Joint Venture is the best use and return on investment for the remaining two vacant 20-acre parcels without the Company expending additional capital. About International Land Alliance, Inc.: International Land Alliance, Inc. (OTCQB:ILAL) is an international land investment and development firm based in San Diego, California. As its' core mission, the Company has embraced technology for sustainable and socially responsible solutions, in addition to using proptech and construction tech advanced applications to meet these goals. The Company is focused on acquiring attractive raw land primarily in Northern Baja California, often within driving distance from Southern California. The Company serves its shareholders by devoting considerable time and resources to seeking out the finest sites available and obtaining the necessary development permits to build a compelling portfolio of properties, which provide a diversity of investment and living options. Please visit: www.ila.company. Safe Harbor Statement The press release may include certain statements that are not descriptions of historical facts but are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements may include the description of our plans and objectives for future operations, assumptions underlying such plans and objectives, and other forward-looking terminology such as "may," "expects," "believes," "anticipates," "intends," "projects," or similar terms, variations of such terms or the negative of such terms. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements made herein. Such information is based upon various assumptions made by, and expectations of, our management that were reasonable when made but may prove to be incorrect. All of such assumptions are inherently subject to significant economic and competitive uncertainties and contingencies beyond our control and upon assumptions with respect to the future business decisions which are subject to change. Accordingly, there can be no assurance that actual results will meet expectation and actual results may vary (perhaps materially) from certain of the results anticipated herein. SOURCE International Land Alliance, Inc.

edtsum102

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON--(BUSINESS WIRE)--Technavio has been monitoring the cleanroom technology equipment market and it is poised to grow by USD 1.36 billion during 2020-2024, at a CAGR of almost 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts Frequently Asked Questions- The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Alpiq Holding Ltd., Ansell Ltd., Ardmac, Azbil Corp., Clean Air Products, CME Corp., Connect 2 Cleanrooms Ltd., Exyte Group, Kimberly-Clark Corp., and Taikisha Ltd. are some of the major market participants. The growing healthcare industry will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Cleanroom Technology Equipment Market 2020-2024: Segmentation Cleanroom Technology Equipment Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43622 Cleanroom Technology Equipment Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The cleanroom technology equipment market report covers the following areas: This study identifies the introduction of new universal standards for air filters as one of the prime reasons driving the cleanroom technology equipment market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Cleanroom Technology Equipment Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Customer landscape Geographic Landscape Market Drivers Market Challenges Market Trends Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Answer:

Cleanroom Technology Equipment Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Growing Healthcare Industry to Boost the Market Growth | Technavio

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the cleanroom technology equipment market and it is poised to grow by USD 1.36 billion during 2020-2024, at a CAGR of almost 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts Frequently Asked Questions- The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Alpiq Holding Ltd., Ansell Ltd., Ardmac, Azbil Corp., Clean Air Products, CME Corp., Connect 2 Cleanrooms Ltd., Exyte Group, Kimberly-Clark Corp., and Taikisha Ltd. are some of the major market participants. The growing healthcare industry will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Cleanroom Technology Equipment Market 2020-2024: Segmentation Cleanroom Technology Equipment Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43622 Cleanroom Technology Equipment Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The cleanroom technology equipment market report covers the following areas: This study identifies the introduction of new universal standards for air filters as one of the prime reasons driving the cleanroom technology equipment market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Cleanroom Technology Equipment Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Product Customer landscape Geographic Landscape Market Drivers Market Challenges Market Trends Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

edtsum107

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON, April 16, 2020 /PRNewswire/ -- Roots Analysishas announced the addition ofthe "Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030" report to its list of offerings. In fact, several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge. To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this link Key Market Insights Presently, there are 270+ trials evaluating a number of oligonucleotide-based interventions Of these, around 40% are investigating the use of antisense oligonucleotides. Till date, more than 47,000 patients have been enrolled in ongoing / planned trials; majority of them being enrolled in Europe. Over 80 companies claim to offer manufacturing services, at different scales of operation, for oligonucleotides The market landscape is currently dominated by the presence of small firms (1-50 employees), which represent close to 50% of the total number of industry stakeholders. This is followed by the larger and more established firms (~32%) and mid-sized players (~20%). More than 40% of service providers claim to operate at all scales of operation. More than 70% service providers focus on production of oligonucleotides for research and diagnostic applications However, several players are shifting their focus onto manufacturing oligonucleotides for therapeutic use. It worth highlighting that close to 20% of service providers engaged in this domain claim to offer manufacturing services for research, diagnostic, and therapeutic applications. Partnership activity has increased at a CAGR of over 60% within this domain, since 2014 Majority of the agreements (40%) were signed to offer manufacturing services to oligonucleotide-based product developers, followed by mergers / acquisitions (21%), aimed at the consolidation of existing service portfolios. Multiple expansion initiatives were undertaken by service providers, between 2014 and 2019 Over 45% of such initiatives were reported to be focused on expanding manufacturing-related capabilities, followed by building new facilities (25%). Demand for oligonucleotides is anticipated to grow at a CAGR of 13.3%, during 2020-2030 Given the fact that several oligonucleotide-based drug products were approved in the last 3-4 years, the commercial demand for oligonucleotides is high. Interestingly, over 65% of the estimated commercial demand was observed to have generated from products intended for treating neuromuscular disorders. The US and EU have emerged as major oligonucleotide manufacturing hubs, both in terms of number of facilities and installed capacity More than 55 oligonucleotide manufacturers were observed to have facilities in the US and EU. At present, the annual, installed manufacturing capacity in these regions is estimated to represent around 75% of the available global capacity. This is primarily driven by players with commercial scale expertise / capabilities. Antisense oligonucleotides and siRNAs are anticipated to capture over 70% of the market share. by 2030 Interestingly, the manufacturing services market for miRNAs and other novel oligonucleotides is anticipated to grow at a relatively faster rate during the next decade. To request a sample copy / brochure of this report, please visit thislink Key Questions Answered Who are the leading manufacturers of oligonucleotides for use in research, diagnostic and therapeutic applications? What are the preferred custom synthesis, modification and purification methods used for oligonucleotides? What are the key challenges faced by oligonucleotide manufacturers? What kind of partnership models are commonly adopted by industry stakeholders? What are the recent expansion initiatives undertaken by service providers within this domain? What is the annual clinical and commercial demand for oligonucleotides? What is the current, installed manufacturing capacity for oligonucleotides? What percentage of oligonucleotide manufacturing operations are outsourced to service providers? What are the opportunities in emerging markets for oligonucleotide manufacturing? How is the current and future market opportunity likely to be distributed across key market segments? What are the anticipated future trends related to oligonucleotide manufacturing? The ~USD 3.0 billion financial opportunity (by 2030) within the oligonucleotide synthesis, modification and purification services market has been analyzed across the following segments: Application Research and diagnostics Therapeutics Type of oligonucleotide manufactured Antisense miRNA siRNA Other oligonucleotides Scale of Operation Preclinical / Clinical Commercial Company Size Small Mid-sized Large Target Therapeutic Area Oncological disorders Ophthalmic disorders Metabolic disorders Autoimmune disorders Other therapeutic areas Key geographical regions North America Europe Asia-Pacific Rest of the world The report features inputs from the eminent industry stakeholders, according to whom the oligonucleotide manufacturing services market is primarily driven by the increasing demand for such molecules for use in diagnostic and therapeutic applications. The report includes detailed transcripts of discussions held with the following experts: Joachim Bertram (Chief Scientific Officer and Managing Director, IBA Lifesciences) Tobias Pohlmann (Founder and Managing Director, BianoScience) The research covers detailed profiles, featuring a brief company overview, its financial information (if available), information related to its service portfolio, manufacturing facilities, details on partnerships, recent developments (expansions), and awards received by the firm, as well as an informed future outlook. Agilent Technologies Ajinomoto Bio-Pharma Services BioSpring CordenPharma Integrated DNA Technologies Kaneka Eurogentec LGC Biosearch Technologies Microsynth Nitto Denko Avecia Sigma Aldrich Thermo Fisher Scientific Trilink Biotechnologies For additional details, please visit https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.htmlor email [emailprotected] You may also be interested in the following titles: 1. China Biopharmaceutical Contract Manufacturing Market, 2020-2030 2. China Pharmaceutical Contract Manufacturing Services Market, 2020-2030 3. Pharmaceutical Continuous Manufacturing Market, 2020-2030 4. Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030 5. Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030 Contact: Gaurav Chaudhary +1 (415) 800-3415 +44 (122) 391-1091[emailprotected] SOURCE Roots Analysis Answer:

The Oligonucleotide Synthesis, Modification and Purification Services Market is Expected to Grow at an Annualized Rate of over 10%, Claims Roots Analysis The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting up manufacturing facilities, has generated a range of new opportunities for custom manufacturers

LONDON, April 16, 2020 /PRNewswire/ -- Roots Analysishas announced the addition ofthe "Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030" report to its list of offerings. In fact, several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge. To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this link Key Market Insights Presently, there are 270+ trials evaluating a number of oligonucleotide-based interventions Of these, around 40% are investigating the use of antisense oligonucleotides. Till date, more than 47,000 patients have been enrolled in ongoing / planned trials; majority of them being enrolled in Europe. Over 80 companies claim to offer manufacturing services, at different scales of operation, for oligonucleotides The market landscape is currently dominated by the presence of small firms (1-50 employees), which represent close to 50% of the total number of industry stakeholders. This is followed by the larger and more established firms (~32%) and mid-sized players (~20%). More than 40% of service providers claim to operate at all scales of operation. More than 70% service providers focus on production of oligonucleotides for research and diagnostic applications However, several players are shifting their focus onto manufacturing oligonucleotides for therapeutic use. It worth highlighting that close to 20% of service providers engaged in this domain claim to offer manufacturing services for research, diagnostic, and therapeutic applications. Partnership activity has increased at a CAGR of over 60% within this domain, since 2014 Majority of the agreements (40%) were signed to offer manufacturing services to oligonucleotide-based product developers, followed by mergers / acquisitions (21%), aimed at the consolidation of existing service portfolios. Multiple expansion initiatives were undertaken by service providers, between 2014 and 2019 Over 45% of such initiatives were reported to be focused on expanding manufacturing-related capabilities, followed by building new facilities (25%). Demand for oligonucleotides is anticipated to grow at a CAGR of 13.3%, during 2020-2030 Given the fact that several oligonucleotide-based drug products were approved in the last 3-4 years, the commercial demand for oligonucleotides is high. Interestingly, over 65% of the estimated commercial demand was observed to have generated from products intended for treating neuromuscular disorders. The US and EU have emerged as major oligonucleotide manufacturing hubs, both in terms of number of facilities and installed capacity More than 55 oligonucleotide manufacturers were observed to have facilities in the US and EU. At present, the annual, installed manufacturing capacity in these regions is estimated to represent around 75% of the available global capacity. This is primarily driven by players with commercial scale expertise / capabilities. Antisense oligonucleotides and siRNAs are anticipated to capture over 70% of the market share. by 2030 Interestingly, the manufacturing services market for miRNAs and other novel oligonucleotides is anticipated to grow at a relatively faster rate during the next decade. To request a sample copy / brochure of this report, please visit thislink Key Questions Answered Who are the leading manufacturers of oligonucleotides for use in research, diagnostic and therapeutic applications? What are the preferred custom synthesis, modification and purification methods used for oligonucleotides? What are the key challenges faced by oligonucleotide manufacturers? What kind of partnership models are commonly adopted by industry stakeholders? What are the recent expansion initiatives undertaken by service providers within this domain? What is the annual clinical and commercial demand for oligonucleotides? What is the current, installed manufacturing capacity for oligonucleotides? What percentage of oligonucleotide manufacturing operations are outsourced to service providers? What are the opportunities in emerging markets for oligonucleotide manufacturing? How is the current and future market opportunity likely to be distributed across key market segments? What are the anticipated future trends related to oligonucleotide manufacturing? The ~USD 3.0 billion financial opportunity (by 2030) within the oligonucleotide synthesis, modification and purification services market has been analyzed across the following segments: Application Research and diagnostics Therapeutics Type of oligonucleotide manufactured Antisense miRNA siRNA Other oligonucleotides Scale of Operation Preclinical / Clinical Commercial Company Size Small Mid-sized Large Target Therapeutic Area Oncological disorders Ophthalmic disorders Metabolic disorders Autoimmune disorders Other therapeutic areas Key geographical regions North America Europe Asia-Pacific Rest of the world The report features inputs from the eminent industry stakeholders, according to whom the oligonucleotide manufacturing services market is primarily driven by the increasing demand for such molecules for use in diagnostic and therapeutic applications. The report includes detailed transcripts of discussions held with the following experts: Joachim Bertram (Chief Scientific Officer and Managing Director, IBA Lifesciences) Tobias Pohlmann (Founder and Managing Director, BianoScience) The research covers detailed profiles, featuring a brief company overview, its financial information (if available), information related to its service portfolio, manufacturing facilities, details on partnerships, recent developments (expansions), and awards received by the firm, as well as an informed future outlook. Agilent Technologies Ajinomoto Bio-Pharma Services BioSpring CordenPharma Integrated DNA Technologies Kaneka Eurogentec LGC Biosearch Technologies Microsynth Nitto Denko Avecia Sigma Aldrich Thermo Fisher Scientific Trilink Biotechnologies For additional details, please visit https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.htmlor email [emailprotected] You may also be interested in the following titles: 1. China Biopharmaceutical Contract Manufacturing Market, 2020-2030 2. China Pharmaceutical Contract Manufacturing Services Market, 2020-2030 3. Pharmaceutical Continuous Manufacturing Market, 2020-2030 4. Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030 5. Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030 Contact: Gaurav Chaudhary +1 (415) 800-3415 +44 (122) 391-1091[emailprotected] SOURCE Roots Analysis

edtsum108

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DALLAS, Jan. 5, 2021 /PRNewswire/ -- Customer Support Transformation: The Guide to Essential Practices and Metrics, the new research-based report by Service Excellence Research Group (ServiceXRG) in collaboration with TeamSupport, examines important trends in customer support delivery and offers tangible guidance for customer support and service professionals to meet growing expectations of both customers and company executives. "B2B support demand is growing by almost 11 percent," acknowledges Melissa Hendrick, Chief Marketing Officer at TeamSupport, an award-winning post-sale B2B customer support software solution provider for technology-enabled companies. "The customer support function traditionally has been reactive and transactional, butit is evolving to be more proactive, helping tostrengthencustomer relationships." She goes on, "Customer support is now playing a key role in drivingrecurring revenues and dramatically reducing churn." Customer support is evolving to be more proactive, playing a key role in driving recurring revenues and reducing churn. Tweet this "The Customer Support Transformation report highlights the challenges customer support leaders face and offers insights into the practices and metrics companies need to successfully scale support and deliver the level of service customers expect,"saidTom Sweeny, CEO of ServiceXRG, a leading industry research and consulting firm. It outlines ten actionable Support imperatives that customer support leaders must focus on to drive the continued transformation of this function, including: Focusing on delivering positive experiences that retain customer relationships Prioritizing investment in customer support initiatives to reduce demand and to help customers gain greater self-sufficiency Leveraging customer interactions and support case data to identify predictive and preventative opportunities "Support has always been ready to embrace new ways to improve customer experiences and achieve greater efficiencies," Sweeny concludes. "This study finds that Support has reached an inflection point where subscription-based relationships, the imperative to drive product adoption, and the perennial challenges of resource constraints and demands for cost efficiency suggest that incremental changes to Support are no longer enough." The full report is now available for download.About TeamSupportTeamSupport is a post-sale award-winning customer support software provider built specifically for the unique needs of B2B (business-to-business) technology-enabled companies within the computer software, hardware, information technology services, and telecom industries. Created by B2B customer support industry experts, TeamSupport has spent the past decade creating a support solution that helps build passionate customer bases for its clients.TeamSupport stands alone as the leading support solution that helps solve for sophisticated client needs and fuels successful client interactions. The TeamSupport suite of solutions includes TeamInsights, a customizable reporting and analytics dashboard.TeamSupport is headquartered in Dallas, Texas. Learn more at TeamSupport.com.About Service Excellence Research GroupSince 2004, ServiceXRG has guided the world's leading technology companies in their strategic efforts to retain customers, grow recurring revenue, and achieve cost efficiencies through the delivery of high-quality Technical Support and Customer Success services. We accomplish this through in-depth technology services industry research, best practices and performance benchmarking, and expert coaching services. Learn more at ServiceXRG.com. SOURCE TeamSupport, LLC. Related Links http://www.teamsupport.com Answer:

Customer Support Demand Rises, Shifts to Proactive Revenue-Driving Focus New research-based report examines current trends in customer support delivery, offers tangible guidance for B2B customer support and service professionals.

DALLAS, Jan. 5, 2021 /PRNewswire/ -- Customer Support Transformation: The Guide to Essential Practices and Metrics, the new research-based report by Service Excellence Research Group (ServiceXRG) in collaboration with TeamSupport, examines important trends in customer support delivery and offers tangible guidance for customer support and service professionals to meet growing expectations of both customers and company executives. "B2B support demand is growing by almost 11 percent," acknowledges Melissa Hendrick, Chief Marketing Officer at TeamSupport, an award-winning post-sale B2B customer support software solution provider for technology-enabled companies. "The customer support function traditionally has been reactive and transactional, butit is evolving to be more proactive, helping tostrengthencustomer relationships." She goes on, "Customer support is now playing a key role in drivingrecurring revenues and dramatically reducing churn." Customer support is evolving to be more proactive, playing a key role in driving recurring revenues and reducing churn. Tweet this "The Customer Support Transformation report highlights the challenges customer support leaders face and offers insights into the practices and metrics companies need to successfully scale support and deliver the level of service customers expect,"saidTom Sweeny, CEO of ServiceXRG, a leading industry research and consulting firm. It outlines ten actionable Support imperatives that customer support leaders must focus on to drive the continued transformation of this function, including: Focusing on delivering positive experiences that retain customer relationships Prioritizing investment in customer support initiatives to reduce demand and to help customers gain greater self-sufficiency Leveraging customer interactions and support case data to identify predictive and preventative opportunities "Support has always been ready to embrace new ways to improve customer experiences and achieve greater efficiencies," Sweeny concludes. "This study finds that Support has reached an inflection point where subscription-based relationships, the imperative to drive product adoption, and the perennial challenges of resource constraints and demands for cost efficiency suggest that incremental changes to Support are no longer enough." The full report is now available for download.About TeamSupportTeamSupport is a post-sale award-winning customer support software provider built specifically for the unique needs of B2B (business-to-business) technology-enabled companies within the computer software, hardware, information technology services, and telecom industries. Created by B2B customer support industry experts, TeamSupport has spent the past decade creating a support solution that helps build passionate customer bases for its clients.TeamSupport stands alone as the leading support solution that helps solve for sophisticated client needs and fuels successful client interactions. The TeamSupport suite of solutions includes TeamInsights, a customizable reporting and analytics dashboard.TeamSupport is headquartered in Dallas, Texas. Learn more at TeamSupport.com.About Service Excellence Research GroupSince 2004, ServiceXRG has guided the world's leading technology companies in their strategic efforts to retain customers, grow recurring revenue, and achieve cost efficiencies through the delivery of high-quality Technical Support and Customer Success services. We accomplish this through in-depth technology services industry research, best practices and performance benchmarking, and expert coaching services. Learn more at ServiceXRG.com. SOURCE TeamSupport, LLC. Related Links http://www.teamsupport.com

edtsum109

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PARAMUS, N.J., Nov. 25, 2020 /PRNewswire/ --PolaryxTherapeutics, Inc., abiotechcompany developing small molecule therapeutics forlysosomalstorage disorders, announced today that it has received from the U.S. Food and Drug Administration (FDA) both Rare Pediatric Disease and Orphan Drug designations for the treatment of GM2 gangliosidosis with PLX-300. GM2 gangliosidosis, also known as Tay-Sachs and Sandhoff diseases, are ultra-rare and fatal pediatric neurodegenerative disorders caused by defects in Hexosaminidase A (HEXA) and Hexosaminidase B (HEXB), key enzymes in the lysosome, respectively. These genetic defects lead to abnormal accumulation of gangliosides, resulting in severe progressive neurodegeneration, seizures, loss of mobility, hearing, and vision, and early death. There is no cure for these diseases and the only treatment is supportive care. Under theFDA'srare pediatric disease designation program, the FDA grants Rare Pediatric Disease designation for serious or life-threatening diseases with patients aged from birth to 18 years which affects fewer than 200,000 people in the U.S. If a new drug application (NDA) for PLX-300 is approved, the Company is eligible to receive a priority review voucher that may be sold or transferred to others. In addition, because orphan drug designation has been granted to PLX-300 for GM2 gangliosidosis from the FDA, the Company can receive the FDA's expedited review and approval process. "We are very excited to receive both rare pediatric disease and orphan drug designations from the FDA for the treatment of GM2 gangliosidosis with PLX-300. These designations clearly demonstrate the translational excellence of the PLX-300 from bench to bedside. We are now doing required preclinical studies in order to enter into Phase1/2 studies as soon as possible," says Dr. Hahn-Jun Lee, M.Sc., Ph.D., President and CEO ofPolaryxTherapeutics, Inc. Alex Yang, J.D., LLM, President and CEO ofMstonePartners Hong Kong and Chairof the Board atPolaryxTherapeutics, stated, "We are making tremendous steps towards developing several promising drugs to treat a number of highly unmet diseases affecting the lysosomal enzymes in the brain.On top of the recent commencement of other lysosomal storage disorders, we will also make every effort to bring the effective drugs for children suffering from these life-threatening diseases." PolaryxTherapeutics, Inc. PolaryxTherapeutics, Inc. is developing drug candidates forlysosomalstorage disorders, for which there are currently no safe and patient-friendly treatment options available.Lysosomalstorage disorders are a group of rare inherited genetic disorders caused by the dysfunction oflysosomalenzymes and/or molecules important in the function of these enzymes. Young children are victims of these devastating diseases and die at an early age due to lack of treatment options. PLX-300 PLX-300 is a novel, small molecule found in many plants as a deaminated product of phenylalanine. It is widely used as a spice or flavoring material for food. It activatesPPAR, which enhances production of transcription factor EB (TFEB). TFEB then binds to the promoter of genes involved inlysosomebiogenesisand activates their production. PLX-300 also has additional activities, such as reducing inflammation and preventing cell death (apoptosis). GM2 gangliosidosis The GM2 gangliosidosis is caused by mutations in the HEXA and HEXB genes encoding subunits of ganglioside -hexosaminidase (Hex), the lysosomal enzyme that normally degrades GM2. As a result, GM2 ganglioside accumulates in the lysosomes of nerve cells resulting in distended neurons engorged with swollen lysosomes (membranous cytoplasmic bodies; MCB) throughout the nervous system. There are two major forms of Hex: HEXA, a heterodimer composed of one and one subunit, and HEXB, composed of two subunits. TaySachs disease is caused by mutations in the HEXA gene encoding the subunit of HEXA. The much rarer Sandhoff disease, a more severe form of Tay-Sachs disease, is caused by mutations in the HEXB gene encoding the subunit, leading to deficiency of both HEXA and HEXB activities. Media ContactHahn-Jun Lee, M.Sc., Ph.D.201-724-1786[emailprotected] Related Images image1.png SOURCE Polaryx Therapeutics, Inc Answer:

Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of GM2 Gangliosidosis With PLX-300

PARAMUS, N.J., Nov. 25, 2020 /PRNewswire/ --PolaryxTherapeutics, Inc., abiotechcompany developing small molecule therapeutics forlysosomalstorage disorders, announced today that it has received from the U.S. Food and Drug Administration (FDA) both Rare Pediatric Disease and Orphan Drug designations for the treatment of GM2 gangliosidosis with PLX-300. GM2 gangliosidosis, also known as Tay-Sachs and Sandhoff diseases, are ultra-rare and fatal pediatric neurodegenerative disorders caused by defects in Hexosaminidase A (HEXA) and Hexosaminidase B (HEXB), key enzymes in the lysosome, respectively. These genetic defects lead to abnormal accumulation of gangliosides, resulting in severe progressive neurodegeneration, seizures, loss of mobility, hearing, and vision, and early death. There is no cure for these diseases and the only treatment is supportive care. Under theFDA'srare pediatric disease designation program, the FDA grants Rare Pediatric Disease designation for serious or life-threatening diseases with patients aged from birth to 18 years which affects fewer than 200,000 people in the U.S. If a new drug application (NDA) for PLX-300 is approved, the Company is eligible to receive a priority review voucher that may be sold or transferred to others. In addition, because orphan drug designation has been granted to PLX-300 for GM2 gangliosidosis from the FDA, the Company can receive the FDA's expedited review and approval process. "We are very excited to receive both rare pediatric disease and orphan drug designations from the FDA for the treatment of GM2 gangliosidosis with PLX-300. These designations clearly demonstrate the translational excellence of the PLX-300 from bench to bedside. We are now doing required preclinical studies in order to enter into Phase1/2 studies as soon as possible," says Dr. Hahn-Jun Lee, M.Sc., Ph.D., President and CEO ofPolaryxTherapeutics, Inc. Alex Yang, J.D., LLM, President and CEO ofMstonePartners Hong Kong and Chairof the Board atPolaryxTherapeutics, stated, "We are making tremendous steps towards developing several promising drugs to treat a number of highly unmet diseases affecting the lysosomal enzymes in the brain.On top of the recent commencement of other lysosomal storage disorders, we will also make every effort to bring the effective drugs for children suffering from these life-threatening diseases." PolaryxTherapeutics, Inc. PolaryxTherapeutics, Inc. is developing drug candidates forlysosomalstorage disorders, for which there are currently no safe and patient-friendly treatment options available.Lysosomalstorage disorders are a group of rare inherited genetic disorders caused by the dysfunction oflysosomalenzymes and/or molecules important in the function of these enzymes. Young children are victims of these devastating diseases and die at an early age due to lack of treatment options. PLX-300 PLX-300 is a novel, small molecule found in many plants as a deaminated product of phenylalanine. It is widely used as a spice or flavoring material for food. It activatesPPAR, which enhances production of transcription factor EB (TFEB). TFEB then binds to the promoter of genes involved inlysosomebiogenesisand activates their production. PLX-300 also has additional activities, such as reducing inflammation and preventing cell death (apoptosis). GM2 gangliosidosis The GM2 gangliosidosis is caused by mutations in the HEXA and HEXB genes encoding subunits of ganglioside -hexosaminidase (Hex), the lysosomal enzyme that normally degrades GM2. As a result, GM2 ganglioside accumulates in the lysosomes of nerve cells resulting in distended neurons engorged with swollen lysosomes (membranous cytoplasmic bodies; MCB) throughout the nervous system. There are two major forms of Hex: HEXA, a heterodimer composed of one and one subunit, and HEXB, composed of two subunits. TaySachs disease is caused by mutations in the HEXA gene encoding the subunit of HEXA. The much rarer Sandhoff disease, a more severe form of Tay-Sachs disease, is caused by mutations in the HEXB gene encoding the subunit, leading to deficiency of both HEXA and HEXB activities. Media ContactHahn-Jun Lee, M.Sc., Ph.D.201-724-1786[emailprotected] Related Images image1.png SOURCE Polaryx Therapeutics, Inc

edtsum111

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems and Proton International announced today that they have signed a two-system contract to bring Mevions compact proton therapy solution to new centers in locations to be announced in South Texas and the Southeast United States. The new centers will feature the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS). HYPERSCAN enables faster and sharper delivery of therapeutic radiation to tumors. The systems leading-edge clinical capabilities, combined with its compact, affordable design, and industry-leading ramp-up time, has changed the landscape of proton therapy. Today, more cancer centers are considering providing compact proton therapy to their patients because of the technology Mevion has advanced. We selected Mevions compact system because it has the ability to offer an efficient clinical solution adopted by many major cancer programs while minimizing costs, said Chris Chandler, chief executive officer of Proton International. PI specializes in providing custom single-room proton therapy solutions to our clinical providers, and this technology will be a powerful addition to their cancer treatment arsenal. Proton Internationals successful approach to proton therapy by focusing on building and operating centers that support their customers goals made them a natural partner, said Tina Yu, Ph.D., chief executive officer of Mevion. We look forward to collaborating closely with Proton International on these new centers and providing greater access to this lifesaving technology to patients in Texas and the Southeast. As the leading supplier of compact proton therapy systems in the United States, Mevion has been selected by more NCI-Designated Cancer Centers than any other manufacturer. In July, another MEVION S250i Proton Therapy System began treating patients at Barnes-Jewish Hospital in St. Louis, MO, and Huntsman Cancer Institute at the University of Utah in Salt Lake City, Utah will be clinically operational at the end of 2020. About Mevion Medical Systems Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion was the first company to innovate this new single-room platform and continues to further the science and application of proton therapy. Mevions flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the worlds smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems. Mevion is headquartered in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com. Follow us on Twitter: @MevionMedical Connect with us on LinkedIn: Mevion Medical Systems Like Us on Facebook: MevionMedical About Proton International Proton International, www.protonintl.com, has an experienced team dedicated to bringing proton therapy to patients. The company works with hospitals and physician groups to develop one- and two-room proton therapy facilities on a turnkey basis. The PI team has developed and operated multiple centers and is currently active on several projects. Proton International completed proton centers at William Beaumont Hospital in Royal Oak, Michigan University Medical Center in Groningen, The Netherlands, University of Alabama Birmingham, and Delray Beach, Florida; where the centers are currently treating patients. The company has several additional centers under design and construction. PIs business model ensures that projects are completed on time, on budget, and within the scope and needs of the institution. Services include business planning, organizational structure, financing, building design and construction, installation and commissioning, equipment, staff training, and more. Answer:

Mevion and Proton International to Partner on Two Proton Therapy Centers

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems and Proton International announced today that they have signed a two-system contract to bring Mevions compact proton therapy solution to new centers in locations to be announced in South Texas and the Southeast United States. The new centers will feature the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS). HYPERSCAN enables faster and sharper delivery of therapeutic radiation to tumors. The systems leading-edge clinical capabilities, combined with its compact, affordable design, and industry-leading ramp-up time, has changed the landscape of proton therapy. Today, more cancer centers are considering providing compact proton therapy to their patients because of the technology Mevion has advanced. We selected Mevions compact system because it has the ability to offer an efficient clinical solution adopted by many major cancer programs while minimizing costs, said Chris Chandler, chief executive officer of Proton International. PI specializes in providing custom single-room proton therapy solutions to our clinical providers, and this technology will be a powerful addition to their cancer treatment arsenal. Proton Internationals successful approach to proton therapy by focusing on building and operating centers that support their customers goals made them a natural partner, said Tina Yu, Ph.D., chief executive officer of Mevion. We look forward to collaborating closely with Proton International on these new centers and providing greater access to this lifesaving technology to patients in Texas and the Southeast. As the leading supplier of compact proton therapy systems in the United States, Mevion has been selected by more NCI-Designated Cancer Centers than any other manufacturer. In July, another MEVION S250i Proton Therapy System began treating patients at Barnes-Jewish Hospital in St. Louis, MO, and Huntsman Cancer Institute at the University of Utah in Salt Lake City, Utah will be clinically operational at the end of 2020. About Mevion Medical Systems Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion was the first company to innovate this new single-room platform and continues to further the science and application of proton therapy. Mevions flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the worlds smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems. Mevion is headquartered in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com. Follow us on Twitter: @MevionMedical Connect with us on LinkedIn: Mevion Medical Systems Like Us on Facebook: MevionMedical About Proton International Proton International, www.protonintl.com, has an experienced team dedicated to bringing proton therapy to patients. The company works with hospitals and physician groups to develop one- and two-room proton therapy facilities on a turnkey basis. The PI team has developed and operated multiple centers and is currently active on several projects. Proton International completed proton centers at William Beaumont Hospital in Royal Oak, Michigan University Medical Center in Groningen, The Netherlands, University of Alabama Birmingham, and Delray Beach, Florida; where the centers are currently treating patients. The company has several additional centers under design and construction. PIs business model ensures that projects are completed on time, on budget, and within the scope and needs of the institution. Services include business planning, organizational structure, financing, building design and construction, installation and commissioning, equipment, staff training, and more.

edtsum113

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SALT LAKE CITY, Oct. 21, 2020 /PRNewswire/ --Ivanti, the company that automates IT and Security Operations to discover, manage, secure and service from cloud to edge, announces the release of Ivanti Neurons for Patch Intelligence and Ivanti Neurons for Spend Intelligence. These solutions build on the Ivanti Neurons hyper-automation platform, first announced in July 2020, which empowers organizations to autonomously self-heal and self-secure devices and self-service end users. "The future of work, where working from anywhere on any device is the new normal, means that proactively managing the ever-increasing security risks and asset spend is top of mind for every enterprise," said Nayaki Nayyar, executive vice president and chief product officer, Ivanti. "Our latest additions to the Ivanti Neurons Platform for Patch and Spend Intelligence leverage our strength in patching to assess patch reliability and risk-based patch prioritization using supervised and unsupervised machine learning algorithms to automate vulnerability remediation and proactively manage software spend." Ivanti Neurons enables the self-healing autonomous edge with adaptive security and a contextualized, personalized experience for today's remote workforce. Customers of Ivanti Neurons are realizing over 50 percent reductions in support call times, eliminating duplicate work between IT operations and security teams, reducing the number of vulnerable devices by up to 50 percent.* Jesse Miller, information technology specialist for SouthStar Bank recalls his conversation with his compliance auditor about Ivanti Neurons for Patch Intelligence, "I am blown away by how Ivanti has built in a community response directly into their remediation system. I have never found anything like this! Instead of talking about security and patching for hours with a compliance auditor, we spent only minutes on it and moved onto other things. I have been impressed with the entire solution." The new Ivanti Neurons capabilities help enable users to reduce their time-to-patch for an overall improved security posture. They also dramatically improve the asset deployment and reclamation process for IT operations and security teams to take action and collaboratively work. New Ivanti Neurons solutions and capabilities include: Ivanti Neurons for Patch Intelligence helps enable organizations to achieve faster SLAs for their vulnerability remediation efforts via supervised and unsupervised machine learning algorithms. Drawing on the Ivanti patch management expertise, which deploys over 1.2 billion patch updates annually, Ivanti Neurons for Patch Intelligence helps users easily research, prioritize and receive better insights for patch management processes in one central location. Patch reliability data is automatically delivered with actionable intelligence pulled from thousands of public and crowdsourced sentiment data. This information provides improved patch reliability so security teams can act on threats faster and reduce their time-to-patch. A precise picture of the organization's threat landscape is provided through prioritized, risk-based metrics and feature-rich compliance dashboards. Ivanti Neurons for Patch Intelligence delivers highly accurate data that reduces the time it takes to respond to threats. Ivanti Neurons for Spend Intelligence which provides insights into an organization's software landscape and application spend for on-premises, cloud and edge environments to help improve operational speed and asset visibility, improve utilization and manage costs. Unlike complex software licensing tools, Ivanti Neurons for Spend Intelligence is easy and intuitive to use, with faster time-to-value. Within minutes, a detailed analysis of usage, licenses types, purchases, subscriptions, renewals and instances are presented in engaging dashboards to help users more effectively track usage, purchase history, upcoming renewals, contract expirations, and ongoing overall spend. Potential under and overspend issues and opportunities for automated reclamation are also highlighted, managing cost and reducing risk. Ivanti Neurons for Patch Intelligence and Ivanti Neurons for Spend Intelligence are available now as part of the Ivanti Neurons hyper-automation platform. In addition, enhancements across the Ivanti Neurons platform include broader out-of-the-box automation queries and actions to detect, diagnose and resolve issues, provide powerful data filtering to help IT make better decisions, and increase visibility through additional IT and non-IT devices and connector support. For more information visit: https://www.ivanti.com/neurons or join the Ivanti Neurons webinar on October 28. You can register here. Ivanti: Better Experiences, Better Outcomes.Ivanti automates IT and Security Operations to discover, manage, secure and service from cloud to edge. From PCs to mobile devices, VDI, and the data center, Ivantidiscovers IT assets on-premises, in cloud, and at the edge, improves IT service delivery, and reduces risk with insights and automation. The company also helps organizations leverage modern technology in the warehouse and across the supply chain to improve delivery without modifying backend systems. Ivanti is headquartered in Salt Lake City, Utah and has offices all over the world. For more information, visitwww.ivanti.comand follow @GoIvanti. Copyright 2020, Ivanti. All rights reserved. *Customer results are specific to their total environment and experience, of which Ivanti is a part. Individual results may vary based on each customer's unique environment. SOURCE Ivanti Related Links https://www.ivanti.com Answer:

Ivanti Adds New Ivanti Neurons Innovations Powered by Machine Learning to Improve Security Posture and Optimize Asset Spend Ivanti Neurons for Patch Intelligence and Spend Intelligence Leverages Supervised and Unsupervised Machine Learning Algorithms to Automate Vulnerability Remediation and Optimize Software Spend

SALT LAKE CITY, Oct. 21, 2020 /PRNewswire/ --Ivanti, the company that automates IT and Security Operations to discover, manage, secure and service from cloud to edge, announces the release of Ivanti Neurons for Patch Intelligence and Ivanti Neurons for Spend Intelligence. These solutions build on the Ivanti Neurons hyper-automation platform, first announced in July 2020, which empowers organizations to autonomously self-heal and self-secure devices and self-service end users. "The future of work, where working from anywhere on any device is the new normal, means that proactively managing the ever-increasing security risks and asset spend is top of mind for every enterprise," said Nayaki Nayyar, executive vice president and chief product officer, Ivanti. "Our latest additions to the Ivanti Neurons Platform for Patch and Spend Intelligence leverage our strength in patching to assess patch reliability and risk-based patch prioritization using supervised and unsupervised machine learning algorithms to automate vulnerability remediation and proactively manage software spend." Ivanti Neurons enables the self-healing autonomous edge with adaptive security and a contextualized, personalized experience for today's remote workforce. Customers of Ivanti Neurons are realizing over 50 percent reductions in support call times, eliminating duplicate work between IT operations and security teams, reducing the number of vulnerable devices by up to 50 percent.* Jesse Miller, information technology specialist for SouthStar Bank recalls his conversation with his compliance auditor about Ivanti Neurons for Patch Intelligence, "I am blown away by how Ivanti has built in a community response directly into their remediation system. I have never found anything like this! Instead of talking about security and patching for hours with a compliance auditor, we spent only minutes on it and moved onto other things. I have been impressed with the entire solution." The new Ivanti Neurons capabilities help enable users to reduce their time-to-patch for an overall improved security posture. They also dramatically improve the asset deployment and reclamation process for IT operations and security teams to take action and collaboratively work. New Ivanti Neurons solutions and capabilities include: Ivanti Neurons for Patch Intelligence helps enable organizations to achieve faster SLAs for their vulnerability remediation efforts via supervised and unsupervised machine learning algorithms. Drawing on the Ivanti patch management expertise, which deploys over 1.2 billion patch updates annually, Ivanti Neurons for Patch Intelligence helps users easily research, prioritize and receive better insights for patch management processes in one central location. Patch reliability data is automatically delivered with actionable intelligence pulled from thousands of public and crowdsourced sentiment data. This information provides improved patch reliability so security teams can act on threats faster and reduce their time-to-patch. A precise picture of the organization's threat landscape is provided through prioritized, risk-based metrics and feature-rich compliance dashboards. Ivanti Neurons for Patch Intelligence delivers highly accurate data that reduces the time it takes to respond to threats. Ivanti Neurons for Spend Intelligence which provides insights into an organization's software landscape and application spend for on-premises, cloud and edge environments to help improve operational speed and asset visibility, improve utilization and manage costs. Unlike complex software licensing tools, Ivanti Neurons for Spend Intelligence is easy and intuitive to use, with faster time-to-value. Within minutes, a detailed analysis of usage, licenses types, purchases, subscriptions, renewals and instances are presented in engaging dashboards to help users more effectively track usage, purchase history, upcoming renewals, contract expirations, and ongoing overall spend. Potential under and overspend issues and opportunities for automated reclamation are also highlighted, managing cost and reducing risk. Ivanti Neurons for Patch Intelligence and Ivanti Neurons for Spend Intelligence are available now as part of the Ivanti Neurons hyper-automation platform. In addition, enhancements across the Ivanti Neurons platform include broader out-of-the-box automation queries and actions to detect, diagnose and resolve issues, provide powerful data filtering to help IT make better decisions, and increase visibility through additional IT and non-IT devices and connector support. For more information visit: https://www.ivanti.com/neurons or join the Ivanti Neurons webinar on October 28. You can register here. Ivanti: Better Experiences, Better Outcomes.Ivanti automates IT and Security Operations to discover, manage, secure and service from cloud to edge. From PCs to mobile devices, VDI, and the data center, Ivantidiscovers IT assets on-premises, in cloud, and at the edge, improves IT service delivery, and reduces risk with insights and automation. The company also helps organizations leverage modern technology in the warehouse and across the supply chain to improve delivery without modifying backend systems. Ivanti is headquartered in Salt Lake City, Utah and has offices all over the world. For more information, visitwww.ivanti.comand follow @GoIvanti. Copyright 2020, Ivanti. All rights reserved. *Customer results are specific to their total environment and experience, of which Ivanti is a part. Individual results may vary based on each customer's unique environment. SOURCE Ivanti Related Links https://www.ivanti.com

edtsum116

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: GREENEVILLE, Tenn., July 16, 2020 /PRNewswire/ -- TEVET, a premium test and measurement supplier, today announced the company received the Honeywell KCNSC Small Business HUBZone Award. After years of exceptional service including OEM agreements, PO consolidation, marketplace customization, and on-time delivery, TEVET has helped keep Honeywell missions a success. TEVET maintains a commitment to service within HUBZone communities, and as a result, was recognized as a small business and HUBZone leader amongst Honeywell's numerous suppliers with the Kansas City National Security Campus Small Business HUBZone Award. "The support Honeywell KCNSC has demonstrated over the years by working with TEVET speaks volumes to their commitment of meeting small business goals and using DOE SCMC contracts for streamlined procurement transactions," said TEVET Account Manager, Evie Webster. "The Honeywell NSC Procurement and Small Business Diversity teams have processes and communication tools in place that allow us to work together and supply successful components for mission-critical systems." Commitment to Customers and Community With TEVET, customers like Honeywell can join in and invest in HUBZone businesses while also protecting their technology investment by selecting an acquisition partner with the foundation, processes, and certifications in place to meet current and future requirements. "It's an honor to be recognized for our commitments and service to our customers, and community," said Tracy Solomon, CEO of TEVET. "Our success has and will always continue to be our community's success." TEVET makes business easy for customers, using sophisticated processes and systems not typical for small businesses, including: Established partnerships with leading technology companies, including OEMs and worldwide distributors ERP integration with Oracle and other cloud-based platforms within the TEVET Marketplace For more information, contact TEVET or visit tevetllc.com/about-tevet/. About TEVET Selecting and acquiring the right technology to meet specific challenges requires a partner that can add value at every step. TEVETbrings more than 15 years of experience to the acquisition of technical products, systems, and instrumentation - with support from identification to sustainment. With competencies in quality, technology, and personnel, TEVET provides best-in-class acquisition strategies, so customers, suppliers, and partners are successful. TEVET strives to execute at the highest levels, providing service to Country, Customer, and Community. For more information on TEVET, visit www.tevetllc.com. CONTACT: Morgan Norris, [emailprotected] SOURCE TEVET Related Links https://tevetllc.com Answer:

TEVET Awarded Honeywell KCNSC Small Business HUBZone Award for Making Technology Acquisition Easier and Supporting the US Economy Test and measurement supplier helps mission-critical businesses acquire effective solutions, maximize capital investment, and support the community

GREENEVILLE, Tenn., July 16, 2020 /PRNewswire/ -- TEVET, a premium test and measurement supplier, today announced the company received the Honeywell KCNSC Small Business HUBZone Award. After years of exceptional service including OEM agreements, PO consolidation, marketplace customization, and on-time delivery, TEVET has helped keep Honeywell missions a success. TEVET maintains a commitment to service within HUBZone communities, and as a result, was recognized as a small business and HUBZone leader amongst Honeywell's numerous suppliers with the Kansas City National Security Campus Small Business HUBZone Award. "The support Honeywell KCNSC has demonstrated over the years by working with TEVET speaks volumes to their commitment of meeting small business goals and using DOE SCMC contracts for streamlined procurement transactions," said TEVET Account Manager, Evie Webster. "The Honeywell NSC Procurement and Small Business Diversity teams have processes and communication tools in place that allow us to work together and supply successful components for mission-critical systems." Commitment to Customers and Community With TEVET, customers like Honeywell can join in and invest in HUBZone businesses while also protecting their technology investment by selecting an acquisition partner with the foundation, processes, and certifications in place to meet current and future requirements. "It's an honor to be recognized for our commitments and service to our customers, and community," said Tracy Solomon, CEO of TEVET. "Our success has and will always continue to be our community's success." TEVET makes business easy for customers, using sophisticated processes and systems not typical for small businesses, including: Established partnerships with leading technology companies, including OEMs and worldwide distributors ERP integration with Oracle and other cloud-based platforms within the TEVET Marketplace For more information, contact TEVET or visit tevetllc.com/about-tevet/. About TEVET Selecting and acquiring the right technology to meet specific challenges requires a partner that can add value at every step. TEVETbrings more than 15 years of experience to the acquisition of technical products, systems, and instrumentation - with support from identification to sustainment. With competencies in quality, technology, and personnel, TEVET provides best-in-class acquisition strategies, so customers, suppliers, and partners are successful. TEVET strives to execute at the highest levels, providing service to Country, Customer, and Community. For more information on TEVET, visit www.tevetllc.com. CONTACT: Morgan Norris, [emailprotected] SOURCE TEVET Related Links https://tevetllc.com

edtsum117

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LOS ANGELES, Jan. 21, 2021 /PRNewswire/ --FlowerHire, the leading staffing and talent strategy firm serving the regulated cannabis industry, announced today the launch of its new platform, CareersinCannabis.com. The specialized career portal equips both companies and job candidates with the tools and insights necessary to build a robust, quality workforce. The service officially launches at the inaugural Careers in Cannabis virtual talent conference on January 28. The AI-powered software behind CareersinCannabis.com is enginX - created by engin sciences, inc.. The platform blends psychographic data with FlowerHire's cannabis and HR expertise to create quantified PowerProfiles, a fusion of hard and soft skills overlayed with relevant personality traits. The PowerProfile helps candidates find a match with the best open roles. The system gamifies the job application process, allowing HR managers to quickly evaluate applicants, engage with viable candidates, and route people to the jobs to which they are best suited. "While cannabis is one of the fastest growing industries in the country, there's a scalability issue that has yet to be addressed," said David Belsky, CEO of FlowerHire. "As with any industry, cannabis is, at its core, only as strong as its operational infrastructure. Over the next 10 years, we anticipate more than one million jobs created within the cannabis ecosystem, and CareersinCannabis.com will effectively address the challenge of acquisition, retention and development of talent across all levels within the industry." Many of FlowerHire's clients, which include some of the most recognized companies in the industry, found success when it came to using a staffing and talent firm to fill C-level and senior salaried positions within their teams; however, there was still a disconnect when it came time to staff the hundreds of thousands of hourly and frontline employees. CareersinCannabis.com addresses these issues head-on, unlocking the potential of the cannabis workforce and reducing turnover within the industry. "We're incredibly proud to power a much needed and transformative platform key to the fundamental growth of the legal cannabis industry," said Sloane Barbour, Founder and CEO at engin sciences. "Our vision to help hourly and frontline workers fits perfectly with the cannabis industry's needs today and, as the country reopens, our software will help millions of Americans get back to work and take control of their career." The website launches in conjunction with the Careers in Cannabis Virtual Talent Conference, focusing on the opportunities and challenges faced by executives and HR leaders in the fastest growing industry in the country. Hosted by Jacobi Holland and Lulu Tsui of REVEL, the event features more than 200 companies, 50+ speakers, and musical guests DJ Babu & Rakaa of Dilated Peoples. To learn more about Careers in Cannabis and register for the free event, click here. About FlowerHireFlowerHire is on a mission to build a conscious cannabis community, one hire at a time. Founded in 2017, we are a team of experienced talent and recruiting professionals and dedicated to helping companies build, scale, and retain world class teams. We partner with cannabis and hemp companies at any stage of their growth to provide high-touch services including contingency placement, retained and embedded search, and strategic talent advisory. We have also brought to market our software and AI-driven platform, FlowerHireX, to solve the talent puzzle for companies looking to hire and retain frontline workers - and to empower individuals to own their career in cannabis. Since our inception, we have helped hundreds of cannabis companies build and optimize their talent chain, and have helped countless candidates understand this unique and exciting industry and find a job that fits. FlowerHire is Talent in Cannabis About engin sciences, incFor the past decade, Sloane Barbour and Dr. Valerie Fraysse, PhD drove the evolution of AI-assisted hiring and workplace satisfaction as VP of Sales at Hired.com, and as co-founder and CTO of Good&Co (good.co). The engin virtual talent management system allows HR managers to gamify the job application process on any site, quickly evaluates applicants, engages with viable candidates, and routes people to the jobs to which they're best suited. Media Contact:North 6th Agency for FlowerHire[emailprotected]212-334-9753, ext. 147 SOURCE FlowerHire Related Links https://flowerhire.com Answer:

FlowerHire Presents the CareersinCannabis.com Virtual Talent Conference on January 28th New HR Tech platform, powered by engin sciences, inc., blends qualitative insights with automated tech to connect businesses with all levels of industry talent

LOS ANGELES, Jan. 21, 2021 /PRNewswire/ --FlowerHire, the leading staffing and talent strategy firm serving the regulated cannabis industry, announced today the launch of its new platform, CareersinCannabis.com. The specialized career portal equips both companies and job candidates with the tools and insights necessary to build a robust, quality workforce. The service officially launches at the inaugural Careers in Cannabis virtual talent conference on January 28. The AI-powered software behind CareersinCannabis.com is enginX - created by engin sciences, inc.. The platform blends psychographic data with FlowerHire's cannabis and HR expertise to create quantified PowerProfiles, a fusion of hard and soft skills overlayed with relevant personality traits. The PowerProfile helps candidates find a match with the best open roles. The system gamifies the job application process, allowing HR managers to quickly evaluate applicants, engage with viable candidates, and route people to the jobs to which they are best suited. "While cannabis is one of the fastest growing industries in the country, there's a scalability issue that has yet to be addressed," said David Belsky, CEO of FlowerHire. "As with any industry, cannabis is, at its core, only as strong as its operational infrastructure. Over the next 10 years, we anticipate more than one million jobs created within the cannabis ecosystem, and CareersinCannabis.com will effectively address the challenge of acquisition, retention and development of talent across all levels within the industry." Many of FlowerHire's clients, which include some of the most recognized companies in the industry, found success when it came to using a staffing and talent firm to fill C-level and senior salaried positions within their teams; however, there was still a disconnect when it came time to staff the hundreds of thousands of hourly and frontline employees. CareersinCannabis.com addresses these issues head-on, unlocking the potential of the cannabis workforce and reducing turnover within the industry. "We're incredibly proud to power a much needed and transformative platform key to the fundamental growth of the legal cannabis industry," said Sloane Barbour, Founder and CEO at engin sciences. "Our vision to help hourly and frontline workers fits perfectly with the cannabis industry's needs today and, as the country reopens, our software will help millions of Americans get back to work and take control of their career." The website launches in conjunction with the Careers in Cannabis Virtual Talent Conference, focusing on the opportunities and challenges faced by executives and HR leaders in the fastest growing industry in the country. Hosted by Jacobi Holland and Lulu Tsui of REVEL, the event features more than 200 companies, 50+ speakers, and musical guests DJ Babu & Rakaa of Dilated Peoples. To learn more about Careers in Cannabis and register for the free event, click here. About FlowerHireFlowerHire is on a mission to build a conscious cannabis community, one hire at a time. Founded in 2017, we are a team of experienced talent and recruiting professionals and dedicated to helping companies build, scale, and retain world class teams. We partner with cannabis and hemp companies at any stage of their growth to provide high-touch services including contingency placement, retained and embedded search, and strategic talent advisory. We have also brought to market our software and AI-driven platform, FlowerHireX, to solve the talent puzzle for companies looking to hire and retain frontline workers - and to empower individuals to own their career in cannabis. Since our inception, we have helped hundreds of cannabis companies build and optimize their talent chain, and have helped countless candidates understand this unique and exciting industry and find a job that fits. FlowerHire is Talent in Cannabis About engin sciences, incFor the past decade, Sloane Barbour and Dr. Valerie Fraysse, PhD drove the evolution of AI-assisted hiring and workplace satisfaction as VP of Sales at Hired.com, and as co-founder and CTO of Good&Co (good.co). The engin virtual talent management system allows HR managers to gamify the job application process on any site, quickly evaluates applicants, engages with viable candidates, and routes people to the jobs to which they're best suited. Media Contact:North 6th Agency for FlowerHire[emailprotected]212-334-9753, ext. 147 SOURCE FlowerHire Related Links https://flowerhire.com

edtsum119

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: VALENCIA, Spain, June 1, 2020 /PRNewswire/ --Zeleros Hyperloop has completed a financing round worth more than 7 million. The company starts a new and important phase in the development of its unique version of hyperloop, the "fifth mode of transport," the best alternative for the future to connect efficiently and sustainably long-distance routes for passenger and cargo transportation. Connections like Paris Berlin could be reduced to less than an hour. Zeleros opens this new stage thanks to the support of companies such as Altran, Grupo Red Elctrica and also strategic investors at national and international level, including among others Goldacre Ventures (United Kingdom), Road Ventures (Switzerland), Plug and Play (USA), and the Spanish Angels Capital and MBHA. The funds will be used to impulse further development of Zeleros' hyperloop vehicle and its core technologies, which place them as the best alternative to cover efficiently routes between 400 and 1,500 kilometers in distance, with special benefits such as the reduction of the overall infrastructure costs and the operation at safer pressures for passengers. Commenting on the announcement, David Pistoni, Chief Executive Officer at Zeleros, said: "For Zeleros it is key to have partners of this relevance and expertise onboard. Their support will accelerate the development of our technologies, unlocking the path towards hyperloop-based routes and corridors in Europe and worldwide.These new funds will boost a major milestone of developing and demonstrating our technologies in a real environment of operation, bringing Zeleros closer to a multibillion market opportunity to be captured in the next decades." Pilar Rodrguez, Strategy, Innovation and R&D Director at Altran, participating as lead investor, said: "As a world-leading engineering company, Altran acts as a technological catalyst in various strategic sectors. By supporting Zeleros,we areaccelerating disruptive innovation in a sector, such as mobility, that is reinventing itself. With technologies like hyperloop we are changing the future of mobility. Altran has been collaborating with Zeleros since 2017 and will now contribute all of its experience and multidisciplinary talent to help the company accelerate the development of hyperloop technology." Miguel Ruiz Dealbert, CEO at MBHA Group, highlighted: "Our companies are committedto supporting technologies and start-ups that accelerate the transition towards a more sustainable mobility. Zeleros has a great potential to decarbonize intercity mobility sector, currently covered mainly by regional aviation. Our company ZIUR Composite Solutions will bring its wide experience in the development of complex structures of composite materials and process automation, supporting Zeleros to reduce the time of implementation and commercialization of their technologies." The following step will be the deployment of the European Hyperloop Development Centre in Spain, including a 3-km test-track to demonstrate the effectiveness of its technologies at high speed. The aim of this project is to accelerate the development of the hyperloop industry in Europe, by creating an ecosystem of international industrial, technological and institutional partners."Hyperloop is a great development that requires the participation of first-class players," says David Pistoni. Contact: Juan Vicen [emailprotected] +34-676-777-578 SOURCE Zeleros by Bracken Related Links https://zeleros.com Answer:

Spain's Zeleros Raises 7M in Financing to Lead the Development of Hyperloop in Europe English Franais Deutsch

VALENCIA, Spain, June 1, 2020 /PRNewswire/ --Zeleros Hyperloop has completed a financing round worth more than 7 million. The company starts a new and important phase in the development of its unique version of hyperloop, the "fifth mode of transport," the best alternative for the future to connect efficiently and sustainably long-distance routes for passenger and cargo transportation. Connections like Paris Berlin could be reduced to less than an hour. Zeleros opens this new stage thanks to the support of companies such as Altran, Grupo Red Elctrica and also strategic investors at national and international level, including among others Goldacre Ventures (United Kingdom), Road Ventures (Switzerland), Plug and Play (USA), and the Spanish Angels Capital and MBHA. The funds will be used to impulse further development of Zeleros' hyperloop vehicle and its core technologies, which place them as the best alternative to cover efficiently routes between 400 and 1,500 kilometers in distance, with special benefits such as the reduction of the overall infrastructure costs and the operation at safer pressures for passengers. Commenting on the announcement, David Pistoni, Chief Executive Officer at Zeleros, said: "For Zeleros it is key to have partners of this relevance and expertise onboard. Their support will accelerate the development of our technologies, unlocking the path towards hyperloop-based routes and corridors in Europe and worldwide.These new funds will boost a major milestone of developing and demonstrating our technologies in a real environment of operation, bringing Zeleros closer to a multibillion market opportunity to be captured in the next decades." Pilar Rodrguez, Strategy, Innovation and R&D Director at Altran, participating as lead investor, said: "As a world-leading engineering company, Altran acts as a technological catalyst in various strategic sectors. By supporting Zeleros,we areaccelerating disruptive innovation in a sector, such as mobility, that is reinventing itself. With technologies like hyperloop we are changing the future of mobility. Altran has been collaborating with Zeleros since 2017 and will now contribute all of its experience and multidisciplinary talent to help the company accelerate the development of hyperloop technology." Miguel Ruiz Dealbert, CEO at MBHA Group, highlighted: "Our companies are committedto supporting technologies and start-ups that accelerate the transition towards a more sustainable mobility. Zeleros has a great potential to decarbonize intercity mobility sector, currently covered mainly by regional aviation. Our company ZIUR Composite Solutions will bring its wide experience in the development of complex structures of composite materials and process automation, supporting Zeleros to reduce the time of implementation and commercialization of their technologies." The following step will be the deployment of the European Hyperloop Development Centre in Spain, including a 3-km test-track to demonstrate the effectiveness of its technologies at high speed. The aim of this project is to accelerate the development of the hyperloop industry in Europe, by creating an ecosystem of international industrial, technological and institutional partners."Hyperloop is a great development that requires the participation of first-class players," says David Pistoni. Contact: Juan Vicen [emailprotected] +34-676-777-578 SOURCE Zeleros by Bracken Related Links https://zeleros.com

edtsum123

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DEDHAM, Mass.--(BUSINESS WIRE)--Reflexis Systems (now part of Zebra Technologies), a leading provider of AI-powered workforce management and real-time execution solutions for multi-site businesses in retail, food service, hospitality and banking, has been recognized by Nucleus Research as a Leader in the 2021 WFM (Workforce Management) Technology Value Matrix. This is the third consecutive year Reflexis has placed in the Leader quadrant of this analyst report. A complimentary copy of the full report is available here. We positioned Reflexis Systems as a Leader in the 2021 WFM Technology Value Matrix for the third straight year due to the continued strength and agility of Reflexis ONE TM, said Trevor White, Analyst at Nucleus Research. Reflexis Workforce Scheduler and Employee Self-Service empower businesses across a wide range of industries to simplify store execution while streamlining labor and scheduling processes. Nucleus Research evaluated 17 WFM solutions and ranked them on their delivery of value to customers via both the functionality and usability of the software. Reflexis received accolades for its AI-powered Reflexis ONE platform, which allows retailers, quick service restaurants, hotels and banks to optimize execution processes and labor expenditures. Reflexis Systems is honored Nucleus Research has again recognized us as a Leader in the 2021 WFM Technology Value Matrix, said Suresh Menon, Senior Vice President and General Manager for Software Solutions, Zebra Technologies. Reflexis ONE helps businesses across a wide range of industries optimize labor budgeting, forecasting and scheduling via our AI-powered Workforce Scheduler, while Employee Self-Service increases employee productivity, engagement and retention. KEY TAKEAWAYS ABOUT ZEBRA TECHNOLOGIES Zebra (NASDAQ: ZBRA) empowers the front line in retail/ecommerce, manufacturing, transportation and logistics, healthcare, public sector and other industries to achieve a performance edge. With more than 10,000 partners across 100 countries, Zebra delivers industry-tailored, end-to-end solutions to enable every asset and worker to be visible, connected and fully optimized. The companys market-leading solutions elevate the shopping experience, track and manage inventory as well as improve supply chain efficiency and patient care. In 2020, Zebra made Forbes Global 2000 list for the second consecutive year and was listed among Fast Companys Best Companies for Innovators. For more information, visit www.zebra.com or sign up for news alerts. Participate in Zebras Your Edge blog, follow the company on LinkedIn, Twitter and Facebook, and check out our Story Hub: Zebra Perspectives. ABOUT REFLEXIS SYSTEMS Reflexis Systems (now part of Zebra Technologies), is the leading provider of intelligent workforce management, execution and communication solutions for multi-site organizations in retail, food service, hospitality and banking. The Reflexis ONE intelligent work platform is used by our customers across the globe to simplify execution, improve communication and optimize labor decisions. Today, over 275 leaders in retail, food service, hospitality and banking are leveraging Reflexis ONE to achieve measurable improvements in customer engagement & employee productivity and retention. Reflexis Systems is headquartered in Dedham, Massachusetts and has offices in Atlanta, Columbus, London, Dsseldorf, and Pune (India), with additional sales presence across Europe and Latin America. For further information, please visit www.Reflexisinc.com. Follow Reflexis on: LinkedIn | Blog | Twitter | YouTube ABOUT NUCLEUS RESEARCH Nucleus Research is the recognized global leader in investigative ROI technology research. Using a case-based approach, we provide research streams and advisory services that allow vendors and end users to quantify and maximize the return from their technology investments. We deliver the numbers that drive better business decisions. For more information, visit NucleusResearch.com or follow our latest updates on LinkedIn. Answer:

Reflexis Systems Named a Leader in Nucleus Researchs 2021 WFM Technology Value Matrix This marks the third consecutive year as a Leader for Reflexis, now part of Zebra Technologies

DEDHAM, Mass.--(BUSINESS WIRE)--Reflexis Systems (now part of Zebra Technologies), a leading provider of AI-powered workforce management and real-time execution solutions for multi-site businesses in retail, food service, hospitality and banking, has been recognized by Nucleus Research as a Leader in the 2021 WFM (Workforce Management) Technology Value Matrix. This is the third consecutive year Reflexis has placed in the Leader quadrant of this analyst report. A complimentary copy of the full report is available here. We positioned Reflexis Systems as a Leader in the 2021 WFM Technology Value Matrix for the third straight year due to the continued strength and agility of Reflexis ONE TM, said Trevor White, Analyst at Nucleus Research. Reflexis Workforce Scheduler and Employee Self-Service empower businesses across a wide range of industries to simplify store execution while streamlining labor and scheduling processes. Nucleus Research evaluated 17 WFM solutions and ranked them on their delivery of value to customers via both the functionality and usability of the software. Reflexis received accolades for its AI-powered Reflexis ONE platform, which allows retailers, quick service restaurants, hotels and banks to optimize execution processes and labor expenditures. Reflexis Systems is honored Nucleus Research has again recognized us as a Leader in the 2021 WFM Technology Value Matrix, said Suresh Menon, Senior Vice President and General Manager for Software Solutions, Zebra Technologies. Reflexis ONE helps businesses across a wide range of industries optimize labor budgeting, forecasting and scheduling via our AI-powered Workforce Scheduler, while Employee Self-Service increases employee productivity, engagement and retention. KEY TAKEAWAYS ABOUT ZEBRA TECHNOLOGIES Zebra (NASDAQ: ZBRA) empowers the front line in retail/ecommerce, manufacturing, transportation and logistics, healthcare, public sector and other industries to achieve a performance edge. With more than 10,000 partners across 100 countries, Zebra delivers industry-tailored, end-to-end solutions to enable every asset and worker to be visible, connected and fully optimized. The companys market-leading solutions elevate the shopping experience, track and manage inventory as well as improve supply chain efficiency and patient care. In 2020, Zebra made Forbes Global 2000 list for the second consecutive year and was listed among Fast Companys Best Companies for Innovators. For more information, visit www.zebra.com or sign up for news alerts. Participate in Zebras Your Edge blog, follow the company on LinkedIn, Twitter and Facebook, and check out our Story Hub: Zebra Perspectives. ABOUT REFLEXIS SYSTEMS Reflexis Systems (now part of Zebra Technologies), is the leading provider of intelligent workforce management, execution and communication solutions for multi-site organizations in retail, food service, hospitality and banking. The Reflexis ONE intelligent work platform is used by our customers across the globe to simplify execution, improve communication and optimize labor decisions. Today, over 275 leaders in retail, food service, hospitality and banking are leveraging Reflexis ONE to achieve measurable improvements in customer engagement & employee productivity and retention. Reflexis Systems is headquartered in Dedham, Massachusetts and has offices in Atlanta, Columbus, London, Dsseldorf, and Pune (India), with additional sales presence across Europe and Latin America. For further information, please visit www.Reflexisinc.com. Follow Reflexis on: LinkedIn | Blog | Twitter | YouTube ABOUT NUCLEUS RESEARCH Nucleus Research is the recognized global leader in investigative ROI technology research. Using a case-based approach, we provide research streams and advisory services that allow vendors and end users to quantify and maximize the return from their technology investments. We deliver the numbers that drive better business decisions. For more information, visit NucleusResearch.com or follow our latest updates on LinkedIn.

edtsum124

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, March 12, 2021 /PRNewswire/ --At its 2021 Annual Meeting this month, the Association of Schools and Programs of Public Health (ASPPH) will present the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) with the Harrison C. Spencer Award for Outstanding Community Service. The prestigious award was created to honor Dr. Spencer, a pioneer in public health with a long-standing commitment to principles of social justice with a focus on community engagement to address the social determinants of health. Community engagement is integral to CUNY SPH's vision of promoting health and social justice in New York City and across the globe through innovation and excellence in education, research, and service in public health. We embrace a multifaceted concept of "community" that includes half a million CUNY students at its center, exceeding a million when including the students families and close social circle. The school is also engaged with its immediate neighborhood in Harlem, with its rich cultural heritage anchored in social justice an civil liberty, and with the broader New York City public health community of government agencies, health care institutions, community-based and private sector organizations, and academia whose mission is to improve population health. CUNY SPH is being recognized for its recent work to promote population health, especially amidst the Covid-19 pandemic, including the CONVINCE USA Initiative, which seeks to promote vaccine literacy and confidence in Covid-19 vaccines in particular; the Healthy CUNY Initiative, which strives to promote the health of CUNY students in order to support their academic success; the Harlem Strong Program, a community-based mental health and economic empowerment initiative to support greater mental health awareness, community advocacy and collaboration through community networks; the Covid-19 Resource Navigator Program (RNAV), which has trained CUNY students and alumni and CBOs to assist nearly 7,000 individuals in obtaining the resources and services necessary to quarantine at home due to exposure to Covid-19; the CUNY SPH Covid-19 Tracking Survey, which documented the impact of the pandemic on New York City and State residents over several months; and the Harlem Health Initiative, which supports and strengthens local organizations in Harlem where the school is located. "We are delighted and humbled by the news of this award," said CUNY SPH Dean Ayman El-Mohandes. "We look forward to continuing our work to partner with our community in New York City and beyond, to advance social justice, and to improve health outcomes for all." The Spencer Award is given annually to an ASPPH-member, CEPH- accredited school or program of public health demonstrating a major institutional commitment to addressing community needs through education, practice, and/or research. The award will be presented on day three of the Annual Meeting, March 25 at 2:30pm. See the full agenda and RSVP here. Media contact:Ariana Costakes[emailprotected]646-364-9649 SOURCE CUNY SPH Related Links https://sph.cuny.edu Answer:

CUNY SPH to be honored with ASPPH Award for Outstanding Community Service

NEW YORK, March 12, 2021 /PRNewswire/ --At its 2021 Annual Meeting this month, the Association of Schools and Programs of Public Health (ASPPH) will present the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) with the Harrison C. Spencer Award for Outstanding Community Service. The prestigious award was created to honor Dr. Spencer, a pioneer in public health with a long-standing commitment to principles of social justice with a focus on community engagement to address the social determinants of health. Community engagement is integral to CUNY SPH's vision of promoting health and social justice in New York City and across the globe through innovation and excellence in education, research, and service in public health. We embrace a multifaceted concept of "community" that includes half a million CUNY students at its center, exceeding a million when including the students families and close social circle. The school is also engaged with its immediate neighborhood in Harlem, with its rich cultural heritage anchored in social justice an civil liberty, and with the broader New York City public health community of government agencies, health care institutions, community-based and private sector organizations, and academia whose mission is to improve population health. CUNY SPH is being recognized for its recent work to promote population health, especially amidst the Covid-19 pandemic, including the CONVINCE USA Initiative, which seeks to promote vaccine literacy and confidence in Covid-19 vaccines in particular; the Healthy CUNY Initiative, which strives to promote the health of CUNY students in order to support their academic success; the Harlem Strong Program, a community-based mental health and economic empowerment initiative to support greater mental health awareness, community advocacy and collaboration through community networks; the Covid-19 Resource Navigator Program (RNAV), which has trained CUNY students and alumni and CBOs to assist nearly 7,000 individuals in obtaining the resources and services necessary to quarantine at home due to exposure to Covid-19; the CUNY SPH Covid-19 Tracking Survey, which documented the impact of the pandemic on New York City and State residents over several months; and the Harlem Health Initiative, which supports and strengthens local organizations in Harlem where the school is located. "We are delighted and humbled by the news of this award," said CUNY SPH Dean Ayman El-Mohandes. "We look forward to continuing our work to partner with our community in New York City and beyond, to advance social justice, and to improve health outcomes for all." The Spencer Award is given annually to an ASPPH-member, CEPH- accredited school or program of public health demonstrating a major institutional commitment to addressing community needs through education, practice, and/or research. The award will be presented on day three of the Annual Meeting, March 25 at 2:30pm. See the full agenda and RSVP here. Media contact:Ariana Costakes[emailprotected]646-364-9649 SOURCE CUNY SPH Related Links https://sph.cuny.edu

edtsum131

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: INNSBRUCK, Austria, July 8, 2020 /PRNewswire/ -- Independent security testing labAV-Comparativeshas published thereportof its 2020 investigation into antivirus apps for the Android mobile platform. The Innsbruck-based institute tested 9 popular security apps with regard to malware protection, battery drain and anti-theft functionality. Third-party products made by Avast, AVG, Avira, Bitdefender, G DATA, Kaspersky, Securion and Trend Micro were all scrutinised, along with Google's built-in security measures in the Android platform. Products mobile 2020 (PRNewsfoto/AV-Comparatives) Results mobile 2020 (PRNewsfoto/AV-Comparatives) Please read the full report here: https://www.av-comparatives.org/tests/mobile-security-review-2020/. The latest version of Google's mobile OS, Android 10, was used for thetest. Users who are planning on buying a new smartphone, or updating their existing phones to the newest OS version, can see how well the tested products perform on the latest incarnation of Android. In the malware protection test, over 3,000 recent malicious applications for the Android operating system were used. The results clearly showed the advantage of using a third-party antivirus product to protect smartphones against Android malware.To ensure that the tested products do not achieve protection at the expense of high rates of false alarms, a false-positives test was also run, using 500 popular legitimate apps.Anti-theft functionality was also considered. This allows a user whose smartphone has been lost or stolen to, e.g., locate it, lock it, and wipe private data. Anti-theft features in the tested products were tested for reliable operation.A past criticism of security programs is that they cause significant drain on the device's battery. AV-Comparatives addressed this issue by running a battery-drain test. The effect each product has on battery life during everyday phone usage (making calls, surfing the Internet, watching videos and sending emails) was measured.As well as the results of the tests, the report includes general security advice and information for users of Android devices. The new security measures incorporated into Android 10 are considered, along with the effect these have on third-party security apps. Security tips for Android users are also provided.Like all AV-Comparatives' public reports, the report of the 2020 Android Mobile Security Test can be downloaded free of charge from the institute's website,www.av-comparatives.org."Even as Google's built-in malware protection improved, it still offers the weakest protection of all tested products. We highly recommend using a third-party app."- Peter Stelzhammer, co-founder, AV-ComparativesAV-Comparatives offers AVC UnDroid, a well-done malware analysis tool, which is available free to all users. It is a static analysis system for detecting suspected Android malware and adware and providing statistics about it. Users can upload APK files and see the results in various analysis mechanisms.Check it out:https://www.av-comparatives.org/specials/undroid/Photo - https://mma.prnewswire.com/media/1200602/AV_Comparatives_Products_Mobile_2020.jpg Photo - https://mma.prnewswire.com/media/1200603/AV_Comparatives_Results_Mobile_2020.jpg Logo - https://mma.prnewswire.com/media/1200605/AV_Comparatives_Logo.jpgContact:Peter Stelzhammer[emailprotected]SOURCE AV-Comparatives Related Links https://www.av-comparatives.org Answer:

AV-Comparatives Releases Results of 2020 Android Security Test English Deutschland - Deutsch The results show that third-party security apps protect at a high level, but Google's protection fails

INNSBRUCK, Austria, July 8, 2020 /PRNewswire/ -- Independent security testing labAV-Comparativeshas published thereportof its 2020 investigation into antivirus apps for the Android mobile platform. The Innsbruck-based institute tested 9 popular security apps with regard to malware protection, battery drain and anti-theft functionality. Third-party products made by Avast, AVG, Avira, Bitdefender, G DATA, Kaspersky, Securion and Trend Micro were all scrutinised, along with Google's built-in security measures in the Android platform. Products mobile 2020 (PRNewsfoto/AV-Comparatives) Results mobile 2020 (PRNewsfoto/AV-Comparatives) Please read the full report here: https://www.av-comparatives.org/tests/mobile-security-review-2020/. The latest version of Google's mobile OS, Android 10, was used for thetest. Users who are planning on buying a new smartphone, or updating their existing phones to the newest OS version, can see how well the tested products perform on the latest incarnation of Android. In the malware protection test, over 3,000 recent malicious applications for the Android operating system were used. The results clearly showed the advantage of using a third-party antivirus product to protect smartphones against Android malware.To ensure that the tested products do not achieve protection at the expense of high rates of false alarms, a false-positives test was also run, using 500 popular legitimate apps.Anti-theft functionality was also considered. This allows a user whose smartphone has been lost or stolen to, e.g., locate it, lock it, and wipe private data. Anti-theft features in the tested products were tested for reliable operation.A past criticism of security programs is that they cause significant drain on the device's battery. AV-Comparatives addressed this issue by running a battery-drain test. The effect each product has on battery life during everyday phone usage (making calls, surfing the Internet, watching videos and sending emails) was measured.As well as the results of the tests, the report includes general security advice and information for users of Android devices. The new security measures incorporated into Android 10 are considered, along with the effect these have on third-party security apps. Security tips for Android users are also provided.Like all AV-Comparatives' public reports, the report of the 2020 Android Mobile Security Test can be downloaded free of charge from the institute's website,www.av-comparatives.org."Even as Google's built-in malware protection improved, it still offers the weakest protection of all tested products. We highly recommend using a third-party app."- Peter Stelzhammer, co-founder, AV-ComparativesAV-Comparatives offers AVC UnDroid, a well-done malware analysis tool, which is available free to all users. It is a static analysis system for detecting suspected Android malware and adware and providing statistics about it. Users can upload APK files and see the results in various analysis mechanisms.Check it out:https://www.av-comparatives.org/specials/undroid/Photo - https://mma.prnewswire.com/media/1200602/AV_Comparatives_Products_Mobile_2020.jpg Photo - https://mma.prnewswire.com/media/1200603/AV_Comparatives_Results_Mobile_2020.jpg Logo - https://mma.prnewswire.com/media/1200605/AV_Comparatives_Logo.jpgContact:Peter Stelzhammer[emailprotected]SOURCE AV-Comparatives Related Links https://www.av-comparatives.org

edtsum138

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ROCKPORT, Mass., Sept. 30, 2020 /PRNewswire/ -- The Film Detective (TFD), a classic media streaming network and film archive that restores and distributes classic films for today's cord-cutters is proud to announce the return of31 Days of Horror. Every night at 10 p.m. ET in October, The Film Detective will feature a different classic scare from Lon Chaney'sThe Phantom of the Opera(1925)tomade-for-TV thrills likeDark Night of the Scarecrow(1981). Continue Reading The Film Detective As part of the 31 Days of Horror, The Film Detective is proud to announce the arrival ofFriday Fright, every Fridayat 10 p.m. ET. Co-created by Greg and Gail Martin, this late-night classic featuresRavena, the Goddess of Stonehenge and her faithful companionAnokpresenting horror classics like Bela Lugosi'sWhite Zombie(1932). SaidGreg Martin, "We are ecstatic to partner with The Film Detective and bring you the classic Friday Fright show in October. We hope you will loveRavena, the Goddess of Stonehenge and her companionAnokas much as we do." Accompanying Friday Frightthroughout October will be aTrailers from Hell-oweenMarathonon Oct. 31. FeaturingdirectorsMary Lambert, MickGarris, and "Trailers from Hell" founder Joe Dante, this 24-hour Halloween marathon includes exclusive commentary from some of Hollywood's most talentedfilmmakers in "Trailers from Hell"shorts to be followed by the full films they discuss, includingCarnival of Souls(1962) andDementia 13(1963).Enthusiasts from horrorto punk rockand even politics willenjoy upcomingadditionson The Film Detectiveapp. Punk rockers should mark their calendars for the Oct. 1 worldwide debut ofChaos! Sex Pistols,McLaren, Art & Dave Goodman: Director's Cut 2020.This stunning documentary about the rise of UK Punk and the Sex Pistols is a fascinating historical piece, featuring members of Sex Pistols, The Clash, MalcolmMcLaren, and thePistols'first producer, Dave Goodman.Also available on The Film Detectiveappstarting Oct. 1isThe Scroll ofMorlok(2020), a contemporary homage to the silent German Expressionist classics of the 1920s.The Scroll ofMorlok(2020)will be joined by footage from the1956 Democratic National Conventionand episodes ofMedic(1954-1956),starring Richard Boone.No matter the genre, The Film Detective hasclassic film fans covered.For more information, visithttps://www.thefilmdetective.com/.About The Film Detective:The Film Detective is a leading distributor of restored classic programming, including feature films, television, foreign imports, and documentaries. Launched in 2014, The Film Detective has distributed its extensive library of 3,000+ hours of film on DVD andBlu-ray and throughplatforms including TCM,EPIX,Amazon,and PBS.The Film Detective has released its classic movieappon web, Android,iOS,Roku, Amazon Fire TV, and Apple TV and is available live via Sling, STIRR,Plex, andDistroTV.Contact:Kerry Ryan[emailprotected]Related Imagesimage1.jpg Related LinksThe Film Detective TV SOURCE The Film Detective Answer:

From Punk Rockers to Scream Queens - The Film Detective Presents 31 Days of Horror The Film Detective Celebrates the Return (From the Dead) of 31 Days of Horror with Monster Mashes and Mosh Pits

ROCKPORT, Mass., Sept. 30, 2020 /PRNewswire/ -- The Film Detective (TFD), a classic media streaming network and film archive that restores and distributes classic films for today's cord-cutters is proud to announce the return of31 Days of Horror. Every night at 10 p.m. ET in October, The Film Detective will feature a different classic scare from Lon Chaney'sThe Phantom of the Opera(1925)tomade-for-TV thrills likeDark Night of the Scarecrow(1981). Continue Reading The Film Detective As part of the 31 Days of Horror, The Film Detective is proud to announce the arrival ofFriday Fright, every Fridayat 10 p.m. ET. Co-created by Greg and Gail Martin, this late-night classic featuresRavena, the Goddess of Stonehenge and her faithful companionAnokpresenting horror classics like Bela Lugosi'sWhite Zombie(1932). SaidGreg Martin, "We are ecstatic to partner with The Film Detective and bring you the classic Friday Fright show in October. We hope you will loveRavena, the Goddess of Stonehenge and her companionAnokas much as we do." Accompanying Friday Frightthroughout October will be aTrailers from Hell-oweenMarathonon Oct. 31. FeaturingdirectorsMary Lambert, MickGarris, and "Trailers from Hell" founder Joe Dante, this 24-hour Halloween marathon includes exclusive commentary from some of Hollywood's most talentedfilmmakers in "Trailers from Hell"shorts to be followed by the full films they discuss, includingCarnival of Souls(1962) andDementia 13(1963).Enthusiasts from horrorto punk rockand even politics willenjoy upcomingadditionson The Film Detectiveapp. Punk rockers should mark their calendars for the Oct. 1 worldwide debut ofChaos! Sex Pistols,McLaren, Art & Dave Goodman: Director's Cut 2020.This stunning documentary about the rise of UK Punk and the Sex Pistols is a fascinating historical piece, featuring members of Sex Pistols, The Clash, MalcolmMcLaren, and thePistols'first producer, Dave Goodman.Also available on The Film Detectiveappstarting Oct. 1isThe Scroll ofMorlok(2020), a contemporary homage to the silent German Expressionist classics of the 1920s.The Scroll ofMorlok(2020)will be joined by footage from the1956 Democratic National Conventionand episodes ofMedic(1954-1956),starring Richard Boone.No matter the genre, The Film Detective hasclassic film fans covered.For more information, visithttps://www.thefilmdetective.com/.About The Film Detective:The Film Detective is a leading distributor of restored classic programming, including feature films, television, foreign imports, and documentaries. Launched in 2014, The Film Detective has distributed its extensive library of 3,000+ hours of film on DVD andBlu-ray and throughplatforms including TCM,EPIX,Amazon,and PBS.The Film Detective has released its classic movieappon web, Android,iOS,Roku, Amazon Fire TV, and Apple TV and is available live via Sling, STIRR,Plex, andDistroTV.Contact:Kerry Ryan[emailprotected]Related Imagesimage1.jpg Related LinksThe Film Detective TV SOURCE The Film Detective

edtsum139

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, June 11, 2020 /PRNewswire/ -- The "Deep Sea, Coastal, And Great Lakes Global Market Report 2020-30: Covid 19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering. This report provides the strategists, marketers and senior management with the critical information they need to assess the global deep sea, coastal, and great lakes market as it emerges from the Covid 19 shut down.The global deep sea, coastal, and great lakes market is expected to decline from $491.1 billion in 2019 to $463.7 billion in 2020 at a compound annual growth rate (CAGR) of -5.6%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 5% from 2021 and reach $526.7 billion in 2023. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. Create regional and country strategies on the basis of local data and analysis. Identify growth segments for investment. Outperform competitors using forecast data and the drivers and trends shaping the market. Understand customers based on the latest market research findings. Benchmark performance against key competitors. Utilize the relationships between key data sets for superior strategizing. Suitable for supporting your internal and external presentations with reliable high quality data and analysis Report will be updated with the latest data and delivered to you within 3 working days of order. Where is the largest and fastest growing market for the deep sea, coastal, and great lakes? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Deep Sea, Coastal, And Great Lakes global market report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider deep sea, coastal, and great lakes market, and compares it with other markets. The market characteristics section of the report defines and explains the market. The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery. Market segmentations break down market into sub markets. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets. Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers. The deep sea, coastal, and great lakes market section of the report gives context. It compares the deep sea, coastal, and great lakes market with other segments of the water transportation market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, deep sea, coastal, and great lakes indicators comparison. The deep sea, coastal, and great lakes transportation market consists of sales of deep sea, coastal, and great lakes transportation services by entities (organizations, sole traders and partnerships) that provide deep sea, coastal, and great lakes transportation of passengers and cargo using watercraft, such as ships, barges, and boats.Asia Pacific was the largest region in the global deep sea, coastal, and great lakes market, accounting for 45% of the market in 2019. Western Europe was the second largest region accounting for 32% of the global deep sea, coastal, and great lakes market. Africa was the smallest region in the global deep sea, coastal, and great lakes market.Changing shift towards highly available less polluting fuels such as liquefied natural gas(LNG), biofuels and many more are growing recently. Pricing and low emission has resulted in increase in the demand of LNG. Furthermore, European Commission also planned to have 139 LNG refueling facilities for seagoing and inland vessels. Growth of LNG powered ships are likely to play a major role in Deep sea, coastal, and great lakes water transportation industry in the next decade. Companies namely Rolls Royce, Wartsila, MAN have developed different LNG engine technologies for better throughput.Key Topics Covered: 1. Executive Summary 2. Report Structure 3. Deep Sea, Coastal, And Great Lakes Market Characteristics 3.1. Market Definition 3.2. Key Segmentations 4. Deep Sea, Coastal, And Great Lakes Market Product Analysis 4.1. Leading Products/ Services 4.2. Key Features and Differentiators 4.3. Development Products 5. Deep Sea, Coastal, And Great Lakes Market Supply Chain 5.1. Supply Chain 5.2. Distribution 5.3. End Customers 6. Deep Sea, Coastal, And Great Lakes Market Customer Information 6.1. Customer Preferences 6.2. End Use Market Size and Growth 7. Deep Sea, Coastal, And Great Lakes Market Trends And Strategies 8. Deep Sea, Coastal, And Great Lakes Market Size And Growth 8.1. Market Size 8.2. Historic Market Growth, Value ($ Billion) 8.2.1. Drivers Of The Market 8.2.2. Restraints On The Market 8.3. Forecast Market Growth, Value ($ Billion) 8.3.1. Drivers Of The Market 8.3.2. Restraints On The Market 9. Deep Sea, Coastal, And Great Lakes Market Regional Analysis 9.1. Global Deep Sea, Coastal, And Great Lakes Market, 2019, By Region, Value ($ Billion) 9.2. Global Deep Sea, Coastal, And Great Lakes Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region 9.3. Global Deep Sea, Coastal, And Great Lakes Market, Growth And Market Share Comparison, By Region 10. Deep Sea, Coastal, And Great Lakes Market Segmentation 10.1. Global Deep Sea, Coastal, And Great Lakes Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion11. Deep Sea, Coastal, And Great Lakes Market Metrics 11.1. Deep Sea, Coastal, And Great Lakes Market Size, Percentage Of GDP, 2015-2023, Global 11.2. Per Capita Average Deep Sea, Coastal, And Great Lakes Market Expenditure, 2015-2023, Global 12. Asia-Pacific Deep Sea, Coastal, And Great Lakes Market13. Western Europe Deep Sea, Coastal, And Great Lakes Market14. Eastern Europe Deep Sea, Coastal, And Great Lakes Market15. North America Deep Sea, Coastal, And Great Lakes Market16. South America Deep Sea, Coastal, And Great Lakes Market17. Middle East Deep Sea, Coastal, And Great Lakes Market18. Africa Deep Sea, Coastal, And Great Lakes Market19. Deep Sea, Coastal, And Great Lakes Market Competitive Landscape 19.1. Competitive Market Overview 19.2. Market Shares 19.3. Company Profiles 19.3.1. Carnival Corporation 19.3.1.1. Company Overview 19.3.1.2. Products And Services 19.3.1.3. Strategy 19.3.1.4. Financial Performance 19.3.2. A.P. Moller 19.3.2.1. Company Overview 19.3.2.2. Products And Services 19.3.2.3. Strategy 19.3.2.4. Financial Performance 19.3.3. MSC Mediterranean Shipping Company SA 19.3.3.1. Company Overview 19.3.3.2. Products And Services 19.3.3.3. Strategy 19.3.3.4. Financial Performance 19.3.4. K-Line America 19.3.4.1. Company Overview 19.3.4.2. Products And Services 19.3.4.3. Strategy 19.3.4.4. Financial Performance 19.3.5. Seacor Holdings Inc 19.3.5.1. Company Overview 19.3.5.2. Products And Services 19.3.5.3. Strategy 19.3.5.4. Financial Performance 20. Key Mergers And Acquisitions In The Deep Sea, Coastal, And Great Lakes Market 21. Market Background: Water Transportation Market 21.1. Water Transportation Market Characteristics 21.2. Water Transportation Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global 21.3. Global Water Transportation Market, 2019, By Region, Value ($ Billion) 21.4. Global Water Transportation Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region 21.5. Global Water Transportation Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion) 22. Recommendations 22.1. Global Deep Sea, Coastal, And Great Lakes Market In 2023- Growth Countries 22.2. Global Deep Sea, Coastal, And Great Lakes Market In 2023- Growth Segments 22.3. Global Deep Sea, Coastal, And Great Lakes Market In 2023- Growth Strategies 23. Appendix 23.1. NAICS Definitions Of Industry Covered In This Report 23.2. Abbreviations 23.3. Currencies 23.4. Research Inquiries 23.5. About the Publisher 24. Copyright And DisclaimerCompanies Mentioned Carnival Corporation A.P. Moller MSC Mediterranean Shipping Company SA K-Line America Seacor Holdings Inc For more information about this report visit https://www.researchandmarkets.com/r/aiv6hi Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

Worldwide Deep Sea, Coastal and Great Lakes Market to 2030 - Featuring Carnival, K-Line America & Seacor Holdings Among Others

DUBLIN, June 11, 2020 /PRNewswire/ -- The "Deep Sea, Coastal, And Great Lakes Global Market Report 2020-30: Covid 19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering. This report provides the strategists, marketers and senior management with the critical information they need to assess the global deep sea, coastal, and great lakes market as it emerges from the Covid 19 shut down.The global deep sea, coastal, and great lakes market is expected to decline from $491.1 billion in 2019 to $463.7 billion in 2020 at a compound annual growth rate (CAGR) of -5.6%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 5% from 2021 and reach $526.7 billion in 2023. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. Create regional and country strategies on the basis of local data and analysis. Identify growth segments for investment. Outperform competitors using forecast data and the drivers and trends shaping the market. Understand customers based on the latest market research findings. Benchmark performance against key competitors. Utilize the relationships between key data sets for superior strategizing. Suitable for supporting your internal and external presentations with reliable high quality data and analysis Report will be updated with the latest data and delivered to you within 3 working days of order. Where is the largest and fastest growing market for the deep sea, coastal, and great lakes? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Deep Sea, Coastal, And Great Lakes global market report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider deep sea, coastal, and great lakes market, and compares it with other markets. The market characteristics section of the report defines and explains the market. The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery. Market segmentations break down market into sub markets. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets. Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers. The deep sea, coastal, and great lakes market section of the report gives context. It compares the deep sea, coastal, and great lakes market with other segments of the water transportation market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, deep sea, coastal, and great lakes indicators comparison. The deep sea, coastal, and great lakes transportation market consists of sales of deep sea, coastal, and great lakes transportation services by entities (organizations, sole traders and partnerships) that provide deep sea, coastal, and great lakes transportation of passengers and cargo using watercraft, such as ships, barges, and boats.Asia Pacific was the largest region in the global deep sea, coastal, and great lakes market, accounting for 45% of the market in 2019. Western Europe was the second largest region accounting for 32% of the global deep sea, coastal, and great lakes market. Africa was the smallest region in the global deep sea, coastal, and great lakes market.Changing shift towards highly available less polluting fuels such as liquefied natural gas(LNG), biofuels and many more are growing recently. Pricing and low emission has resulted in increase in the demand of LNG. Furthermore, European Commission also planned to have 139 LNG refueling facilities for seagoing and inland vessels. Growth of LNG powered ships are likely to play a major role in Deep sea, coastal, and great lakes water transportation industry in the next decade. Companies namely Rolls Royce, Wartsila, MAN have developed different LNG engine technologies for better throughput.Key Topics Covered: 1. Executive Summary 2. Report Structure 3. Deep Sea, Coastal, And Great Lakes Market Characteristics 3.1. Market Definition 3.2. Key Segmentations 4. Deep Sea, Coastal, And Great Lakes Market Product Analysis 4.1. Leading Products/ Services 4.2. Key Features and Differentiators 4.3. Development Products 5. Deep Sea, Coastal, And Great Lakes Market Supply Chain 5.1. Supply Chain 5.2. Distribution 5.3. End Customers 6. Deep Sea, Coastal, And Great Lakes Market Customer Information 6.1. Customer Preferences 6.2. End Use Market Size and Growth 7. Deep Sea, Coastal, And Great Lakes Market Trends And Strategies 8. Deep Sea, Coastal, And Great Lakes Market Size And Growth 8.1. Market Size 8.2. Historic Market Growth, Value ($ Billion) 8.2.1. Drivers Of The Market 8.2.2. Restraints On The Market 8.3. Forecast Market Growth, Value ($ Billion) 8.3.1. Drivers Of The Market 8.3.2. Restraints On The Market 9. Deep Sea, Coastal, And Great Lakes Market Regional Analysis 9.1. Global Deep Sea, Coastal, And Great Lakes Market, 2019, By Region, Value ($ Billion) 9.2. Global Deep Sea, Coastal, And Great Lakes Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region 9.3. Global Deep Sea, Coastal, And Great Lakes Market, Growth And Market Share Comparison, By Region 10. Deep Sea, Coastal, And Great Lakes Market Segmentation 10.1. Global Deep Sea, Coastal, And Great Lakes Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion11. Deep Sea, Coastal, And Great Lakes Market Metrics 11.1. Deep Sea, Coastal, And Great Lakes Market Size, Percentage Of GDP, 2015-2023, Global 11.2. Per Capita Average Deep Sea, Coastal, And Great Lakes Market Expenditure, 2015-2023, Global 12. Asia-Pacific Deep Sea, Coastal, And Great Lakes Market13. Western Europe Deep Sea, Coastal, And Great Lakes Market14. Eastern Europe Deep Sea, Coastal, And Great Lakes Market15. North America Deep Sea, Coastal, And Great Lakes Market16. South America Deep Sea, Coastal, And Great Lakes Market17. Middle East Deep Sea, Coastal, And Great Lakes Market18. Africa Deep Sea, Coastal, And Great Lakes Market19. Deep Sea, Coastal, And Great Lakes Market Competitive Landscape 19.1. Competitive Market Overview 19.2. Market Shares 19.3. Company Profiles 19.3.1. Carnival Corporation 19.3.1.1. Company Overview 19.3.1.2. Products And Services 19.3.1.3. Strategy 19.3.1.4. Financial Performance 19.3.2. A.P. Moller 19.3.2.1. Company Overview 19.3.2.2. Products And Services 19.3.2.3. Strategy 19.3.2.4. Financial Performance 19.3.3. MSC Mediterranean Shipping Company SA 19.3.3.1. Company Overview 19.3.3.2. Products And Services 19.3.3.3. Strategy 19.3.3.4. Financial Performance 19.3.4. K-Line America 19.3.4.1. Company Overview 19.3.4.2. Products And Services 19.3.4.3. Strategy 19.3.4.4. Financial Performance 19.3.5. Seacor Holdings Inc 19.3.5.1. Company Overview 19.3.5.2. Products And Services 19.3.5.3. Strategy 19.3.5.4. Financial Performance 20. Key Mergers And Acquisitions In The Deep Sea, Coastal, And Great Lakes Market 21. Market Background: Water Transportation Market 21.1. Water Transportation Market Characteristics 21.2. Water Transportation Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global 21.3. Global Water Transportation Market, 2019, By Region, Value ($ Billion) 21.4. Global Water Transportation Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region 21.5. Global Water Transportation Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion) 22. Recommendations 22.1. Global Deep Sea, Coastal, And Great Lakes Market In 2023- Growth Countries 22.2. Global Deep Sea, Coastal, And Great Lakes Market In 2023- Growth Segments 22.3. Global Deep Sea, Coastal, And Great Lakes Market In 2023- Growth Strategies 23. Appendix 23.1. NAICS Definitions Of Industry Covered In This Report 23.2. Abbreviations 23.3. Currencies 23.4. Research Inquiries 23.5. About the Publisher 24. Copyright And DisclaimerCompanies Mentioned Carnival Corporation A.P. Moller MSC Mediterranean Shipping Company SA K-Line America Seacor Holdings Inc For more information about this report visit https://www.researchandmarkets.com/r/aiv6hi Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum143

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SYDNEY, Dec. 15, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of $25,000,410. Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, commented, "It has been a pivotal year for Clarity with numerous critical milestones achieved in the development of our main products, advancement of our platform, as well as accelerated corporate and strategic activities despite facing an unprecedented global environment. "The money raised will enable us to keep the momentum from 2020 going and provide financial resources to progress the following important initiatives: - SARTATE Progress the Cu-64/Cu-67 SARTATE Neuroblastoma trial at the Memorial Sloan Kettering Cancer Center in children with neuroblastoma; Expand the Cu-64/Cu-67 SARTATE Neuroblastoma trial to additional clinical sites across the US with the ultimate goal of developing better treatment options for children with cancer; and Commence patient recruitment in Phase II Cu-64 SARTATE Neuroendocrine trial. - SAR-Bombesin Progress and expand the Cu-64 BOmbesin in Breast CAncer Trial (C-BOBCAT) led by A/Prof Louise Emmett, Director of Theranostics and Nuclear Medicine, at St Vincent's Hospital in Sydney with an aim of developing better treatment options to women with metastatic breast cancer, an area currently with a high unmet need; Expand the C-BOBCAT trial to include prostate cancer patients; and Seek US Food and Drug Administration's (FDA) approval for an Investigational New Drug (IND) Application. - SAR-bisPSMA Commence a clinical trial in the US for Cu-64/Cu-67 SAR-bisPSMA (theranostic) and in Australia for Cu-64 SAR-bisPSMA (diagnostic) to build on the promising pre-clinical data with the help of an internationally recognised team of key opinion leaders in the prostate cancer field; and Seek US FDA approval for an IND Application. - Develop new targeted theranostic productsfor a broad range of cancer types, utilising Clarity's SAR Technology Platform and the Cu-64/Cu-67 pairing." Dr Taylor continued, "Clarity has a strong focus on getting its lead product SARTATE to market, supported by the US FDA granting both Cu-67 SARTATE and Cu-64 SARTATE Orphan Drug Designations and Rare Paediatric Disease Designations for the treatment and clinical management of neuroblastoma, as well as developing the copper platform in large and unmet clinical indications." "It has been a very exciting year for Clarity" Dr Taylor added. "We would like to sincerely thank our long-term shareholders for their continued support of Clarity, as well as welcome and thank a broad range of new shareholders including institutions, family offices, high net-worth individuals and others who wanted to be part of the Clarity story. We would also like to thank Blue Ocean Equities for their contribution in assisting us with the capital raise." About Clarity Clarity is a clinical stage radiopharmaceutical company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceuticals, developing targeted therapies based on it's SAR Technology Platform for the treatment of cancer and other serious diseases in adults and children. www.claritypharmaceuticals.com SOURCE Clarity Pharmaceuticals Related Links www.claritypharmaceuticals.com Answer:

Clarity Pharmaceuticals closes $25m capital raising

SYDNEY, Dec. 15, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of $25,000,410. Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, commented, "It has been a pivotal year for Clarity with numerous critical milestones achieved in the development of our main products, advancement of our platform, as well as accelerated corporate and strategic activities despite facing an unprecedented global environment. "The money raised will enable us to keep the momentum from 2020 going and provide financial resources to progress the following important initiatives: - SARTATE Progress the Cu-64/Cu-67 SARTATE Neuroblastoma trial at the Memorial Sloan Kettering Cancer Center in children with neuroblastoma; Expand the Cu-64/Cu-67 SARTATE Neuroblastoma trial to additional clinical sites across the US with the ultimate goal of developing better treatment options for children with cancer; and Commence patient recruitment in Phase II Cu-64 SARTATE Neuroendocrine trial. - SAR-Bombesin Progress and expand the Cu-64 BOmbesin in Breast CAncer Trial (C-BOBCAT) led by A/Prof Louise Emmett, Director of Theranostics and Nuclear Medicine, at St Vincent's Hospital in Sydney with an aim of developing better treatment options to women with metastatic breast cancer, an area currently with a high unmet need; Expand the C-BOBCAT trial to include prostate cancer patients; and Seek US Food and Drug Administration's (FDA) approval for an Investigational New Drug (IND) Application. - SAR-bisPSMA Commence a clinical trial in the US for Cu-64/Cu-67 SAR-bisPSMA (theranostic) and in Australia for Cu-64 SAR-bisPSMA (diagnostic) to build on the promising pre-clinical data with the help of an internationally recognised team of key opinion leaders in the prostate cancer field; and Seek US FDA approval for an IND Application. - Develop new targeted theranostic productsfor a broad range of cancer types, utilising Clarity's SAR Technology Platform and the Cu-64/Cu-67 pairing." Dr Taylor continued, "Clarity has a strong focus on getting its lead product SARTATE to market, supported by the US FDA granting both Cu-67 SARTATE and Cu-64 SARTATE Orphan Drug Designations and Rare Paediatric Disease Designations for the treatment and clinical management of neuroblastoma, as well as developing the copper platform in large and unmet clinical indications." "It has been a very exciting year for Clarity" Dr Taylor added. "We would like to sincerely thank our long-term shareholders for their continued support of Clarity, as well as welcome and thank a broad range of new shareholders including institutions, family offices, high net-worth individuals and others who wanted to be part of the Clarity story. We would also like to thank Blue Ocean Equities for their contribution in assisting us with the capital raise." About Clarity Clarity is a clinical stage radiopharmaceutical company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceuticals, developing targeted therapies based on it's SAR Technology Platform for the treatment of cancer and other serious diseases in adults and children. www.claritypharmaceuticals.com SOURCE Clarity Pharmaceuticals Related Links www.claritypharmaceuticals.com

edtsum145

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Jan. 13, 2021 /PRNewswire/ --Wheels Up, the leading brand in private aviation, today announces the appointment of Francesca Molinari to the newly created position of Chief People Officer. In this role, Molinari will lead all aspects of human resources and culture at Wheels Up including organizational design, talent acquisition, development, and retention, as well as diversity and inclusion functions. Molinari will report directly to Wheels Up Founder and CEO Kenny Dichter. Wheels Up Taps Francesca Molinari as Chief People Officer "Francesca's deep experience running global HR for some of the world's largest digital brands will be key in furthering our culture, attracting new talent, and leveraging the strength and passion of our over 2,000 Wheels Up employees," said Dichter. "With her leadership, we will continue to strive for organizational excellence and to foster an exceptionally smart, motivated, and diverse team." "I am excited to be joining a company that believes as strongly in supporting their own employees as they do in supporting their Members and Customers. I'm impressed by everyone at Wheels Up and their passion for the Company and being a part a winning culture," said Molinari. Molinari most recently led Human Resources Business Partnering for Adobe's Digital Experience marketing cloud business, with a focus on driving organizational growth, scalability, and transformation for more than 5,000 employees worldwide. She successfully achieved high levels of employee engagement and retention while supporting the business' organic growth and the back-to-back acquisitions of Magento and Marketo. Prior to her time at Adobe, she served as Chief Human Resources Officer at Magento. Molinari also held leadership roles in people management for major corporations including eBay, GE Capital, and Macy's.Molinari holds an undergraduate degree from Hofstra University and a Masters degree in Human Resources Management from The New School University.About Wheels Up:Wheels Up, the leading brand in private aviation and the only company in the industry to offer a total private aviation solution, was founded and is led by renowned entrepreneurKenny Dichter. Wheels Up delivers world-class safety, service, and flexibility through on-demand flights, membership programs, corporate solutions, aircraft management, whole aircraft sales, and commercial travel benefits through a strategic partnership with Delta Air Lines. Wheels UpCustomers and Members have access to over1,500 safety-vetted and verified aircraft.Through the Wheels Up App anyone can search, book and fly.Wheels UpConnect, Core, and Business memberships provideenhancements such as flight sharing, empty-leg Hot Flights, ShuttleFlights, Shared Flights, signature Wheels Down events, and exclusive member benefits from preeminent lifestyle brands.The Company's ongoing Wheels Up Cares program aligns with philanthropic organizations and initiatives that affect and matter to the Company and its customers, members, stakeholders, families, and friends. The Wheels Up Cares fleet is comprised of five custom painted Beechcraft King Air 350i aircraft; each plane serves as a flying symbol for a specific cause.To learn more about Wheels Up, go toWheelsup.com.Follow Wheels Up onFacebook|Twitter|Instagram|GoogleWheels Up Media Contact:JONESWORKS[emailprotected](212) 839-0111SOURCE Wheels Up Answer:

Wheels Up Taps Francesca Molinari as Chief People Officer

NEW YORK, Jan. 13, 2021 /PRNewswire/ --Wheels Up, the leading brand in private aviation, today announces the appointment of Francesca Molinari to the newly created position of Chief People Officer. In this role, Molinari will lead all aspects of human resources and culture at Wheels Up including organizational design, talent acquisition, development, and retention, as well as diversity and inclusion functions. Molinari will report directly to Wheels Up Founder and CEO Kenny Dichter. Wheels Up Taps Francesca Molinari as Chief People Officer "Francesca's deep experience running global HR for some of the world's largest digital brands will be key in furthering our culture, attracting new talent, and leveraging the strength and passion of our over 2,000 Wheels Up employees," said Dichter. "With her leadership, we will continue to strive for organizational excellence and to foster an exceptionally smart, motivated, and diverse team." "I am excited to be joining a company that believes as strongly in supporting their own employees as they do in supporting their Members and Customers. I'm impressed by everyone at Wheels Up and their passion for the Company and being a part a winning culture," said Molinari. Molinari most recently led Human Resources Business Partnering for Adobe's Digital Experience marketing cloud business, with a focus on driving organizational growth, scalability, and transformation for more than 5,000 employees worldwide. She successfully achieved high levels of employee engagement and retention while supporting the business' organic growth and the back-to-back acquisitions of Magento and Marketo. Prior to her time at Adobe, she served as Chief Human Resources Officer at Magento. Molinari also held leadership roles in people management for major corporations including eBay, GE Capital, and Macy's.Molinari holds an undergraduate degree from Hofstra University and a Masters degree in Human Resources Management from The New School University.About Wheels Up:Wheels Up, the leading brand in private aviation and the only company in the industry to offer a total private aviation solution, was founded and is led by renowned entrepreneurKenny Dichter. Wheels Up delivers world-class safety, service, and flexibility through on-demand flights, membership programs, corporate solutions, aircraft management, whole aircraft sales, and commercial travel benefits through a strategic partnership with Delta Air Lines. Wheels UpCustomers and Members have access to over1,500 safety-vetted and verified aircraft.Through the Wheels Up App anyone can search, book and fly.Wheels UpConnect, Core, and Business memberships provideenhancements such as flight sharing, empty-leg Hot Flights, ShuttleFlights, Shared Flights, signature Wheels Down events, and exclusive member benefits from preeminent lifestyle brands.The Company's ongoing Wheels Up Cares program aligns with philanthropic organizations and initiatives that affect and matter to the Company and its customers, members, stakeholders, families, and friends. The Wheels Up Cares fleet is comprised of five custom painted Beechcraft King Air 350i aircraft; each plane serves as a flying symbol for a specific cause.To learn more about Wheels Up, go toWheelsup.com.Follow Wheels Up onFacebook|Twitter|Instagram|GoogleWheels Up Media Contact:JONESWORKS[emailprotected](212) 839-0111SOURCE Wheels Up

edtsum148

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, Dec. 21, 2020 /PRNewswire/ -- The "More Electric Aircraft Market by End User (Civil, Military), Aircraft System, Component, Application (Power Generation, Power Distribution, Power Conversion, Energy Storage), Aircraft Type (Fixed Wing, Rotary Wing), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global more electric aircraft market is estimated to be USD 1,504 million in 2020 and is projected to reach USD 3,359 million by 2025, at a CAGR of 17.4% during the forecast period. Recent technological advancements in the field of power electronics, fault-tolerant architecture, electro-hydrostatic actuators, flight control systems, high-density electric motors, and power generation and conversion systems have fueled the adoption of MEA. The COVID-19 outbreak has impacted the aviation industry adversely due to air travel restrictions on domestic as well as international flights across countries, resulting in the sudden decrease in the air traffic. This is expected to negatively impact the more electric aircraft market in the short term; slow recovery is expected in Q1 of 2021. The aviation industry could take 2-3 years to recover from the financial effects of COVID-19, leading to lower air travels and passenger traffic compared to previous estimates. Based on aircraft system, propulsion segment projected to lead more electric aircraft market during the forecast period Based on aircraft system, the more electric aircraft market is segmented into propulsion system and airframe system. Electrification of various propulsion and airframe systems enables aircraft to reduce carbon emissions and the overall operational cost. The rising focus of major OEMs such as Airbus on the development of electric propulsion systems is expected to drive the propulsion system segment during the forecast period Based on application, power distribution segment projected to lead more electric aircraft market during the forecast period Based on application, the more electric aircraft is segmented into power generation, power distribution, power conversion, and energy storage. The power distribution system is highly flexible, fault-tolerant, and is controlled by a redundant microprocessor system. In this system, electrical power is supplied to the primary power distribution system, wherein the contactor control unit (CCU) and high-power contactor are located across generators, auxiliary power units (APU), batteries, and ground sources. Based on end user, the civil segment accounts for the largest market size during the forecast period Based on end user, the more electric aircraft market is segmented into civil and military. The civil segment is estimated to account for a larger share in 2020 as compared to the military segment. Carbon and nitrogen oxide emissions, high fuel consumption, and high maintenance costs are some of the challenges in the civil segment. Europe is expected to account for the largest share in 2020 The more electric aircraft market has been studied for North America, Europe, Asia Pacific, Middle East & Africa and Africa. Europe is estimated to account for the largest share of the global market in 2020. The aviation industry in Europe is aiming to use new advanced materials, such as gamma-titanium aluminides and single crystals, with improved mechanical properties in aircraft; these advanced engines help aircraft reduce their fuel consumption, carbon emissions, and noise. Key manufacturers of more electric aircraft in Europe include Rolls-Royce (UK), Safran Group (France), Airbus (Netherlands), and Thales Group (France). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Attractive Opportunities in More Electric Aircraft Market4.2 More Electric Aircraft Market, by Application4.3 More Electric Aircraft Market, by Major Countries5 Market Overview5.1 Market Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Optimized Aircraft Performance5.2.1.2 Reduction in Operational and Maintenance Costs5.2.1.3 Reduced Emissions and Noise Pollution5.2.2 Restraints5.2.2.1 Heavy Investments and Longer Clearance Period5.2.3 Opportunities5.2.3.1 Advancements in High-Density Battery Solutions5.2.3.2 Emergence of Alternative Power Sources for Electric Power Generation5.2.3.3 Development of Advanced Power Electronic Components5.2.4 Challenges5.2.4.1 Thermal Management in Electrical Systems5.2.4.2 Reliability of Electrical Systems in Harsh Environments5.2.4.3 Economic Challenges Faced by the Aviation Industry due to COVID-195.3 Range/Scenarios5.4 COVID-19 Impact Analysis5.5 Trends/Disruptions Impacting Customers' Business5.5.1 Revenue Shift and New Revenue Pockets for More Electric Aircraft Market5.6 Market Ecosystem5.6.1 Prominent Companies5.6.2 Private and Small Enterprises5.6.3 End-users5.7 Pricing Analysis5.8 Value Chain Analysis5.9 Porter's Five Forces Analysis5.10 Technology Analysis5.10.1 Fuel Cell Technology5.10.2 Electric Actuation System5.11 Case Study Analysis5.11.1 More Electric Architecture by Honeywell5.12 More Electric Aircraft, by Aircraft Type6 Industry Trends6.1 Introduction6.2 Aircraft Electrification Technology Roadmap (2016 to 2040)6.3 Industry Trends6.3.1 Electrical Systems in Aircraft6.3.2 Shift from Hydraulic Landing Gear & Braking Systems to Electric6.3.3 Electric-Powered Aircraft6.3.4 Electrical and Electronics Technologies6.3.4.1 Machine Technologies6.3.4.2 Power Electronics6.3.4.3 Energy Management6.4 Advanced Batteries6.4.1 Lithium-Sulfur (Li-S)6.5 Electric Motor-Driven Smart Pumps6.6 Impact of Megatrends6.7 Innovations and Patent Registrations7 More Electric Aircraft Market, by Aircraft System7.1 Introduction7.2 Propulsion System7.2.1 Development of Propulsion Systems by Oems is Expected to Drive this Segment7.2.2 Fuel Management System7.2.3 Thrust Reverser System7.3 Airframe System7.3.1 Increasing Demand to Ensure Safety During Flight Operations is Expected to Drive this Segment7.3.2 Environmental Control System7.3.3 Accessory Drive System7.3.4 Power Management System7.3.5 Cabin Interior System7.3.6 Flight Control System8 More Electric Aircraft Market, by Component8.1 Introduction8.2 Engines8.2.1 No-Bleed Engine Architecture is Used for Engine Cowl Ice Protection and Pressurization of Hydraulic Reservoirs in Mea8.3 Batteries8.3.1 Lithium-Sulfur and Lithium Titanate Batteries are the Future of Aircraft Batteries8.3.2 Nickel-Based8.3.3 Lead-Acid-Based8.3.4 Lithium-Based8.4 Fuel Cells8.4.1 Increased Efficiency of a Fuel Cell Can Reduce the Fuel Load on Aircraft8.5 Solar Cells8.5.1 Airplanes Equipped with Solar Cells Can Fly Without Liquid Fuel8.6 Generators8.6.1 Enerators Convert Mechanical Energy into Electrical Energy and are Widely Used in Light Aircraft8.6.2 Starter Generator8.6.3 Auxiliary Power Unit (APU)8.6.4 Variable Speed Constant Frequency (VSCF) Generator8.7 Actuators8.7.1 Actuators Helps in Achieving Physical Movement Through Conversion of Electrical Energy8.7.2 Electric8.7.3 Hybrid Electric8.7.3.1 Electro-Hydro-Static Actuators(Eha)8.7.3.2 Electro-Mechanical Actuators (Ema)8.7.3.3 Electrical-Backup Hydraulic Actuators8.8 Electric Pumps8.8.1 Adoption of Electric Pumps is Increasing for Next-Generation Aircraft8.9 Power Electronics8.9.1 Growing Focus to Reduce Aircraft Weight with Higher Electric Power Generation Capacity Expected to Stimulate the Demand for Power Electronics8.9.2 Rectifiers8.9.3 Inverters8.9.4 Converters8.10 Distribution Devices8.10.1 Need for Distribution of Electricity with Minimal Leakage of Power Drive the Demand for Distribution Devices8.10.2 Wires & Cables8.10.3 Connectors & Connector Accessories8.10.4 Busbars8.11 Valves8.11.1 Valves are Intended to Regulate Gas Levels in the MEA Engine8.12 Landing Gear8.12.1 Growing Adoption of Components in Landing Gear Driven by Electric Energy is Expected to Drive the Market9 More Electric Aircraft Market, by Application9.1 Introduction9.2 Power Generation9.2.1 Increasing Demand for More Electric Architecture Fueling the Growth of the Power Generation9.3 Power Distribution9.3.1 Ability to Detect Voltage and Provide Prompt Load Shut-Off Drive this Segment9.4 Power Conversion9.4.1 Increase in Operational Efficiency & Weight Reduction Drive the Demand for Power Conversion Systems9.5 Energy Storage9.5.1 Increasing Use of Advanced Battery and Fuel Cell Systems Boosting the Demand for Energy Storage10 More Electric Aircraft Market, by Aircraft Type10.1 Introduction10.2 Impact of COVID-19 on Aircraft Type Segment10.2.1 Most Impacted Aircraft Type Segment10.2.1.1 Fixed Wing10.2.2 Least Impacted Aircraft Type Segment10.2.2.1 Rotary Wing10.3 Fixed Wing10.3.1 Frequent Modifications in Aircraft Architecture Expected to Fuel the Demand for More Electric Architecture in Fixed Wing Aircraft10.3.2 Narrow Body Aircraft (NBA)10.3.3 Wide Body Aircraft (WBA)10.3.4 Regional Aircraft10.3.5 Fighter Jets10.3.6 Business Jets10.4 Rotary Wing10.4.1 Fans in Rotary Wing Aircraft are Powered by Distributed Electric Systems Using Conventional Gas Turbine Engines10.4.2 Medium Helicopters10.4.3 Heavy Helicopters11 More Electric Aircraft Market, by End-user11.1 Introduction11.2 Impact of COVID-19 on End-user Segment11.2.1 Most Impacted End-user Segment11.2.1.1 Civil11.2.2 Least Impacted End-user Segment11.2.2.1 Military11.3 Civil11.3.1 Increasing Demand to Reduce Aircraft Weight Has Propelled the Growth of Civil More Electric Aircraft Market11.4 Military11.4.1 Development of New Technologies and Electric Equipment to Strengthen Military Operations Drive this Segment12 Regional Analysis12.1 Introduction12.2 Impact of COVID-19 on More Electric Aircraft Market, by Region12.3 Global Scenarios of More Electric Aircraft Market12.4 North America12.5 Europe12.6 Asia-Pacific12.7 Middle East & Africa12.8 Latin America13 Competitive Landscape13.1 Overview13.2 Ranking of Leading Players, 201913.3 Market Share Analysis of Leading Players, 201913.4 Company Evaluation Quadrant13.4.1 Star13.4.2 Emerging Leader13.4.3 Pervasive13.4.4 Participant13.4.5 More Electric Aircraft Market Competitive Leadership Mapping (Startups)13.4.5.1 Progressive Companies13.4.5.2 Responsive Companies13.4.5.3 Dynamic Companies13.4.5.4 Starting Blocks13.5 Competitive Scenario13.5.1 Mergers & Acquisitions13.5.2 New Product Launches13.5.3 Contracts, Partnerships & Agreements13.5.4 Collaborations14 Company Profiles - System Integrators and Component Manufacturers14.1 Safran S.A.14.2 Honeywell International Inc14.3 Raytheon Technologies Corporation14.4 Thales Group14.5 GE Aviation14.6 Bae Systems14.7 Embraer S.A14.8 Liebherr14.9 Magnix14.10 Ametek.Inc14.11 Nabtesco Corporation14.12 Elbit Systems14.13 Bombardier14.14 Moog Inc14.15 Astronics Corporation14.16 Rolls-Royce plc14.17 Eaton14.18 Parker Hannifin Corp14.19 Amphenol Corporation14.20 Meggit14.21 PBS Aerospace14.22 Avionic Instruments LLC14.23 Eaglepicher Technologies, LLC14.24 Pioneer Magnetics14.25 Wright Electric15 More Electric Aircraft Adjacent Market16 Appendix For more information about this report visit https://www.researchandmarkets.com/r/volv44 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

More Electric Aircraft Market by End-user, Aircraft System, Component, Application, Aircraft Type and Region - Global Forecast to 2025

DUBLIN, Dec. 21, 2020 /PRNewswire/ -- The "More Electric Aircraft Market by End User (Civil, Military), Aircraft System, Component, Application (Power Generation, Power Distribution, Power Conversion, Energy Storage), Aircraft Type (Fixed Wing, Rotary Wing), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global more electric aircraft market is estimated to be USD 1,504 million in 2020 and is projected to reach USD 3,359 million by 2025, at a CAGR of 17.4% during the forecast period. Recent technological advancements in the field of power electronics, fault-tolerant architecture, electro-hydrostatic actuators, flight control systems, high-density electric motors, and power generation and conversion systems have fueled the adoption of MEA. The COVID-19 outbreak has impacted the aviation industry adversely due to air travel restrictions on domestic as well as international flights across countries, resulting in the sudden decrease in the air traffic. This is expected to negatively impact the more electric aircraft market in the short term; slow recovery is expected in Q1 of 2021. The aviation industry could take 2-3 years to recover from the financial effects of COVID-19, leading to lower air travels and passenger traffic compared to previous estimates. Based on aircraft system, propulsion segment projected to lead more electric aircraft market during the forecast period Based on aircraft system, the more electric aircraft market is segmented into propulsion system and airframe system. Electrification of various propulsion and airframe systems enables aircraft to reduce carbon emissions and the overall operational cost. The rising focus of major OEMs such as Airbus on the development of electric propulsion systems is expected to drive the propulsion system segment during the forecast period Based on application, power distribution segment projected to lead more electric aircraft market during the forecast period Based on application, the more electric aircraft is segmented into power generation, power distribution, power conversion, and energy storage. The power distribution system is highly flexible, fault-tolerant, and is controlled by a redundant microprocessor system. In this system, electrical power is supplied to the primary power distribution system, wherein the contactor control unit (CCU) and high-power contactor are located across generators, auxiliary power units (APU), batteries, and ground sources. Based on end user, the civil segment accounts for the largest market size during the forecast period Based on end user, the more electric aircraft market is segmented into civil and military. The civil segment is estimated to account for a larger share in 2020 as compared to the military segment. Carbon and nitrogen oxide emissions, high fuel consumption, and high maintenance costs are some of the challenges in the civil segment. Europe is expected to account for the largest share in 2020 The more electric aircraft market has been studied for North America, Europe, Asia Pacific, Middle East & Africa and Africa. Europe is estimated to account for the largest share of the global market in 2020. The aviation industry in Europe is aiming to use new advanced materials, such as gamma-titanium aluminides and single crystals, with improved mechanical properties in aircraft; these advanced engines help aircraft reduce their fuel consumption, carbon emissions, and noise. Key manufacturers of more electric aircraft in Europe include Rolls-Royce (UK), Safran Group (France), Airbus (Netherlands), and Thales Group (France). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Attractive Opportunities in More Electric Aircraft Market4.2 More Electric Aircraft Market, by Application4.3 More Electric Aircraft Market, by Major Countries5 Market Overview5.1 Market Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Optimized Aircraft Performance5.2.1.2 Reduction in Operational and Maintenance Costs5.2.1.3 Reduced Emissions and Noise Pollution5.2.2 Restraints5.2.2.1 Heavy Investments and Longer Clearance Period5.2.3 Opportunities5.2.3.1 Advancements in High-Density Battery Solutions5.2.3.2 Emergence of Alternative Power Sources for Electric Power Generation5.2.3.3 Development of Advanced Power Electronic Components5.2.4 Challenges5.2.4.1 Thermal Management in Electrical Systems5.2.4.2 Reliability of Electrical Systems in Harsh Environments5.2.4.3 Economic Challenges Faced by the Aviation Industry due to COVID-195.3 Range/Scenarios5.4 COVID-19 Impact Analysis5.5 Trends/Disruptions Impacting Customers' Business5.5.1 Revenue Shift and New Revenue Pockets for More Electric Aircraft Market5.6 Market Ecosystem5.6.1 Prominent Companies5.6.2 Private and Small Enterprises5.6.3 End-users5.7 Pricing Analysis5.8 Value Chain Analysis5.9 Porter's Five Forces Analysis5.10 Technology Analysis5.10.1 Fuel Cell Technology5.10.2 Electric Actuation System5.11 Case Study Analysis5.11.1 More Electric Architecture by Honeywell5.12 More Electric Aircraft, by Aircraft Type6 Industry Trends6.1 Introduction6.2 Aircraft Electrification Technology Roadmap (2016 to 2040)6.3 Industry Trends6.3.1 Electrical Systems in Aircraft6.3.2 Shift from Hydraulic Landing Gear & Braking Systems to Electric6.3.3 Electric-Powered Aircraft6.3.4 Electrical and Electronics Technologies6.3.4.1 Machine Technologies6.3.4.2 Power Electronics6.3.4.3 Energy Management6.4 Advanced Batteries6.4.1 Lithium-Sulfur (Li-S)6.5 Electric Motor-Driven Smart Pumps6.6 Impact of Megatrends6.7 Innovations and Patent Registrations7 More Electric Aircraft Market, by Aircraft System7.1 Introduction7.2 Propulsion System7.2.1 Development of Propulsion Systems by Oems is Expected to Drive this Segment7.2.2 Fuel Management System7.2.3 Thrust Reverser System7.3 Airframe System7.3.1 Increasing Demand to Ensure Safety During Flight Operations is Expected to Drive this Segment7.3.2 Environmental Control System7.3.3 Accessory Drive System7.3.4 Power Management System7.3.5 Cabin Interior System7.3.6 Flight Control System8 More Electric Aircraft Market, by Component8.1 Introduction8.2 Engines8.2.1 No-Bleed Engine Architecture is Used for Engine Cowl Ice Protection and Pressurization of Hydraulic Reservoirs in Mea8.3 Batteries8.3.1 Lithium-Sulfur and Lithium Titanate Batteries are the Future of Aircraft Batteries8.3.2 Nickel-Based8.3.3 Lead-Acid-Based8.3.4 Lithium-Based8.4 Fuel Cells8.4.1 Increased Efficiency of a Fuel Cell Can Reduce the Fuel Load on Aircraft8.5 Solar Cells8.5.1 Airplanes Equipped with Solar Cells Can Fly Without Liquid Fuel8.6 Generators8.6.1 Enerators Convert Mechanical Energy into Electrical Energy and are Widely Used in Light Aircraft8.6.2 Starter Generator8.6.3 Auxiliary Power Unit (APU)8.6.4 Variable Speed Constant Frequency (VSCF) Generator8.7 Actuators8.7.1 Actuators Helps in Achieving Physical Movement Through Conversion of Electrical Energy8.7.2 Electric8.7.3 Hybrid Electric8.7.3.1 Electro-Hydro-Static Actuators(Eha)8.7.3.2 Electro-Mechanical Actuators (Ema)8.7.3.3 Electrical-Backup Hydraulic Actuators8.8 Electric Pumps8.8.1 Adoption of Electric Pumps is Increasing for Next-Generation Aircraft8.9 Power Electronics8.9.1 Growing Focus to Reduce Aircraft Weight with Higher Electric Power Generation Capacity Expected to Stimulate the Demand for Power Electronics8.9.2 Rectifiers8.9.3 Inverters8.9.4 Converters8.10 Distribution Devices8.10.1 Need for Distribution of Electricity with Minimal Leakage of Power Drive the Demand for Distribution Devices8.10.2 Wires & Cables8.10.3 Connectors & Connector Accessories8.10.4 Busbars8.11 Valves8.11.1 Valves are Intended to Regulate Gas Levels in the MEA Engine8.12 Landing Gear8.12.1 Growing Adoption of Components in Landing Gear Driven by Electric Energy is Expected to Drive the Market9 More Electric Aircraft Market, by Application9.1 Introduction9.2 Power Generation9.2.1 Increasing Demand for More Electric Architecture Fueling the Growth of the Power Generation9.3 Power Distribution9.3.1 Ability to Detect Voltage and Provide Prompt Load Shut-Off Drive this Segment9.4 Power Conversion9.4.1 Increase in Operational Efficiency & Weight Reduction Drive the Demand for Power Conversion Systems9.5 Energy Storage9.5.1 Increasing Use of Advanced Battery and Fuel Cell Systems Boosting the Demand for Energy Storage10 More Electric Aircraft Market, by Aircraft Type10.1 Introduction10.2 Impact of COVID-19 on Aircraft Type Segment10.2.1 Most Impacted Aircraft Type Segment10.2.1.1 Fixed Wing10.2.2 Least Impacted Aircraft Type Segment10.2.2.1 Rotary Wing10.3 Fixed Wing10.3.1 Frequent Modifications in Aircraft Architecture Expected to Fuel the Demand for More Electric Architecture in Fixed Wing Aircraft10.3.2 Narrow Body Aircraft (NBA)10.3.3 Wide Body Aircraft (WBA)10.3.4 Regional Aircraft10.3.5 Fighter Jets10.3.6 Business Jets10.4 Rotary Wing10.4.1 Fans in Rotary Wing Aircraft are Powered by Distributed Electric Systems Using Conventional Gas Turbine Engines10.4.2 Medium Helicopters10.4.3 Heavy Helicopters11 More Electric Aircraft Market, by End-user11.1 Introduction11.2 Impact of COVID-19 on End-user Segment11.2.1 Most Impacted End-user Segment11.2.1.1 Civil11.2.2 Least Impacted End-user Segment11.2.2.1 Military11.3 Civil11.3.1 Increasing Demand to Reduce Aircraft Weight Has Propelled the Growth of Civil More Electric Aircraft Market11.4 Military11.4.1 Development of New Technologies and Electric Equipment to Strengthen Military Operations Drive this Segment12 Regional Analysis12.1 Introduction12.2 Impact of COVID-19 on More Electric Aircraft Market, by Region12.3 Global Scenarios of More Electric Aircraft Market12.4 North America12.5 Europe12.6 Asia-Pacific12.7 Middle East & Africa12.8 Latin America13 Competitive Landscape13.1 Overview13.2 Ranking of Leading Players, 201913.3 Market Share Analysis of Leading Players, 201913.4 Company Evaluation Quadrant13.4.1 Star13.4.2 Emerging Leader13.4.3 Pervasive13.4.4 Participant13.4.5 More Electric Aircraft Market Competitive Leadership Mapping (Startups)13.4.5.1 Progressive Companies13.4.5.2 Responsive Companies13.4.5.3 Dynamic Companies13.4.5.4 Starting Blocks13.5 Competitive Scenario13.5.1 Mergers & Acquisitions13.5.2 New Product Launches13.5.3 Contracts, Partnerships & Agreements13.5.4 Collaborations14 Company Profiles - System Integrators and Component Manufacturers14.1 Safran S.A.14.2 Honeywell International Inc14.3 Raytheon Technologies Corporation14.4 Thales Group14.5 GE Aviation14.6 Bae Systems14.7 Embraer S.A14.8 Liebherr14.9 Magnix14.10 Ametek.Inc14.11 Nabtesco Corporation14.12 Elbit Systems14.13 Bombardier14.14 Moog Inc14.15 Astronics Corporation14.16 Rolls-Royce plc14.17 Eaton14.18 Parker Hannifin Corp14.19 Amphenol Corporation14.20 Meggit14.21 PBS Aerospace14.22 Avionic Instruments LLC14.23 Eaglepicher Technologies, LLC14.24 Pioneer Magnetics14.25 Wright Electric15 More Electric Aircraft Adjacent Market16 Appendix For more information about this report visit https://www.researchandmarkets.com/r/volv44 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum151

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ~Continued brand and sales channel expansion for CannMart supports value proposition, new product launches, and revenue growth~ TORONTO, June 22, 2020 /PRNewswire/ -Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), aleading platform for cannabis products, accessories, and education, today announced CannMart Inc. ("CannMart"), a wholly owned subsidiary, has been granted an exclusive license by IGNITE International Brands, Ltd. ("IGNITE") (CSE: BILZ) (OTCQX: BILZF) to utilize certain brand trademarks on cannabis-based products for sale in the legal Canadian marketplace. In addition, CannMart has received approval from Alberta Gaming, Liquor & Cannabis ("AGLC") and the Ontario Cannabis Retail Corporation operating as the Ontario Cannabis Store ("OCS") to begin offering Cannabis 2.0 products. "Our agreement to become the exclusive distributor of IGNITE products in Canada is an important milestone for the company and positively reflects on our value proposition," said Meni Morim, CEO of Namaste Technologies. "CannMart continues to demonstrate its ability to grow its sales distribution channels in the Canadian market and this is attracting the attention of well-established brands like IGNITE. We place a high value on our relationships with these brands as it is our belief that brand recognition will be a major driver of growth as the legal industry matures and transitions to consumer-packaged goods. The opportunity for CannMart to be the exclusive distributor for IGNITE in Canada reinforces our position in the competitive cannabis market as consumers gravitate towards brands that are well known and trusted for their quality." "The listing of Cannabis 2.0 products for the provinces of Ontario and Alberta is an important achievement and opens meaningful additional revenue channels. The Cannabis 2.0 market is a large addressable market and the approval to list our products in Alberta and Ontario, with more than 450 and 90 cannabis stores respectively, represents a substantial increase in the addressable market for CannMart. We expect to continue our recent sales success of cannabis products from premium brands, like IGNITE, through CannMart.com and throughout our network of government partners and retailers." "Canada is an important market for IGNITE International Brands and CannMart has shown its ability to deliver high quality products to our target market," said Lester Lee, President of IGNITE. "The awareness of the IGNITE brand continues to build throughout Canada and our product sales continue to grow. The team at CannMart has been instrumental and has proven their competency to navigate the regulations within the legal market. We trust that our brand can be nurtured in accordance with our high standards and together we can continue to build on our early success as we look to grow market share." Further to the news release of March 20, 2020, CannMart and IGNITE have amended the licensing agreement to add exclusivity to the markets in Canada. The revised agreement grants CannMart an exclusive licence to use certain IGNITE brand trademarks on legal cannabis-based products (the "IGNITE Products") in consideration for certain royalty payments. CannMart's introduction of IGNITE cannabis products has been welcomed by its customers and demand has continued to grow. CannMart's listing of its first Cannabis 2.0 products in the provinces of Alberta and Ontario are now approved by both jurisdictions. CannMart's first offering will be a variety of vape cartridges. The AGLC is responsible for regulating and distributing cannabis to Alberta's licensed retailers and the sole legal online retailer for recreational cannabis at www.albertacannabis.org. The OCS is the sole legal online retailer and wholesaler for recreational cannabis for Canada's most populous province. About Ignite International Brands Ltd.IGNITE is a globalconsumerbrand,operating in the premium product segment of the market. Founded by Dan Bilzerian, IGNITEs 'quality-first' approach is fundamental to the brand and its products. Originally operating in the cannabis and hemp-derived cannabidiol (CBD) wellness space, IGNITE was able to establish its brand awareness. IGNITE product categories now include a full line of CBD oil tinctures, CBD topicals, CBD pet products and CBD vape devices,produced by various partners andsold through select distributors, brick and mortar retailers, and online through IGNITE's website, ignite.co. The IGNITE THC product line, which was launchedsubsequent tothe CBD product line, incorporates quality, locally sourced, cannabis products. Since the launching of its THC and CBD products, IGNITE has expanded into the beverage space, launching a full line of functional performance enhancing drinks. The IGNITE beverage line currently consists of PH-alkaline balanced water, a line of premium performance drinks, named Z-RO as well as a gluten-free, seven-time distilled Vodka. IGNITE beverages will be distributed nationally within the United States and available to purchase on the IGNITE beverages website, IgniteBeverages.co. IGNITE is a socially responsible company and is committed to using its marketing and brand power as a positive catalyst for a healthy lifestyle. The IGNITE management team believes that socially responsible oriented actions have a positive impact on IGNITE, its employees and its shareholders. Shares of IGNITE are listed on the Canadian Securities Exchange (CSE) under the symbol "BILZ" and in the United States on the OTCQX under the symbol "BILZF". About Namaste Technologies Inc. With headquarters in Toronto, ON, and offices in both B.C. and around the globe, Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education. The company's 'everything cannabis store', CannMart.com, provides customers with a diverse selection of hand-picked products from a multitude of federally-licensed cultivators, all on one convenient site. Namaste's global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions. Information on the Company and its many products can be accessed through the links below: NamasteTechnologies.comNamasteMD.comCannmart.comNamasteVapes.caEveryonedoesit.ca FORWARD-LOOKING INFORMATION This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen. The forward-looking information contained herein is made as of the date of this press release and is based on assumptions management believed to be reasonable at the time such statements were made, including management's perceptions of Namaste's standing in the online marketplace for cannabis products and its ability to increase revenue in the Canadian marketplace through the sale of recognized, high quality and premium brands, the size and importance of the Cannabis 2.0 market as a revenue generator for CannMart, and the Company as a whole, the importance of being licensed to sell products throughout the Company's network of government partners and retailers management's perceptions of IGNITE and its standing in the cannabis industry, the expectation by management that IGNITE's brand awareness among Namaste's existing and new customer base will driver sales, future growth, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: risks relating to the Company's ability to execute its business strategy and the benefits realizable therefrom, the Company's inability to achieve anticipated sales results through its exclusive relationship with IGNITE, the failure of the Cannabis 2.0 market to develop as anticipated, consumer reception to premium brands and recognition of trademarks being lesser than expected, risks related to the Cannabis industry in general, and risks relating to the market price of Namaste common shares. Additional risk factors can also be found in the Company's current MD&A which has been filed under the Company's SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release. SOURCE Namaste Technologies Inc. Answer:

Namaste Announces CannMart Success with IGNITE International Exclusivity Agreement and Listing of Cannabis 2.0 Products in Alberta and Ontario

~Continued brand and sales channel expansion for CannMart supports value proposition, new product launches, and revenue growth~ TORONTO, June 22, 2020 /PRNewswire/ -Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), aleading platform for cannabis products, accessories, and education, today announced CannMart Inc. ("CannMart"), a wholly owned subsidiary, has been granted an exclusive license by IGNITE International Brands, Ltd. ("IGNITE") (CSE: BILZ) (OTCQX: BILZF) to utilize certain brand trademarks on cannabis-based products for sale in the legal Canadian marketplace. In addition, CannMart has received approval from Alberta Gaming, Liquor & Cannabis ("AGLC") and the Ontario Cannabis Retail Corporation operating as the Ontario Cannabis Store ("OCS") to begin offering Cannabis 2.0 products. "Our agreement to become the exclusive distributor of IGNITE products in Canada is an important milestone for the company and positively reflects on our value proposition," said Meni Morim, CEO of Namaste Technologies. "CannMart continues to demonstrate its ability to grow its sales distribution channels in the Canadian market and this is attracting the attention of well-established brands like IGNITE. We place a high value on our relationships with these brands as it is our belief that brand recognition will be a major driver of growth as the legal industry matures and transitions to consumer-packaged goods. The opportunity for CannMart to be the exclusive distributor for IGNITE in Canada reinforces our position in the competitive cannabis market as consumers gravitate towards brands that are well known and trusted for their quality." "The listing of Cannabis 2.0 products for the provinces of Ontario and Alberta is an important achievement and opens meaningful additional revenue channels. The Cannabis 2.0 market is a large addressable market and the approval to list our products in Alberta and Ontario, with more than 450 and 90 cannabis stores respectively, represents a substantial increase in the addressable market for CannMart. We expect to continue our recent sales success of cannabis products from premium brands, like IGNITE, through CannMart.com and throughout our network of government partners and retailers." "Canada is an important market for IGNITE International Brands and CannMart has shown its ability to deliver high quality products to our target market," said Lester Lee, President of IGNITE. "The awareness of the IGNITE brand continues to build throughout Canada and our product sales continue to grow. The team at CannMart has been instrumental and has proven their competency to navigate the regulations within the legal market. We trust that our brand can be nurtured in accordance with our high standards and together we can continue to build on our early success as we look to grow market share." Further to the news release of March 20, 2020, CannMart and IGNITE have amended the licensing agreement to add exclusivity to the markets in Canada. The revised agreement grants CannMart an exclusive licence to use certain IGNITE brand trademarks on legal cannabis-based products (the "IGNITE Products") in consideration for certain royalty payments. CannMart's introduction of IGNITE cannabis products has been welcomed by its customers and demand has continued to grow. CannMart's listing of its first Cannabis 2.0 products in the provinces of Alberta and Ontario are now approved by both jurisdictions. CannMart's first offering will be a variety of vape cartridges. The AGLC is responsible for regulating and distributing cannabis to Alberta's licensed retailers and the sole legal online retailer for recreational cannabis at www.albertacannabis.org. The OCS is the sole legal online retailer and wholesaler for recreational cannabis for Canada's most populous province. About Ignite International Brands Ltd.IGNITE is a globalconsumerbrand,operating in the premium product segment of the market. Founded by Dan Bilzerian, IGNITEs 'quality-first' approach is fundamental to the brand and its products. Originally operating in the cannabis and hemp-derived cannabidiol (CBD) wellness space, IGNITE was able to establish its brand awareness. IGNITE product categories now include a full line of CBD oil tinctures, CBD topicals, CBD pet products and CBD vape devices,produced by various partners andsold through select distributors, brick and mortar retailers, and online through IGNITE's website, ignite.co. The IGNITE THC product line, which was launchedsubsequent tothe CBD product line, incorporates quality, locally sourced, cannabis products. Since the launching of its THC and CBD products, IGNITE has expanded into the beverage space, launching a full line of functional performance enhancing drinks. The IGNITE beverage line currently consists of PH-alkaline balanced water, a line of premium performance drinks, named Z-RO as well as a gluten-free, seven-time distilled Vodka. IGNITE beverages will be distributed nationally within the United States and available to purchase on the IGNITE beverages website, IgniteBeverages.co. IGNITE is a socially responsible company and is committed to using its marketing and brand power as a positive catalyst for a healthy lifestyle. The IGNITE management team believes that socially responsible oriented actions have a positive impact on IGNITE, its employees and its shareholders. Shares of IGNITE are listed on the Canadian Securities Exchange (CSE) under the symbol "BILZ" and in the United States on the OTCQX under the symbol "BILZF". About Namaste Technologies Inc. With headquarters in Toronto, ON, and offices in both B.C. and around the globe, Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education. The company's 'everything cannabis store', CannMart.com, provides customers with a diverse selection of hand-picked products from a multitude of federally-licensed cultivators, all on one convenient site. Namaste's global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions. Information on the Company and its many products can be accessed through the links below: NamasteTechnologies.comNamasteMD.comCannmart.comNamasteVapes.caEveryonedoesit.ca FORWARD-LOOKING INFORMATION This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen. The forward-looking information contained herein is made as of the date of this press release and is based on assumptions management believed to be reasonable at the time such statements were made, including management's perceptions of Namaste's standing in the online marketplace for cannabis products and its ability to increase revenue in the Canadian marketplace through the sale of recognized, high quality and premium brands, the size and importance of the Cannabis 2.0 market as a revenue generator for CannMart, and the Company as a whole, the importance of being licensed to sell products throughout the Company's network of government partners and retailers management's perceptions of IGNITE and its standing in the cannabis industry, the expectation by management that IGNITE's brand awareness among Namaste's existing and new customer base will driver sales, future growth, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: risks relating to the Company's ability to execute its business strategy and the benefits realizable therefrom, the Company's inability to achieve anticipated sales results through its exclusive relationship with IGNITE, the failure of the Cannabis 2.0 market to develop as anticipated, consumer reception to premium brands and recognition of trademarks being lesser than expected, risks related to the Cannabis industry in general, and risks relating to the market price of Namaste common shares. Additional risk factors can also be found in the Company's current MD&A which has been filed under the Company's SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release. SOURCE Namaste Technologies Inc.

edtsum152

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: HOUSTON, Jan. 26, 2021 /PRNewswire/ --Dallas-based trial law firm Hedrick Kring, PLLC opened an office in Houston, Texas. Their focus continues to be tackling complex commercial trials. Partner Kevin G. Corcoran is leading the charge, and the goal is to add five to 10 full-time lawyers by the end of this calendar year. Corcoran has decades of experience as a trial lawyer, including international representation from Mexico to Australia. Corcoran has represented clients in complex commercial disputes and catastrophic claims in the High Tech, Oil & Gas, Energy, Petrochemical, Retail, Consumer Product, Maritime, Manufacturing, Trucking and Media & Entertainment Industries. Hedrick Kring co-counseled a case with Corcoran and quickly realized that his values and expertise aligned with theirs, making him the perfect person to begin this Houston-based venture. According to Partner and Co-founder, Jacob Kring, Corcoran is "diligent, smart, and willing to take on a challenge," while putting his clients first. "Opening a branch of Hedrick Kring in Houston is crucial so we can continue serving our clients at the highest level possible. I am humbled to spearhead this extension," said Corcoran. While this physical office is new, the work Hedrick Kring is executing in Houston is not. Hedrick Kring continues to be a firm that handles work across the country and state. This new office provides greater accessibility to prepare for hearings, depositions and trials for existing and future clients who aren't located in the DFW area. The Hedrick Kring Houston office is located at 808 Travis Street, Suite 540 in Houston, Texas. About Hedrick Kring, PLLC Hedrick Kring, PLLC, is a client-focused, results-driven business litigation firm. We act quickly and aggressively to protect your interests, focusing on what is important to you and your business. We are zealous advocates with extensive courtroom experience. We have a reputation for excellence and attention to detail. www.hedrickkring.com SOURCE Hedrick Kring, PLLC Answer:

Litigation Powerhouse Hedrick Kring Opens Houston Office

HOUSTON, Jan. 26, 2021 /PRNewswire/ --Dallas-based trial law firm Hedrick Kring, PLLC opened an office in Houston, Texas. Their focus continues to be tackling complex commercial trials. Partner Kevin G. Corcoran is leading the charge, and the goal is to add five to 10 full-time lawyers by the end of this calendar year. Corcoran has decades of experience as a trial lawyer, including international representation from Mexico to Australia. Corcoran has represented clients in complex commercial disputes and catastrophic claims in the High Tech, Oil & Gas, Energy, Petrochemical, Retail, Consumer Product, Maritime, Manufacturing, Trucking and Media & Entertainment Industries. Hedrick Kring co-counseled a case with Corcoran and quickly realized that his values and expertise aligned with theirs, making him the perfect person to begin this Houston-based venture. According to Partner and Co-founder, Jacob Kring, Corcoran is "diligent, smart, and willing to take on a challenge," while putting his clients first. "Opening a branch of Hedrick Kring in Houston is crucial so we can continue serving our clients at the highest level possible. I am humbled to spearhead this extension," said Corcoran. While this physical office is new, the work Hedrick Kring is executing in Houston is not. Hedrick Kring continues to be a firm that handles work across the country and state. This new office provides greater accessibility to prepare for hearings, depositions and trials for existing and future clients who aren't located in the DFW area. The Hedrick Kring Houston office is located at 808 Travis Street, Suite 540 in Houston, Texas. About Hedrick Kring, PLLC Hedrick Kring, PLLC, is a client-focused, results-driven business litigation firm. We act quickly and aggressively to protect your interests, focusing on what is important to you and your business. We are zealous advocates with extensive courtroom experience. We have a reputation for excellence and attention to detail. www.hedrickkring.com SOURCE Hedrick Kring, PLLC

edtsum156

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: OAKLAND, Calif., April 27, 2020 /PRNewswire/ --Poets&Quants, the definitive online publication for business education news, has unveiled CentreCourt Digital, a virtual version of its highly successful in-person MBA festival. The annual CentreCourt MBA Festivalis a series of multi-city events designed to give potential business school students an inside look at the top MBA programs through panel discussions, exclusive school interviews, and one-on-one meetings with admissions staff. The shift to a virtual format as a way to adhere to social distancing guidelines has, for the first time, brought together 28 of the top 30 MBA programs to interact digitally with would-be B-school applicants. The event, spread over four days, is free to all MBA candidates. "Like many who are locked down during this pandemic, we were initially crestfallen when we realized we could not have our very popular annual festival in person," says John A. Byrne, editor-in-chief of Poets&Quants. "But when we decided to move the physical event online, we discovered unprecedented demand that will make this CentreCourt the most successful MBA admissions event ever. "For the first time ever, we'll have all the admission chiefs of the world's best schools from Harvard, Stanford and Wharton to INSEAD, London Business School, HEC Paris and IESE," Byrne continues. "Already, more than 1,500 prospective students have registered for the event and by the time we open the doors, we expect registrations to surpass 2,500. I'm so looking forward to seeing our worldwide community come together during this difficult time." The new CenterCourt Digital will offer students access to such schools as Harvard Business School, Stanford Graduate School of Business, The Wharton School at the University of Pennsylvania, Northwestern University Kellogg School of Management, Columbia Business School, MIT Sloan School of Management, UC-Berkeley Haas School of Business, INSEAD, HEC Paris, London Business School, Cambridge Judge, and many more. For a full list of participating schools visit Poets&Quants. This event is free for MBA candidates and will take place over four afternoon days: April 28th, 29th, May 5th, and June 2nd, 2020. Learn more and register for CenterCourt Digital here. About Poets&Quants: Poets&Quants is the leading resource for complete coverage of graduate business education. We feature multiple tools and authoritative content, including: consolidated B-school rankings, news and in-depth features, videos, podcasts, two searchable directories and events, empowering our community with information needed to make decisions along their journey from pre- to post-MBA. This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com. SOURCE Poets&Quants Related Links https://poetsandquants.com Answer:

Poets&Quants Launches Virtual Event with Top MBA Programs for Business School Prospects Premier business school news site takes CentreCourt MBA Festival online with unprecedented participation by leading MBA programs

OAKLAND, Calif., April 27, 2020 /PRNewswire/ --Poets&Quants, the definitive online publication for business education news, has unveiled CentreCourt Digital, a virtual version of its highly successful in-person MBA festival. The annual CentreCourt MBA Festivalis a series of multi-city events designed to give potential business school students an inside look at the top MBA programs through panel discussions, exclusive school interviews, and one-on-one meetings with admissions staff. The shift to a virtual format as a way to adhere to social distancing guidelines has, for the first time, brought together 28 of the top 30 MBA programs to interact digitally with would-be B-school applicants. The event, spread over four days, is free to all MBA candidates. "Like many who are locked down during this pandemic, we were initially crestfallen when we realized we could not have our very popular annual festival in person," says John A. Byrne, editor-in-chief of Poets&Quants. "But when we decided to move the physical event online, we discovered unprecedented demand that will make this CentreCourt the most successful MBA admissions event ever. "For the first time ever, we'll have all the admission chiefs of the world's best schools from Harvard, Stanford and Wharton to INSEAD, London Business School, HEC Paris and IESE," Byrne continues. "Already, more than 1,500 prospective students have registered for the event and by the time we open the doors, we expect registrations to surpass 2,500. I'm so looking forward to seeing our worldwide community come together during this difficult time." The new CenterCourt Digital will offer students access to such schools as Harvard Business School, Stanford Graduate School of Business, The Wharton School at the University of Pennsylvania, Northwestern University Kellogg School of Management, Columbia Business School, MIT Sloan School of Management, UC-Berkeley Haas School of Business, INSEAD, HEC Paris, London Business School, Cambridge Judge, and many more. For a full list of participating schools visit Poets&Quants. This event is free for MBA candidates and will take place over four afternoon days: April 28th, 29th, May 5th, and June 2nd, 2020. Learn more and register for CenterCourt Digital here. About Poets&Quants: Poets&Quants is the leading resource for complete coverage of graduate business education. We feature multiple tools and authoritative content, including: consolidated B-school rankings, news and in-depth features, videos, podcasts, two searchable directories and events, empowering our community with information needed to make decisions along their journey from pre- to post-MBA. This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com. SOURCE Poets&Quants Related Links https://poetsandquants.com

edtsum157

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: IRVINE, Calif., July 20, 2020 /PRNewswire/ -- Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company developing first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and cancers, today announced encouraging interim clinical data from its Phase 1/2 open-label clinical study of its lead product candidate BNZ-1 in patients with refractory Cutaneous T-Cell Lymphoma (rCTCL).BNZ-1 is a multi-cytokine inhibitor targeting interleukin (IL)-2, IL-9, and IL-15, that has been successfully studied in two phase 1 studies in healthy volunteers where it demonstrated a favorable safety profile, dose proportionality and exposure-dependent pharmacodynamic activity. This study followed a phase 1/2, multi-center, open-label, dose-escalation clinical study of BNZ-1 and was designed to assess its safety and activity as a single systemic agent in rCTCL patients that have failed standard of care and other available treatment options. The study was designed to recruit a total of 15 patients across 4 doses of 0.5, 1, 2, and 4 mg/kg for intravenous weekly dosing. The primary endpoint was overall safety after 4 weeks of treatment.There was a 3-month treatment extension to further evaluate safety and clinical response. Long term extension was available for patients who benefited from BNZ-1 treatment. Whereas efficacy was observed in all cohorts, the 2 mg/kg cohort was expanded to 19 patients based on a favorable initial clinical response.Overall, BNZ-1 was well tolerated with no dose-limiting toxicities.On average, these rCTCL patients had failed 7 prior skin-directed and systemic therapies. The 2 mg/kg cohort showed signs of clinical improvement with BNZ-1 treatment, as follows: Over 80% of subjects showed some improvement in tumor burden as assessed by the modified severity weighted assessment tool (mSWAT) score in the absence of any concomitant therapy About half achieved a partial response (at least a 50% reduction from baseline) in mSWAT score 5% of subjects achieved a complete response For subjects achieving a partial or complete response, the mean duration of response was 277 days (9.2 months) at the time of the data cut off for this interim analysis Dr. Christiane Querfeld, Director of the Cutaneous Lymphoma Program at the City of Hope, who was the principal investigator of this study, stated "I am pleased with the interim results of the BNZ-1 trial in a highly refractory patient population. Based on this interim analysis, BNZ-1 appears to be safe and well tolerated in CTCL patients.In this trial, BNZ-1 has shown efficacy in heavily pretreated and/or advanced stage patients who have failed standard of care and investigational drugs available to them. As a physician, I look forward to the continued development of BNZ-1 and hope to eventually have this drug in my practice to treat and manage my CTCL patients." "Together with our investigators, we are excited to see the potential clinical benefit of BNZ-1 in highly refractory CTCL patients," said Dr.Nazli Azimi, Founder, President and Chief Executive Officer of Bioniz Therapeutics. "We are eager to further advance the clinical development of BNZ-1 towards approval in CTCL and to evaluate its potential clinical efficacy in other dermatological diseases such as alopecia areata and vitiligo." She added "these data provide additional validation of our platform technology and our approach for multi-cytokine inhibition". Bioniz expects this study to conclude in early Q3 of this year and will submit a request for an end of phase 2 meeting in Q4.Based on the outcome of this meeting, Bioniz anticipates starting phase 3 in 1H 2021. About T-Cell Leukemia and LymphomaT-cell leukemia and lymphoma include a group of rare and often aggressive diseases, including CTCL with limited treatment options and a poor prognosis. Bioniz' product candidate BNZ-1 is a selective inhibitor of cytokines IL-2, IL-9, and IL-15, which are potent T-cell growth factors and key disease drivers in this T-cell malignancy. About BNZ-1The Company's lead development candidate, BNZ-1, is a PEGylated peptide that functions as a selective and simultaneous inhibitor of cytokines IL-2, IL-9, and IL-15. BNZ-1 is currently under investigation in a phase 1/2 clinical trial for refractory Cutaneous T-Cell Lymphoma (rCTCL) and Large Granular Lymphocyte (LGL) Leukemia (www.clinicaltrials.gov identifier: NCT03239392). About BionizBioniz is a clinical-stage biopharmaceutical company developing first-in-class peptide-based multi-cytokine inhibitors for the treatment of cancer and immuno-inflammatory diseases. Bioniz leverages its world class expertise in cytokine biology to develop a novel approach to selectively inhibit functionally redundant cytokines while leaving the rest of the cytokine network intact. Bioniz' innovative platform has resulted in multiple peer-reviewed publications in notable scientific journals. Bioniz is developing a robust pipeline of product candidates in multiple autoimmune and oncology indications. For more information, please visit www.bioniz.com. SOURCE Bioniz Therapeutics, Inc. Related Links http://www.bioniz.com Answer:

Bioniz announces positive efficacy and safety data for BNZ-1 from interim analysis of phase 1/2 study in cutaneous T-cell lymphoma

IRVINE, Calif., July 20, 2020 /PRNewswire/ -- Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company developing first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and cancers, today announced encouraging interim clinical data from its Phase 1/2 open-label clinical study of its lead product candidate BNZ-1 in patients with refractory Cutaneous T-Cell Lymphoma (rCTCL).BNZ-1 is a multi-cytokine inhibitor targeting interleukin (IL)-2, IL-9, and IL-15, that has been successfully studied in two phase 1 studies in healthy volunteers where it demonstrated a favorable safety profile, dose proportionality and exposure-dependent pharmacodynamic activity. This study followed a phase 1/2, multi-center, open-label, dose-escalation clinical study of BNZ-1 and was designed to assess its safety and activity as a single systemic agent in rCTCL patients that have failed standard of care and other available treatment options. The study was designed to recruit a total of 15 patients across 4 doses of 0.5, 1, 2, and 4 mg/kg for intravenous weekly dosing. The primary endpoint was overall safety after 4 weeks of treatment.There was a 3-month treatment extension to further evaluate safety and clinical response. Long term extension was available for patients who benefited from BNZ-1 treatment. Whereas efficacy was observed in all cohorts, the 2 mg/kg cohort was expanded to 19 patients based on a favorable initial clinical response.Overall, BNZ-1 was well tolerated with no dose-limiting toxicities.On average, these rCTCL patients had failed 7 prior skin-directed and systemic therapies. The 2 mg/kg cohort showed signs of clinical improvement with BNZ-1 treatment, as follows: Over 80% of subjects showed some improvement in tumor burden as assessed by the modified severity weighted assessment tool (mSWAT) score in the absence of any concomitant therapy About half achieved a partial response (at least a 50% reduction from baseline) in mSWAT score 5% of subjects achieved a complete response For subjects achieving a partial or complete response, the mean duration of response was 277 days (9.2 months) at the time of the data cut off for this interim analysis Dr. Christiane Querfeld, Director of the Cutaneous Lymphoma Program at the City of Hope, who was the principal investigator of this study, stated "I am pleased with the interim results of the BNZ-1 trial in a highly refractory patient population. Based on this interim analysis, BNZ-1 appears to be safe and well tolerated in CTCL patients.In this trial, BNZ-1 has shown efficacy in heavily pretreated and/or advanced stage patients who have failed standard of care and investigational drugs available to them. As a physician, I look forward to the continued development of BNZ-1 and hope to eventually have this drug in my practice to treat and manage my CTCL patients." "Together with our investigators, we are excited to see the potential clinical benefit of BNZ-1 in highly refractory CTCL patients," said Dr.Nazli Azimi, Founder, President and Chief Executive Officer of Bioniz Therapeutics. "We are eager to further advance the clinical development of BNZ-1 towards approval in CTCL and to evaluate its potential clinical efficacy in other dermatological diseases such as alopecia areata and vitiligo." She added "these data provide additional validation of our platform technology and our approach for multi-cytokine inhibition". Bioniz expects this study to conclude in early Q3 of this year and will submit a request for an end of phase 2 meeting in Q4.Based on the outcome of this meeting, Bioniz anticipates starting phase 3 in 1H 2021. About T-Cell Leukemia and LymphomaT-cell leukemia and lymphoma include a group of rare and often aggressive diseases, including CTCL with limited treatment options and a poor prognosis. Bioniz' product candidate BNZ-1 is a selective inhibitor of cytokines IL-2, IL-9, and IL-15, which are potent T-cell growth factors and key disease drivers in this T-cell malignancy. About BNZ-1The Company's lead development candidate, BNZ-1, is a PEGylated peptide that functions as a selective and simultaneous inhibitor of cytokines IL-2, IL-9, and IL-15. BNZ-1 is currently under investigation in a phase 1/2 clinical trial for refractory Cutaneous T-Cell Lymphoma (rCTCL) and Large Granular Lymphocyte (LGL) Leukemia (www.clinicaltrials.gov identifier: NCT03239392). About BionizBioniz is a clinical-stage biopharmaceutical company developing first-in-class peptide-based multi-cytokine inhibitors for the treatment of cancer and immuno-inflammatory diseases. Bioniz leverages its world class expertise in cytokine biology to develop a novel approach to selectively inhibit functionally redundant cytokines while leaving the rest of the cytokine network intact. Bioniz' innovative platform has resulted in multiple peer-reviewed publications in notable scientific journals. Bioniz is developing a robust pipeline of product candidates in multiple autoimmune and oncology indications. For more information, please visit www.bioniz.com. SOURCE Bioniz Therapeutics, Inc. Related Links http://www.bioniz.com

edtsum167

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BELMONT, Calif.--(BUSINESS WIRE)--RingCentral (NYSE: RNG), a leading provider of global enterprise cloud communications, collaboration, video meetings, and contact center solutions, today announced that CRN, a brand of The Channel Company, has named RingCentrals SVP of Global Channel Sales, Zane Long, on its prestigious list of 2021 Channel Chiefs for the fifth consecutive year. The executives on this annual list include leading IT channel vendor executives who continually demonstrate outstanding leadership, influence, innovation, and growth. The 2021 Channel Chiefs are prominent leaders who have influenced the IT channel with cutting-edge strategies, programs, and partnerships. All honorees are selected by CRNs editorial staff based on their dedication, industry prestige, and exceptional accomplishments as channel advocates. CRNs 2021 Channel Chiefs list includes the industrys biggest channel evangelists, a group of individuals who work tirelessly on behalf of their partners and drive growth through the development of strong partner programs and innovative business strategies that help bring business-critical solutions to market, said Blaine Raddon, CEO of The Channel Company. The Channel Company is proud to recognize these channel influencers and looks forward to following their continued success. Channel partners are essential to our success as an organization, said Phil Sorgen, chief revenue officer of RingCentral. It is through Zanes leadership that we continue to drive momentum for our partner community. We are thrilled that The Channel Company recognizes Zanes contributions, having named him a Channel Chief for five years in a row. CRNs 2021 Channel Chiefs list will be featured in the February 2021 issue of CRN Magazine and online at www.CRN.com/ChannelChiefs. About RingCentral RingCentral, Inc. (NYSE: RNG) is a leading provider of business cloud communications and contact center solutions based on its powerful Message Video Phone(MVP) platform. More flexible and cost effective than legacy on-premise PBX and video conferencing systems that it replaces, RingCentral empowers modern mobile and distributed workforces to communicate, collaborate, and connect via any mode, any device, and any location. RingCentral offers three key products in its portfolio including RingCentral Office, a Unified Communications as a Service (UCaaS) platform including team messaging, video meetings, and a cloud phone system; Glipthe company's free video meetings solution with team messaging that enables Smart Video Meetings; and RingCentral cloud Contact Center solutions. RingCentrals open platform integrates with leading third party business applications and enables customers to easily customize business workflows. RingCentral is headquartered in Belmont, California, and has offices around the world. 2021 RingCentral, Inc. All rights reserved. RingCentral, Message Video Phone, MVP, RingCentral Office, Glip, Smart Video Meetings, and the RingCentral logo are trademarks of RingCentral, Inc. About The Channel Company The Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers and end users. Backed by more than 30 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace. www.thechannelcompany.com Follow The Channel Company: Twitter, LinkedIn, and Facebook. 2021. CRN is a registered trademark of The Channel Company, LLC. All rights reserved. Answer:

Zane Long, RingCentral SVP Global Channel Sales, Recognized as 2021 CRN Channel Chief

BELMONT, Calif.--(BUSINESS WIRE)--RingCentral (NYSE: RNG), a leading provider of global enterprise cloud communications, collaboration, video meetings, and contact center solutions, today announced that CRN, a brand of The Channel Company, has named RingCentrals SVP of Global Channel Sales, Zane Long, on its prestigious list of 2021 Channel Chiefs for the fifth consecutive year. The executives on this annual list include leading IT channel vendor executives who continually demonstrate outstanding leadership, influence, innovation, and growth. The 2021 Channel Chiefs are prominent leaders who have influenced the IT channel with cutting-edge strategies, programs, and partnerships. All honorees are selected by CRNs editorial staff based on their dedication, industry prestige, and exceptional accomplishments as channel advocates. CRNs 2021 Channel Chiefs list includes the industrys biggest channel evangelists, a group of individuals who work tirelessly on behalf of their partners and drive growth through the development of strong partner programs and innovative business strategies that help bring business-critical solutions to market, said Blaine Raddon, CEO of The Channel Company. The Channel Company is proud to recognize these channel influencers and looks forward to following their continued success. Channel partners are essential to our success as an organization, said Phil Sorgen, chief revenue officer of RingCentral. It is through Zanes leadership that we continue to drive momentum for our partner community. We are thrilled that The Channel Company recognizes Zanes contributions, having named him a Channel Chief for five years in a row. CRNs 2021 Channel Chiefs list will be featured in the February 2021 issue of CRN Magazine and online at www.CRN.com/ChannelChiefs. About RingCentral RingCentral, Inc. (NYSE: RNG) is a leading provider of business cloud communications and contact center solutions based on its powerful Message Video Phone(MVP) platform. More flexible and cost effective than legacy on-premise PBX and video conferencing systems that it replaces, RingCentral empowers modern mobile and distributed workforces to communicate, collaborate, and connect via any mode, any device, and any location. RingCentral offers three key products in its portfolio including RingCentral Office, a Unified Communications as a Service (UCaaS) platform including team messaging, video meetings, and a cloud phone system; Glipthe company's free video meetings solution with team messaging that enables Smart Video Meetings; and RingCentral cloud Contact Center solutions. RingCentrals open platform integrates with leading third party business applications and enables customers to easily customize business workflows. RingCentral is headquartered in Belmont, California, and has offices around the world. 2021 RingCentral, Inc. All rights reserved. RingCentral, Message Video Phone, MVP, RingCentral Office, Glip, Smart Video Meetings, and the RingCentral logo are trademarks of RingCentral, Inc. About The Channel Company The Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers and end users. Backed by more than 30 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace. www.thechannelcompany.com Follow The Channel Company: Twitter, LinkedIn, and Facebook. 2021. CRN is a registered trademark of The Channel Company, LLC. All rights reserved.

edtsum168

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, May 13, 2020 /PRNewswire/ -- The "Smart Agriculture Market by Agriculture Type (Precision Farming, Livestock, Aquaculture, Greenhouse), Hardware (GPS, Drones, Sensors, RFID, LED Grow Lights), Software, Services, Application, Farm Size, and Geography - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The Global Smart Agriculture Market is estimated to grow from US$ 13.8 billion in 2020 to US$ 22 billion by 2025, rising at a CAGR of 9.8%. Key factors accelerating the smart agriculture market growth are the surging use of modern technologies in agriculture farms, growing income levels and demand for protein-rich aqua food, the increasing focus of farmers on livestock monitoring and disease detection, and the increasing emphasis on reducing the management cost by adopting advanced livestock monitoring products. Increasing investment and rising R&D expenditure in agriculture technology across the world and increasing the popularity of land-based recirculating aquaculture systems are expected to offer substantial opportunities for the smart agriculture market. Market for software offerings estimated to grow at highest CAGR during the forecast period The market for software offering in the smart agriculture market is expected to grow at the highest CAGR from 2020 tp 2025 due to the substantial cost savings associated with a cloud-based software platform, as well as the rising number of farmers, growers, and ranchers in APAC, Europe, and South America adopting AI-based predictive analytics software. The software can be used for functions such as data management, data security, crop health monitoring, farm work mapping, and inventory management. The software allows farmers and growers to utilize the accumulated data of the past few years to analyze the average yield data, create map-based prescriptions, timely irrigation scheduling, and generate yield maps. Market for variable rate technology in precision farming, followed by livestock monitoring segment, to grow at the significant rate from 2020 to 2025 The wide adoption of VRT in precision farming is because of various benefits associated with it. VRT allows input application rates to be varied across fields for site-specific management of the field variability. The market for VRT is expected to grow at a higher CAGR than that for other technologies as this technology helps in applying the right amount of input at the right place on the field, which minimizes the input waste and increases land and crop productivity. Further, the growing cattle population with the increasing number of dairy farms and the rising adoption of livestock monitoring technology by dairy farmers in developing countries are expected to propel the growth of the livestock monitoring market. Market for weather tracking and forecasting applications in precision farming, and monitoring and surveillance application in aquaculture to grow at a significant rate from 2020 to 2025 The precision farming market for weather tracking and forecasting applications is expected to grow at the highest CAGR from 2020 to 2025 owing to the benefits of climate service initiatives that enable farmers to effectively deal with climate-related disasters and improve food security and decision-making in agriculture. Further, the changing weather patterns due to increasing global warming have impelled the adoption of advanced farming technologies, such as sensor-based irrigation controllers, to enhance farm productivity and crop yield. The smart agriculture market for aquaculture monitoring and surveillance applications is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is predominantly driven by the increasing adoption of hardware devices such as sensors, RFID tags and readers, and livestock collars for early detection of disease in livestock, management of the herd, and identification and tracking of livestock. Smart agriculture market in APAC to grow at highest CAGR from 2020 to 2025 APAC is one of the emerging markets for smart agriculture. The smart agriculture market in APAC is expected to grow at a double-digit rate during the forecast period. India, China, and Japan have embraced this technology and hold a major share of the smart agriculture market. However, significant opportunities are yet to be tapped into other Asian countries. The population in APAC is increasing at a high pace. The high pressure to improve agricultural yields with limited available resources and increased requirements to protect crops from unexpected climatic changes are also expected to increase the adoption of smart agriculture technology in APAC during the forecast period. Impact of COVID-19 on Smart Agriculture Market Precision Farming Livestock Monitoring Precision Aquaculture Smart Greenhouse Precision Forestry Market DynamicsDrivers Rising Pressure on Food Supply System Owing to Rapidly Growing Population Surging Use of Modern Technologies in Agriculture Farms Rising Income Levels and Demand for Protein-Rich Aqua Food Growing Focus of Farmers on Livestock Monitoring and Disease Detection Increasing Emphasis on Reducing Management Cost by Adopting Advanced Livestock Monitoring Products Surging Adoption of Advanced Technologies Such as IoT and AI in Aquaculture Farms Restraints High Upfront Cost for Deployment of Modern Agricultural Equipment Overall Fragmented Agriculture Industry Opportunities Rising Adoption of Livestock Monitoring Solutions in Developing Countries Growing Use of Unmanned Aerial Vehicles or Drones in Agricultural Farms Increasing Popularity of Land-Based Recirculating Aquaculture Systems Growing Focus on Integration of Smartphones With Agricultural Hardware and Software Applications Challenges Management of Large Volumes of Data for Productive Decision Making Environmental Concerns and Global Warming Winning Imperatives Environmental Protection With Utilization of Smart Agriculture Techniques Companies Profiled Key Players Deere & Company Trimble Topcon Positioning Systems Delaval Antelliq (Subsidiary of Merck & Co. Inc.) Afimilk Ltd. Akva Group Innovasea Systems Heliospectra LumiGrow Treemetrics Other Important Players Raven Industries AG Leader Technology Agjunction The Climate Corporation (Subsidiary of Monsanto) Nedap N.V. Boumatic, LLC Fancom B.V. (Subsidiary of CTB International Corp.) Aquabyte Steinsvik Vemco Nexus Certhon Quantum Spatial Hitachi Construction Machinery For more information about this report visit https://www.researchandmarkets.com/r/6pc69j Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

Smart Agriculture Industry Set to Reach $22 Billion by 2025 (COVID-19 Adjusted)

DUBLIN, May 13, 2020 /PRNewswire/ -- The "Smart Agriculture Market by Agriculture Type (Precision Farming, Livestock, Aquaculture, Greenhouse), Hardware (GPS, Drones, Sensors, RFID, LED Grow Lights), Software, Services, Application, Farm Size, and Geography - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The Global Smart Agriculture Market is estimated to grow from US$ 13.8 billion in 2020 to US$ 22 billion by 2025, rising at a CAGR of 9.8%. Key factors accelerating the smart agriculture market growth are the surging use of modern technologies in agriculture farms, growing income levels and demand for protein-rich aqua food, the increasing focus of farmers on livestock monitoring and disease detection, and the increasing emphasis on reducing the management cost by adopting advanced livestock monitoring products. Increasing investment and rising R&D expenditure in agriculture technology across the world and increasing the popularity of land-based recirculating aquaculture systems are expected to offer substantial opportunities for the smart agriculture market. Market for software offerings estimated to grow at highest CAGR during the forecast period The market for software offering in the smart agriculture market is expected to grow at the highest CAGR from 2020 tp 2025 due to the substantial cost savings associated with a cloud-based software platform, as well as the rising number of farmers, growers, and ranchers in APAC, Europe, and South America adopting AI-based predictive analytics software. The software can be used for functions such as data management, data security, crop health monitoring, farm work mapping, and inventory management. The software allows farmers and growers to utilize the accumulated data of the past few years to analyze the average yield data, create map-based prescriptions, timely irrigation scheduling, and generate yield maps. Market for variable rate technology in precision farming, followed by livestock monitoring segment, to grow at the significant rate from 2020 to 2025 The wide adoption of VRT in precision farming is because of various benefits associated with it. VRT allows input application rates to be varied across fields for site-specific management of the field variability. The market for VRT is expected to grow at a higher CAGR than that for other technologies as this technology helps in applying the right amount of input at the right place on the field, which minimizes the input waste and increases land and crop productivity. Further, the growing cattle population with the increasing number of dairy farms and the rising adoption of livestock monitoring technology by dairy farmers in developing countries are expected to propel the growth of the livestock monitoring market. Market for weather tracking and forecasting applications in precision farming, and monitoring and surveillance application in aquaculture to grow at a significant rate from 2020 to 2025 The precision farming market for weather tracking and forecasting applications is expected to grow at the highest CAGR from 2020 to 2025 owing to the benefits of climate service initiatives that enable farmers to effectively deal with climate-related disasters and improve food security and decision-making in agriculture. Further, the changing weather patterns due to increasing global warming have impelled the adoption of advanced farming technologies, such as sensor-based irrigation controllers, to enhance farm productivity and crop yield. The smart agriculture market for aquaculture monitoring and surveillance applications is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is predominantly driven by the increasing adoption of hardware devices such as sensors, RFID tags and readers, and livestock collars for early detection of disease in livestock, management of the herd, and identification and tracking of livestock. Smart agriculture market in APAC to grow at highest CAGR from 2020 to 2025 APAC is one of the emerging markets for smart agriculture. The smart agriculture market in APAC is expected to grow at a double-digit rate during the forecast period. India, China, and Japan have embraced this technology and hold a major share of the smart agriculture market. However, significant opportunities are yet to be tapped into other Asian countries. The population in APAC is increasing at a high pace. The high pressure to improve agricultural yields with limited available resources and increased requirements to protect crops from unexpected climatic changes are also expected to increase the adoption of smart agriculture technology in APAC during the forecast period. Impact of COVID-19 on Smart Agriculture Market Precision Farming Livestock Monitoring Precision Aquaculture Smart Greenhouse Precision Forestry Market DynamicsDrivers Rising Pressure on Food Supply System Owing to Rapidly Growing Population Surging Use of Modern Technologies in Agriculture Farms Rising Income Levels and Demand for Protein-Rich Aqua Food Growing Focus of Farmers on Livestock Monitoring and Disease Detection Increasing Emphasis on Reducing Management Cost by Adopting Advanced Livestock Monitoring Products Surging Adoption of Advanced Technologies Such as IoT and AI in Aquaculture Farms Restraints High Upfront Cost for Deployment of Modern Agricultural Equipment Overall Fragmented Agriculture Industry Opportunities Rising Adoption of Livestock Monitoring Solutions in Developing Countries Growing Use of Unmanned Aerial Vehicles or Drones in Agricultural Farms Increasing Popularity of Land-Based Recirculating Aquaculture Systems Growing Focus on Integration of Smartphones With Agricultural Hardware and Software Applications Challenges Management of Large Volumes of Data for Productive Decision Making Environmental Concerns and Global Warming Winning Imperatives Environmental Protection With Utilization of Smart Agriculture Techniques Companies Profiled Key Players Deere & Company Trimble Topcon Positioning Systems Delaval Antelliq (Subsidiary of Merck & Co. Inc.) Afimilk Ltd. Akva Group Innovasea Systems Heliospectra LumiGrow Treemetrics Other Important Players Raven Industries AG Leader Technology Agjunction The Climate Corporation (Subsidiary of Monsanto) Nedap N.V. Boumatic, LLC Fancom B.V. (Subsidiary of CTB International Corp.) Aquabyte Steinsvik Vemco Nexus Certhon Quantum Spatial Hitachi Construction Machinery For more information about this report visit https://www.researchandmarkets.com/r/6pc69j Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum173

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LAGUNA BEACH, Calif., Feb. 5, 2021 /PRNewswire/ --Laguna Residents First (LRF), a residents' advocacy organization, just announced the appointment of a new member to its board.Laguna Beach resident Chris Catsimanes was tapped to lead efforts to increase community awareness about LRF's ballot initiative, which would give Laguna Beach voters the right to approve or deny major commercial projects. Costa Mesa, Newport Beach and Dana Point have passed similar initiatives. Laguna Beach resident Chris Catsimanes was tapped to lead efforts to increase community awareness about LRF. Tweet this During the pandemic, the organization has been unable to commence signature gathering. However, it continues to work with land use attorneys, donors, and supporters. "We're thrilled to welcome Chris to the board," said officer and co-founder David Raber. "His work ethic, collaborative style and grasp of the issues made this an easy decision. We look forward to moving things along with his help." Prior to retiring, Catsimanes was involved in both defense related and commercial organizations in design and management positions involving electronic systems.The LRF ballot initiative pertains only to commercial projects within 750 feet of Coast Highway or Laguna Canyon Road. A vote would be triggered by projects larger than 22,000 square feet, adding more than 200 car trips a day or exceeding the city's 36-foot height limit, as well as other factors. More details are available at: www.lagunaresidentsfirst.orgFor additional information, contact Mike Morris at 562-412-2684 Laguna Residents First is a Political Action Committee. State of California PAC No. 1421491SOURCE Laguna Residents First Related Links www.lagunaresidentsfirst.org Answer:

Laguna Residents First Appoints New Board Member Chris Catsimanes for Ballot Initiative Work

LAGUNA BEACH, Calif., Feb. 5, 2021 /PRNewswire/ --Laguna Residents First (LRF), a residents' advocacy organization, just announced the appointment of a new member to its board.Laguna Beach resident Chris Catsimanes was tapped to lead efforts to increase community awareness about LRF's ballot initiative, which would give Laguna Beach voters the right to approve or deny major commercial projects. Costa Mesa, Newport Beach and Dana Point have passed similar initiatives. Laguna Beach resident Chris Catsimanes was tapped to lead efforts to increase community awareness about LRF. Tweet this During the pandemic, the organization has been unable to commence signature gathering. However, it continues to work with land use attorneys, donors, and supporters. "We're thrilled to welcome Chris to the board," said officer and co-founder David Raber. "His work ethic, collaborative style and grasp of the issues made this an easy decision. We look forward to moving things along with his help." Prior to retiring, Catsimanes was involved in both defense related and commercial organizations in design and management positions involving electronic systems.The LRF ballot initiative pertains only to commercial projects within 750 feet of Coast Highway or Laguna Canyon Road. A vote would be triggered by projects larger than 22,000 square feet, adding more than 200 car trips a day or exceeding the city's 36-foot height limit, as well as other factors. More details are available at: www.lagunaresidentsfirst.orgFor additional information, contact Mike Morris at 562-412-2684 Laguna Residents First is a Political Action Committee. State of California PAC No. 1421491SOURCE Laguna Residents First Related Links www.lagunaresidentsfirst.org

edtsum180

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Cannabis Heat-Not-Burn Products: Technical Analysis of Vaporization Technologies for Cannabis Heated Sticks" report has been added to ResearchAndMarkets.com's offering. The report includes complete technical analysis of all existent to the date of the report mass-market products: Aim of the report is to examine existent heating solutions for cannabis heated sticks, answer the question are they the copy-cats of existent tobacco heat-not-burn devices or use their own technology solution. In this report, we provide complete data about technical parameters, and results of professional tests of cannabis-related e-devices, review the internal structure of cannabis heated sticks. In the result of analysis, we had a complete technical view on all current aspects of cannabis heat-not-burn technology development. During the cannabis e-devices teardown were found technological innovation earlier never met in conventional tobacco heat-not-burn industry. Classic heat-not-burn industry driven by big tobacco giants has a lot of developments and real products like IQOS and Heets, glo and Neosticks and so on. Using the successful format of heated products like Heets, certain cannabis companies in USA and Canada launched their own heat-not-burn products in cannabis vaporizers industry. Well known, that vaporization temperature of tobacco material and cannabis or hemp differs in temperature and heating curve. Thus, range of temperature for tobacco heated material in existent tobacco heated products is 240-350 C, meanwhile for regular dry herb cannabis flower recommended temperatures for vaporization is 160-180C (CBD activation), and near 157C for THC activation. The recommended temperature for isolating cannabinoids imposes certain technological restrictions to design of vaporization technologies for cannabis heated sticks, as well as for conventional dry herb cannabis vaporizers. Key Topics Covered: Executive summary 1. Elon cannabis heat-not-burn device technical analysis 2. Omura Series 1 heat-not-burn device technical analysis 3. Omura Series X heat-not-burn device technical analysis 4. Heated cannabis sticks analysis References Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/adsnt3 Answer:

Cannabis Heat-Not-Burn Products Analysis 2021 Featuring British American Tobacco, E1011 Labs, Elon Labs, Flat Planet, Omura & Philip Morris - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cannabis Heat-Not-Burn Products: Technical Analysis of Vaporization Technologies for Cannabis Heated Sticks" report has been added to ResearchAndMarkets.com's offering. The report includes complete technical analysis of all existent to the date of the report mass-market products: Aim of the report is to examine existent heating solutions for cannabis heated sticks, answer the question are they the copy-cats of existent tobacco heat-not-burn devices or use their own technology solution. In this report, we provide complete data about technical parameters, and results of professional tests of cannabis-related e-devices, review the internal structure of cannabis heated sticks. In the result of analysis, we had a complete technical view on all current aspects of cannabis heat-not-burn technology development. During the cannabis e-devices teardown were found technological innovation earlier never met in conventional tobacco heat-not-burn industry. Classic heat-not-burn industry driven by big tobacco giants has a lot of developments and real products like IQOS and Heets, glo and Neosticks and so on. Using the successful format of heated products like Heets, certain cannabis companies in USA and Canada launched their own heat-not-burn products in cannabis vaporizers industry. Well known, that vaporization temperature of tobacco material and cannabis or hemp differs in temperature and heating curve. Thus, range of temperature for tobacco heated material in existent tobacco heated products is 240-350 C, meanwhile for regular dry herb cannabis flower recommended temperatures for vaporization is 160-180C (CBD activation), and near 157C for THC activation. The recommended temperature for isolating cannabinoids imposes certain technological restrictions to design of vaporization technologies for cannabis heated sticks, as well as for conventional dry herb cannabis vaporizers. Key Topics Covered: Executive summary 1. Elon cannabis heat-not-burn device technical analysis 2. Omura Series 1 heat-not-burn device technical analysis 3. Omura Series X heat-not-burn device technical analysis 4. Heated cannabis sticks analysis References Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/adsnt3

edtsum181

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NORWALK, Conn., SHANGHAI and HONG KONG, March7, 2021 /PRNewswire/ -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information and analytical applications, and Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", HKEX: 2318; SSE: 601318) today announced a joint offering for investors considering environmental, social and corporate governance (ESG) metrics for companies incorporated in China. The offering will be launched by FactSet and Ping An's associate company OneConnect Financial Technology Co., Ltd. (hereafter "OneConnect",NYSE:OCFT), a leading technology-as-a-service platform for financial institutions in China. FactSet will integrate OneConnect's artificial intelligence (AI)-driven ESG content sets into its workstations, standard data feed, and application programming interfaces (APIs) to accelerate the availability of ESG metrics for over 3,500 Chinese class A-share companies. OneConnect offers comprehensive coverage of ESG factors and assessments for companies listed on the Shanghai and Shenzhen Stock Exchanges. These factors are derived from a combination of different sources of information obtained by AI technologies, such as natural language processing (NLP). OneConnect also provides a range of analytics tools in addition to the content that will be integrated into FactSet, such as NLP-driven disclosure transparency assessments, portfolio sustainability performance evaluation and adjustment, and a climate risk evaluation tool to help investors better integrate ESG measurements into their investment processes. "ESG investing is accelerating globally and client demand is high for information on companies in China," said Tom Griffiths, Senior Vice President, Asia Pacific, FactSet. "Working with Ping An to strengthen FactSet's ESG offering is an exciting step as we further expand integrated workflow solutions for our global client base. Combining OneConnect's leading content with FactSet's suite of applications will offer investment professionals a differentiated perspective on ESG impacts in the Chinese market." "We are excited to build this partnership with FactSet," said Ye Wangchun, Chairman and CEO of OneConnect. "By integrating OneConnect's AI-ESG information sets into FactSet's powerful investment data and technology platform, investors can expand both the breadth and depth of their ESG investments, drawing on a broader set of China-focused ESG content and tools." OneConnect's ESG content will be available in the coming months in the FactSet workstation as well as via standard data feed and APIs. For more information, please visit:https://www.factset.com/solutions/business-needs/esg-solutions. About FactSet FactSet (NYSE:FDS |NASDAQ:FDS) delivers superior content, analytics, and flexible technology to help more than 138,000 users see and seize opportunity sooner. We give investment professionals the edge to outperform with informed insights, workflow solutions across the portfolio lifecycle, and industry-leading support from dedicated specialists. We're proud to have been recognized with multiple awards for our analytical and data-driven solutions and repeatedly scored 100 by the Human Rights Campaign Corporate Equality Index for our LGBTQ+ inclusive policies and practices. Subscribe to our thought leadership blog to get fresh insight delivered daily at insight.factset.com. Learn more atwww.factset.comand follow us on Twitter: www.twitter.com/factset. About Ping An Group Ping An Insurance (Group) Company of China, Ltd. ("Ping An") is a world-leading technology-powered retail financial services group. With over 218 million retail customers and 598 million Internet users, Ping An is one of the largest financial services companies in the world. Ping An focuses on two over-arching domains of activity, "pan financial assets" and "pan health care", covering the provision of financial and health care services through our integrated financial services platform and our ecosystems; in financial services, health care, auto services and smart city services. Our "finance + technology" and "finance + ecosystem" transformation strategies aim to provide customers and internet users with innovative and simple products and services using technology. As China's first joint stock insurance company, Ping An is committed to upholding the highest standards of corporate reporting and corporate governance. The Group is listed on the stock exchanges in Hong Kong and Shanghai. In 2020, Ping An ranked 7th in the Forbes Global 2000 list and ranked 21st in the Fortune Global 500 list. Ping An also ranked 38th in the 2020 WPP Kantar Millward Brown BrandZTM Top 100 Most Valuable Global Brands list. For more information, please visit www.group.pingan.comand follow us on LinkedIn - PING AN. About OneConnect OneConnect is a leading technology-as-a-service platform for financial institutions in China. The Company's platform provides cloud-native technology solutions that integrate extensive financial services industry expertise with market-leading technology. The Company's solutions provide technology applications and technology-enabled business services to financial institutions. Together they enable the Company's customers' digital transformations, which help them increase revenue, manage risks, improve efficiency, enhance service quality and reduce costs. Our technology-as-a-service platform strategically covers multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services, as well as technology infrastructure such as data management, program development, and cloud services. SOURCE OneConnect; FactSet; Ping An Answer:

FactSet and Ping An to Offer Investors ESG Content and Analytics on Chinese Companies

NORWALK, Conn., SHANGHAI and HONG KONG, March7, 2021 /PRNewswire/ -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information and analytical applications, and Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", HKEX: 2318; SSE: 601318) today announced a joint offering for investors considering environmental, social and corporate governance (ESG) metrics for companies incorporated in China. The offering will be launched by FactSet and Ping An's associate company OneConnect Financial Technology Co., Ltd. (hereafter "OneConnect",NYSE:OCFT), a leading technology-as-a-service platform for financial institutions in China. FactSet will integrate OneConnect's artificial intelligence (AI)-driven ESG content sets into its workstations, standard data feed, and application programming interfaces (APIs) to accelerate the availability of ESG metrics for over 3,500 Chinese class A-share companies. OneConnect offers comprehensive coverage of ESG factors and assessments for companies listed on the Shanghai and Shenzhen Stock Exchanges. These factors are derived from a combination of different sources of information obtained by AI technologies, such as natural language processing (NLP). OneConnect also provides a range of analytics tools in addition to the content that will be integrated into FactSet, such as NLP-driven disclosure transparency assessments, portfolio sustainability performance evaluation and adjustment, and a climate risk evaluation tool to help investors better integrate ESG measurements into their investment processes. "ESG investing is accelerating globally and client demand is high for information on companies in China," said Tom Griffiths, Senior Vice President, Asia Pacific, FactSet. "Working with Ping An to strengthen FactSet's ESG offering is an exciting step as we further expand integrated workflow solutions for our global client base. Combining OneConnect's leading content with FactSet's suite of applications will offer investment professionals a differentiated perspective on ESG impacts in the Chinese market." "We are excited to build this partnership with FactSet," said Ye Wangchun, Chairman and CEO of OneConnect. "By integrating OneConnect's AI-ESG information sets into FactSet's powerful investment data and technology platform, investors can expand both the breadth and depth of their ESG investments, drawing on a broader set of China-focused ESG content and tools." OneConnect's ESG content will be available in the coming months in the FactSet workstation as well as via standard data feed and APIs. For more information, please visit:https://www.factset.com/solutions/business-needs/esg-solutions. About FactSet FactSet (NYSE:FDS |NASDAQ:FDS) delivers superior content, analytics, and flexible technology to help more than 138,000 users see and seize opportunity sooner. We give investment professionals the edge to outperform with informed insights, workflow solutions across the portfolio lifecycle, and industry-leading support from dedicated specialists. We're proud to have been recognized with multiple awards for our analytical and data-driven solutions and repeatedly scored 100 by the Human Rights Campaign Corporate Equality Index for our LGBTQ+ inclusive policies and practices. Subscribe to our thought leadership blog to get fresh insight delivered daily at insight.factset.com. Learn more atwww.factset.comand follow us on Twitter: www.twitter.com/factset. About Ping An Group Ping An Insurance (Group) Company of China, Ltd. ("Ping An") is a world-leading technology-powered retail financial services group. With over 218 million retail customers and 598 million Internet users, Ping An is one of the largest financial services companies in the world. Ping An focuses on two over-arching domains of activity, "pan financial assets" and "pan health care", covering the provision of financial and health care services through our integrated financial services platform and our ecosystems; in financial services, health care, auto services and smart city services. Our "finance + technology" and "finance + ecosystem" transformation strategies aim to provide customers and internet users with innovative and simple products and services using technology. As China's first joint stock insurance company, Ping An is committed to upholding the highest standards of corporate reporting and corporate governance. The Group is listed on the stock exchanges in Hong Kong and Shanghai. In 2020, Ping An ranked 7th in the Forbes Global 2000 list and ranked 21st in the Fortune Global 500 list. Ping An also ranked 38th in the 2020 WPP Kantar Millward Brown BrandZTM Top 100 Most Valuable Global Brands list. For more information, please visit www.group.pingan.comand follow us on LinkedIn - PING AN. About OneConnect OneConnect is a leading technology-as-a-service platform for financial institutions in China. The Company's platform provides cloud-native technology solutions that integrate extensive financial services industry expertise with market-leading technology. The Company's solutions provide technology applications and technology-enabled business services to financial institutions. Together they enable the Company's customers' digital transformations, which help them increase revenue, manage risks, improve efficiency, enhance service quality and reduce costs. Our technology-as-a-service platform strategically covers multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services, as well as technology infrastructure such as data management, program development, and cloud services. SOURCE OneConnect; FactSet; Ping An

edtsum191

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: CINCINNATI, May 13, 2020 /PRNewswire/ -- Clubessential, the leading provider of full-suite and mobile-first private club management software and payment services, today announced a solution suite enabling private clubs to interact with members digitally, while also bringing value virtually. This touchless suite is to assist the many clubs that have recently been forced to pivot their operations around new government restrictions. For many clubs, investment decisions have historically centered on facilities and capital equipment, but over the last 6 weeks, private clubs have had to innovate new operational processes that balance the safety of their members with the connection and personal experience those same members desire. Using software and mobile-first technology as a critical success factor in delivering this experience is evident, and one that will persist well beyond the temporary changes clubs are currently managing. Take-out dining and restricted golf experiences are examples of this response. But as clubs prepare to reopen their doors, there's a need for technology that will allow them to manage their operations and deliver member experiences in a phased and controlled manner. With over twenty years serving private clubs, Clubessential's strong history and mobile-first approach are creating a smooth transition for its customers as they deploy new touch-less experiences. "We want your members to view your club as a valued service that they can't do without. We look at our business and think the same about you,"said Lynn Mangan, President of Clubessential. "We want our technology to deliver solutions that allow you to create members for life. Easy, functional, practical and innovative to provide the best member experiences possible and run your club with ease and precision. These are solutions that will benefit your clubs and members long-term." Clubessential's new Essential Suite empowers clubs to make data-driven decisions and develop a safe touchless club experience, while delivering value that enables members to pursue and enjoy the club lifestyle anywhere, with the frictionless user-experiences they've come to expect. Solutions include Mobile Point of Sale for tee times and outdoor dining, Mobile Ordering for to-go, curbside pick-up, ready-to-make meals and grocery ordering. The Essential Suite contains self-serve kiosks and check-in for golf and other activities, reservations for restricting and tracking capacity from the course to courts, fitness center and pool. In addition to its flexible tee sheets, the suite provides clubs new ways to service their members through an online retail ordering. The Essential Suite also supports secure online and touchless payments. From distance dining, to remote community engagements, to new restrictions in reservations, these solutions enable clubs to safely address this new reality while still delivering the lifestyle, value, and brand of the club. General Managers can access compliance reporting on space usage and contact tracing, benchmark and compare trends in spend, club utilization, online ordering, online booking, and timeliness of payments to understand member engagement and make decisions on club accessibility and operations. They can control the number of members utilizing courses, courts, pools, and fitness centers, and build in time for sanitizing through configured reservation booking. They can expand outdoor dining, shift large annual club events to take-and-go virtual activities, and communicate important reopening information through the preferred channel of their members. Greg Gilg, General Manager at Field Club of Omahaexemplifies a club that's pivoted in this new environment. "We had to identify a way to deliver what our long-time members have come to expect while also allocating resources to the new and exciting things our newer members demand," explained Greg. "This suite provides the tools our team needs to enhance the member experience, and our members are responding. 60% of our members are using mobile for activities like to-go orders, groceries, and Mother's Day Spa Baskets." Members have the ability to exercise social distancing through online ordering, self check-in, and booking family reservations. And for those members not ready to return to the club immediately, they can order their favorite food to-go, have groceries delivered, manage their bills and payments, and participate in virtual club events like online wine tastings, golf instruction, and fitness classes. The Essential Suite allows members to engage with their club based on their level of comfort well beyond state mandates. Members can now connect and access the club, both on and off grounds, in ways that are responsible and intuitive. This allows clubs to engage and retain their members, as well as nurture new prospective members. Through these virtually connected experiences, General Managers can also make operational decisions with the safety of members and the financial health of the club in mind. You can learn more about the Essential Suite for your club here. Clubessential Clubessential provides a full suite of membership and club management solutions to country, golf, city, yacht and other private clubs. The Clubessential Suite consists of website, tee times, mobile apps, accounting, POS, CRM, payments and other software solutions that help over 1,300 private clubs better attract, engage and retain their members. Clubessential Holdings LLC Clubessential Holdings is a Battery Ventures company, fulfilling their global mission of investing in and creating cutting-edge, category-defining businesses by providing a full suite of membership and club management Software as a Service solutions to private clubs, health & fitness clubs, military organizations, municipalities, and college athletic programs. Across four brands - Clubessential, ClubReady, PrestoSports and Vermont Systems - the company offers a variety of forward-thinking technology and services which help more than 8,000 customers attract, engage, and retain club and community members and fans for life. For more information, visit the following websites: Clubessential http://www.clubessential.com; ClubReady http://www.clubready.com; PrestoSports http://www.prestosports.com; Vermont Systems: http://www.vermontsystems.com. Media ContactMarilyn CoxPhone: 513-322-4194Email: [emailprotected] Related Images image1.png SOURCE Clubessential Related Links http://www.clubessential.com Answer:

Clubessential Doubles-Down on Mobile With Their Essential Suite for Private Clubs to Provide Safer Member Experiences The Essential Suite Allows Private Clubs to Provide Safe Member Experiences and Deliver Virtual Value to its Members

CINCINNATI, May 13, 2020 /PRNewswire/ -- Clubessential, the leading provider of full-suite and mobile-first private club management software and payment services, today announced a solution suite enabling private clubs to interact with members digitally, while also bringing value virtually. This touchless suite is to assist the many clubs that have recently been forced to pivot their operations around new government restrictions. For many clubs, investment decisions have historically centered on facilities and capital equipment, but over the last 6 weeks, private clubs have had to innovate new operational processes that balance the safety of their members with the connection and personal experience those same members desire. Using software and mobile-first technology as a critical success factor in delivering this experience is evident, and one that will persist well beyond the temporary changes clubs are currently managing. Take-out dining and restricted golf experiences are examples of this response. But as clubs prepare to reopen their doors, there's a need for technology that will allow them to manage their operations and deliver member experiences in a phased and controlled manner. With over twenty years serving private clubs, Clubessential's strong history and mobile-first approach are creating a smooth transition for its customers as they deploy new touch-less experiences. "We want your members to view your club as a valued service that they can't do without. We look at our business and think the same about you,"said Lynn Mangan, President of Clubessential. "We want our technology to deliver solutions that allow you to create members for life. Easy, functional, practical and innovative to provide the best member experiences possible and run your club with ease and precision. These are solutions that will benefit your clubs and members long-term." Clubessential's new Essential Suite empowers clubs to make data-driven decisions and develop a safe touchless club experience, while delivering value that enables members to pursue and enjoy the club lifestyle anywhere, with the frictionless user-experiences they've come to expect. Solutions include Mobile Point of Sale for tee times and outdoor dining, Mobile Ordering for to-go, curbside pick-up, ready-to-make meals and grocery ordering. The Essential Suite contains self-serve kiosks and check-in for golf and other activities, reservations for restricting and tracking capacity from the course to courts, fitness center and pool. In addition to its flexible tee sheets, the suite provides clubs new ways to service their members through an online retail ordering. The Essential Suite also supports secure online and touchless payments. From distance dining, to remote community engagements, to new restrictions in reservations, these solutions enable clubs to safely address this new reality while still delivering the lifestyle, value, and brand of the club. General Managers can access compliance reporting on space usage and contact tracing, benchmark and compare trends in spend, club utilization, online ordering, online booking, and timeliness of payments to understand member engagement and make decisions on club accessibility and operations. They can control the number of members utilizing courses, courts, pools, and fitness centers, and build in time for sanitizing through configured reservation booking. They can expand outdoor dining, shift large annual club events to take-and-go virtual activities, and communicate important reopening information through the preferred channel of their members. Greg Gilg, General Manager at Field Club of Omahaexemplifies a club that's pivoted in this new environment. "We had to identify a way to deliver what our long-time members have come to expect while also allocating resources to the new and exciting things our newer members demand," explained Greg. "This suite provides the tools our team needs to enhance the member experience, and our members are responding. 60% of our members are using mobile for activities like to-go orders, groceries, and Mother's Day Spa Baskets." Members have the ability to exercise social distancing through online ordering, self check-in, and booking family reservations. And for those members not ready to return to the club immediately, they can order their favorite food to-go, have groceries delivered, manage their bills and payments, and participate in virtual club events like online wine tastings, golf instruction, and fitness classes. The Essential Suite allows members to engage with their club based on their level of comfort well beyond state mandates. Members can now connect and access the club, both on and off grounds, in ways that are responsible and intuitive. This allows clubs to engage and retain their members, as well as nurture new prospective members. Through these virtually connected experiences, General Managers can also make operational decisions with the safety of members and the financial health of the club in mind. You can learn more about the Essential Suite for your club here. Clubessential Clubessential provides a full suite of membership and club management solutions to country, golf, city, yacht and other private clubs. The Clubessential Suite consists of website, tee times, mobile apps, accounting, POS, CRM, payments and other software solutions that help over 1,300 private clubs better attract, engage and retain their members. Clubessential Holdings LLC Clubessential Holdings is a Battery Ventures company, fulfilling their global mission of investing in and creating cutting-edge, category-defining businesses by providing a full suite of membership and club management Software as a Service solutions to private clubs, health & fitness clubs, military organizations, municipalities, and college athletic programs. Across four brands - Clubessential, ClubReady, PrestoSports and Vermont Systems - the company offers a variety of forward-thinking technology and services which help more than 8,000 customers attract, engage, and retain club and community members and fans for life. For more information, visit the following websites: Clubessential http://www.clubessential.com; ClubReady http://www.clubready.com; PrestoSports http://www.prestosports.com; Vermont Systems: http://www.vermontsystems.com. Media ContactMarilyn CoxPhone: 513-322-4194Email: [emailprotected] Related Images image1.png SOURCE Clubessential Related Links http://www.clubessential.com

edtsum194

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: AUSTIN, Texas--(BUSINESS WIRE)--Elena Ionenko, co-founder of TurnKey Lender, has been selected as Finovates 2020 Innovator of the Year. The Award Winners were announced this week at the FinovateFall Digital event. Its a wonderful recognition of our teams efforts in an extraordinary year, says Ionenko. Our company has innovation baked into its DNA which comes in handy when your core mission is to bring profitable new ideas to the banking space, a sometimes hyper-conservative industry. The Innovator of the Year Award is given to an individual whose innovative ideas and creations have had the greatest impact on the financial technology industry for the year. Weve long been a champion of artificial intelligence in lending, and its all coming together this year, says TurnKey Lender CEO and co-founder Dmitry Voronenko. Were applying it not just to loan origination, where its been used for a while, but to every phase of the loan lifecycle and businesses around the world have responded with genuine interest. In just five years, TurnKey Lender entered over 40 global markets, and provided customization for auto financing, P2P lending, factoring and invoice financing, in-house retail financing, and digital banking. Were determined to continue leading the financial industry as a global leader in Unified Lending Management, says Ionenko. This means serving large financial institutions with sophisticated processes and multiple credit products as well as non-lending organizations that want to sell more of their goods and services by providing buy-now-pay-later purchase options to their customers. TurnKey Lenders Unified Lending Solution is an intelligent unified lending management system that automates loan processing from origination to settlement. The digital platform includes a borrowers portal, instant application processing, risk assessment, decisioning, loan origination, underwriting, servicing, collections, reporting, archiving, and compliance. This allows for better user experiences for lenders and borrowers alike at a time when seamless digital lending processes are vital. For TurnKey Lender, the award of the 2020 Innovator of the Year by Finovate to Ionenko is a sign the company is on the right track in driving the industry forward at a critical time in history. Answer:

TurnKey Lender Co-Founder Elena Ionenko Awarded Winner of Finovates 2020 Innovator of the Year

AUSTIN, Texas--(BUSINESS WIRE)--Elena Ionenko, co-founder of TurnKey Lender, has been selected as Finovates 2020 Innovator of the Year. The Award Winners were announced this week at the FinovateFall Digital event. Its a wonderful recognition of our teams efforts in an extraordinary year, says Ionenko. Our company has innovation baked into its DNA which comes in handy when your core mission is to bring profitable new ideas to the banking space, a sometimes hyper-conservative industry. The Innovator of the Year Award is given to an individual whose innovative ideas and creations have had the greatest impact on the financial technology industry for the year. Weve long been a champion of artificial intelligence in lending, and its all coming together this year, says TurnKey Lender CEO and co-founder Dmitry Voronenko. Were applying it not just to loan origination, where its been used for a while, but to every phase of the loan lifecycle and businesses around the world have responded with genuine interest. In just five years, TurnKey Lender entered over 40 global markets, and provided customization for auto financing, P2P lending, factoring and invoice financing, in-house retail financing, and digital banking. Were determined to continue leading the financial industry as a global leader in Unified Lending Management, says Ionenko. This means serving large financial institutions with sophisticated processes and multiple credit products as well as non-lending organizations that want to sell more of their goods and services by providing buy-now-pay-later purchase options to their customers. TurnKey Lenders Unified Lending Solution is an intelligent unified lending management system that automates loan processing from origination to settlement. The digital platform includes a borrowers portal, instant application processing, risk assessment, decisioning, loan origination, underwriting, servicing, collections, reporting, archiving, and compliance. This allows for better user experiences for lenders and borrowers alike at a time when seamless digital lending processes are vital. For TurnKey Lender, the award of the 2020 Innovator of the Year by Finovate to Ionenko is a sign the company is on the right track in driving the industry forward at a critical time in history.

edtsum214

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK--(BUSINESS WIRE)--Taste of Iceland, an annual festival that celebrates Icelands vibrant culture, announced today, for the first time ever, that it is going virtual from November 18 - 22. In the wake of the ongoing pandemic, the festival will be held entirely online to safely bring people across North America together to enjoy all that Iceland has to offer. Presented by Iceland Naturally, the five-day festival will highlight the very best of Icelands unique culture, including cuisine, music, literature, film, and more through a variety of free livestreamed events. Participants can bring Iceland into their homes throughout the festival by entering to win prizes from top Icelandic brands, learning new Icelandic cooking and cocktail recipes, and streaming Icelandic music! Taste of Iceland in North America will be streamed from several cities around the world, including: Seattle, Chicago, Boston, Ottawa, Winnipeg, and Reykjavik. A first-of-its-kind variety show will stream directly from Seattle to showcase an array of Icelandic culture on Saturday, November 21. Produced by KEXP, Reykjavk Calling will be a celebration of Icelandic music and culture, featuring performances from Icelandic and US-based musical groups, cooking demonstrations and more. Throughout the festival, virtual attendees can enter to win prizes such as a grand prize trip to Iceland, Blue Lagoon skin care, Icelandic Provisions skyr and more! Participants can enter the first-ever Wheel of Prizes, presented by Icelandair through this form and winners will be selected live on Saturday, November 21 during the Reykjavk Calling Variety Show with KEXP. Schedule of Events November 18-22 |12:00pm - 4:00pm ET | Woman at War Screening | Free November 18-21 | 1:00pm ET | Western Icelander Series | Free November 18 | 5:00pm ET | Boston Cooking Demonstration + Cocktail Takeout | Free + Cocktails for Purchase November 18 | 8:00pm ET | The Inspiration for the Retreats Experience and Interior Design | Free November 19 | 5:00pm ET | Cooking Class with Icelandic Brand Seafood | Free November 19 | 9:00pm ET | Literature and Music Discussion | Free November 20 | 5:00pm ET | Chicago Cooking Demonstration | Free November 20 | 8:00pm ET | Cocktail Class with Reyka Vodka | Free November 21 | 5:00pm ET | Reykjavk Calling Variety Show with KEXP | Free November 21 | 8:00pm ET | Live from Reykjavk with Mammt | Free November 22 | 4:00pm ET | Woman at War Director Q&A | Free Event Details November 18-22 Woman At War Screening | Free Tickets The acclaimed Icelandic film Woman at War will be available online to enjoy from the comfort of your home from 12:00pm ET on November 18 through 4:00pm ET on November 22. Viewers can watch the film by clicking here to register for their free ticket by November 18 at 12:00pm ET. Tickets will be sent via email and will be valid for the entire weekend. And be sure to tune into a Q+A discussion with Woman at War director Benedikt Erlingsson on Sunday, November 22 at 4:00pm ET. November 18-21 Western Icelanders Series | Free Facebook Tune in to the four-part series on Icelandic history and culture, Western Icelanders. Each day at 1:00pm ET from Wednesday, November 18 through Saturday, November 21, viewers will enjoy a new episode on Iceland Naturallys Facebook page that explores influential Icelanders throughout history. November 18 Boston Cooking Demonstration and Cocktail Takeout 5:00pm ET | Create Gallery and Cocktail Lounge | 1 Bow Market Way, Somerville, MA 02143 | Facebook Calling all foodies and chefs - join Chef Louis DiBiccari of Create Gallery and Cocktail Lounge in Boston as he presents a cooking demonstration of an Icelandic-inspired dish! For those in the Boston area, visit Create Gallery and Cocktail Lounge from November 18-22 to grab cocktails to-go and bring a taste of Iceland to your own kitchen. The Inspiration for the Retreats Experience and Interior Design | Free 8:00pm ET | Facebook Participate in an online discussion with Sigurdur Thorsteinsson, Blue Lagoons Chief Brand Officer since 1997, to learn more about the wellness-driven and human-centered approach that inspired the design of the Retreat at Blue Lagoon Iceland. November 19 Cooking Class with Icelandic Brand Seafood | Free 5:00pm ET | Facebook Tune in for a livestreamed cooking class to learn how to make two unique Icelandic Brand seafood dishes - Smoked Salmon Blintz and Miso Marinated Icelandic Cod Loin. With over two decades of experience in the food industry and a vast array of experience working in restaurants, hotels, bakeries, entrepreneurial ventures and all things culinary, Chef Graham of High Liner Foods seeks to share his true passion of cooking and seafood with all of you. Icelandic Brand seafood is available exclusively through High Liner Foods. Literature and Music Discussion: On Time and Water | Free 9:00pm ET | Facebook In partnership with the National Nordic Museum in Seattle, participate in a one-of-a-kind performance from author Andri Snr Magnason and singer-songwriter Hgni as they combine forces in a special presentation featuring storytelling, images, old films, and science. Following the presentation, stick around for a live Q+A moderated by Dominic Boyer and Cymene Howe. November 20 Chicago Cooking Demonstration | Free 5:00pm ET | Facebook Join us live from Chicago as James Beard Award Finalist, Chef Paul Virant of Gaijin, Vie, and Vistro restaurants demonstrates a seasonal dish inspired by Icelandic cuisine. Cocktail Class with Reyka Vodka | Free 8:00pm ET | Facebook Join renowned Reyka Vodka mixologist Trevor Schneider for a special Facebook Live class to learn about the flavors that make a cocktail uniquely Icelandic, and make an Icelandic Espresso Martini, a Reyka 5:1 Martini, and an Icelandic Mule. This is a 21+ event. November 21 KEXP Presents Reykjavk Calling | Free 5:00 - 6:30pm ET | KEXP YouTube KEXP is proud to present the return of Reykjavik Calling, a celebration of Icelandic music and culture. During the 90-minute show hosted by KEXPs Kevin Cole and Icelandic writer and speaker Bergur Ebbi, tune in for a live concert with performances by Icelandic artists Kristn Anna and Supersport! and Seattle artist Tomo Nakayama. Viewers will also enjoy a presentation of Icelands unique cuisine from Chef rinn of Smac restaurant. The show will also feature Icelandairs Wheel of Prizes, which will have three first prize winners and one grand prize winner selected live. The grand prize will be a trip to Iceland! Visit kexp.org/events for more info. Live from Reykjavk with Mammt | Free 8:00pm ET | Facebook Presented by Iceland Airwaves, tune in at 8:00pm ET on November 21 for a special rebroadcast of Icelandic rock band Mammts concert from Live from Reykjavk 2020! November 22 Q+A with discussion with Woman at War director Benedikt Erlingsson | Free 4:00pm ET | Facebook After viewers stream Woman at War, participate in a live Q+A session moderated by Tomris Laffly with the acclaimed film director Benedikt Erlingsson. RSVP to the virtual events on Facebook and be sure to share your experience with us on Instagram and Twitter by tagging @IcelandNatural with #TasteofIceland. Facebook: Iceland Naturally Twitter: @IcelandNatural Instagram: @IcelandNatural About Taste of Iceland in North America Taste of Iceland in North America is presented by Iceland Naturally in cooperation with, Icelandair, Icelandic Group, Reyka Vodka, City of Reykjavik, Icelandic Glacial Water, Blue Lagoon, Keflavik International Airport (KEF), Landsvirkjun, lgerin Egill Skallagrmsson, Icelandic Lamb, Promote Iceland, Icelandic Provisions, the Government of Iceland, National Nordic Museum, KEXP, Create Gallery and Cocktail Lounge, Gaijin, Vie, and Vistro. About Iceland Naturally Iceland Naturally is a cooperative marketing organization that promotes the services, products and culture of Iceland. Through events, promotions and online marketing initiatives, Iceland Naturally introduces Icelands creativity and natural wonders to North Americans. The group is comprised of Icelands top companies and organizations: Icelandair, Icelandic Group, Reyka Vodka, City of Reykjavik, Icelandic Glacial Water, Blue Lagoon, Keflavik International Airport (KEF), Landsvirkjun, lgerin Egill Skallagrmsson, Icelandic Lamb, Promote Iceland, Icelandic Provisions and the Government of Iceland. Answer:

Iceland Naturally Presents First-Ever Virtual Taste of Iceland in North America Festival From November 18-22, 2020, the festival will be held online with a 90-minute variety show, concert, cooking class, literature discussion, cocktail class, and more to celebrate the best of Icelandic culture.

NEW YORK--(BUSINESS WIRE)--Taste of Iceland, an annual festival that celebrates Icelands vibrant culture, announced today, for the first time ever, that it is going virtual from November 18 - 22. In the wake of the ongoing pandemic, the festival will be held entirely online to safely bring people across North America together to enjoy all that Iceland has to offer. Presented by Iceland Naturally, the five-day festival will highlight the very best of Icelands unique culture, including cuisine, music, literature, film, and more through a variety of free livestreamed events. Participants can bring Iceland into their homes throughout the festival by entering to win prizes from top Icelandic brands, learning new Icelandic cooking and cocktail recipes, and streaming Icelandic music! Taste of Iceland in North America will be streamed from several cities around the world, including: Seattle, Chicago, Boston, Ottawa, Winnipeg, and Reykjavik. A first-of-its-kind variety show will stream directly from Seattle to showcase an array of Icelandic culture on Saturday, November 21. Produced by KEXP, Reykjavk Calling will be a celebration of Icelandic music and culture, featuring performances from Icelandic and US-based musical groups, cooking demonstrations and more. Throughout the festival, virtual attendees can enter to win prizes such as a grand prize trip to Iceland, Blue Lagoon skin care, Icelandic Provisions skyr and more! Participants can enter the first-ever Wheel of Prizes, presented by Icelandair through this form and winners will be selected live on Saturday, November 21 during the Reykjavk Calling Variety Show with KEXP. Schedule of Events November 18-22 |12:00pm - 4:00pm ET | Woman at War Screening | Free November 18-21 | 1:00pm ET | Western Icelander Series | Free November 18 | 5:00pm ET | Boston Cooking Demonstration + Cocktail Takeout | Free + Cocktails for Purchase November 18 | 8:00pm ET | The Inspiration for the Retreats Experience and Interior Design | Free November 19 | 5:00pm ET | Cooking Class with Icelandic Brand Seafood | Free November 19 | 9:00pm ET | Literature and Music Discussion | Free November 20 | 5:00pm ET | Chicago Cooking Demonstration | Free November 20 | 8:00pm ET | Cocktail Class with Reyka Vodka | Free November 21 | 5:00pm ET | Reykjavk Calling Variety Show with KEXP | Free November 21 | 8:00pm ET | Live from Reykjavk with Mammt | Free November 22 | 4:00pm ET | Woman at War Director Q&A | Free Event Details November 18-22 Woman At War Screening | Free Tickets The acclaimed Icelandic film Woman at War will be available online to enjoy from the comfort of your home from 12:00pm ET on November 18 through 4:00pm ET on November 22. Viewers can watch the film by clicking here to register for their free ticket by November 18 at 12:00pm ET. Tickets will be sent via email and will be valid for the entire weekend. And be sure to tune into a Q+A discussion with Woman at War director Benedikt Erlingsson on Sunday, November 22 at 4:00pm ET. November 18-21 Western Icelanders Series | Free Facebook Tune in to the four-part series on Icelandic history and culture, Western Icelanders. Each day at 1:00pm ET from Wednesday, November 18 through Saturday, November 21, viewers will enjoy a new episode on Iceland Naturallys Facebook page that explores influential Icelanders throughout history. November 18 Boston Cooking Demonstration and Cocktail Takeout 5:00pm ET | Create Gallery and Cocktail Lounge | 1 Bow Market Way, Somerville, MA 02143 | Facebook Calling all foodies and chefs - join Chef Louis DiBiccari of Create Gallery and Cocktail Lounge in Boston as he presents a cooking demonstration of an Icelandic-inspired dish! For those in the Boston area, visit Create Gallery and Cocktail Lounge from November 18-22 to grab cocktails to-go and bring a taste of Iceland to your own kitchen. The Inspiration for the Retreats Experience and Interior Design | Free 8:00pm ET | Facebook Participate in an online discussion with Sigurdur Thorsteinsson, Blue Lagoons Chief Brand Officer since 1997, to learn more about the wellness-driven and human-centered approach that inspired the design of the Retreat at Blue Lagoon Iceland. November 19 Cooking Class with Icelandic Brand Seafood | Free 5:00pm ET | Facebook Tune in for a livestreamed cooking class to learn how to make two unique Icelandic Brand seafood dishes - Smoked Salmon Blintz and Miso Marinated Icelandic Cod Loin. With over two decades of experience in the food industry and a vast array of experience working in restaurants, hotels, bakeries, entrepreneurial ventures and all things culinary, Chef Graham of High Liner Foods seeks to share his true passion of cooking and seafood with all of you. Icelandic Brand seafood is available exclusively through High Liner Foods. Literature and Music Discussion: On Time and Water | Free 9:00pm ET | Facebook In partnership with the National Nordic Museum in Seattle, participate in a one-of-a-kind performance from author Andri Snr Magnason and singer-songwriter Hgni as they combine forces in a special presentation featuring storytelling, images, old films, and science. Following the presentation, stick around for a live Q+A moderated by Dominic Boyer and Cymene Howe. November 20 Chicago Cooking Demonstration | Free 5:00pm ET | Facebook Join us live from Chicago as James Beard Award Finalist, Chef Paul Virant of Gaijin, Vie, and Vistro restaurants demonstrates a seasonal dish inspired by Icelandic cuisine. Cocktail Class with Reyka Vodka | Free 8:00pm ET | Facebook Join renowned Reyka Vodka mixologist Trevor Schneider for a special Facebook Live class to learn about the flavors that make a cocktail uniquely Icelandic, and make an Icelandic Espresso Martini, a Reyka 5:1 Martini, and an Icelandic Mule. This is a 21+ event. November 21 KEXP Presents Reykjavk Calling | Free 5:00 - 6:30pm ET | KEXP YouTube KEXP is proud to present the return of Reykjavik Calling, a celebration of Icelandic music and culture. During the 90-minute show hosted by KEXPs Kevin Cole and Icelandic writer and speaker Bergur Ebbi, tune in for a live concert with performances by Icelandic artists Kristn Anna and Supersport! and Seattle artist Tomo Nakayama. Viewers will also enjoy a presentation of Icelands unique cuisine from Chef rinn of Smac restaurant. The show will also feature Icelandairs Wheel of Prizes, which will have three first prize winners and one grand prize winner selected live. The grand prize will be a trip to Iceland! Visit kexp.org/events for more info. Live from Reykjavk with Mammt | Free 8:00pm ET | Facebook Presented by Iceland Airwaves, tune in at 8:00pm ET on November 21 for a special rebroadcast of Icelandic rock band Mammts concert from Live from Reykjavk 2020! November 22 Q+A with discussion with Woman at War director Benedikt Erlingsson | Free 4:00pm ET | Facebook After viewers stream Woman at War, participate in a live Q+A session moderated by Tomris Laffly with the acclaimed film director Benedikt Erlingsson. RSVP to the virtual events on Facebook and be sure to share your experience with us on Instagram and Twitter by tagging @IcelandNatural with #TasteofIceland. Facebook: Iceland Naturally Twitter: @IcelandNatural Instagram: @IcelandNatural About Taste of Iceland in North America Taste of Iceland in North America is presented by Iceland Naturally in cooperation with, Icelandair, Icelandic Group, Reyka Vodka, City of Reykjavik, Icelandic Glacial Water, Blue Lagoon, Keflavik International Airport (KEF), Landsvirkjun, lgerin Egill Skallagrmsson, Icelandic Lamb, Promote Iceland, Icelandic Provisions, the Government of Iceland, National Nordic Museum, KEXP, Create Gallery and Cocktail Lounge, Gaijin, Vie, and Vistro. About Iceland Naturally Iceland Naturally is a cooperative marketing organization that promotes the services, products and culture of Iceland. Through events, promotions and online marketing initiatives, Iceland Naturally introduces Icelands creativity and natural wonders to North Americans. The group is comprised of Icelands top companies and organizations: Icelandair, Icelandic Group, Reyka Vodka, City of Reykjavik, Icelandic Glacial Water, Blue Lagoon, Keflavik International Airport (KEF), Landsvirkjun, lgerin Egill Skallagrmsson, Icelandic Lamb, Promote Iceland, Icelandic Provisions and the Government of Iceland.

edtsum216

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SEATTLE, March 11, 2021 /PRNewswire/ -- CareListings, the nation's most comprehensive resource for families and caregiver job seekers exploring senior living and home care optionsonline, has launched a newportal which provides detailed nursing home and salary informationfor every city, state, and facility in the United States. The salary information is based upon nearly 12billion hours of employment data systematically assembled from tens of millions of data points from annual nursing home filings withthe Centers for Medicare & Medicaid for fiscal years ending in 2013-2019. It builds upon the capabilities of the platform to connect families and caregiver job seekersto over 140,000 senior care providers in the United States. "Twenty-four hours per day, sevendays per week,pandemic or not, nurses are caring for over one million people at nursing homesevery day.It is aprivilege to help connect so many caregivers and nurses with great employment opportunities, but it is abundantlyclear that nursing homes and other senior careemployers needmore help in providinglivable wages to the direct care worker heroes," says the founder and CEO of CareListings, Carl Rogers. CareListings now contains salary information forCertified Nursing Assistants (CNA),Licensed Practical Nurses (LPN), andRegistered Nurses (RN)across all U.S. states and major cities from 2013 to 2019based on 11,954,263,238hours of wage data reported by Medicare and Medicaid certified nursing homes. With a single click, anyone can see the average level of salaries being paid to caregivers and compare city-level data to state-level data. About CareListingsCareListings is the nation's most comprehensive resource for families and healthcare professionals exploring senior care options online, with direct contact information for over 140,000 long-term care providers for free - including assisted living homes, home care & home health agencies, skilled nursing facilities, dialysis facilities, and other types of senior care providers. Employers hiring nurses and caregivershave the ability toupdate the listing information for theirbusiness, post free job listings, and browse nearby caregiver job seekers at no cost. CareListings' Premium Listings are subscription-based and allow providers to reach even more families and source more candidates directly, without referral or placement fees. Caregivers and nurses exploring nearby job opportunities in senior carecan create a centralized profile on the platform and notify hiring managers of their interest in available positions. CareListings is based in the Ballard neighborhood of Seattle, Washington, and serves families, caregiver job seekers, and senior care employers across the United States. Learn more atcarelistings.com. Media Contacts:Carl Rogers, Email:[emailprotected]Courtney Clayton, Email:[emailprotected] Related Imagescarelistings.png CareListings Nursing Homes, CNA, LPN/LVN, RN Salaries and Jobs on CareListings Related LinksNursing Homes CNA, LPN/LVN, RN Salaries SOURCE CareListings Related Links http://carelistings.com Answer:

CNA, LPN, and RN Salary History Available for 15,000+ Nursing Homes on CareListings Seattle startup launches tool analyzing 12 billion hours for CNA, LPN/LVN and RN employees at skilled nursing facilities for every city, state and facility in the U.S.

SEATTLE, March 11, 2021 /PRNewswire/ -- CareListings, the nation's most comprehensive resource for families and caregiver job seekers exploring senior living and home care optionsonline, has launched a newportal which provides detailed nursing home and salary informationfor every city, state, and facility in the United States. The salary information is based upon nearly 12billion hours of employment data systematically assembled from tens of millions of data points from annual nursing home filings withthe Centers for Medicare & Medicaid for fiscal years ending in 2013-2019. It builds upon the capabilities of the platform to connect families and caregiver job seekersto over 140,000 senior care providers in the United States. "Twenty-four hours per day, sevendays per week,pandemic or not, nurses are caring for over one million people at nursing homesevery day.It is aprivilege to help connect so many caregivers and nurses with great employment opportunities, but it is abundantlyclear that nursing homes and other senior careemployers needmore help in providinglivable wages to the direct care worker heroes," says the founder and CEO of CareListings, Carl Rogers. CareListings now contains salary information forCertified Nursing Assistants (CNA),Licensed Practical Nurses (LPN), andRegistered Nurses (RN)across all U.S. states and major cities from 2013 to 2019based on 11,954,263,238hours of wage data reported by Medicare and Medicaid certified nursing homes. With a single click, anyone can see the average level of salaries being paid to caregivers and compare city-level data to state-level data. About CareListingsCareListings is the nation's most comprehensive resource for families and healthcare professionals exploring senior care options online, with direct contact information for over 140,000 long-term care providers for free - including assisted living homes, home care & home health agencies, skilled nursing facilities, dialysis facilities, and other types of senior care providers. Employers hiring nurses and caregivershave the ability toupdate the listing information for theirbusiness, post free job listings, and browse nearby caregiver job seekers at no cost. CareListings' Premium Listings are subscription-based and allow providers to reach even more families and source more candidates directly, without referral or placement fees. Caregivers and nurses exploring nearby job opportunities in senior carecan create a centralized profile on the platform and notify hiring managers of their interest in available positions. CareListings is based in the Ballard neighborhood of Seattle, Washington, and serves families, caregiver job seekers, and senior care employers across the United States. Learn more atcarelistings.com. Media Contacts:Carl Rogers, Email:[emailprotected]Courtney Clayton, Email:[emailprotected] Related Imagescarelistings.png CareListings Nursing Homes, CNA, LPN/LVN, RN Salaries and Jobs on CareListings Related LinksNursing Homes CNA, LPN/LVN, RN Salaries SOURCE CareListings Related Links http://carelistings.com

edtsum224

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PORTLAND, Oregon, July 7, 2020 /PRNewswire/ -- Allied Market Research recently published a report, "Global Flexible Pipes Market by Raw Material (High-density Polyethylene, Polyamide, Polyvinylidene Fluoride, and Others) and Application (Onshore and Offshore): Global Opportunity Analysis and Industry Forecast, 20202027". According to the report, the global flexible pipe industry was pegged at $0.8 billion in 2019, and is projected to reach $1.2 billion by 2027, growing at a CAGR of 4.7% from 2020 to 2027. Drivers, opportunities, and restraints: Technological advancements in drilling activities drive the growth of the global flexible pipe market. However, stringent regulation in the oil & gas industry hampers the market. On the contrary, surge in exploration of horizontal wells is expected to create lucrative opportunities for the market players in the coming future. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6904 COVID-19 scenario: The outbreak of COVID-19 has greatly affected the global flexible pipe market. Lockdown in various countries and shortage of labor have temporarily suspended the manufacturing of advanced materials. Dearth of raw materials and disrupted supply chain has affected the manufacturing of flexible pipes. HDPE segment dominated the market: By raw material, the HDPE segment held the largest share in 2019, accounting for nearly two-fifths of the global flexible pipe market. However, the PVDF segment is projected to register the highest CAGRof 5.1% during the forecast period, as it has the characteristic stability of fluoropolymers when exposed to harsh thermal, chemical, and ultraviolet environments while retaining the properties of a conventional thermoplastic material. Onshore segment to garner highest CAGR through 2027: By application, the onshore segment is projected to portray the highest CAGR of 4.7% during the study period, due to high demand for flexible pipe in onshore extraction and processing activities that involves several flammable gases, chemicals, and materials. However, the offshore segment held the largest share in 2019, contributing to more than half of the global flexible pipe market. Flexible pipe helps in drilling activities in water which makes it reliable and safe choice in offshore applications. Get Detailed COVID-19 Impact Analysis on the Flexible Pipes Market @ https://www.alliedmarketresearch.com/request-for-customization/6904?reqfor=covid North America held largest share: By region, the global flexible pipe market across North America held the lion's share in 2019, accounting for more than one-third of the market, owing to presence of large number of corporations in the region and creased activities in oil & gas industry and energy transmission. However, the market across Asia-Pacific is anticipated to register the highest CAGR of 5.1% during the forecast period, due to expansion in the oil and gas industry and highest number of patents files by countries such as China, Japan, Australia, and South Korea. Major market players Baker Hughes Company National Oilwell Varco, Inc. FlexSteel Pipeline Technologies, Inc. Magma Global Ltd. Pipelife Nederland B.V. Shawcor Ltd. Technip FMC Plc. Airborne Oil & Gas B.V. ContiTech AG Prysmian Group Interested in Procuring this Report? visit: https://www.alliedmarketresearch.com/purchase-enquiry/6904 Avenue Basic Plan | Library Access | 1 Year Subscription | Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan. Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter Get more information: https://www.alliedmarketresearch.com/library-access Similar Reports: HDPE Pipes Market: Global Opportunity Analysis and Industry Forecast, 2018 - 2025 Technical Ceramics Market: Global Opportunity Analysis and Industry Forecast, 20192026 3D Printing Metal Market: Global Opportunity Analysis and Industry Forecast, 20192026 Conductive Polymer Market: Global Opportunity Analysis and Industry Forecast, 20192026 About Us Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact: David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):1-800-792-5285, 1-503-894-6022, 1-503-446-1141UK:+44-845-528-1300Hong Kong:+852-301-84916India (Pune):+91-20-66346060Fax:+1(855)550-5975[emailprotected] Web:https://www.alliedmarketresearch.com Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research SOURCE Allied Market Research Answer:

Flexible Pipes Market to Garner $1.2 Billion, Globally, by 2027 at 4.7% CAGR, Says Allied Market Research Technological advancements in drilling activities drive the growth of the global flexible pipe market

PORTLAND, Oregon, July 7, 2020 /PRNewswire/ -- Allied Market Research recently published a report, "Global Flexible Pipes Market by Raw Material (High-density Polyethylene, Polyamide, Polyvinylidene Fluoride, and Others) and Application (Onshore and Offshore): Global Opportunity Analysis and Industry Forecast, 20202027". According to the report, the global flexible pipe industry was pegged at $0.8 billion in 2019, and is projected to reach $1.2 billion by 2027, growing at a CAGR of 4.7% from 2020 to 2027. Drivers, opportunities, and restraints: Technological advancements in drilling activities drive the growth of the global flexible pipe market. However, stringent regulation in the oil & gas industry hampers the market. On the contrary, surge in exploration of horizontal wells is expected to create lucrative opportunities for the market players in the coming future. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6904 COVID-19 scenario: The outbreak of COVID-19 has greatly affected the global flexible pipe market. Lockdown in various countries and shortage of labor have temporarily suspended the manufacturing of advanced materials. Dearth of raw materials and disrupted supply chain has affected the manufacturing of flexible pipes. HDPE segment dominated the market: By raw material, the HDPE segment held the largest share in 2019, accounting for nearly two-fifths of the global flexible pipe market. However, the PVDF segment is projected to register the highest CAGRof 5.1% during the forecast period, as it has the characteristic stability of fluoropolymers when exposed to harsh thermal, chemical, and ultraviolet environments while retaining the properties of a conventional thermoplastic material. Onshore segment to garner highest CAGR through 2027: By application, the onshore segment is projected to portray the highest CAGR of 4.7% during the study period, due to high demand for flexible pipe in onshore extraction and processing activities that involves several flammable gases, chemicals, and materials. However, the offshore segment held the largest share in 2019, contributing to more than half of the global flexible pipe market. Flexible pipe helps in drilling activities in water which makes it reliable and safe choice in offshore applications. Get Detailed COVID-19 Impact Analysis on the Flexible Pipes Market @ https://www.alliedmarketresearch.com/request-for-customization/6904?reqfor=covid North America held largest share: By region, the global flexible pipe market across North America held the lion's share in 2019, accounting for more than one-third of the market, owing to presence of large number of corporations in the region and creased activities in oil & gas industry and energy transmission. However, the market across Asia-Pacific is anticipated to register the highest CAGR of 5.1% during the forecast period, due to expansion in the oil and gas industry and highest number of patents files by countries such as China, Japan, Australia, and South Korea. Major market players Baker Hughes Company National Oilwell Varco, Inc. FlexSteel Pipeline Technologies, Inc. Magma Global Ltd. Pipelife Nederland B.V. Shawcor Ltd. Technip FMC Plc. Airborne Oil & Gas B.V. ContiTech AG Prysmian Group Interested in Procuring this Report? visit: https://www.alliedmarketresearch.com/purchase-enquiry/6904 Avenue Basic Plan | Library Access | 1 Year Subscription | Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan. Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter Get more information: https://www.alliedmarketresearch.com/library-access Similar Reports: HDPE Pipes Market: Global Opportunity Analysis and Industry Forecast, 2018 - 2025 Technical Ceramics Market: Global Opportunity Analysis and Industry Forecast, 20192026 3D Printing Metal Market: Global Opportunity Analysis and Industry Forecast, 20192026 Conductive Polymer Market: Global Opportunity Analysis and Industry Forecast, 20192026 About Us Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact: David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):1-800-792-5285, 1-503-894-6022, 1-503-446-1141UK:+44-845-528-1300Hong Kong:+852-301-84916India (Pune):+91-20-66346060Fax:+1(855)550-5975[emailprotected] Web:https://www.alliedmarketresearch.com Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research SOURCE Allied Market Research

edtsum225

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: RESTON, Va., March 19, 2020 /PRNewswire/ -- PagnatoKarp was named 2020 BEST MULTI-FAMILY OFFICE ($2.5B to $5B AUA/AUM) at the 7th annual FAMILY WEALTH REPORT Awards. One of four firms to be shortlisted in the category, PagnatoKarp earned the coveted top award in the competitive family office space. The firm has $4.8 billion assets under advisement and is frequently ranked on top wealth advisor lists by Barron's and Forbes, as well as being a Best Place to Work. "We are laser focused on helping protect and empower our clients each and every day, especially during volatile times," says Paul Pagnato, CEO Founder at PagnatoKarp. "This prestigious award showcases the incredible teamwork from our firm, partners, and advisors as we continue to provide innovation and leadership to the families we serve." Showcasing 'best of breed' providers in the global private banking, wealth management and trusted advisor communities, the Family Wealth Report Awards were designed to recognize companies, teams and individuals which the prestigious panel of judges deemed to have 'demonstrated innovation and excellence during 2019'. According to FWR, these awards recognize the very best in the private client industry, with 'independence', 'integrity' and 'genuine insight', the watchwords of the judging process - such that the awards truly reflect excellence in wealth management. Stephen Harris, CEO of ClearView Financial Media and Publisher of WealthBriefing, was first to extend his congratulations to all the winners. He said: "The firms who triumphed in these awards are all worthy winners, and I would like to extend my heartiest congratulations. These awards were judged solely on the basis of entrants' submissions and their response to a number of specific questions, which had to be answered focusing on the client experience, not quantitative performance metrics. That is a unique, and I believe, compelling feature." PagnatoKarp was previously named 2018 Best Multi-Family Office (New Entrant) and was a 2019 Finalist in the $2.5B to $5B AUM/AUA category. The firm is also a 2020 Best Place to Work in Virginia. Paul Pagnato is ranked #1 in Northern Virginia on Forbes 2020 Top Wealth Advisors and #2 in Virginia on 2019 Barron's Top 1,200 Financial Advisors: State-by-State.Paul Pagnato is also author of the upcoming book Transparency Wave: Exponential Changes That Will Transform Our World. About PagnatoKarpWith $4.8 billion assets under advisement, PagnatoKarpspecializes in Intelligent Wealth Management for CEO Founders, entrepreneurs, wealth creators and ultra-high-net-worth families. With True Fiduciary standards of transparency, we embrace the legal obligation to put your interests first while focusing on asset protection, cash flow, and opportunities. Frequently ranked on top financial advisor lists by Barron's and Forbes, and a Virginia Best Place to Work, PagnatoKarp's goal is to simplify and elevate your life so you have more time to spend on what matters to you most. Contact: Cathy RiederDirector, Client Experience & BrandingPagnatoKarp703-468-2733 SOURCE PagnatoKarp Related Links http://www.pagnatokarp.com Answer:

PagnatoKarp Named Best Multi-Family Office ($2.5B to $5B AUM/AUA) at 2020 FWR Awards

RESTON, Va., March 19, 2020 /PRNewswire/ -- PagnatoKarp was named 2020 BEST MULTI-FAMILY OFFICE ($2.5B to $5B AUA/AUM) at the 7th annual FAMILY WEALTH REPORT Awards. One of four firms to be shortlisted in the category, PagnatoKarp earned the coveted top award in the competitive family office space. The firm has $4.8 billion assets under advisement and is frequently ranked on top wealth advisor lists by Barron's and Forbes, as well as being a Best Place to Work. "We are laser focused on helping protect and empower our clients each and every day, especially during volatile times," says Paul Pagnato, CEO Founder at PagnatoKarp. "This prestigious award showcases the incredible teamwork from our firm, partners, and advisors as we continue to provide innovation and leadership to the families we serve." Showcasing 'best of breed' providers in the global private banking, wealth management and trusted advisor communities, the Family Wealth Report Awards were designed to recognize companies, teams and individuals which the prestigious panel of judges deemed to have 'demonstrated innovation and excellence during 2019'. According to FWR, these awards recognize the very best in the private client industry, with 'independence', 'integrity' and 'genuine insight', the watchwords of the judging process - such that the awards truly reflect excellence in wealth management. Stephen Harris, CEO of ClearView Financial Media and Publisher of WealthBriefing, was first to extend his congratulations to all the winners. He said: "The firms who triumphed in these awards are all worthy winners, and I would like to extend my heartiest congratulations. These awards were judged solely on the basis of entrants' submissions and their response to a number of specific questions, which had to be answered focusing on the client experience, not quantitative performance metrics. That is a unique, and I believe, compelling feature." PagnatoKarp was previously named 2018 Best Multi-Family Office (New Entrant) and was a 2019 Finalist in the $2.5B to $5B AUM/AUA category. The firm is also a 2020 Best Place to Work in Virginia. Paul Pagnato is ranked #1 in Northern Virginia on Forbes 2020 Top Wealth Advisors and #2 in Virginia on 2019 Barron's Top 1,200 Financial Advisors: State-by-State.Paul Pagnato is also author of the upcoming book Transparency Wave: Exponential Changes That Will Transform Our World. About PagnatoKarpWith $4.8 billion assets under advisement, PagnatoKarpspecializes in Intelligent Wealth Management for CEO Founders, entrepreneurs, wealth creators and ultra-high-net-worth families. With True Fiduciary standards of transparency, we embrace the legal obligation to put your interests first while focusing on asset protection, cash flow, and opportunities. Frequently ranked on top financial advisor lists by Barron's and Forbes, and a Virginia Best Place to Work, PagnatoKarp's goal is to simplify and elevate your life so you have more time to spend on what matters to you most. Contact: Cathy RiederDirector, Client Experience & BrandingPagnatoKarp703-468-2733 SOURCE PagnatoKarp Related Links http://www.pagnatokarp.com

edtsum227

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: KANSAS CITY, Mo.--(BUSINESS WIRE)--SafetyCulture, the worlds leading platform for workplace safety and quality, has released findings detailing workers' likelihood to speak up about COVID-19 safety in US workplaces. More than one in four males (27%) and only one in five females (20%) who will be returning to their place of work are unlikely to ask a colleague or boss to put on a mask, wash their hands or distance themselves, according to the national survey conducted by YouGov and SafetyCulture of over 2,500 adults*. Millennials are most likely to comment on safety concerns and measures over Gen Z, Gen X, and Baby Boomers. When it comes to work meetings, more than one in five (22%) are unlikely to speak up if the room is deemed overcapacity. Although October 2020 was a month of frightening COVID-19 records, over eight in 10 (81%) of these workers are confident that their workplace has or will take the appropriate actions to put safety checks in place for a safe return to the office. Key findings from the survey also include: Safe workplaces will win the war for talent The majority of these workers agree that their trust and confidence in a workplace would increase with certain safety measures put in place, including: Bob Butler, General Manager, Americas, SafetyCulture, cautions against a top-down approach to safety in workplaces: Companies which will survive and thrive today are those which proactively lean into challenges, encourage employee feedback, and take ownership of risks. They build visibility across their workplace through real-time data capture, and they empower all workers to have a voice when it comes to safety. Organizations must actively encourage employees of all levels to speak up when something raises a concern in the workplace. Everyone needs to take responsibility to create a genuine culture of safety, from the frontline to senior management. One way of doing this is by investing in the right tools that enable employees to be the eyes and ears of the organization, Butler said. To help businesses prepare for 2021, SafetyCulture is bringing together an international lineup of high profile personalities to reveal key lessons targeted to business operators for a free virtual event: SafetyCulture Summit 2020: From Surviving to Thriving. The November 18 event will explore adaptation and innovation and how businesses can capitalize on recent shifts in business operations to grow rapidly into 2021. Last month, SafetyCulture partnered with the Society for Human Resources Management (SHRM) to raise safety standards across US workplaces. The partnership will support 300,000 HR and business leaders to effectively manage risk in the face of COVID-19. Already, more than 75,000 people worldwide are using SafetyCultures iAuditor app to complete daily COVID-19 inspections. In August, iAuditor was announced as Best SaaS (Software as a Service) for Health and Safety or Risk Management in the international 2020 SaaS Awards, which celebrate excellence in software. *Methodology: This survey has been conducted using an online interview administered to members of the YouGov Plc panel of individuals who have agreed to take part in surveys. All figures, unless otherwise stated, are from YouGov Plc. The total sample size was 2578 adults, 802 of which were employed adults who are or will be returning to their place of work. Fieldwork was undertaken between 23rd - 27th October 2020. The survey was carried out online. The figures have been weighted and are representative of all US adults (aged 18+). About SafetyCulture SafetyCulture is a global technology company that supports businesses to do their best work every day. Its adaptive, mobile-first products help to streamline operations and foster high performing, safer workplaces. Its flagship product, iAuditor, is used by more than 26,000 organizations in nearly every industry to optimize processes and performance. The technology empowers teams to perform checks, report issues, collect on-the-ground data, and communicate fluidly. In 2020, iAuditor was named winner of Best SaaS for Health and Safety or Risk Management at the SaaS Awards. Answer:

1 In 4 American Workers Hesitant to Ask Their Boss to Wear a Mask or Stay Socially Distant Nationwide YouGov & SafetyCulture Survey Assesses Employee Reluctance to Speak to Supervisors & Coworkers About COVID-19 Safety Behavior in the Workplace

KANSAS CITY, Mo.--(BUSINESS WIRE)--SafetyCulture, the worlds leading platform for workplace safety and quality, has released findings detailing workers' likelihood to speak up about COVID-19 safety in US workplaces. More than one in four males (27%) and only one in five females (20%) who will be returning to their place of work are unlikely to ask a colleague or boss to put on a mask, wash their hands or distance themselves, according to the national survey conducted by YouGov and SafetyCulture of over 2,500 adults*. Millennials are most likely to comment on safety concerns and measures over Gen Z, Gen X, and Baby Boomers. When it comes to work meetings, more than one in five (22%) are unlikely to speak up if the room is deemed overcapacity. Although October 2020 was a month of frightening COVID-19 records, over eight in 10 (81%) of these workers are confident that their workplace has or will take the appropriate actions to put safety checks in place for a safe return to the office. Key findings from the survey also include: Safe workplaces will win the war for talent The majority of these workers agree that their trust and confidence in a workplace would increase with certain safety measures put in place, including: Bob Butler, General Manager, Americas, SafetyCulture, cautions against a top-down approach to safety in workplaces: Companies which will survive and thrive today are those which proactively lean into challenges, encourage employee feedback, and take ownership of risks. They build visibility across their workplace through real-time data capture, and they empower all workers to have a voice when it comes to safety. Organizations must actively encourage employees of all levels to speak up when something raises a concern in the workplace. Everyone needs to take responsibility to create a genuine culture of safety, from the frontline to senior management. One way of doing this is by investing in the right tools that enable employees to be the eyes and ears of the organization, Butler said. To help businesses prepare for 2021, SafetyCulture is bringing together an international lineup of high profile personalities to reveal key lessons targeted to business operators for a free virtual event: SafetyCulture Summit 2020: From Surviving to Thriving. The November 18 event will explore adaptation and innovation and how businesses can capitalize on recent shifts in business operations to grow rapidly into 2021. Last month, SafetyCulture partnered with the Society for Human Resources Management (SHRM) to raise safety standards across US workplaces. The partnership will support 300,000 HR and business leaders to effectively manage risk in the face of COVID-19. Already, more than 75,000 people worldwide are using SafetyCultures iAuditor app to complete daily COVID-19 inspections. In August, iAuditor was announced as Best SaaS (Software as a Service) for Health and Safety or Risk Management in the international 2020 SaaS Awards, which celebrate excellence in software. *Methodology: This survey has been conducted using an online interview administered to members of the YouGov Plc panel of individuals who have agreed to take part in surveys. All figures, unless otherwise stated, are from YouGov Plc. The total sample size was 2578 adults, 802 of which were employed adults who are or will be returning to their place of work. Fieldwork was undertaken between 23rd - 27th October 2020. The survey was carried out online. The figures have been weighted and are representative of all US adults (aged 18+). About SafetyCulture SafetyCulture is a global technology company that supports businesses to do their best work every day. Its adaptive, mobile-first products help to streamline operations and foster high performing, safer workplaces. Its flagship product, iAuditor, is used by more than 26,000 organizations in nearly every industry to optimize processes and performance. The technology empowers teams to perform checks, report issues, collect on-the-ground data, and communicate fluidly. In 2020, iAuditor was named winner of Best SaaS for Health and Safety or Risk Management at the SaaS Awards.

edtsum228

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SHANGHAI, May 5, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced a broadened partnership and territory expansion agreement with Karyopharm Therapeutics Inc. (NASDAQ: KPTI) (Karyopharm) for development and commercialization of four oral novel drugs and drug candidates to support its mission of treating patients beyond borders. This agreement broadens Antengene's rights in the Asia Pacific region for XPOVIO (selinexor, aka ATG-010), the first-in-class selective inhibitor of nuclear export (SINE); eltanexor (ATG-016), a second-generation SINE compound; verdinexor (ATG-527), a lead compound in development for anti-viral and other non-oncology indications; and KPT-9274 (ATG-019), a dual inhibitor of PAK4 and NAMPT. In May 2018, Antengene and Karyopharm entered into a strategic collaboration for the development, manufacturing and commercialization of XPOVIO and eltanexor for all human oncology indications in mainland China and Macau; and KPT-9274 in all human oncology indications and verdinexor in human non-oncology indications in mainland China, Macau, Taiwan, Hong Kong, South Korea, and the ASEAN markets. As part of the expanded territory, Antengene has received extended rights to develop, manufacture and commercialize XPOVIO and eltanexor in Australia, New Zealand, South Korea, Taiwan, Hong Kong, and the entire ASEAN markets; KPT-9274 and verdinexor rights have also been extended to Australia and New Zealand. This expanded collaboration broadens Antengene's portfolio and geographic footprint to additional Asian markets. In July 2019, the U.S. FDA approved XPOVIOin combination with low-dose dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma (RRMM). The data from the recently released phase 3 BOSTON trial comparing SVd to Vd in 2nd and later lines in RRMM patients, has been selected as a late-breaking abstract for oral presentation at the upcoming virtual ASCO conference later this month. Antengene is presently expanding its commercial operations to support the launch of XPOVIOin mainland China and other APAC markets; and conducting clinical trials with XPOVIOin RRMM, diffuse large B-cell lymphoma (DLBCL) and T-cell lymphomas in China. Antengene has also announced the ongoing recruitment of patients with advanced solid tumor and non-Hodgkin's lymphoma in a clinical trial with ATG-019 (KPT-9274). In addition,clinical trials of ATG-016(eltanexor) and ATG-527 (verdinexor) will be initiated in these markets in 2020. "Upon the achievement of significant regulatory and clinical milestones inmainland China and other markets in Asia, Antengene is now expanding to additional Asia Pacific markets with clinical development and commercialization. We are pleased to have expanded our collaboration and partnership with Karyopharm in developing these novel drugs for patients in Asia Pacific," said Jay Mei, MD, PhD, Chairman and Chief Executive Officer of Antengene. "This critical geographic expansion is a step in our development and commercialization strategy, and we are building aworld-classcommercial team whilecontinuing to add clinical andcommercial-stage first-in-class novel drugs to address unmet medical needs and to further expand our strong pipeline. This is a further testament to our mission of treating patients beyond borders." "We are delighted to have the opportunity to expand our very productive, efficient and results-driven collaboration with Antengene which began two years ago," said Michael G. Kauffman, MD, PhD, Chief Executive Officer of Karyopharm. "The exemplary partnership between the two companies enables Karyopharm to fulfill its mission to develop and deliver novel drug candidates to patients around the world." About XPOVIO (selinexor) XPOVIO is a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound. XPOVIO functions by selectively binding to and inhibiting the nuclear export protein exportin 1 (XPO1, also called CRM1). XPOVIO blocks the nuclear export of tumor suppressor, growth regulatory and anti-inflammatory proteins, leading to accumulation of these proteins in the nucleus and enhancing their anti-cancer activity in the cell. The forced nuclear retention of these proteins can counteract a multitude of the oncogenic pathways that, unchecked, allow cancer cells with severe DNA damage to continue to grow and divide in an unrestrained fashion. Karyopharm received acceleratedU.S. Food and Drug Administration(FDA) approval of XPOVIO inJuly 2019in combination with dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody. Karyopharm has also submitted a Marketing Authorization Application (MAA) to theEuropean Medicines Agency(EMA) with a request for conditional approval of selinexor.A supplemental New Drug Application was accepted by the FDA seeking accelerated approval for selinexor as a new treatment for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), and selinexor has received Fast Track and Orphan designation and Priority Review from the FDA with a scheduled PDUFA date ofJune 23, 2020for this patient population. Selinexor is also being evaluated in several other mid-and later-phase clinical trials across multiple cancer indications, including in multiple myeloma in a pivotal, randomized Phase 3 study in combination with Velcade (bortezomib) and low-dose dexamethasone (BOSTON), for which Karyopharm announced positive top-line results inMarch 2020.Additional, ongoing trials for selinexor include as a potential backbone therapy in combination with approved myeloma therapies (STOMP), in liposarcoma (SEAL) and in endometrial cancer (SIENDO), among others. Additional Phase 1, Phase 2 and Phase 3 studies are ongoing or currently planned, including multiple studies in combination with approved therapies in a variety of tumor types to further inform Karyopharm's clinical development priorities for selinexor. Additional clinical trial information for selinexor is available atwww.clinicaltrials.gov. In China, Antengene is conducting registration clinical trials in relapsed refractory multiple myeloma (MARCH) and in diffuse large B-cell lymphoma (SEARCH), and has initiated the clinical trial for the treatment of peripheral T-cells lymphoma and NK / T-cell lymphoma (TOUCH). About Eltanexor Eltanexor (ATG-016) is a second generation oral SINE compound. Eltanexor functions by binding to and inhibiting the nuclear export protein XPO1 (also called CRM1), leading to the accumulation of tumor suppressor proteins in the cell nucleus. Eltanexor has demonstrated minimal brain penetration in animals, which has been associated with reduced toxicities in preclinical studies while maintaining potent anti-tumor effects. A Phase 1/2 clinical study is currently ongoing evaluating eltanexor in myelodysplastic syndrome, colorectal cancer and castrate-resistant prostate cancer. About Verdinexor Verdinexor (ATG-527) is a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound being investigated across a variety of non-oncology indications in humans with an initial focus as a potential broad-spectrum treatment for viral diseases. Verdinexor functions by binding to and inhibiting the nuclear export protein XPO1 (also called CRM1), which is believed to be responsible for the movement of critical host cell and pathogen encoded cargoes across the nuclear membrane into the cytoplasm. Inhibition of this process with verdinexor results in accumulation of these cargoes in the nucleus, where they promote an anti-inflammatory state and prevent key steps in pathogen replication from occurring. Prior preclinical research showed efficacy of verdinexor in several viral models, including HIV and promising pre-clinical data has also been observed in multiple additional non-oncology indications. In a previously conducted randomized, double-blind, placebo-controlled, dose-escalating Phase 1 clinical trial in healthy human volunteers, verdinexor was found to be generally safe and well tolerated, with adverse events occurring in similar number and grade as placebo. About KPT-9274 KPT-9274 (ATG-019) is a first-in-class, orally bioavailable, small molecule immunometabolic modulator that works through non-competitive dual inhibition of p21-activated kinase 4 (PAK4) and nicotinamide phosphoribosyltransferase (NAMPT). NAMPT and NAPRT (Nicotinate Phosphoribosyltransferas) are the two main pathways for production of the NAD (nicotinamide dinucleotide). About 15-30% of all solid tumors are deficient in NAPRT, making them reliant on NAMPT for NAD production. Co-inhibition of PAK4 and NAMPT is believed to lead to synergistic anti-tumor effects through suppression of -catenin by blocking PAK4, leading to both immune cell activation and inhibition of tumor growth, blockade of DNA repair, cell cycle arrest, and energy depletion through NAMPT inhibition, and ultimately apoptosis. KPT-9274 may therefore have both immune-activating and direct antitumor effects. Tumors deficient in NAPRT may be particularly susceptible to KPT-9274's actions. In contrast, normal cells are less sensitive to inhibition by KPT-9274 due in part to their relative genomic stability and lower metabolic demands. KPT-9274 is currently being evaluated in a Phase 1 clinical study in advanced solid tumors and non-Hodgkin's lymphoma. About Antengene Antengene is a biopharmaceutical company with integrated drug discovery, clinical development, manufacturing and commercialization anchored in Asia Pacific region with global layout, aiming to provide the most advanced and first-in-class anti-cancer drugs and other treatments for patients in China, the rest of Asia and around the world. In April 2017, Celgene (now officially acquired by Bristol-Myers Squibb, and become the world's top ten pharmaceutical company after the merge), a global leading innovative biopharmaceutical company became a long-term strategic partner and obtained an equity position as an investor in Antengene. Over the past 3 years, Antengene has obtained 7 IND approvals with 6 first-in-class drugs in more than 10 ongoing cross-regional clinical trials in Asia Pacific regions, and has built a product pipeline of 12 clinical and pre-clinical stage programs. The vision of Antengene, "Treating Patients Beyond Borders", is to meet the unmet medical needs of patients in Asia Pacific regions and around the world through research & development and commercialization of first-in-class drugs. ATG-010 (selinexor) is the first oral selective inhibitor of nuclear export compound with novel mechanisms in the world. In July 2019, the U.S. FDA approved selinexor in combination with low-dose dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma. Currently, the registrational clinical trials of ATG-010 in relapsed refractory multiple myeloma (RRMM) and diffuse large B-cell lymphoma (DLBCL) is ongoing in China. The compound is also in late clinical development for various other hematologic malignancies and solid tumors. In addition, preclinical studies have shown that inhibitors of nuclear protein export can effectively treat KRAS mutant tumor, and related clinical studies is currently being conducted; ATG-008 is a second-generation dual mTORC1/2 inhibitor and is in a multi-regional clinical trial for treatment of advanced liver cancer, lung cancer, and several other tumors; ATG-016 is a second-generation oral selective inhibitor of nuclear export protein, and is currently being studied in myelodysplastic syndrome (MDS) as well as in several clinical trials of solid tumors, including colorectal cancer (CRC) and prostate cancer (PrC) ; ATG-019 is the first-in-class PAK4/NAMPT dual-target inhibitors, and is currently been studied in a number of clinical trials including non-Hodgkin's lymphoma (NHL), colorectal cancer, lung cancer, and melanoma. In addition, preclinical studies have demonstrated that ATG-019 in combination with anti-PD-1 antibodies can effectively improve the anti-tumor activity and is effective in patients who acquire resistance to anti-PD-1 therapy. Related clinical trial is about to initiate; ATG-527 is an innovative product under development for antiviral and treatment of autoimmune diseases, and has been in clinical trials conducted in Epstein-Barr virus (EBV), respiratory syncytial virus (RSV) infection, cytomegalovirus (CMV) infection and Systemic lupus erythematosus (SLE) and other related diseases; ATG-017 is a potent and selective small molecule extracellular signalregulated kinases 1 and 2 (ERK1/2) inhibitor, in clinical development for the treatment of various solid tumors, non-Hodgkin's lymphoma, acute myelocytic leukemia (AML) and multiple myeloma. In addition, the drug discovery team of Antengene focuses on the early preclinical development of multiple innovative target drugs in the fields of small molecule, monoclonal and bi-specific antibodies.For more information, please visit www.antengene.com. About Karyopharm Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm's lead compound, XPOVIO(selinexor), received accelerated approval from the U.S. Food and Drug Administration (FDA) in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency. A supplemental New Drug Application was accepted by the FDA seeking accelerated approval for selinexor as a new treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development. For more information, please visit www.karyopharm.com. SOURCE Antengene Corporation Related Links http://www.antengene.com Answer:

Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets

SHANGHAI, May 5, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced a broadened partnership and territory expansion agreement with Karyopharm Therapeutics Inc. (NASDAQ: KPTI) (Karyopharm) for development and commercialization of four oral novel drugs and drug candidates to support its mission of treating patients beyond borders. This agreement broadens Antengene's rights in the Asia Pacific region for XPOVIO (selinexor, aka ATG-010), the first-in-class selective inhibitor of nuclear export (SINE); eltanexor (ATG-016), a second-generation SINE compound; verdinexor (ATG-527), a lead compound in development for anti-viral and other non-oncology indications; and KPT-9274 (ATG-019), a dual inhibitor of PAK4 and NAMPT. In May 2018, Antengene and Karyopharm entered into a strategic collaboration for the development, manufacturing and commercialization of XPOVIO and eltanexor for all human oncology indications in mainland China and Macau; and KPT-9274 in all human oncology indications and verdinexor in human non-oncology indications in mainland China, Macau, Taiwan, Hong Kong, South Korea, and the ASEAN markets. As part of the expanded territory, Antengene has received extended rights to develop, manufacture and commercialize XPOVIO and eltanexor in Australia, New Zealand, South Korea, Taiwan, Hong Kong, and the entire ASEAN markets; KPT-9274 and verdinexor rights have also been extended to Australia and New Zealand. This expanded collaboration broadens Antengene's portfolio and geographic footprint to additional Asian markets. In July 2019, the U.S. FDA approved XPOVIOin combination with low-dose dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma (RRMM). The data from the recently released phase 3 BOSTON trial comparing SVd to Vd in 2nd and later lines in RRMM patients, has been selected as a late-breaking abstract for oral presentation at the upcoming virtual ASCO conference later this month. Antengene is presently expanding its commercial operations to support the launch of XPOVIOin mainland China and other APAC markets; and conducting clinical trials with XPOVIOin RRMM, diffuse large B-cell lymphoma (DLBCL) and T-cell lymphomas in China. Antengene has also announced the ongoing recruitment of patients with advanced solid tumor and non-Hodgkin's lymphoma in a clinical trial with ATG-019 (KPT-9274). In addition,clinical trials of ATG-016(eltanexor) and ATG-527 (verdinexor) will be initiated in these markets in 2020. "Upon the achievement of significant regulatory and clinical milestones inmainland China and other markets in Asia, Antengene is now expanding to additional Asia Pacific markets with clinical development and commercialization. We are pleased to have expanded our collaboration and partnership with Karyopharm in developing these novel drugs for patients in Asia Pacific," said Jay Mei, MD, PhD, Chairman and Chief Executive Officer of Antengene. "This critical geographic expansion is a step in our development and commercialization strategy, and we are building aworld-classcommercial team whilecontinuing to add clinical andcommercial-stage first-in-class novel drugs to address unmet medical needs and to further expand our strong pipeline. This is a further testament to our mission of treating patients beyond borders." "We are delighted to have the opportunity to expand our very productive, efficient and results-driven collaboration with Antengene which began two years ago," said Michael G. Kauffman, MD, PhD, Chief Executive Officer of Karyopharm. "The exemplary partnership between the two companies enables Karyopharm to fulfill its mission to develop and deliver novel drug candidates to patients around the world." About XPOVIO (selinexor) XPOVIO is a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound. XPOVIO functions by selectively binding to and inhibiting the nuclear export protein exportin 1 (XPO1, also called CRM1). XPOVIO blocks the nuclear export of tumor suppressor, growth regulatory and anti-inflammatory proteins, leading to accumulation of these proteins in the nucleus and enhancing their anti-cancer activity in the cell. The forced nuclear retention of these proteins can counteract a multitude of the oncogenic pathways that, unchecked, allow cancer cells with severe DNA damage to continue to grow and divide in an unrestrained fashion. Karyopharm received acceleratedU.S. Food and Drug Administration(FDA) approval of XPOVIO inJuly 2019in combination with dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody. Karyopharm has also submitted a Marketing Authorization Application (MAA) to theEuropean Medicines Agency(EMA) with a request for conditional approval of selinexor.A supplemental New Drug Application was accepted by the FDA seeking accelerated approval for selinexor as a new treatment for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), and selinexor has received Fast Track and Orphan designation and Priority Review from the FDA with a scheduled PDUFA date ofJune 23, 2020for this patient population. Selinexor is also being evaluated in several other mid-and later-phase clinical trials across multiple cancer indications, including in multiple myeloma in a pivotal, randomized Phase 3 study in combination with Velcade (bortezomib) and low-dose dexamethasone (BOSTON), for which Karyopharm announced positive top-line results inMarch 2020.Additional, ongoing trials for selinexor include as a potential backbone therapy in combination with approved myeloma therapies (STOMP), in liposarcoma (SEAL) and in endometrial cancer (SIENDO), among others. Additional Phase 1, Phase 2 and Phase 3 studies are ongoing or currently planned, including multiple studies in combination with approved therapies in a variety of tumor types to further inform Karyopharm's clinical development priorities for selinexor. Additional clinical trial information for selinexor is available atwww.clinicaltrials.gov. In China, Antengene is conducting registration clinical trials in relapsed refractory multiple myeloma (MARCH) and in diffuse large B-cell lymphoma (SEARCH), and has initiated the clinical trial for the treatment of peripheral T-cells lymphoma and NK / T-cell lymphoma (TOUCH). About Eltanexor Eltanexor (ATG-016) is a second generation oral SINE compound. Eltanexor functions by binding to and inhibiting the nuclear export protein XPO1 (also called CRM1), leading to the accumulation of tumor suppressor proteins in the cell nucleus. Eltanexor has demonstrated minimal brain penetration in animals, which has been associated with reduced toxicities in preclinical studies while maintaining potent anti-tumor effects. A Phase 1/2 clinical study is currently ongoing evaluating eltanexor in myelodysplastic syndrome, colorectal cancer and castrate-resistant prostate cancer. About Verdinexor Verdinexor (ATG-527) is a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound being investigated across a variety of non-oncology indications in humans with an initial focus as a potential broad-spectrum treatment for viral diseases. Verdinexor functions by binding to and inhibiting the nuclear export protein XPO1 (also called CRM1), which is believed to be responsible for the movement of critical host cell and pathogen encoded cargoes across the nuclear membrane into the cytoplasm. Inhibition of this process with verdinexor results in accumulation of these cargoes in the nucleus, where they promote an anti-inflammatory state and prevent key steps in pathogen replication from occurring. Prior preclinical research showed efficacy of verdinexor in several viral models, including HIV and promising pre-clinical data has also been observed in multiple additional non-oncology indications. In a previously conducted randomized, double-blind, placebo-controlled, dose-escalating Phase 1 clinical trial in healthy human volunteers, verdinexor was found to be generally safe and well tolerated, with adverse events occurring in similar number and grade as placebo. About KPT-9274 KPT-9274 (ATG-019) is a first-in-class, orally bioavailable, small molecule immunometabolic modulator that works through non-competitive dual inhibition of p21-activated kinase 4 (PAK4) and nicotinamide phosphoribosyltransferase (NAMPT). NAMPT and NAPRT (Nicotinate Phosphoribosyltransferas) are the two main pathways for production of the NAD (nicotinamide dinucleotide). About 15-30% of all solid tumors are deficient in NAPRT, making them reliant on NAMPT for NAD production. Co-inhibition of PAK4 and NAMPT is believed to lead to synergistic anti-tumor effects through suppression of -catenin by blocking PAK4, leading to both immune cell activation and inhibition of tumor growth, blockade of DNA repair, cell cycle arrest, and energy depletion through NAMPT inhibition, and ultimately apoptosis. KPT-9274 may therefore have both immune-activating and direct antitumor effects. Tumors deficient in NAPRT may be particularly susceptible to KPT-9274's actions. In contrast, normal cells are less sensitive to inhibition by KPT-9274 due in part to their relative genomic stability and lower metabolic demands. KPT-9274 is currently being evaluated in a Phase 1 clinical study in advanced solid tumors and non-Hodgkin's lymphoma. About Antengene Antengene is a biopharmaceutical company with integrated drug discovery, clinical development, manufacturing and commercialization anchored in Asia Pacific region with global layout, aiming to provide the most advanced and first-in-class anti-cancer drugs and other treatments for patients in China, the rest of Asia and around the world. In April 2017, Celgene (now officially acquired by Bristol-Myers Squibb, and become the world's top ten pharmaceutical company after the merge), a global leading innovative biopharmaceutical company became a long-term strategic partner and obtained an equity position as an investor in Antengene. Over the past 3 years, Antengene has obtained 7 IND approvals with 6 first-in-class drugs in more than 10 ongoing cross-regional clinical trials in Asia Pacific regions, and has built a product pipeline of 12 clinical and pre-clinical stage programs. The vision of Antengene, "Treating Patients Beyond Borders", is to meet the unmet medical needs of patients in Asia Pacific regions and around the world through research & development and commercialization of first-in-class drugs. ATG-010 (selinexor) is the first oral selective inhibitor of nuclear export compound with novel mechanisms in the world. In July 2019, the U.S. FDA approved selinexor in combination with low-dose dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma. Currently, the registrational clinical trials of ATG-010 in relapsed refractory multiple myeloma (RRMM) and diffuse large B-cell lymphoma (DLBCL) is ongoing in China. The compound is also in late clinical development for various other hematologic malignancies and solid tumors. In addition, preclinical studies have shown that inhibitors of nuclear protein export can effectively treat KRAS mutant tumor, and related clinical studies is currently being conducted; ATG-008 is a second-generation dual mTORC1/2 inhibitor and is in a multi-regional clinical trial for treatment of advanced liver cancer, lung cancer, and several other tumors; ATG-016 is a second-generation oral selective inhibitor of nuclear export protein, and is currently being studied in myelodysplastic syndrome (MDS) as well as in several clinical trials of solid tumors, including colorectal cancer (CRC) and prostate cancer (PrC) ; ATG-019 is the first-in-class PAK4/NAMPT dual-target inhibitors, and is currently been studied in a number of clinical trials including non-Hodgkin's lymphoma (NHL), colorectal cancer, lung cancer, and melanoma. In addition, preclinical studies have demonstrated that ATG-019 in combination with anti-PD-1 antibodies can effectively improve the anti-tumor activity and is effective in patients who acquire resistance to anti-PD-1 therapy. Related clinical trial is about to initiate; ATG-527 is an innovative product under development for antiviral and treatment of autoimmune diseases, and has been in clinical trials conducted in Epstein-Barr virus (EBV), respiratory syncytial virus (RSV) infection, cytomegalovirus (CMV) infection and Systemic lupus erythematosus (SLE) and other related diseases; ATG-017 is a potent and selective small molecule extracellular signalregulated kinases 1 and 2 (ERK1/2) inhibitor, in clinical development for the treatment of various solid tumors, non-Hodgkin's lymphoma, acute myelocytic leukemia (AML) and multiple myeloma. In addition, the drug discovery team of Antengene focuses on the early preclinical development of multiple innovative target drugs in the fields of small molecule, monoclonal and bi-specific antibodies.For more information, please visit www.antengene.com. About Karyopharm Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm's lead compound, XPOVIO(selinexor), received accelerated approval from the U.S. Food and Drug Administration (FDA) in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency. A supplemental New Drug Application was accepted by the FDA seeking accelerated approval for selinexor as a new treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development. For more information, please visit www.karyopharm.com. SOURCE Antengene Corporation Related Links http://www.antengene.com

edtsum233

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, April 27, 2021 /PRNewswire/ -- Braze, the comprehensive customer engagement platform, today announced new product features and a new integration that help brands navigate the "next normal" in customer engagement. Over the past year, brands have had to adapt rapidly and frequently due to constantly changing conditions. With the world evolving to a new post pandemic business landscape, Braze's new offerings include a Shopify integration, updates to Braze Predictive Suite and Report Builder, and a new lineup of easy, flexible tools that empower companies to build campaigns with greater speed and accuracy. "While consumer spending is predicted to recover, preferences and behaviors have evolved and form the foundation of the 'next normal,'" said Kevin Wang, Senior Vice President of Product at Braze. "Consumers will expect companies to be able to adjust quickly to these shifting behaviors, and the introduction of these new features, enhancements, and integrations will enable brands to evolve their customer engagement programs to meet expectations." Power Personalized Ecommerce Campaigns with Shopify Ecommerce companies have seen rapid customer growth in the past year, along with shifting consumer expectations and behaviors. With Braze's new Shopify integration, brands will be able to increase sales and bolster retention through data-enriched communications. The integration, which is expected in summer 2021, will enable marketers to use real-time Shopify data to drive their Braze segmentation, cross-channel commerce experiences, and message personalization. Make Better Decisions with Advanced Insights Braze has expanded its breadth of offerings that help brands measure campaign performance and leverage behavioral insights to power more personalized campaigns. Predictive Purchases is the Braze platform's latest addition to its machine learning-powered Predictive Suite. The tool increases conversions and drives revenue by uncovering insights on who is and isn't likely to make a future purchase. "Knowing which users are likely to make future purchases based on behavioral indicators has historically been challenging for brands," said Marlie Vermeeren, CRM Manager at 8fit. "We have been piloting Predictive Purchases, and our first round of testing has shown we can create data-driven strategies to motivate unlikely purchases and nudge likely purchasers over the finish line. So far with Braze we've seen an uplift of 2.8X. We're eager to continue our close partnership with Braze to shape the future of customer engagement." Using the new Canvas data feature, brands can build customized reports to understand and compare customer journey performance directly within Report Builder. Brands can now better understand how different journeys moved the needle on key metrics at a high-level and also broken down by individual variant and message. Execute with Easy, Flexible Tools Braze continues to focus on platform experience by providing easy and flexible tools with the addition of two new components for Braze Canvas, the customer journey tool. Audience Pathsgives brands more clarity and control over the customer journey by funneling users down different paths based on audience criteria, so that every user moves to the most relevant next step. Audience Syncto Google helps brands reach consumers across more channelssearch, YouTube, Gmail, and Google Display Networkby dynamically syncing first-party user data from Braze directly to Google for retargeting and lookalike modeling. Additionally, a new Drag-and-Drop Email Editor helps marketers design emails more quickly and efficiently without HTML. Brands will be able to drag and drop content in a visual editor and integrate directly with features such as Content Blocks that allow teams to collaborate and design emails together. For more information about today's announcement, please visit our blog: About Braze Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in Forrester's 2020 Mobile Engagement Automation Wave report and was recognized as one of Inc. Magazine's Best Workplaces two years in a row. Braze is headquartered in New York with offices in Chicago, London, San Francisco, Singapore, and Tokyo. Learn more at braze.com. Contact:Quincy ZhaiSenior Communications Manager[emailprotected] SOURCE Braze Related Links https://www.braze.com/ Answer:

Braze Announces Shopify Integration to Help Brands Navigate Customer Engagement in 'Next Normal' Customer Engagement Platform Reveals Updates to its Predictive Suite, Enhanced Performance Measurement Solutions, and Flexible Customer Journey Tools

NEW YORK, April 27, 2021 /PRNewswire/ -- Braze, the comprehensive customer engagement platform, today announced new product features and a new integration that help brands navigate the "next normal" in customer engagement. Over the past year, brands have had to adapt rapidly and frequently due to constantly changing conditions. With the world evolving to a new post pandemic business landscape, Braze's new offerings include a Shopify integration, updates to Braze Predictive Suite and Report Builder, and a new lineup of easy, flexible tools that empower companies to build campaigns with greater speed and accuracy. "While consumer spending is predicted to recover, preferences and behaviors have evolved and form the foundation of the 'next normal,'" said Kevin Wang, Senior Vice President of Product at Braze. "Consumers will expect companies to be able to adjust quickly to these shifting behaviors, and the introduction of these new features, enhancements, and integrations will enable brands to evolve their customer engagement programs to meet expectations." Power Personalized Ecommerce Campaigns with Shopify Ecommerce companies have seen rapid customer growth in the past year, along with shifting consumer expectations and behaviors. With Braze's new Shopify integration, brands will be able to increase sales and bolster retention through data-enriched communications. The integration, which is expected in summer 2021, will enable marketers to use real-time Shopify data to drive their Braze segmentation, cross-channel commerce experiences, and message personalization. Make Better Decisions with Advanced Insights Braze has expanded its breadth of offerings that help brands measure campaign performance and leverage behavioral insights to power more personalized campaigns. Predictive Purchases is the Braze platform's latest addition to its machine learning-powered Predictive Suite. The tool increases conversions and drives revenue by uncovering insights on who is and isn't likely to make a future purchase. "Knowing which users are likely to make future purchases based on behavioral indicators has historically been challenging for brands," said Marlie Vermeeren, CRM Manager at 8fit. "We have been piloting Predictive Purchases, and our first round of testing has shown we can create data-driven strategies to motivate unlikely purchases and nudge likely purchasers over the finish line. So far with Braze we've seen an uplift of 2.8X. We're eager to continue our close partnership with Braze to shape the future of customer engagement." Using the new Canvas data feature, brands can build customized reports to understand and compare customer journey performance directly within Report Builder. Brands can now better understand how different journeys moved the needle on key metrics at a high-level and also broken down by individual variant and message. Execute with Easy, Flexible Tools Braze continues to focus on platform experience by providing easy and flexible tools with the addition of two new components for Braze Canvas, the customer journey tool. Audience Pathsgives brands more clarity and control over the customer journey by funneling users down different paths based on audience criteria, so that every user moves to the most relevant next step. Audience Syncto Google helps brands reach consumers across more channelssearch, YouTube, Gmail, and Google Display Networkby dynamically syncing first-party user data from Braze directly to Google for retargeting and lookalike modeling. Additionally, a new Drag-and-Drop Email Editor helps marketers design emails more quickly and efficiently without HTML. Brands will be able to drag and drop content in a visual editor and integrate directly with features such as Content Blocks that allow teams to collaborate and design emails together. For more information about today's announcement, please visit our blog: About Braze Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in Forrester's 2020 Mobile Engagement Automation Wave report and was recognized as one of Inc. Magazine's Best Workplaces two years in a row. Braze is headquartered in New York with offices in Chicago, London, San Francisco, Singapore, and Tokyo. Learn more at braze.com. Contact:Quincy ZhaiSenior Communications Manager[emailprotected] SOURCE Braze Related Links https://www.braze.com/

edtsum234

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, July 22, 2020 /PRNewswire/ -- The "Digital Twin Market Research Report: By Type, Technology, Enterprise, Application, Industry - Global Industry Size, Share, Trends, Growth Analysis and Forecast Report to 2030" report has been added to ResearchAndMarkets.com's offering. By 2025, the number of internet of things (IoT) devices in operation will surge beyond 41 billion. The technology is rapidly finding its way into the industrial sector, with the new concept being termed industrial internet of things (IIoT). To analyze the huge volumes of unstructured data generated by these connected devices and share it among the different manufacturers of these devices, digital clone technology is being adopted.Additionally, this technology helps in the enhancement of the entire production ecosystem, by monitoring the performance of every device. Hence, with the increasing adoption of IIoT, the global digital twin market share is expected to witness a 31.9% CAGR between 2020 and 2030 (forecast period). At this rate, the revenue generated in the industry would rise from $3,645.1 million in 2019 to $73,245.4 million by 2030.Predictive Maintenance to Be the Fastest Growing ApplicationDuring the forecast period, predictive maintenance is expected to witness the highest CAGR, of 33.7%, in the digital twin market, as organizations are utilizing this technology to automate operations, gather real-time information, schedule maintenance, and forecast downtime. Further, cloning a product digitally helps users in making their operations more efficient.The product category dominated the digital twin market in 2019, owing to the rapid integrating of digital clones to track the performance of every individual component of a product, in order to bring down the mean time to repair (MTTR) and mean time between failure (MTBF). All this ultimately decreases the operating costs and increases the operational efficiency.The IoT division will generate the highest revenue in the market till 2030, as the number of IoT devices is rising, and companies are rapidly shifting toward using sensors in product development.In 2019, large enterprises were the largest digital twin market category. This is ascribed to the quick penetration of Industry 4.0 in large enterprises, as these updated standards lead to better flexibility and agility, improved productivity, and increased profitability. With digital transformation, large companies are using digital twins for predicting faults at an early stage, developing better products, and scheduling timely maintenance.The automotive division is expected to experience the fastest growth in the digital twin market during the forecast period. The automotive industry quickly is embracing Industry 4.0 standards, which is why it is increasingly using data in the manufacturing process. By using digital twins, challenges in vehicle manufacturing, design, services, and sales can be effectively addressed, which is why automakers are swiftly incorporating this technology into their operations.Asia-Pacific (APAC) would grow at the highest pace in the digital twin market till 2030. This is attributed to the surging investments in the IT sector, economic prosperity, increasing number of government initiatives promoting the deployment of artificial intelligence (AI) and IoT, and technological advancements.In the last few years, the major companies in the digital twin market have engaged in a number of partnerships, to: Create more effective solutions by combining their capabilities Enhance their portfolio of digital clone software Target a wider customer base with better offerings Intensify research and development (R&D) in the field Explore the growth areas in the market Key Topics Covered Chapter 1. Research BackgroundChapter 2. Research MethodologyChapter 3. Executive SummaryChapter 4. Introduction4.1 Definition of Market Segments4.1.1 By Type4.1.1.1 Product4.1.1.2 System4.1.1.3 Process4.1.2 By Technology4.1.2.1 IoT4.1.2.2 AI & ML4.1.2.3 Blockchain4.1.2.4 Big Data Analytics4.1.2.5 Others4.1.3 By Enterprise4.1.3.1 Large Enterprises4.1.3.2 SMEs4.1.4 By Application4.1.4.1 Product Design & Development4.1.4.2 Performance Monitoring4.1.4.3 Predictive Maintenance4.1.4.4 Inventory Management4.1.4.5 Business Optimization4.1.4.6 Others4.1.5 By Industry4.1.5.1 Manufacturing4.1.5.2 Automotive4.1.5.3 Aerospace & Defense4.1.5.4 Energy & Utilities4.1.5.5 Oil & Gas4.1.5.6 Healthcare4.1.5.7 Others4.2 Value Chain Analysis4.3 Market Dynamics4.3.1 Trends4.3.1.1 Common Platform for Multiple Digital Twins4.3.2 Drivers4.3.2.1 Widespread Adoption of IoT4.3.2.2 Growing Focus on Intelligent Maintenance4.3.2.3 Impact Analysis of Drivers on Market Forecast4.3.3 Restraints4.3.3.1 Concerns Over Data Security4.3.3.2 Impact Analysis of Restraints on Market Forecast4.3.4 Opportunities4.3.4.1 Logistics & Transportation Sector to Leverage the Technology4.3.4.2 Convergence of Information Technology (IT) and Operational Technology (OT)4.4 Porter's Five Forces AnalysisChapter 5. Global Market Size and Forecast5.1 By Type5.2 By Technology5.3 By Enterprise5.4 By Application5.5 By Industry5.6 By RegionChapter 6. North America Market Size and ForecastChapter 7. Europe Market Size and ForecastChapter 8. APAC Market Size and ForecastChapter 9. MEA Market Size and ForecastChapter 10. LATAM Market Size and ForecastChapter 11. Competitive Landscape11.1 Market Share Analysis of Key Players11.2 List of Players and Their Offerings11.3 Strategic Developments of Players11.3.1 Mergers & Acquisitions11.3.2 Partnerships11.3.3 Product LaunchesChapter 12. Company Profiles12.1 IBM Corporation12.1.1 Business Overview12.1.2 Product & Service Offerings12.1.3 Key Financial Summary12.2 Microsoft Corporation12.3 PTC Inc.12.4 SAS Institute Inc.12.5 Oracle Corporation12.6 Siemens AG12.7 Dassault Systemes12.8 Robert Bosch GmbH12.9 Ansys Inc.12.10 Swim.AI Inc.12.11 TIBCO Software Inc.12.12 ABB Ltd.12.13 Bentley Systems IncorporatedFor more information about this report visit https://www.researchandmarkets.com/r/csa3o1 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

Global Digital Twin Market Outlook, 2030 - Widespread Adoption of IoT and Growing Focus on Intelligent Maintenance are Key Drivers

DUBLIN, July 22, 2020 /PRNewswire/ -- The "Digital Twin Market Research Report: By Type, Technology, Enterprise, Application, Industry - Global Industry Size, Share, Trends, Growth Analysis and Forecast Report to 2030" report has been added to ResearchAndMarkets.com's offering. By 2025, the number of internet of things (IoT) devices in operation will surge beyond 41 billion. The technology is rapidly finding its way into the industrial sector, with the new concept being termed industrial internet of things (IIoT). To analyze the huge volumes of unstructured data generated by these connected devices and share it among the different manufacturers of these devices, digital clone technology is being adopted.Additionally, this technology helps in the enhancement of the entire production ecosystem, by monitoring the performance of every device. Hence, with the increasing adoption of IIoT, the global digital twin market share is expected to witness a 31.9% CAGR between 2020 and 2030 (forecast period). At this rate, the revenue generated in the industry would rise from $3,645.1 million in 2019 to $73,245.4 million by 2030.Predictive Maintenance to Be the Fastest Growing ApplicationDuring the forecast period, predictive maintenance is expected to witness the highest CAGR, of 33.7%, in the digital twin market, as organizations are utilizing this technology to automate operations, gather real-time information, schedule maintenance, and forecast downtime. Further, cloning a product digitally helps users in making their operations more efficient.The product category dominated the digital twin market in 2019, owing to the rapid integrating of digital clones to track the performance of every individual component of a product, in order to bring down the mean time to repair (MTTR) and mean time between failure (MTBF). All this ultimately decreases the operating costs and increases the operational efficiency.The IoT division will generate the highest revenue in the market till 2030, as the number of IoT devices is rising, and companies are rapidly shifting toward using sensors in product development.In 2019, large enterprises were the largest digital twin market category. This is ascribed to the quick penetration of Industry 4.0 in large enterprises, as these updated standards lead to better flexibility and agility, improved productivity, and increased profitability. With digital transformation, large companies are using digital twins for predicting faults at an early stage, developing better products, and scheduling timely maintenance.The automotive division is expected to experience the fastest growth in the digital twin market during the forecast period. The automotive industry quickly is embracing Industry 4.0 standards, which is why it is increasingly using data in the manufacturing process. By using digital twins, challenges in vehicle manufacturing, design, services, and sales can be effectively addressed, which is why automakers are swiftly incorporating this technology into their operations.Asia-Pacific (APAC) would grow at the highest pace in the digital twin market till 2030. This is attributed to the surging investments in the IT sector, economic prosperity, increasing number of government initiatives promoting the deployment of artificial intelligence (AI) and IoT, and technological advancements.In the last few years, the major companies in the digital twin market have engaged in a number of partnerships, to: Create more effective solutions by combining their capabilities Enhance their portfolio of digital clone software Target a wider customer base with better offerings Intensify research and development (R&D) in the field Explore the growth areas in the market Key Topics Covered Chapter 1. Research BackgroundChapter 2. Research MethodologyChapter 3. Executive SummaryChapter 4. Introduction4.1 Definition of Market Segments4.1.1 By Type4.1.1.1 Product4.1.1.2 System4.1.1.3 Process4.1.2 By Technology4.1.2.1 IoT4.1.2.2 AI & ML4.1.2.3 Blockchain4.1.2.4 Big Data Analytics4.1.2.5 Others4.1.3 By Enterprise4.1.3.1 Large Enterprises4.1.3.2 SMEs4.1.4 By Application4.1.4.1 Product Design & Development4.1.4.2 Performance Monitoring4.1.4.3 Predictive Maintenance4.1.4.4 Inventory Management4.1.4.5 Business Optimization4.1.4.6 Others4.1.5 By Industry4.1.5.1 Manufacturing4.1.5.2 Automotive4.1.5.3 Aerospace & Defense4.1.5.4 Energy & Utilities4.1.5.5 Oil & Gas4.1.5.6 Healthcare4.1.5.7 Others4.2 Value Chain Analysis4.3 Market Dynamics4.3.1 Trends4.3.1.1 Common Platform for Multiple Digital Twins4.3.2 Drivers4.3.2.1 Widespread Adoption of IoT4.3.2.2 Growing Focus on Intelligent Maintenance4.3.2.3 Impact Analysis of Drivers on Market Forecast4.3.3 Restraints4.3.3.1 Concerns Over Data Security4.3.3.2 Impact Analysis of Restraints on Market Forecast4.3.4 Opportunities4.3.4.1 Logistics & Transportation Sector to Leverage the Technology4.3.4.2 Convergence of Information Technology (IT) and Operational Technology (OT)4.4 Porter's Five Forces AnalysisChapter 5. Global Market Size and Forecast5.1 By Type5.2 By Technology5.3 By Enterprise5.4 By Application5.5 By Industry5.6 By RegionChapter 6. North America Market Size and ForecastChapter 7. Europe Market Size and ForecastChapter 8. APAC Market Size and ForecastChapter 9. MEA Market Size and ForecastChapter 10. LATAM Market Size and ForecastChapter 11. Competitive Landscape11.1 Market Share Analysis of Key Players11.2 List of Players and Their Offerings11.3 Strategic Developments of Players11.3.1 Mergers & Acquisitions11.3.2 Partnerships11.3.3 Product LaunchesChapter 12. Company Profiles12.1 IBM Corporation12.1.1 Business Overview12.1.2 Product & Service Offerings12.1.3 Key Financial Summary12.2 Microsoft Corporation12.3 PTC Inc.12.4 SAS Institute Inc.12.5 Oracle Corporation12.6 Siemens AG12.7 Dassault Systemes12.8 Robert Bosch GmbH12.9 Ansys Inc.12.10 Swim.AI Inc.12.11 TIBCO Software Inc.12.12 ABB Ltd.12.13 Bentley Systems IncorporatedFor more information about this report visit https://www.researchandmarkets.com/r/csa3o1 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum238

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: FORT WORTH, Texas, March 3, 2021 /PRNewswire/ -- Jason Stephens, founder of Stephens Law, a Fort Worth law firm focusing exclusively on serious personal injury and wrongful death claims, received multiple professional recognitions from his peers and the media in 2020. "Despite the tragedies of 2020, our firm has continued charging ahead on behalf of its clients," Jason says. "We're especially proud of the recognitions we received last year during a time that has presented us all with new and unique challenges." Among the many recognitions Jason received in 2020 was his 17th consecutive appearance on the Super Lawyerslist. No more than 5 percent of attorneys in each state are selected to the annual list of the nation's top attorneys. Likewise, he was named to The Best Lawyers in America, one of the most highly regarded lawyer rankings in the country, for the fifth year in a row. Both publications compile their lists based on a combined peer nominations and independent research system; attorneys are not permitted to compensate either organization in exchange for a listing. In recognition of his skill and reputation as a trial attorney, Jason was also selected to The National Trial Lawyers: Top 100, an invitation-only organization composed of the premier trial lawyers from each state or region who meet stringent qualifications as civil plaintiff and/or criminal defense trial lawyers. Local publications also recognized his work in 2020. Fort Worth Magazine has named him a Top Lawyer every year since 2003; he was also named to 360 West's Attorneys Worth Knowing, and recognized as "The Face of Personal Injury Law" by 76107 Magazine. Ongoing honors Jason achieved prior to 2020 include a 10-star ("superb") rating on AVVO and an AV Preeminent rating by Martindale-Hubbell, both the highest level of recognition from each organization. He is also a Lifetime Member of the Multi-Million-Dollar Advocates Forum, which includes fewer than 1 percent of lawyers, and a member of the American Board of Trial Advocates, an invitation-only group of attorneys who meet specific professional requirements. Notable resolutions throughout his career include the 47th largest verdict in the U.S. in 2004 as recognized by the National Law Journal, the 5th largest verdict in Texas in 2004 as acknowledged by Texas Lawyer, and the 8th largest motor vehicle verdict in Texas in 2012 as observed by Texas Lawyer. About Stephens Law Stephens Law focuses exclusively on handlingserious personal injuryandwrongful deathclaims.Jason Stephens, the firm's founder, has over two decades of experience and a proven track record of success in helping individuals and families who have been harmed by the wrongdoing or negligence of others. Jason is one of a fewtop-rated Fort Worth lawyerswho are experienced in handlingcar accident,truck accident,motorcycle accident,distracted driving,andbrain injuries. For more information, visit StephensLaw.com. Media contact: Amy Hunt, Muse Communications 214-801-8116 or [emailprotected] SOURCE Stephens Law Answer:

Fort Worth's Jason Stephens Racks Up Numerous Professional Accolades in 2020

FORT WORTH, Texas, March 3, 2021 /PRNewswire/ -- Jason Stephens, founder of Stephens Law, a Fort Worth law firm focusing exclusively on serious personal injury and wrongful death claims, received multiple professional recognitions from his peers and the media in 2020. "Despite the tragedies of 2020, our firm has continued charging ahead on behalf of its clients," Jason says. "We're especially proud of the recognitions we received last year during a time that has presented us all with new and unique challenges." Among the many recognitions Jason received in 2020 was his 17th consecutive appearance on the Super Lawyerslist. No more than 5 percent of attorneys in each state are selected to the annual list of the nation's top attorneys. Likewise, he was named to The Best Lawyers in America, one of the most highly regarded lawyer rankings in the country, for the fifth year in a row. Both publications compile their lists based on a combined peer nominations and independent research system; attorneys are not permitted to compensate either organization in exchange for a listing. In recognition of his skill and reputation as a trial attorney, Jason was also selected to The National Trial Lawyers: Top 100, an invitation-only organization composed of the premier trial lawyers from each state or region who meet stringent qualifications as civil plaintiff and/or criminal defense trial lawyers. Local publications also recognized his work in 2020. Fort Worth Magazine has named him a Top Lawyer every year since 2003; he was also named to 360 West's Attorneys Worth Knowing, and recognized as "The Face of Personal Injury Law" by 76107 Magazine. Ongoing honors Jason achieved prior to 2020 include a 10-star ("superb") rating on AVVO and an AV Preeminent rating by Martindale-Hubbell, both the highest level of recognition from each organization. He is also a Lifetime Member of the Multi-Million-Dollar Advocates Forum, which includes fewer than 1 percent of lawyers, and a member of the American Board of Trial Advocates, an invitation-only group of attorneys who meet specific professional requirements. Notable resolutions throughout his career include the 47th largest verdict in the U.S. in 2004 as recognized by the National Law Journal, the 5th largest verdict in Texas in 2004 as acknowledged by Texas Lawyer, and the 8th largest motor vehicle verdict in Texas in 2012 as observed by Texas Lawyer. About Stephens Law Stephens Law focuses exclusively on handlingserious personal injuryandwrongful deathclaims.Jason Stephens, the firm's founder, has over two decades of experience and a proven track record of success in helping individuals and families who have been harmed by the wrongdoing or negligence of others. Jason is one of a fewtop-rated Fort Worth lawyerswho are experienced in handlingcar accident,truck accident,motorcycle accident,distracted driving,andbrain injuries. For more information, visit StephensLaw.com. Media contact: Amy Hunt, Muse Communications 214-801-8116 or [emailprotected] SOURCE Stephens Law

edtsum241

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ARLINGTON, Va., Nov. 30, 2020 /PRNewswire/ -- The Mitchell Institute for Aerospace Studies will release the first in a new podcast series titled The Aerospace Advantage on Monday, Nov. 30. Hosted by former Air Force Weapons School instructor and Thunderbird pilot Lt Col (ret.) John "Slick" Baum, the series will delve into all aspects of air and space warfare, emphasizing first-hand accounts from current experts in the field. Baum will guide listeners into the world of aerospace power, sharing insights from renowned experts on what it takes to fly, fight, and win in the sky, as well as how to advance and protect America's interests in space. Whether interviewing top generals, standing on a flight line full of combat aircraft, witnessing a rocket being prepared for launch, or listing to heroes who have laid it all on the line in defense of the nationthis podcast will afford unprecedented access to the combat aerospace community and unparalleled insight into where it is headedand why. Each episode will focus on a key challenge and feature senior leaders, frontline warfighters, technical experts, and experienced policy leaders sharing their behind-the-scenes insights on what it takes to accomplish the mission and how to make that happen. "The first five episodes will provide a foundational understanding of today's Air Force and Space Force and the issues these forces face," said Mitchell Institute Dean Lt Gen (ret) Dave Deptula. "Subsequent episodes delving into specific mission areas and technical zones. As a former combat fighter pilot, 'Slick' Baum is supremely qualified to make complex topics come to life for listeners and introduce them to current warfighterspeople they'd never meet otherwise." The Aerospace Advantagewill focus on making complex strategies, operational concepts, and technologies accessible to the layman and professional, alike. By emphasizing firsthand experiences and perspectives, the story of aerospace power will come to life for listeners at every experience level. "At the end of the day, this all comes down to better understanding what it takes to build and maintain the air and space power America needs to ensure a secure future," said Deptula. Listen to The Aerospace Advantage at: https://mitchellinstituteaerospaceadvantage.podbean.com as well as all major podcast outlets. New episodes will be released every other week. The Air Force Association's Mitchell Institute for Aerospace Studies educates the public about aerospace power's contribution to America's global interests, informs policy and budget deliberations, and cultivates the next generation of thought leaders to exploit the advantages of operating in air, space, and cyberspace. Visit mitchellaerospacepower.org. SOURCE Air Force Association Answer:

Mitchell Institute Launches "Aerospace Advantage" Podcast Insiders' Perspectives on U.S. Air and Space Forces and the Use of Aerospace Power

ARLINGTON, Va., Nov. 30, 2020 /PRNewswire/ -- The Mitchell Institute for Aerospace Studies will release the first in a new podcast series titled The Aerospace Advantage on Monday, Nov. 30. Hosted by former Air Force Weapons School instructor and Thunderbird pilot Lt Col (ret.) John "Slick" Baum, the series will delve into all aspects of air and space warfare, emphasizing first-hand accounts from current experts in the field. Baum will guide listeners into the world of aerospace power, sharing insights from renowned experts on what it takes to fly, fight, and win in the sky, as well as how to advance and protect America's interests in space. Whether interviewing top generals, standing on a flight line full of combat aircraft, witnessing a rocket being prepared for launch, or listing to heroes who have laid it all on the line in defense of the nationthis podcast will afford unprecedented access to the combat aerospace community and unparalleled insight into where it is headedand why. Each episode will focus on a key challenge and feature senior leaders, frontline warfighters, technical experts, and experienced policy leaders sharing their behind-the-scenes insights on what it takes to accomplish the mission and how to make that happen. "The first five episodes will provide a foundational understanding of today's Air Force and Space Force and the issues these forces face," said Mitchell Institute Dean Lt Gen (ret) Dave Deptula. "Subsequent episodes delving into specific mission areas and technical zones. As a former combat fighter pilot, 'Slick' Baum is supremely qualified to make complex topics come to life for listeners and introduce them to current warfighterspeople they'd never meet otherwise." The Aerospace Advantagewill focus on making complex strategies, operational concepts, and technologies accessible to the layman and professional, alike. By emphasizing firsthand experiences and perspectives, the story of aerospace power will come to life for listeners at every experience level. "At the end of the day, this all comes down to better understanding what it takes to build and maintain the air and space power America needs to ensure a secure future," said Deptula. Listen to The Aerospace Advantage at: https://mitchellinstituteaerospaceadvantage.podbean.com as well as all major podcast outlets. New episodes will be released every other week. The Air Force Association's Mitchell Institute for Aerospace Studies educates the public about aerospace power's contribution to America's global interests, informs policy and budget deliberations, and cultivates the next generation of thought leaders to exploit the advantages of operating in air, space, and cyberspace. Visit mitchellaerospacepower.org. SOURCE Air Force Association

edtsum247

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NASHVILLE, Tenn., Nov. 12, 2020 /PRNewswire/ --Leading global tire maker Hankook Tire will equip the 2021 Chevrolet Silverado and GMC Sierra Heavy Duty models with Dynapro MT2 tires. Both the Silverado and Sierra, two of GM's most durable heavy-duty pickup trucks, will be fitted in the size LT275/70R18. Hankook Tire announces it is supplying the 2021 Chevrolet Silverado Heavy Duty models with the award-winning Dynapro MT2 tires, which will provide improved steering function and off-road capability. Hankook expands its partnership with GM to equip the 2021 GMC Sierra Heavy Duty models with the award-winning Dynapro MT2 tires. The Dynapro MT2, Hankook's Red Dot Award-winning new generation mud-terrain tire, is designed with off-road traction and on-road durability in mind. The Dynapro MT2 features an aggressive connected shoulder tread, V-shape shoulder scallops and stone-ejecting technology that provides additional rigidity, traction and protection against punctures. Engineered with 3D simulation software, the Dynapro MT2 comes equipped with an optimized terrain-strike tread design and a high turn-up three ply sidewall that provides added protection against off-road abrasions while also maintaining on-road comfort and functionality. "When designing the Dynapro MT2, we took special care in its steering functionality and driving comfort," said Hyunjun Cho, Head of Hankook Tire OE Division. "As a result, though it is an off-road tire, its on-road performance is quite pleasant." "The Dynapro MT2 is equipped with the most aggressive tread pattern that we have ever offered, making it a great fit for the heavy-duty Silverado and Sierra," said Kijong Kil,Vice President of Central R&D Center. "We developed the Dynapro MT2 with a new split mold technology and 3D simulation software that allows for a more aggressive tread with a seamless sidewall that helps reduce noise and improve durability." Hankook Tire began supplying original equipment tires to General Motors in 2002 and continues to equip multiple vehicles from GM such as the Chevrolet Malibu, Equinox, Spark, Sonic and Trailblazer, as well as the GMC Terrain and Buick Encore. Including the partnership with General Motors, Hankook Tire successfully supplies original equipment tires for 46 automakers.About Hankook Tire America Corp.Hankook Tire America Corp. is a growing leader in the U.S. tire market, leveraging investments in technology, manufacturing and marketing to deliver high-quality, reliable products that are safer for consumers and the environment. Headquartered in Nashville, Tennessee, Hankook America markets and distributes a complete line of high-performance and ultra-high-performance passenger tires, light truck and SUV tires as well as medium truck and bus tires in the United States. Hankook Tire America is a subsidiary of Hankook Tire Co., Ltd., a Forbes Global 2000 company headquartered in Seoul, Korea. SOURCE Hankook Tire America Corp. Answer:

Hankook Tire to Supply 2021 Chevy Silverado and GMC Sierra Heavy Duty Models with Dynapro MT2 Tires

NASHVILLE, Tenn., Nov. 12, 2020 /PRNewswire/ --Leading global tire maker Hankook Tire will equip the 2021 Chevrolet Silverado and GMC Sierra Heavy Duty models with Dynapro MT2 tires. Both the Silverado and Sierra, two of GM's most durable heavy-duty pickup trucks, will be fitted in the size LT275/70R18. Hankook Tire announces it is supplying the 2021 Chevrolet Silverado Heavy Duty models with the award-winning Dynapro MT2 tires, which will provide improved steering function and off-road capability. Hankook expands its partnership with GM to equip the 2021 GMC Sierra Heavy Duty models with the award-winning Dynapro MT2 tires. The Dynapro MT2, Hankook's Red Dot Award-winning new generation mud-terrain tire, is designed with off-road traction and on-road durability in mind. The Dynapro MT2 features an aggressive connected shoulder tread, V-shape shoulder scallops and stone-ejecting technology that provides additional rigidity, traction and protection against punctures. Engineered with 3D simulation software, the Dynapro MT2 comes equipped with an optimized terrain-strike tread design and a high turn-up three ply sidewall that provides added protection against off-road abrasions while also maintaining on-road comfort and functionality. "When designing the Dynapro MT2, we took special care in its steering functionality and driving comfort," said Hyunjun Cho, Head of Hankook Tire OE Division. "As a result, though it is an off-road tire, its on-road performance is quite pleasant." "The Dynapro MT2 is equipped with the most aggressive tread pattern that we have ever offered, making it a great fit for the heavy-duty Silverado and Sierra," said Kijong Kil,Vice President of Central R&D Center. "We developed the Dynapro MT2 with a new split mold technology and 3D simulation software that allows for a more aggressive tread with a seamless sidewall that helps reduce noise and improve durability." Hankook Tire began supplying original equipment tires to General Motors in 2002 and continues to equip multiple vehicles from GM such as the Chevrolet Malibu, Equinox, Spark, Sonic and Trailblazer, as well as the GMC Terrain and Buick Encore. Including the partnership with General Motors, Hankook Tire successfully supplies original equipment tires for 46 automakers.About Hankook Tire America Corp.Hankook Tire America Corp. is a growing leader in the U.S. tire market, leveraging investments in technology, manufacturing and marketing to deliver high-quality, reliable products that are safer for consumers and the environment. Headquartered in Nashville, Tennessee, Hankook America markets and distributes a complete line of high-performance and ultra-high-performance passenger tires, light truck and SUV tires as well as medium truck and bus tires in the United States. Hankook Tire America is a subsidiary of Hankook Tire Co., Ltd., a Forbes Global 2000 company headquartered in Seoul, Korea. SOURCE Hankook Tire America Corp.

edtsum250

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Aug. 25, 2020 /PRNewswire/ -- In the most comprehensive study of its kind on the effects of the Music & Memory program, researchers from the Betty Irene Moore School of Nursing at UC Davisfound that personalized music is associated with a reduction in the amount of antipsychotic medication taken by nursing home residents and fewer distressed behaviors. The results are published in the Journal for Post-acute and Long-term Care Medicine (JAMDA) MUSIC & MEMORY is a non-profit organization that creates personalized music playlists for individuals in nursing homes and other long-term care organizations, who suffer from a wide range of cognitive and physical challenges, to find renewed meaning and connection in their lives through music-triggered memories. The program works to reduce the use of antipsychotic medications in all populations and improve their quality of life. Music & Memory has been adopted by more than 5,000 healthcare organizations in the United States and has been adopted as state policy in 22 states. A three-year study of 4,107 residents in 265 California nursing homes found the use of antipsychotic drugs declined by 13% and anti-anxiety medications declined by 17% each quarter for residents with dementia using the music program. The odds of depressive symptoms decreased 16% per quarter and the odds of reported pain decreased 17% per quarter. In addition, the number of days on medications declined by 30% and aggressive behaviors reduced by 20%. "This Study provides further evidence of the positive impact personalized music programs can have for those with Alzheimer's disease and dementia - not only on improved quality of life but also on the cost and quality of caring," said Concetta Tomaino, DA, LCAT, MT-BC, Music & Memory Board Member. Given the size of the study and the overwhelming evidence that personalized music reduces negative outcomes, it's now more clear than ever that adoption of the Music & Memory program contributes to positive outcomes and quality of care for those living with Alzheimer's and other forms of dementia and cognitive loss. Music & Memory will continue to provide updates on the impact of this study and others like it, as well as share how successful this approach has been (all over the US and several countries). Those interested in supporting Music & Memory can donate here: musicandmemory.org/donate For more information, visit musicandmemory.org Contact: Justin Russo, Music & Memory Program Director [emailprotected] SOURCE Music & Memory Related Links http://musicandmemory.org Answer:

New Study Finds Music & Memory Program Reduces Distressed Behavior and Decreases Need for Antipsychotic Medication in Dementia Patients

NEW YORK, Aug. 25, 2020 /PRNewswire/ -- In the most comprehensive study of its kind on the effects of the Music & Memory program, researchers from the Betty Irene Moore School of Nursing at UC Davisfound that personalized music is associated with a reduction in the amount of antipsychotic medication taken by nursing home residents and fewer distressed behaviors. The results are published in the Journal for Post-acute and Long-term Care Medicine (JAMDA) MUSIC & MEMORY is a non-profit organization that creates personalized music playlists for individuals in nursing homes and other long-term care organizations, who suffer from a wide range of cognitive and physical challenges, to find renewed meaning and connection in their lives through music-triggered memories. The program works to reduce the use of antipsychotic medications in all populations and improve their quality of life. Music & Memory has been adopted by more than 5,000 healthcare organizations in the United States and has been adopted as state policy in 22 states. A three-year study of 4,107 residents in 265 California nursing homes found the use of antipsychotic drugs declined by 13% and anti-anxiety medications declined by 17% each quarter for residents with dementia using the music program. The odds of depressive symptoms decreased 16% per quarter and the odds of reported pain decreased 17% per quarter. In addition, the number of days on medications declined by 30% and aggressive behaviors reduced by 20%. "This Study provides further evidence of the positive impact personalized music programs can have for those with Alzheimer's disease and dementia - not only on improved quality of life but also on the cost and quality of caring," said Concetta Tomaino, DA, LCAT, MT-BC, Music & Memory Board Member. Given the size of the study and the overwhelming evidence that personalized music reduces negative outcomes, it's now more clear than ever that adoption of the Music & Memory program contributes to positive outcomes and quality of care for those living with Alzheimer's and other forms of dementia and cognitive loss. Music & Memory will continue to provide updates on the impact of this study and others like it, as well as share how successful this approach has been (all over the US and several countries). Those interested in supporting Music & Memory can donate here: musicandmemory.org/donate For more information, visit musicandmemory.org Contact: Justin Russo, Music & Memory Program Director [emailprotected] SOURCE Music & Memory Related Links http://musicandmemory.org

edtsum253

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON--(BUSINESS WIRE)-- Malmo Stad Issue of SEK 500,000,000 Floating Rate Green Bonds due September 2021 Series 26 Tranche 1 MTN ISSUE NAME. Our Ref. ML9533 ISIN Code. XS1991005726 INTEREST AMT PER DENOM. CURRENCY CODE. SEK DAY BASIS. Actual/360 (A004) NUM OF DAYS. 90 INTEREST RATE. 0.648 PCT VALUE DATE. 15/03/2021 INTEREST PERIOD. 15/12/2020 TO 15/03/2021 SEK 1,000,000.00 IS SEK 1,620.0000 POOL FACTOR. N/A Answer:

FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)-- Malmo Stad Issue of SEK 500,000,000 Floating Rate Green Bonds due September 2021 Series 26 Tranche 1 MTN ISSUE NAME. Our Ref. ML9533 ISIN Code. XS1991005726 INTEREST AMT PER DENOM. CURRENCY CODE. SEK DAY BASIS. Actual/360 (A004) NUM OF DAYS. 90 INTEREST RATE. 0.648 PCT VALUE DATE. 15/03/2021 INTEREST PERIOD. 15/12/2020 TO 15/03/2021 SEK 1,000,000.00 IS SEK 1,620.0000 POOL FACTOR. N/A

edtsum266

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: CLAYTON, Mo., May 14, 2020 /PRNewswire/ --Olin Corporation (NYSE: OLN)announced today that it intends to offer (the "Offering") $500 million aggregate principal amount of senior notes due 2025 (the "Senior Notes"), subject to market and other conditions. Olin expects to use the net proceeds of the Offering to fund general corporate purposes. The Senior Notes will be offered in a private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Senior Notes will be offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Senior Notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. This press release does not constitute an offer to sell, or a solicitation of an offer to buy, the Senior Notes nor shall there be any sale of the Senior Notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No assurance can be made that the Offering will be consummated on its proposed terms or at all. COMPANY DESCRIPTION Olin Corporation is a leading vertically-integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, and industrial cartridges. CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS Statements in this press release which are not historical in nature are "forward-looking statements" within the meaning of the federal securities laws, including statements regarding the offering of the Senior Notes. These statements often include words such as "anticipate," "intend," "may," "expect," "believe," "should," "plan," "project," "estimate," "forecast," "optimistic," or similar expressions relate to analyses and other information that are based on management's beliefs, certain assumptions made by management, forecasts of future events, and current expectations, estimates and projections about the offering of the Senior Notes. However, you should understand that these statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, actual outcomes and results may differ materially from those matters expressed or implied in such forward-looking statements. We undertake no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise. The risks, uncertainties and assumptions involved in our forward-looking statements, many of which are discussed in more detail in our filings with the Securities and Exchange Commission, including without limitation the "Risk Factors" section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 as supplemented by the additional Risk Factor set forth in Part II, Item 1A of our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2020, include, but are not limited to the following: sensitivity to economic, business and market conditions in the United States and overseas, including economic instability or a downturn in the sectors served by us, such as vinyls, urethanes, and pulp and paper; the cyclical nature of our operating results, particularly declines in average selling prices in the chlor alkali industry and the supply/demand balance for our products, including the impact of excess industry capacity or an imbalance in demand for our chlor alkali products; our reliance on a limited number of suppliers for specified feedstock and services and our reliance on third-party transportation; higher-than-expected raw material, energy, transportation and/or logistics costs; failure to control costs or to achieve targeted cost reductions; new regulations or public policy changes regarding the transportation of hazardous chemicals and the security of chemical manufacturing facilities; the occurrence of unexpected manufacturing interruptions and outages, including those occurring as a result of labor disruptions and production hazards; weak industry conditions affecting our ability to comply with the financial maintenance covenants in our senior credit facility; the negative impact from the COVID-19 pandemic and the global response to the pandemic; the failure or an interruption of our information technology systems; complications resulting from our multiple enterprise resource planning systems and the conversion to a new system; a loss of a substantial customer for either chlorine or caustic soda could cause an imbalance in customer demand for these products; our substantial amount of indebtedness and significant debt service obligations; unexpected litigation outcomes; changes in, or failure to comply with, legislation or government regulations or policies; costs and other expenditures in excess of those projected for environmental investigation and remediation or other legal proceedings; failure to attract, retain and motivate key employees; the effects of any declines in global equity markets on asset values and any declines in interest rates used to value the liabilities in our pension plan; adverse changes in international markets, including economic, political or regulatory changes; our long range plan assumptions not being realized causing a non-cash impairment charge of long-lived assets; adverse conditions in the credit and capital markets, limiting or preventing our ability to borrow or raise capital; and various risks associated with our transition and subsequent operation of the Lake City U.S. Army Ammunition Plant. All of our forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of our forward-looking statements. We may not consummate the Offering and, if the Offering is consummated, we cannot provide any assurances regarding the final terms of the Offering. 2020-08 SOURCE Olin Corporation Related Links http://www.olin.com Answer:

Olin To Pursue Private Offering Of Senior Notes

CLAYTON, Mo., May 14, 2020 /PRNewswire/ --Olin Corporation (NYSE: OLN)announced today that it intends to offer (the "Offering") $500 million aggregate principal amount of senior notes due 2025 (the "Senior Notes"), subject to market and other conditions. Olin expects to use the net proceeds of the Offering to fund general corporate purposes. The Senior Notes will be offered in a private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The Senior Notes will be offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Senior Notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. This press release does not constitute an offer to sell, or a solicitation of an offer to buy, the Senior Notes nor shall there be any sale of the Senior Notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. No assurance can be made that the Offering will be consummated on its proposed terms or at all. COMPANY DESCRIPTION Olin Corporation is a leading vertically-integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, and industrial cartridges. CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS Statements in this press release which are not historical in nature are "forward-looking statements" within the meaning of the federal securities laws, including statements regarding the offering of the Senior Notes. These statements often include words such as "anticipate," "intend," "may," "expect," "believe," "should," "plan," "project," "estimate," "forecast," "optimistic," or similar expressions relate to analyses and other information that are based on management's beliefs, certain assumptions made by management, forecasts of future events, and current expectations, estimates and projections about the offering of the Senior Notes. However, you should understand that these statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, actual outcomes and results may differ materially from those matters expressed or implied in such forward-looking statements. We undertake no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise. The risks, uncertainties and assumptions involved in our forward-looking statements, many of which are discussed in more detail in our filings with the Securities and Exchange Commission, including without limitation the "Risk Factors" section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 as supplemented by the additional Risk Factor set forth in Part II, Item 1A of our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2020, include, but are not limited to the following: sensitivity to economic, business and market conditions in the United States and overseas, including economic instability or a downturn in the sectors served by us, such as vinyls, urethanes, and pulp and paper; the cyclical nature of our operating results, particularly declines in average selling prices in the chlor alkali industry and the supply/demand balance for our products, including the impact of excess industry capacity or an imbalance in demand for our chlor alkali products; our reliance on a limited number of suppliers for specified feedstock and services and our reliance on third-party transportation; higher-than-expected raw material, energy, transportation and/or logistics costs; failure to control costs or to achieve targeted cost reductions; new regulations or public policy changes regarding the transportation of hazardous chemicals and the security of chemical manufacturing facilities; the occurrence of unexpected manufacturing interruptions and outages, including those occurring as a result of labor disruptions and production hazards; weak industry conditions affecting our ability to comply with the financial maintenance covenants in our senior credit facility; the negative impact from the COVID-19 pandemic and the global response to the pandemic; the failure or an interruption of our information technology systems; complications resulting from our multiple enterprise resource planning systems and the conversion to a new system; a loss of a substantial customer for either chlorine or caustic soda could cause an imbalance in customer demand for these products; our substantial amount of indebtedness and significant debt service obligations; unexpected litigation outcomes; changes in, or failure to comply with, legislation or government regulations or policies; costs and other expenditures in excess of those projected for environmental investigation and remediation or other legal proceedings; failure to attract, retain and motivate key employees; the effects of any declines in global equity markets on asset values and any declines in interest rates used to value the liabilities in our pension plan; adverse changes in international markets, including economic, political or regulatory changes; our long range plan assumptions not being realized causing a non-cash impairment charge of long-lived assets; adverse conditions in the credit and capital markets, limiting or preventing our ability to borrow or raise capital; and various risks associated with our transition and subsequent operation of the Lake City U.S. Army Ammunition Plant. All of our forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of our forward-looking statements. We may not consummate the Offering and, if the Offering is consummated, we cannot provide any assurances regarding the final terms of the Offering. 2020-08 SOURCE Olin Corporation Related Links http://www.olin.com

edtsum270

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: TEL AVIV, Israel, Aug. 3, 2020 /PRNewswire/ -- More than 60% of the world's population depends on agriculture for its survival. In the Unites States alone, agriculture and related industries contribute over $1 trillion to GDP. Yet, as one of the slowest sectors to adopt new technologies, the entire food system is being impacted by the COVID-19 pandemic and the climate crisis. Today, Agritask, a global leader in precision agronomics, emphasized its commitment to the role of insurance solutions in catalysing the agricultural sector's resilience to acute shocks and chronic stresses. To better address the challenges of food security, Agritask has appointed Daniel Stander, a global pioneer in decision science and resilience finance, as senior advisor to its leadership team. The appointment demonstrates Agritask's intent to further expand its value to the agricultural supply chain with risk-informed, data-driven, decision-useful insights. Daniel began advising Agritask earlier this year, helping drive the innovation required to address the productivity challenges facing growers, investors, ag-buyers and governments. Motivated by a desire to make communities and economies more resilient, Daniel has spent much of his career at the intersection of risk and strategic innovation. Over the last 20 years, he has worked on every continent, advising governments, NGOs and financial services institutions on a variety of complex risks, from natural hazards and environmental stresses to pandemics and cyber exposure. He has been a pioneer of #ResilienceFinance, helping capital find responsible investments in the face of climate extremes. Daniel spent 14 successful years at RMS. Prior to RMS, Daniel was part of the group strategy and development function at an 80,000-employee, 10bn global healthcare group, serving 30 million customers in over 190 countries. He also has considerable start-up experience, having been a founding member of an award-winning SaaS company, establishing the use of internet technologies across the insurance value chain. Ofir Ardon, Chief Executive Officer at Agritask, said: "Daniel possesses both unrivalled industry knowledge and significant experience in growing technology companies. Businesses and governments around the world have benefited from Daniel's pragmatic approach to innovation, as well as his sensitive thought leadership. His insights are perceptive, his relationships strong and his passion infectious. These qualities will help us deliver new and differentiated value to the markets we serve, thereby increasing the relevance of our business." Daniel's appointment follows that of Dr. Rom Aviv, an expert in insurance-linked securities, as Managing Director and Head of Insurance at Agritask. Commenting on today's news, Dr. Aviv said: "About 50% of the world's food is produced by 500 million smallholders. Yet these farmers typically do not have access to affordable insurance. There are no quick and easy solutions here. After all, agricultural insurance is complex and dynamic. However, Daniel's business acumen, relentless energy and domain experience will empower us to transform this industry with technological innovations. We are already profiting from his advice on value-chain digitization and decision science to the benefit of our insurance sector clients. More than that, though, Daniel's experience leading mission-driven businesses will ensure we fulfil our societal purpose of eradicating poverty and food insecurity by making crop insurance accessible to all." Ernesto Costa, Head of Private Equity Investments at BlueOrchard and Agritask Board Member, said: "In delivering on the Sustainable Development Goals, three things will be paramount: technology adoption, agricultural ecosystems and risk finance. Daniel deeply understands the importance of and the interplay between each. He is a seasoned professional and brings Agritask the kind of experience and expertise that will help the company grow by unlocking new value for its customers. I am looking forward to his contributions as we scale inclusive insurance, thereby improving the financial stability of 25 million smallholder farmers along with the quantity, quality and predictability of their yield." Based in London, Daniel will work closely with Agritask's teams in Tel Aviv, London and Sofia, as well as Agritask's clients in South America, Africa and Asia. In addition to his role with Agritask, Daniel continues to serve as a private sector representative to the United Nations on matters of disaster risk reduction. Daniel Stander, Senior Advisor at Agritask said, "Over 1.3 billion people worldwide work in agriculture, generating about $2.5 trillion for the global economy. More than that, there is a close correlation between agricultural performance and poverty reduction. Yet, if left unmanaged, acute and chronic risks will increasingly undermine global food security, hurting food production, disrupting supply chains and stressing people's ability to access nutritious and affordable food. Agricultural ecosystems are at an inflection point. Unprecedented opportunities exist to harness advances in remote sensing, data analytics, machine learning and climate risk finance. The significant investments Agritask is making in its agronomics platform will hasten the adoption of climate-smart food systems, increasing productivity, enhancing resilience and reducing emissions while at the same time making agribusinesses more equitable and less volatile. The team at Agritask is already delivering value that seemed impossible just a few years ago. I am excited by the potential. I am keen to collaborate, innovate, deliver and grow." Note: This release has been revised to remove inaccurate information about RMS. About Agritask Agritask is a holistic ag-operations platform, designed to scale fact-based decision making for agricultural businesses. The platform has been successfully deployed in more than 30 countries. It is being used by every participant in the agricultural ecosystem, including large growers, multi-farm corporations, ag-buyers, food conglomerates, private equity managers, ag-financiers, insurance companies, governments and NGOs. The Agritask platform enables the development and delivery of highly personalized and rigorouscrop insuranceproducts, with a capacity to serve millions of smallholders in a single insurance programme.The platform registers and maps small farms, obtains field data and correlates high-resolution weather and other secondary data at the plot level. This empowers users to dynamically assess risks, design targetedinsuranceproducts and monitorcropperformance at scale through the season.Using remote sensing and GIS capabilities, such as satellite-based auto-cropand auto-plot detection models,crophealth monitoring and post-event damage assessment, Agritask is enabling capital to cover hitherto uninsurable risks across the agricultural value chain. For additional information, please visit: www.agritask.com About BlueOrchard Finance Ltd BlueOrchard is a leading global impact investment manager and a member of the Schroders group. The firm is dedicated to fostering inclusive and climate-smart growth in emerging and frontier markets, while providing attractive returns for investors. BlueOrchard was founded in 2001, by initiative of the UN, as the world's first commercial manager of microfinance debt investments. The firm has built a distinct track record in offering premium impact investment solutions, including credit, private equity, and sustainable infrastructure. Being an expert in innovative blended finance mandates, the firm is a trusted partner of leading global development finance institutions. BlueOrchard has invested to date more than USD 6bn for sophisticated global private and public clients, enabling tangible social and environmental impact. For additional information, please visit:www.blueorchard.com For media inquiries only, please contact Lilach Bar-Tal at [emailprotected]. SOURCE Agritask Related Links http://www.agritask.com/ Answer:

Appointment of Daniel Stander Underscores Agritask's Commitment to Securing Global Food Systems with Agricultural Insurance Solutions English English New Advisor brings over 20 years of experience in finance, technology and data science

TEL AVIV, Israel, Aug. 3, 2020 /PRNewswire/ -- More than 60% of the world's population depends on agriculture for its survival. In the Unites States alone, agriculture and related industries contribute over $1 trillion to GDP. Yet, as one of the slowest sectors to adopt new technologies, the entire food system is being impacted by the COVID-19 pandemic and the climate crisis. Today, Agritask, a global leader in precision agronomics, emphasized its commitment to the role of insurance solutions in catalysing the agricultural sector's resilience to acute shocks and chronic stresses. To better address the challenges of food security, Agritask has appointed Daniel Stander, a global pioneer in decision science and resilience finance, as senior advisor to its leadership team. The appointment demonstrates Agritask's intent to further expand its value to the agricultural supply chain with risk-informed, data-driven, decision-useful insights. Daniel began advising Agritask earlier this year, helping drive the innovation required to address the productivity challenges facing growers, investors, ag-buyers and governments. Motivated by a desire to make communities and economies more resilient, Daniel has spent much of his career at the intersection of risk and strategic innovation. Over the last 20 years, he has worked on every continent, advising governments, NGOs and financial services institutions on a variety of complex risks, from natural hazards and environmental stresses to pandemics and cyber exposure. He has been a pioneer of #ResilienceFinance, helping capital find responsible investments in the face of climate extremes. Daniel spent 14 successful years at RMS. Prior to RMS, Daniel was part of the group strategy and development function at an 80,000-employee, 10bn global healthcare group, serving 30 million customers in over 190 countries. He also has considerable start-up experience, having been a founding member of an award-winning SaaS company, establishing the use of internet technologies across the insurance value chain. Ofir Ardon, Chief Executive Officer at Agritask, said: "Daniel possesses both unrivalled industry knowledge and significant experience in growing technology companies. Businesses and governments around the world have benefited from Daniel's pragmatic approach to innovation, as well as his sensitive thought leadership. His insights are perceptive, his relationships strong and his passion infectious. These qualities will help us deliver new and differentiated value to the markets we serve, thereby increasing the relevance of our business." Daniel's appointment follows that of Dr. Rom Aviv, an expert in insurance-linked securities, as Managing Director and Head of Insurance at Agritask. Commenting on today's news, Dr. Aviv said: "About 50% of the world's food is produced by 500 million smallholders. Yet these farmers typically do not have access to affordable insurance. There are no quick and easy solutions here. After all, agricultural insurance is complex and dynamic. However, Daniel's business acumen, relentless energy and domain experience will empower us to transform this industry with technological innovations. We are already profiting from his advice on value-chain digitization and decision science to the benefit of our insurance sector clients. More than that, though, Daniel's experience leading mission-driven businesses will ensure we fulfil our societal purpose of eradicating poverty and food insecurity by making crop insurance accessible to all." Ernesto Costa, Head of Private Equity Investments at BlueOrchard and Agritask Board Member, said: "In delivering on the Sustainable Development Goals, three things will be paramount: technology adoption, agricultural ecosystems and risk finance. Daniel deeply understands the importance of and the interplay between each. He is a seasoned professional and brings Agritask the kind of experience and expertise that will help the company grow by unlocking new value for its customers. I am looking forward to his contributions as we scale inclusive insurance, thereby improving the financial stability of 25 million smallholder farmers along with the quantity, quality and predictability of their yield." Based in London, Daniel will work closely with Agritask's teams in Tel Aviv, London and Sofia, as well as Agritask's clients in South America, Africa and Asia. In addition to his role with Agritask, Daniel continues to serve as a private sector representative to the United Nations on matters of disaster risk reduction. Daniel Stander, Senior Advisor at Agritask said, "Over 1.3 billion people worldwide work in agriculture, generating about $2.5 trillion for the global economy. More than that, there is a close correlation between agricultural performance and poverty reduction. Yet, if left unmanaged, acute and chronic risks will increasingly undermine global food security, hurting food production, disrupting supply chains and stressing people's ability to access nutritious and affordable food. Agricultural ecosystems are at an inflection point. Unprecedented opportunities exist to harness advances in remote sensing, data analytics, machine learning and climate risk finance. The significant investments Agritask is making in its agronomics platform will hasten the adoption of climate-smart food systems, increasing productivity, enhancing resilience and reducing emissions while at the same time making agribusinesses more equitable and less volatile. The team at Agritask is already delivering value that seemed impossible just a few years ago. I am excited by the potential. I am keen to collaborate, innovate, deliver and grow." Note: This release has been revised to remove inaccurate information about RMS. About Agritask Agritask is a holistic ag-operations platform, designed to scale fact-based decision making for agricultural businesses. The platform has been successfully deployed in more than 30 countries. It is being used by every participant in the agricultural ecosystem, including large growers, multi-farm corporations, ag-buyers, food conglomerates, private equity managers, ag-financiers, insurance companies, governments and NGOs. The Agritask platform enables the development and delivery of highly personalized and rigorouscrop insuranceproducts, with a capacity to serve millions of smallholders in a single insurance programme.The platform registers and maps small farms, obtains field data and correlates high-resolution weather and other secondary data at the plot level. This empowers users to dynamically assess risks, design targetedinsuranceproducts and monitorcropperformance at scale through the season.Using remote sensing and GIS capabilities, such as satellite-based auto-cropand auto-plot detection models,crophealth monitoring and post-event damage assessment, Agritask is enabling capital to cover hitherto uninsurable risks across the agricultural value chain. For additional information, please visit: www.agritask.com About BlueOrchard Finance Ltd BlueOrchard is a leading global impact investment manager and a member of the Schroders group. The firm is dedicated to fostering inclusive and climate-smart growth in emerging and frontier markets, while providing attractive returns for investors. BlueOrchard was founded in 2001, by initiative of the UN, as the world's first commercial manager of microfinance debt investments. The firm has built a distinct track record in offering premium impact investment solutions, including credit, private equity, and sustainable infrastructure. Being an expert in innovative blended finance mandates, the firm is a trusted partner of leading global development finance institutions. BlueOrchard has invested to date more than USD 6bn for sophisticated global private and public clients, enabling tangible social and environmental impact. For additional information, please visit:www.blueorchard.com For media inquiries only, please contact Lilach Bar-Tal at [emailprotected]. SOURCE Agritask Related Links http://www.agritask.com/

edtsum271

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: OAKLAND, Calif., Nov. 25, 2020 /PRNewswire/ --Two groups in Northern California are addressing the issue of physician burnout.AltaisClinical Services, a division of the healthcare services company Altais, and Brown & Toland Physicians, an independent network of more than 2,700 physicians serving more than 350,000 patients in the San Francisco Bay Area, today completed their affiliation. The two organizations have formally joined to expand the transformation of patient care for improved health outcomes at an affordable cost and accelerate the improvement of the physician and patient experience. Brown & Toland Physicians is now a subsidiary of Altais Clinical Services. Kelly Robison remains Brown & Toland Physicians' chief executive officer. Brown & Toland Studies recently cited by JAMA Networkdemonstrate that widespread physician burnout is a major contributor to the current shortage of physicians in the United States. Some of the factors creating this burnout include the significant time required by physicians to manage electronic health records and the increasing complexities of operating a practice. These and other pressures take physicians' time away from caring for patients. The COVID-19 pandemic has exacerbated the problem, according to the New England Journal of Medicine. Brown & Toland Physicians will continue to operate under its current brand and continue to service all payers. As part of Altais Clinical Services, Brown & Toland Physicians now has access to additional capital, services and a wide range of programs and tools for physicians to operate independent practices under a value-based model. All Brown & Toland Physicians' patients can continue to see their physicians with no interruption in care. As part of Altais Clinical Services, Brown & Toland Physicians will continue to provide a clinically integrated system of coordinated care to ensure its physicians spend time doing what they do best caring for patients. This includes sophisticated clinical tools and a technology management platform to enhance clinical and service quality for physicians and their patients. "Altais Clinical Services and Brown & Toland Physicians share the vision of a reimagined physician practice experience. We will serve as an innovator for independent physicians, providing deeper levels of support and the tools they need to deliver high-quality, affordable care to their patients in this increasingly value-based world," said Robison."Physicians will benefit from a more robust practice management platform that uses an advanced set of data, insights and tools to care for patients where and when they need it.""We at Altais Clinical Services are delighted to have Brown & Toland Physicians join us. Together, we look to bring even greater value to physicians. Our goal is to accelerate the capacity of physicians and the clinical community to maximize the health and well-being of their patients and set practices up for long-term success," said Jeff Bailet, M.D., Altais' president and chief executive officer. "Our focus is to restore the vibrancy of independent physician practices, so they can direct more of their focus on patient care." About AltaisAltais is a healthcare services company that helps physicians and the clinical community maximize the health and well-being of their patients in an affordable and sustainable way. Altais has two divisions. Altais Clinical Services offers a range of affiliation and employment models for physicians, and high-quality, affordable care for patients. Altais Health offers a broad platform of clinical support tools and technology, along with high-touch support. Altais seeks to enhance the vibrancy of physician practice and strengthen the heart of medicine physicians connecting with patients and providing personalized, high-quality care. For more information about Altais, please visit www.altais.com.About Brown & Toland PhysiciansBrown & Toland Physicians, a subsidiary of Altais Clinical Services, is a leading network of independent doctors focused on delivering personalized and high-quality healthcare to the San Francisco Bay Area. Its network of more than 2,700 physicians, serving more than 350,000 HMO and PPO patients, is dedicated to improving care and reducing costs through innovative care management and care coordination programs, use of healthcare technology and population health management strategies. Brown & Toland collaborates with leading hospitals and health plan providers to deliver high quality care in the Bay Area. To learn more, please visit: www.brownandtoland.com. Media Contact:David CumpstonLandis Communications Inc.[emailprotected](415) 902-4461www.landispr.comSOURCE Altais Related Links https://altais.com Answer:

Altais Clinical Services and Brown & Toland Physicians Combine Forces To Accelerate Improvement of Physician and Patient Experiences

OAKLAND, Calif., Nov. 25, 2020 /PRNewswire/ --Two groups in Northern California are addressing the issue of physician burnout.AltaisClinical Services, a division of the healthcare services company Altais, and Brown & Toland Physicians, an independent network of more than 2,700 physicians serving more than 350,000 patients in the San Francisco Bay Area, today completed their affiliation. The two organizations have formally joined to expand the transformation of patient care for improved health outcomes at an affordable cost and accelerate the improvement of the physician and patient experience. Brown & Toland Physicians is now a subsidiary of Altais Clinical Services. Kelly Robison remains Brown & Toland Physicians' chief executive officer. Brown & Toland Studies recently cited by JAMA Networkdemonstrate that widespread physician burnout is a major contributor to the current shortage of physicians in the United States. Some of the factors creating this burnout include the significant time required by physicians to manage electronic health records and the increasing complexities of operating a practice. These and other pressures take physicians' time away from caring for patients. The COVID-19 pandemic has exacerbated the problem, according to the New England Journal of Medicine. Brown & Toland Physicians will continue to operate under its current brand and continue to service all payers. As part of Altais Clinical Services, Brown & Toland Physicians now has access to additional capital, services and a wide range of programs and tools for physicians to operate independent practices under a value-based model. All Brown & Toland Physicians' patients can continue to see their physicians with no interruption in care. As part of Altais Clinical Services, Brown & Toland Physicians will continue to provide a clinically integrated system of coordinated care to ensure its physicians spend time doing what they do best caring for patients. This includes sophisticated clinical tools and a technology management platform to enhance clinical and service quality for physicians and their patients. "Altais Clinical Services and Brown & Toland Physicians share the vision of a reimagined physician practice experience. We will serve as an innovator for independent physicians, providing deeper levels of support and the tools they need to deliver high-quality, affordable care to their patients in this increasingly value-based world," said Robison."Physicians will benefit from a more robust practice management platform that uses an advanced set of data, insights and tools to care for patients where and when they need it.""We at Altais Clinical Services are delighted to have Brown & Toland Physicians join us. Together, we look to bring even greater value to physicians. Our goal is to accelerate the capacity of physicians and the clinical community to maximize the health and well-being of their patients and set practices up for long-term success," said Jeff Bailet, M.D., Altais' president and chief executive officer. "Our focus is to restore the vibrancy of independent physician practices, so they can direct more of their focus on patient care." About AltaisAltais is a healthcare services company that helps physicians and the clinical community maximize the health and well-being of their patients in an affordable and sustainable way. Altais has two divisions. Altais Clinical Services offers a range of affiliation and employment models for physicians, and high-quality, affordable care for patients. Altais Health offers a broad platform of clinical support tools and technology, along with high-touch support. Altais seeks to enhance the vibrancy of physician practice and strengthen the heart of medicine physicians connecting with patients and providing personalized, high-quality care. For more information about Altais, please visit www.altais.com.About Brown & Toland PhysiciansBrown & Toland Physicians, a subsidiary of Altais Clinical Services, is a leading network of independent doctors focused on delivering personalized and high-quality healthcare to the San Francisco Bay Area. Its network of more than 2,700 physicians, serving more than 350,000 HMO and PPO patients, is dedicated to improving care and reducing costs through innovative care management and care coordination programs, use of healthcare technology and population health management strategies. Brown & Toland collaborates with leading hospitals and health plan providers to deliver high quality care in the Bay Area. To learn more, please visit: www.brownandtoland.com. Media Contact:David CumpstonLandis Communications Inc.[emailprotected](415) 902-4461www.landispr.comSOURCE Altais Related Links https://altais.com

edtsum272

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: CHICAGO, Aug. 14, 2020 /PRNewswire/ -- Kalderos, the country's first Drug Discount Manager, today announced it is now working with 3,000 340B covered entities through the Reviewtool in its Discount Monitoring solution, a revolutionary application that simplifies and streamlines collaboration on good faith inquiries for covered entities, ensuring compliance in the 340B Drug Pricing Program. The 3,000 participating covered entities span the range of providers, but include some of the largest Medicare Disproportionate Share Hospitals (DSH) in the nation. Kalderos' Drug Discount Management platform strengthens the integrity of the 340B Drug Pricing Program, making the process more transparent and making compliance seamless for healthcare providers, drug manufacturers, states and, ultimately, patients. "We are proud to reach this milestone and grateful to the 3,000 covered entities working with us to ensure the drug discount system works as intended. This level of partnership and engagement is a very public endorsement of our solution," said Micah Litow, president and COO, Kalderos. "Because of our offering, covered entities can now operate with confidence, manufacturers can verify their discount dollars are going to the right party, and, ultimately, all stakeholders can focus their time on improving the lives of patients." 340B covered entities, such as Federally Qualified Health Centers and Disproportionate Share Hospitals, provide care to vulnerable and underserved populations and are a vital component to the health and wellbeing of many Americans. The 340B Drug Pricing Program makes prescription drugs available at an affordable price, but requires careful and often challenging accounting and reporting to avoid duplicating discounts, which are often applied alongside the Medicaid Drug Rebate Program. Historically, compliance has been difficult, resource-intensive and inaccurate. "I imagine it is a combination of their background and their tech, but Kalderos is the only solution we've found that simplifies and streamlines our participation in 340B good faith inquiries," said Peter Tawfik, director of pharmacy, Omni Family Health. "I would like to thank Kalderos for helping us to refine our audits so that we may detect potential inaccurate claims and prevent duplicate discounts from occurring," said Greg Redding, pharmacy director, MHC Healthcare. Founded in 2016, Kalderos has built the only modern technology solution that leverages a robust rules engine and a collaborative marketplace to ensure compliance in the drug discount market. Combining industry expertise, artificial intelligence and comprehensive, deep-data libraries, Kalderos quickly identifies errors that have previously gone undetected, ensuring the right discount to the right party on the right transaction. About Kalderos Kalderos combines industry expertise, design thinking and technology to target waste and to improve efficiency as the category leader in healthcare network management. Its SaaS products, 340B Pay and Discount Monitoring solutions, form the world's first Drug Discount Management platform, which identifies, checks and resolves noncompliance. Using sophisticated models and machine learning processes, Kalderos detects inconsistencies overlooked by current methods, providing material benefits by eliminating waste. Based in Chicago, Kalderos was founded in 2016 by a team firmly rooted in the belief that it is essential to fix this problem in order to help patients and reduce inefficiencies. More information can be found atwww.kalderos.com. SOURCE Kalderos Related Links https://www.kalderos.com/ Answer:

Kalderos Now Working with 3,000 Covered Entities to Bring Transparency and Integrity to Prescription Drug Pricing Programs

CHICAGO, Aug. 14, 2020 /PRNewswire/ -- Kalderos, the country's first Drug Discount Manager, today announced it is now working with 3,000 340B covered entities through the Reviewtool in its Discount Monitoring solution, a revolutionary application that simplifies and streamlines collaboration on good faith inquiries for covered entities, ensuring compliance in the 340B Drug Pricing Program. The 3,000 participating covered entities span the range of providers, but include some of the largest Medicare Disproportionate Share Hospitals (DSH) in the nation. Kalderos' Drug Discount Management platform strengthens the integrity of the 340B Drug Pricing Program, making the process more transparent and making compliance seamless for healthcare providers, drug manufacturers, states and, ultimately, patients. "We are proud to reach this milestone and grateful to the 3,000 covered entities working with us to ensure the drug discount system works as intended. This level of partnership and engagement is a very public endorsement of our solution," said Micah Litow, president and COO, Kalderos. "Because of our offering, covered entities can now operate with confidence, manufacturers can verify their discount dollars are going to the right party, and, ultimately, all stakeholders can focus their time on improving the lives of patients." 340B covered entities, such as Federally Qualified Health Centers and Disproportionate Share Hospitals, provide care to vulnerable and underserved populations and are a vital component to the health and wellbeing of many Americans. The 340B Drug Pricing Program makes prescription drugs available at an affordable price, but requires careful and often challenging accounting and reporting to avoid duplicating discounts, which are often applied alongside the Medicaid Drug Rebate Program. Historically, compliance has been difficult, resource-intensive and inaccurate. "I imagine it is a combination of their background and their tech, but Kalderos is the only solution we've found that simplifies and streamlines our participation in 340B good faith inquiries," said Peter Tawfik, director of pharmacy, Omni Family Health. "I would like to thank Kalderos for helping us to refine our audits so that we may detect potential inaccurate claims and prevent duplicate discounts from occurring," said Greg Redding, pharmacy director, MHC Healthcare. Founded in 2016, Kalderos has built the only modern technology solution that leverages a robust rules engine and a collaborative marketplace to ensure compliance in the drug discount market. Combining industry expertise, artificial intelligence and comprehensive, deep-data libraries, Kalderos quickly identifies errors that have previously gone undetected, ensuring the right discount to the right party on the right transaction. About Kalderos Kalderos combines industry expertise, design thinking and technology to target waste and to improve efficiency as the category leader in healthcare network management. Its SaaS products, 340B Pay and Discount Monitoring solutions, form the world's first Drug Discount Management platform, which identifies, checks and resolves noncompliance. Using sophisticated models and machine learning processes, Kalderos detects inconsistencies overlooked by current methods, providing material benefits by eliminating waste. Based in Chicago, Kalderos was founded in 2016 by a team firmly rooted in the belief that it is essential to fix this problem in order to help patients and reduce inefficiencies. More information can be found atwww.kalderos.com. SOURCE Kalderos Related Links https://www.kalderos.com/

edtsum278

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Global Sustainable Athleisure Market By Type (Mass and Premium), By Product (Shirt, Yoga Pant, Leggings, Shorts and others), By Gender (Women and Men), By Distribution Channel (Offline and Online), By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The Global Sustainable Athleisure Market size is expected to reach $126.9 billion by 2026, rising at a market growth of 10.5% CAGR during the forecast period. Athleisure has evolved as the new fashion industry trend that includes, comfort, style, and functionality. This urban fashion movement has achieved huge popularity in the last couple of years. In recent years, consumers are more inclined towards sustainable athleisure as it has become the most comfortable form of clothing. As a result, the demand for sustainable athleisure market has been high since the last couple of years. To manage the high demand, various apparel brands are involved in ethical trade practices and recycling fabrics to offer high-performance activewear for the individual while keeping up the environment safe. The fitness trends have increasingly been popular, which further boost the demand for sports and athletic wear. Sustainable athleisure also finds its application in the corporate culture; a majority of people prefer to wear comfortable casual wear to workplaces. In the modern era, the working population prefers an ideal mix of elegance and functionality, which is encouraging them to purchase more athleisure outfits. Sustainable athleisure is made of high-quality, reliable materials that make it appropriate for numerous fitness and recreational activities such as yoga, running, cycling, and mountain climbing, etc. Companies Profiled Unique Offerings from the Publisher Key Topics Covered: Chapter 1. Market Scope & Methodology 1.1 Market Definition 1.2 Objectives 1.3 Market Scope 1.4 Segmentation 1.4.1 Global Sustainable Athleisure Market, by Type 1.4.2 Global Sustainable Athleisure Market, by Product 1.4.3 Global Sustainable Athleisure Market, by Gender 1.4.4 Global Sustainable Athleisure Market, by Distribution Channel 1.4.5 Global Sustainable Athleisure Market, by Geography 1.5 Methodology for the research Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.2 Market Composition 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. Competition Analysis - Global 3.1 Cardinal Matrix 3.2 Recent Industry Wide Strategic Developments 3.2.1 Partnerships, Collaborations and Agreements 3.2.2 Product Launches and Product Expansions 3.2.3 Geographical Expansions 3.2.4 Acquisition and Mergers 3.3 Top Winning Strategies 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020) Chapter 4. Global Sustainable Athleisure Market by Type 4.1 Global Mass Market by Region 4.2 Global Premium Market by Region Chapter 5. Global Sustainable Athleisure Market by Product 5.1 Global Shirt Market by Region 5.2 Global Yoga Pant Market by Region 5.3 Global Leggings Market by Region 5.4 Global Shorts Market by Region 5.5 Global Other Product Market by Region Chapter 6. Global Sustainable Athleisure Market by Gender 6.1 Global Women Market by Region 6.2 Global Men Market by Region Chapter 7. Global Sustainable Athleisure Market by Distribution Channel 7.1 Global Online Market by Region 7.2 Global Offline Market by Region Chapter 8. Global Sustainable Athleisure Market by Region 8.1 North America Sustainable Athleisure Market 8.2 Europe Sustainable Athleisure Market 8.3 Asia Pacific Sustainable Athleisure Market 8.4 LAMEA Sustainable Athleisure Market Chapter 9. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/mptlxa Answer:

Worldwide Sustainable Athleisure Industry to 2026 - Featuring Adidas, Under Armour and Hanesbrands Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Sustainable Athleisure Market By Type (Mass and Premium), By Product (Shirt, Yoga Pant, Leggings, Shorts and others), By Gender (Women and Men), By Distribution Channel (Offline and Online), By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The Global Sustainable Athleisure Market size is expected to reach $126.9 billion by 2026, rising at a market growth of 10.5% CAGR during the forecast period. Athleisure has evolved as the new fashion industry trend that includes, comfort, style, and functionality. This urban fashion movement has achieved huge popularity in the last couple of years. In recent years, consumers are more inclined towards sustainable athleisure as it has become the most comfortable form of clothing. As a result, the demand for sustainable athleisure market has been high since the last couple of years. To manage the high demand, various apparel brands are involved in ethical trade practices and recycling fabrics to offer high-performance activewear for the individual while keeping up the environment safe. The fitness trends have increasingly been popular, which further boost the demand for sports and athletic wear. Sustainable athleisure also finds its application in the corporate culture; a majority of people prefer to wear comfortable casual wear to workplaces. In the modern era, the working population prefers an ideal mix of elegance and functionality, which is encouraging them to purchase more athleisure outfits. Sustainable athleisure is made of high-quality, reliable materials that make it appropriate for numerous fitness and recreational activities such as yoga, running, cycling, and mountain climbing, etc. Companies Profiled Unique Offerings from the Publisher Key Topics Covered: Chapter 1. Market Scope & Methodology 1.1 Market Definition 1.2 Objectives 1.3 Market Scope 1.4 Segmentation 1.4.1 Global Sustainable Athleisure Market, by Type 1.4.2 Global Sustainable Athleisure Market, by Product 1.4.3 Global Sustainable Athleisure Market, by Gender 1.4.4 Global Sustainable Athleisure Market, by Distribution Channel 1.4.5 Global Sustainable Athleisure Market, by Geography 1.5 Methodology for the research Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.2 Market Composition 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. Competition Analysis - Global 3.1 Cardinal Matrix 3.2 Recent Industry Wide Strategic Developments 3.2.1 Partnerships, Collaborations and Agreements 3.2.2 Product Launches and Product Expansions 3.2.3 Geographical Expansions 3.2.4 Acquisition and Mergers 3.3 Top Winning Strategies 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020) Chapter 4. Global Sustainable Athleisure Market by Type 4.1 Global Mass Market by Region 4.2 Global Premium Market by Region Chapter 5. Global Sustainable Athleisure Market by Product 5.1 Global Shirt Market by Region 5.2 Global Yoga Pant Market by Region 5.3 Global Leggings Market by Region 5.4 Global Shorts Market by Region 5.5 Global Other Product Market by Region Chapter 6. Global Sustainable Athleisure Market by Gender 6.1 Global Women Market by Region 6.2 Global Men Market by Region Chapter 7. Global Sustainable Athleisure Market by Distribution Channel 7.1 Global Online Market by Region 7.2 Global Offline Market by Region Chapter 8. Global Sustainable Athleisure Market by Region 8.1 North America Sustainable Athleisure Market 8.2 Europe Sustainable Athleisure Market 8.3 Asia Pacific Sustainable Athleisure Market 8.4 LAMEA Sustainable Athleisure Market Chapter 9. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/mptlxa

edtsum280

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, April 27, 2021 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for ATOS, AMC, TTOO, ACRX, and NDRA. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ATOS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATOS&prnumber=042720212 AMC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AMC&prnumber=042720212 TTOO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TTOO&prnumber=042720212 ACRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ACRX&prnumber=042720212 NDRA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NDRA&prnumber=042720212 (Note: You may have to copy this link into your browser then press the [ENTER] key.) InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment. SOURCE InvestorsObserver Related Links http://www.investorsobserver.com Answer:

Thinking about buying stock in Atossa Therapeutics, AMC Entertainment, T2 Biosystems, AcelRx Pharmaceuticals, or ENDRA Life Sciences?

NEW YORK, April 27, 2021 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for ATOS, AMC, TTOO, ACRX, and NDRA. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ATOS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATOS&prnumber=042720212 AMC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AMC&prnumber=042720212 TTOO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=TTOO&prnumber=042720212 ACRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ACRX&prnumber=042720212 NDRA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NDRA&prnumber=042720212 (Note: You may have to copy this link into your browser then press the [ENTER] key.) InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment. SOURCE InvestorsObserver Related Links http://www.investorsobserver.com

edtsum282

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LOUISVILLE, Ky., June 30, 2020 /PRNewswire/ --Les Dames d'Escoffier (LDEI) has a newly established LDEI Relief Fund, created in response to the COVID-19 pandemic and its impact on women in the culinary industry. The LDEI Relief Fund will provide funding to established 501(c)(3)'s, non-governmental agencies (NGO'S) and other recognized international nonprofits benefiting women impacted by COVID-19 and other disasters globally. LDEI is an organization of women leaders in food, beverage and hospitality whose mission is education and philanthropy for the good of the global community. The LDEI Relief Fund priority is to extend assistance to established nonprofits or non-governmental agencies (NGO's) who provide essentials and services to benefit women impacted by catastrophes. Bev Shaffer, LDEI President, said, "The newly formed LDEI Relief Fund stems from the Mission, Vision and Guiding Principles of Les Dames d'Escoffier International. As a preeminent global professional association, we strive to inspire, advance and support women in food, beverage and hospitality to achieve excellence in leadership and philanthropy and are committed to creating lasting change in our communities through focused philanthropy." The LDEI Relief Fundgrants will be made for one year or longer given specific program priorities. LDEI will ask applicants to request amounts meeting the needs of the program that is consistent with the organization's capacity and other anticipated or received support. Additionally, LDEI will support capital requests that help meet compelling community need and offer a broad social benefit to women. "The COVID-19 pandemic and other international disasters impact women around the world in many ways. The LDEI Board of Directors created the LDEI Relief Fund in response to this, with our funding priority to assist established nonprofits or NGOs that provide such support," said Shaffer Detailed LDEI Relief Fund grant criteria can be found and donations made at www.ldei.org. Les Dames d'Escoffier International (LDEI) is a worldwide philanthropic organization of professional women leaders in the fields of food, fine beverage and hospitality. The invitation-only membership, composed of over 2,400 women in 44 chapters across the US, Canada, France, the United Kingdom and Mexico, is highly diversified and reflects the multifaceted fields of contemporary gastronomy and hospitality. For more information, visit www.ldei.org SOURCE Les Dames dEscoffier International (LDEI) Related Links http://www.ldei.org Answer:

Les Dames d'Escoffier International Establishes the LDEI Relief Fund

LOUISVILLE, Ky., June 30, 2020 /PRNewswire/ --Les Dames d'Escoffier (LDEI) has a newly established LDEI Relief Fund, created in response to the COVID-19 pandemic and its impact on women in the culinary industry. The LDEI Relief Fund will provide funding to established 501(c)(3)'s, non-governmental agencies (NGO'S) and other recognized international nonprofits benefiting women impacted by COVID-19 and other disasters globally. LDEI is an organization of women leaders in food, beverage and hospitality whose mission is education and philanthropy for the good of the global community. The LDEI Relief Fund priority is to extend assistance to established nonprofits or non-governmental agencies (NGO's) who provide essentials and services to benefit women impacted by catastrophes. Bev Shaffer, LDEI President, said, "The newly formed LDEI Relief Fund stems from the Mission, Vision and Guiding Principles of Les Dames d'Escoffier International. As a preeminent global professional association, we strive to inspire, advance and support women in food, beverage and hospitality to achieve excellence in leadership and philanthropy and are committed to creating lasting change in our communities through focused philanthropy." The LDEI Relief Fundgrants will be made for one year or longer given specific program priorities. LDEI will ask applicants to request amounts meeting the needs of the program that is consistent with the organization's capacity and other anticipated or received support. Additionally, LDEI will support capital requests that help meet compelling community need and offer a broad social benefit to women. "The COVID-19 pandemic and other international disasters impact women around the world in many ways. The LDEI Board of Directors created the LDEI Relief Fund in response to this, with our funding priority to assist established nonprofits or NGOs that provide such support," said Shaffer Detailed LDEI Relief Fund grant criteria can be found and donations made at www.ldei.org. Les Dames d'Escoffier International (LDEI) is a worldwide philanthropic organization of professional women leaders in the fields of food, fine beverage and hospitality. The invitation-only membership, composed of over 2,400 women in 44 chapters across the US, Canada, France, the United Kingdom and Mexico, is highly diversified and reflects the multifaceted fields of contemporary gastronomy and hospitality. For more information, visit www.ldei.org SOURCE Les Dames dEscoffier International (LDEI) Related Links http://www.ldei.org

edtsum283

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONG BEACH, Calif. and HAYDENVILLE, Mass., Aug. 18, 2020 /PRNewswire/ -- Adding Hydrogen From Local Waste to Microgrids Provides Community Choice Aggregators and Municipalities Resiliency, Energy Independence and Decarbonization Ways2H CEO Jean-Louis Kindler & Local Power President Paul Fenn will discuss hydrogen-fueled community microgrids in an August 19 Webinar Today, as part of a nationwide movement by cities and counties to generate their own clean, locally-sourced power, renewable hydrogen solutions producer Ways2H and municipal energy consultancy Local Power announced a partnership to integrate onsite renewable hydrogen into community microgrids. The move reflects an evolution of Local Power's Community Choice Aggregation blueprint for community microgrids that includes solar with storage, and now hydrogen produced from post-consumer waste, to decarbonize and strengthen communities' resiliency. About 1,500 U.S. municipalities, representing 30 million Americans, provide Community Choice Aggregation (CCA) service and many are looking for new sources of local, affordable, reliable, renewable, resilient electricity generation. Local Power and Ways2H will meet this demand with advanced microgrids powered by zero-emission renewable hydrogen-fueled generators, solar power, battery storage and heating automation. The projects will include sustainable waste disposal through Ways2H's hydrogen production facilities, which use municipal solid waste, plastic and other refuse as a feedstock. "Our goal is to help local governments build affordable renewable energy microgrids to power their communities and critical infrastructure, from hospitals to schools, energy-critical businesses and resilience hubs for residents regardless of utility blackouts," said Local Power Founder and President Paul Fenn, who pioneered the CCA model that has spread across the United States in the past decade, and municipal Green Bond financing, now a trillion-dollar global industry. "We're tying together key components of the climate problem -- energy, decarbonization and resiliency -- and removing grid barriers to deploy local energy generation."Renewable hydrogen-fueled microgrids will help local governments reach their climate and renewable energy goals, reduce the cost of resiliency and serve communities daily and during utility grid blackouts due to extreme weather such as wildfires and powerful storms. Using locally generated waste to produce clean hydrogen will further reduce municipalities' costs for waste disposal.Local Power and Ways2H will support municipalities' use of Green Bonds or other financing options for the projects."We are bringing an integrated approach and a concrete solution that we believe many municipalities are looking for, as they seek technology and resiliency they currently don't have," said Ways2H CEO Jean-Louis Kindler. "Our waste-to-hydrogen production units are modular, transportable and easily installed onsite, close to where waste is produced and where hydrogen fuel is needed for distributed power generation and mobility."CCAs are active in California, Illinois, Massachusetts, New Hampshire, New Jersey, New York, Ohio, Rhode Island and Virginia.About Ways2HWays2H, Inc. is a global team that applies an advanced thermochemical process to convert waste biomass into renewable hydrogen, with a net zero-carbon footprint. The company's patented process extracts hydrogen from the world's worst waste streams municipal solid waste, medical refuse, plastics and organics without incineration to produce clean fuel for mobility and power generation. A joint venture between U.S.-based Clean Energy Enterprises and Japan Blue Energy Corporation, Ways2H is a unique solution for the global $400 billion+ solid waste management market and the rapidly growing hydrogen economy, estimated to reach $2.5 trillion by 2050. Please visit us at www.Ways2H.com.About Local PowerLocal Power (LocalPower.com) has spent the last 25 years creating a new energy market based on local municipal control called Community Choice Aggregation (CCA), which has been authorized in nine U.S states comprising about half of U.S. power demand. Founder Paul Fenn created the CCA model in the 1990s and invented Municipal Green Bonds to allow CCAs to finance energy localization. He developed the CCA 2.0 strategy for CCAs to optimize transitions from grid power to local renewable power that helped 67 U.S. cities and counties achieve 100% clean/renewable energy. In 2020, Local Power introduced the CCA 3.0 strategy for municipalities to decarbonize, generate their own independent renewable energy and increase their climate resiliency. SOURCE Ways2H, Inc. Related Links http://www.ways2h.com/ Answer:

Ways2H and Local Power Partner To Develop Hydrogen-Fueled Community Microgrids

LONG BEACH, Calif. and HAYDENVILLE, Mass., Aug. 18, 2020 /PRNewswire/ -- Adding Hydrogen From Local Waste to Microgrids Provides Community Choice Aggregators and Municipalities Resiliency, Energy Independence and Decarbonization Ways2H CEO Jean-Louis Kindler & Local Power President Paul Fenn will discuss hydrogen-fueled community microgrids in an August 19 Webinar Today, as part of a nationwide movement by cities and counties to generate their own clean, locally-sourced power, renewable hydrogen solutions producer Ways2H and municipal energy consultancy Local Power announced a partnership to integrate onsite renewable hydrogen into community microgrids. The move reflects an evolution of Local Power's Community Choice Aggregation blueprint for community microgrids that includes solar with storage, and now hydrogen produced from post-consumer waste, to decarbonize and strengthen communities' resiliency. About 1,500 U.S. municipalities, representing 30 million Americans, provide Community Choice Aggregation (CCA) service and many are looking for new sources of local, affordable, reliable, renewable, resilient electricity generation. Local Power and Ways2H will meet this demand with advanced microgrids powered by zero-emission renewable hydrogen-fueled generators, solar power, battery storage and heating automation. The projects will include sustainable waste disposal through Ways2H's hydrogen production facilities, which use municipal solid waste, plastic and other refuse as a feedstock. "Our goal is to help local governments build affordable renewable energy microgrids to power their communities and critical infrastructure, from hospitals to schools, energy-critical businesses and resilience hubs for residents regardless of utility blackouts," said Local Power Founder and President Paul Fenn, who pioneered the CCA model that has spread across the United States in the past decade, and municipal Green Bond financing, now a trillion-dollar global industry. "We're tying together key components of the climate problem -- energy, decarbonization and resiliency -- and removing grid barriers to deploy local energy generation."Renewable hydrogen-fueled microgrids will help local governments reach their climate and renewable energy goals, reduce the cost of resiliency and serve communities daily and during utility grid blackouts due to extreme weather such as wildfires and powerful storms. Using locally generated waste to produce clean hydrogen will further reduce municipalities' costs for waste disposal.Local Power and Ways2H will support municipalities' use of Green Bonds or other financing options for the projects."We are bringing an integrated approach and a concrete solution that we believe many municipalities are looking for, as they seek technology and resiliency they currently don't have," said Ways2H CEO Jean-Louis Kindler. "Our waste-to-hydrogen production units are modular, transportable and easily installed onsite, close to where waste is produced and where hydrogen fuel is needed for distributed power generation and mobility."CCAs are active in California, Illinois, Massachusetts, New Hampshire, New Jersey, New York, Ohio, Rhode Island and Virginia.About Ways2HWays2H, Inc. is a global team that applies an advanced thermochemical process to convert waste biomass into renewable hydrogen, with a net zero-carbon footprint. The company's patented process extracts hydrogen from the world's worst waste streams municipal solid waste, medical refuse, plastics and organics without incineration to produce clean fuel for mobility and power generation. A joint venture between U.S.-based Clean Energy Enterprises and Japan Blue Energy Corporation, Ways2H is a unique solution for the global $400 billion+ solid waste management market and the rapidly growing hydrogen economy, estimated to reach $2.5 trillion by 2050. Please visit us at www.Ways2H.com.About Local PowerLocal Power (LocalPower.com) has spent the last 25 years creating a new energy market based on local municipal control called Community Choice Aggregation (CCA), which has been authorized in nine U.S states comprising about half of U.S. power demand. Founder Paul Fenn created the CCA model in the 1990s and invented Municipal Green Bonds to allow CCAs to finance energy localization. He developed the CCA 2.0 strategy for CCAs to optimize transitions from grid power to local renewable power that helped 67 U.S. cities and counties achieve 100% clean/renewable energy. In 2020, Local Power introduced the CCA 3.0 strategy for municipalities to decarbonize, generate their own independent renewable energy and increase their climate resiliency. SOURCE Ways2H, Inc. Related Links http://www.ways2h.com/

edtsum284

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: STOCKHOLM, May 8, 2020 /PRNewswire/ -- The 2020 Annual General Meeting (AGM) of LeoVegas AB (publ) ("LeoVegas" or the "Company") was held today, 8 May 2020, at which the shareholders approved the following resolutions. Adoption of the income statement and balance sheet The AGM resolved to adopt LeoVegas' income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet Distribution of profit and dividend The AGM resolved, in accordance with the Board of Directors' proposal, that of the amount available for distribution to the shareholders, totaling EUR 36,317,631, SEK 142,314,158 shall be distributed to the shareholders, corresponding to an amount of SEK 1.40 per share, and that the remainder, EUR 22,758,736 shall be carried forward. In addition, it was resolved, in accordance with the Board of Directors' proposal, that dividends will be paid out half-yearly in the amount of SEK 0.70 per share, and that the first record date for entitlement to the dividend shall be 12 May 2020, whereby dividends will be paid out via Euroclear Sweden AB on 15 May 2020, and that the second half-yearly dividend record date shall be 12 November 2020, whereby dividends will be paid out via Euroclear Sweden AB on 17 November 2020. DISCHARGE FROM LIABILITY The board members and CEO were discharged from liability for the 2019 financial year. ELECTION OF THE BOARD OF DIRECTORS AND AUDITOR, AND DIRECTORS' AND AUDITORS' FEES The AGM resolved that the Board of Directors shall consist of seven directors and no deputy directors. It was resolved that the Company shall have a chartered auditing firm as auditor. In addition, it was resolved in accordance with the Nomination Committee's proposal that directors' fees shall amount to a total of SEK 2,800,000 including fees for committee work (preceding year: SEK 1,900,000) and shall be paid out to the directors and committee members in the following amounts: SEK 300,000 for each non-executive director and SEK 600,000 for the Chairman of the Board, provided that he is not an employee of the Company; SEK 50,000 for each non-executive director serving as a member of the Remuneration Committee, and SEK 100,000 for the Remuneration Committee chair, provided that he or she is not an employee of the Company; and SEK 50,000 for each member of the Audit Committee and SEK 100,000 for the Audit Committee chair. In addition, it was resolved that the auditor's fees shall be paid in accordance with approved invoices. Anna Frick and Fredrik Rdn were re-elected as directors on the Board. Hlne Westholm, Mathias Hallberg, Carl Larsson, Per Norman och Torsten Sderberg were elected as a new directors. Per Norman was elected as Chairman of the Board. Robin Ramm-Ericson, Mrten Forste and Tuva Palm declined re-election. PricewaterhouseCoopers AB was re-elected as the Company's auditor. PricewaterhouseCoopers AB has announced that Authorised Public Accountant Aleksander Lyckow will continue as auditor-in-charge. PRINCIPLES FOR APPOINTMENT OF THE NOMINATION COMMITTEE The AGM resolved to adopt principles for appointment of the Nomination Committee in accordance with the Nomination Committee's proposal (unchanged principles from the preceding year in all essential respects). GUIDELINES FOR REMUNERATION OF SENIOR EXECUTIVES The AGM resolved in accordance with the Board's proposal to adopt guidelines for remuneration of senior executives. WARRANT BASED INCENTIVE PROGRAM FOR EXECUTIVE MANAGEMENT AND KEY INDIVIDUALS The AGM resolved, in accordance with the board of directors' proposal, to issue a maximum of 1,000,000 warrants, with deviation from the shareholders preferential rights, which may result in a maximum increase in the Company's share capital of approximately EUR 12,000. The warrants shall entitle to subscription of new shares in the Company. The warrants shall be subscribed for by the subsidiary Gears of Leo AB, with the right and obligation to, at one or several occasions, transfer the warrants to a maximum of 50 selected members of the management team, senior executives and key employees, at a price that is not less than the fair market value of the warrant according to the Black & Scholes valuation model and otherwise on the same terms as in the issuance. The subscription price per share shall be determined to 130 percent of the volume weighted average price for the Company's share on Nasdaq Stockholm during the period of five trading days starting with the day following 12 May 2020. The warrants may be exercised for subscription of shares during the period from 1 June 2023 up to and including 30 June 2023. The maximum dilution effect of the incentive program amounts to a maximum of approximately 1.00 percent of the total number of shares and votes in the Company, assuming full subscription, acquisition and exercise of all offered warrants. AUTHORIZATION FOR THE BOARD OF DIRECTORS TO DECIDE ON REPURCHASE AND TRANSFER OF OWN SHARES The AGM resolved, in accordance with the Board's proposal, to authorize the Board of Directors to decide on purchases of the company's own shares. Share repurchases may be made only on Nasdaq Stockholm or any other regulated market. The authorization may be exercised on one or more occasions before the 2021 Annual General Meeting. The maximum number of own shares that may be repurchased so that the Company's holding of shares at any given time does not exceed 10 percent of the total number of shares in the Company. Repurchases of the Company's own shares on Nasdaq Stockholm may only be made at a price within the range of the highest purchase price and lowest selling price at any given time. Payment for the shares shall be made in cash. The AGM also resolved, in accordance with the Board's proposal, to authorize the Board of Directors to to decide on transfers of own shares, with or without deviation from the shareholders' preferential rights. Transfers may be made on (i) Nasdaq Stockholm or (ii) outside of Nasdaq Stockholm in connection with acquisitions of companies, operations or assets. The authorization may be exercised on one or more occasions before the 2021 Annual General Meeting. The maximum number of shares that may be transferred corresponds to the number of shares held by the Company at the point in time of the Board of Directors' decision on the transfer. Transfers of shares on Nasdaq Stockholm may only be made at a price within the range of the highest purchase price and lowest selling price at any given time. For transfers outside of Nasdaq Stockholm, the price shall be set so that the transfer is made at market terms. Payment for transferred shares may be made in cash, through in-kind payment, or through set-off against claims with the Company. The purpose of the authorizations is to give the Board of Directors greater scope to act and the opportunity to adapt and improve the Company's capital structure and thereby create further shareholder value and take advantage of any attractive acquisition opportunities. AUTHORIZATION FOR THE BOARD OF DIRECTORS TO DECIDE ON NEW ISSUE OF SHARES The AGM resolved, in accordance with the Board's proposal, to authorize the Board of Directors, on one or more occasions, during the time up until the next Annual General Meeting, to decide to increase the Company's share capital through a new issue of shares to such extent that it corresponds to a dilution of a maximum of 10% of the number of shares outstanding at the time of the Annual General Meeting calculated after full exercise of the issue authorization now proposed. A new issue of shares may be carried out with or without deviation from the shareholders' preferential rights. Shares issued with deviation from the shareholders' preferential rights shall be issued at market terms. The Board of Directors shall have the right to decide on other terms for the issue. Payment may be made against cash payment, in-kind payment for through set-off against claims with the Company. The purpose of the authorization is to give the Board of Directors greater scope to act and the opportunity to adapt and improve the Company's capital structure and thereby create further shareholder value and take advantage of any attractive acquisition opportunities. For detailed terms regarding the above-described resolutions at the AGM, please refer to the complete proposals, which are available on the Company's website: www.leovegasgroup.com. About LeoVegas Mobile Gaming Group LeoVegas vision and position is "King of Casino".The global groupLeoVegas Mobile Gaming Groupoffers games on Casino, Live Casino and Sport.The parent company LeoVegas AB (publ.)islocated in Sweden and its operations are mainlylocated inMalta.The company's shares are listed on Nasdaq Stockholm.www.leovegasgroup.com FOR FURTHER INFORMATION, PLEASE CONTACTPhilip DoftvikDirector of Investor Relations and Corporate Finance,+4- (0)-73-512-07-20[emailprotected] This information was brought to you by Cision http://news.cision.com https://news.cision.com/leovegas-mobile-gaming-group/r/announcement-from-leovegas-2020-annual-general-meeting,c3107645 The following files are available for download: https://mb.cision.com/Main/17434/3107645/1244624.pdf Announcement from LeoVegas 2020 Annual general meeting SOURCE LeoVegas Mobile Gaming Group Answer:

Announcement from LeoVegas 2020 Annual General Meeting

STOCKHOLM, May 8, 2020 /PRNewswire/ -- The 2020 Annual General Meeting (AGM) of LeoVegas AB (publ) ("LeoVegas" or the "Company") was held today, 8 May 2020, at which the shareholders approved the following resolutions. Adoption of the income statement and balance sheet The AGM resolved to adopt LeoVegas' income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet Distribution of profit and dividend The AGM resolved, in accordance with the Board of Directors' proposal, that of the amount available for distribution to the shareholders, totaling EUR 36,317,631, SEK 142,314,158 shall be distributed to the shareholders, corresponding to an amount of SEK 1.40 per share, and that the remainder, EUR 22,758,736 shall be carried forward. In addition, it was resolved, in accordance with the Board of Directors' proposal, that dividends will be paid out half-yearly in the amount of SEK 0.70 per share, and that the first record date for entitlement to the dividend shall be 12 May 2020, whereby dividends will be paid out via Euroclear Sweden AB on 15 May 2020, and that the second half-yearly dividend record date shall be 12 November 2020, whereby dividends will be paid out via Euroclear Sweden AB on 17 November 2020. DISCHARGE FROM LIABILITY The board members and CEO were discharged from liability for the 2019 financial year. ELECTION OF THE BOARD OF DIRECTORS AND AUDITOR, AND DIRECTORS' AND AUDITORS' FEES The AGM resolved that the Board of Directors shall consist of seven directors and no deputy directors. It was resolved that the Company shall have a chartered auditing firm as auditor. In addition, it was resolved in accordance with the Nomination Committee's proposal that directors' fees shall amount to a total of SEK 2,800,000 including fees for committee work (preceding year: SEK 1,900,000) and shall be paid out to the directors and committee members in the following amounts: SEK 300,000 for each non-executive director and SEK 600,000 for the Chairman of the Board, provided that he is not an employee of the Company; SEK 50,000 for each non-executive director serving as a member of the Remuneration Committee, and SEK 100,000 for the Remuneration Committee chair, provided that he or she is not an employee of the Company; and SEK 50,000 for each member of the Audit Committee and SEK 100,000 for the Audit Committee chair. In addition, it was resolved that the auditor's fees shall be paid in accordance with approved invoices. Anna Frick and Fredrik Rdn were re-elected as directors on the Board. Hlne Westholm, Mathias Hallberg, Carl Larsson, Per Norman och Torsten Sderberg were elected as a new directors. Per Norman was elected as Chairman of the Board. Robin Ramm-Ericson, Mrten Forste and Tuva Palm declined re-election. PricewaterhouseCoopers AB was re-elected as the Company's auditor. PricewaterhouseCoopers AB has announced that Authorised Public Accountant Aleksander Lyckow will continue as auditor-in-charge. PRINCIPLES FOR APPOINTMENT OF THE NOMINATION COMMITTEE The AGM resolved to adopt principles for appointment of the Nomination Committee in accordance with the Nomination Committee's proposal (unchanged principles from the preceding year in all essential respects). GUIDELINES FOR REMUNERATION OF SENIOR EXECUTIVES The AGM resolved in accordance with the Board's proposal to adopt guidelines for remuneration of senior executives. WARRANT BASED INCENTIVE PROGRAM FOR EXECUTIVE MANAGEMENT AND KEY INDIVIDUALS The AGM resolved, in accordance with the board of directors' proposal, to issue a maximum of 1,000,000 warrants, with deviation from the shareholders preferential rights, which may result in a maximum increase in the Company's share capital of approximately EUR 12,000. The warrants shall entitle to subscription of new shares in the Company. The warrants shall be subscribed for by the subsidiary Gears of Leo AB, with the right and obligation to, at one or several occasions, transfer the warrants to a maximum of 50 selected members of the management team, senior executives and key employees, at a price that is not less than the fair market value of the warrant according to the Black & Scholes valuation model and otherwise on the same terms as in the issuance. The subscription price per share shall be determined to 130 percent of the volume weighted average price for the Company's share on Nasdaq Stockholm during the period of five trading days starting with the day following 12 May 2020. The warrants may be exercised for subscription of shares during the period from 1 June 2023 up to and including 30 June 2023. The maximum dilution effect of the incentive program amounts to a maximum of approximately 1.00 percent of the total number of shares and votes in the Company, assuming full subscription, acquisition and exercise of all offered warrants. AUTHORIZATION FOR THE BOARD OF DIRECTORS TO DECIDE ON REPURCHASE AND TRANSFER OF OWN SHARES The AGM resolved, in accordance with the Board's proposal, to authorize the Board of Directors to decide on purchases of the company's own shares. Share repurchases may be made only on Nasdaq Stockholm or any other regulated market. The authorization may be exercised on one or more occasions before the 2021 Annual General Meeting. The maximum number of own shares that may be repurchased so that the Company's holding of shares at any given time does not exceed 10 percent of the total number of shares in the Company. Repurchases of the Company's own shares on Nasdaq Stockholm may only be made at a price within the range of the highest purchase price and lowest selling price at any given time. Payment for the shares shall be made in cash. The AGM also resolved, in accordance with the Board's proposal, to authorize the Board of Directors to to decide on transfers of own shares, with or without deviation from the shareholders' preferential rights. Transfers may be made on (i) Nasdaq Stockholm or (ii) outside of Nasdaq Stockholm in connection with acquisitions of companies, operations or assets. The authorization may be exercised on one or more occasions before the 2021 Annual General Meeting. The maximum number of shares that may be transferred corresponds to the number of shares held by the Company at the point in time of the Board of Directors' decision on the transfer. Transfers of shares on Nasdaq Stockholm may only be made at a price within the range of the highest purchase price and lowest selling price at any given time. For transfers outside of Nasdaq Stockholm, the price shall be set so that the transfer is made at market terms. Payment for transferred shares may be made in cash, through in-kind payment, or through set-off against claims with the Company. The purpose of the authorizations is to give the Board of Directors greater scope to act and the opportunity to adapt and improve the Company's capital structure and thereby create further shareholder value and take advantage of any attractive acquisition opportunities. AUTHORIZATION FOR THE BOARD OF DIRECTORS TO DECIDE ON NEW ISSUE OF SHARES The AGM resolved, in accordance with the Board's proposal, to authorize the Board of Directors, on one or more occasions, during the time up until the next Annual General Meeting, to decide to increase the Company's share capital through a new issue of shares to such extent that it corresponds to a dilution of a maximum of 10% of the number of shares outstanding at the time of the Annual General Meeting calculated after full exercise of the issue authorization now proposed. A new issue of shares may be carried out with or without deviation from the shareholders' preferential rights. Shares issued with deviation from the shareholders' preferential rights shall be issued at market terms. The Board of Directors shall have the right to decide on other terms for the issue. Payment may be made against cash payment, in-kind payment for through set-off against claims with the Company. The purpose of the authorization is to give the Board of Directors greater scope to act and the opportunity to adapt and improve the Company's capital structure and thereby create further shareholder value and take advantage of any attractive acquisition opportunities. For detailed terms regarding the above-described resolutions at the AGM, please refer to the complete proposals, which are available on the Company's website: www.leovegasgroup.com. About LeoVegas Mobile Gaming Group LeoVegas vision and position is "King of Casino".The global groupLeoVegas Mobile Gaming Groupoffers games on Casino, Live Casino and Sport.The parent company LeoVegas AB (publ.)islocated in Sweden and its operations are mainlylocated inMalta.The company's shares are listed on Nasdaq Stockholm.www.leovegasgroup.com FOR FURTHER INFORMATION, PLEASE CONTACTPhilip DoftvikDirector of Investor Relations and Corporate Finance,+4- (0)-73-512-07-20[emailprotected] This information was brought to you by Cision http://news.cision.com https://news.cision.com/leovegas-mobile-gaming-group/r/announcement-from-leovegas-2020-annual-general-meeting,c3107645 The following files are available for download: https://mb.cision.com/Main/17434/3107645/1244624.pdf Announcement from LeoVegas 2020 Annual general meeting SOURCE LeoVegas Mobile Gaming Group

edtsum286

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: RICHMOND, Va.--(BUSINESS WIRE)--Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Learn on Demand Systems on its investment from Shamrock Capital (Shamrock). The transaction was led by Derek Lewis and Bryce Walker of the Harris Williams Business Services Group and Andy Leed of the firms Technology Group. Learn on Demand Systems is a leading provider of cloud-based virtual lab environments, content, and tools that enable organizations to create and deliver hands-on learning experiences for various use cases, including IT and cybersecurity training, sales enablement and demos, and customer support, among others. Learn on Demand Systems was founded by its CEO, Corey Hynes, and recently received an investment from Quad Partners. Learn on Demand Systems is a trusted and vital partner to its clients, and its diverse suite of solutions provides engaging labs, workshops and courses to companies looking to accelerate technology learning throughout their organizations, said Derek Lewis, a managing director at Harris Williams. It was a pleasure working with the team at Learn on Demand Systems, and we are excited to see what the company accomplishes in partnership with Shamrock. We continue to see significant investment activity across the broader education technology sector, specifically in IT and cybersecurity training, where a growing digital skills gap is creating a major drag on productivity across all industries. Best-in-class companies, like Learn on Demand Systems, will continue to command strong market interest despite uncertain economic conditions, added Andy Leed, a director at Harris Williams. Learn on Demand Systems, an Inc. 5000 company, empowers organizations to accelerate technology learning through hands-on experience and skills validation. Its platforms enable organizations of all sizes, including industry leaders Microsoft, AWS, Veritas, Global Knowledge, New Horizons, and Pearson VUE, to deliver hands-on challenge-based learning, learning management, performance-based testing, and badging solutions to customers, partners, and employees. Their innovative challenge labs are paving the way for the broad adoption of performance-based testing across the IT training and certification industry. Quad Partners is a private equity firm committed to creating long-term value by investing in and building high-quality education companies. Founded in 2000, Quad Partners has managed approximately $800 million over its history. Since its inception, Quad Partners has invested in more than 60 education companies, either as platforms or add-on acquisitions. Shamrock is a Los Angeles-based investment firm with approximately $3.5 billion of assets under management, investing exclusively in the media, entertainment and communications sectors. Shamrock was originally founded in 1978 as the family investment company for the late Roy E. Disney and has since evolved into an institutional money manager with a leading group of investors including endowment and pension funds. Shamrock partners with strong management teams and takes an active, collaborative approach to creating value in each investment. In addition to its diverse portfolio of Entertainment IP, Shamrocks current investments include Ad Results Media, Adweek, Appetize, Bayard Advertising, Branded Cities, Canopy Spectrum, DeCurtis, Excel Sports Management, Iyuno Media Group, Maple Media, Mobilitie, Omega Wireless, Pixellot and Wpromote. Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across industry groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC). The Harris Williams Business Services Group has experience advising companies that provide a range of commercial, industrial and professional services. For more information on the firms Business Services Group and other recent transactions, visit the Business Services Groups section of the Harris Williams website. The Harris Williams Technology Group advises leading private and public companies, founders, and private equity, growth equity and venture capital firms on mergers and acquisitions and capital-raising transactions worldwide. The Technology Group has deep domain expertise in software and technology-enabled services and dedicated focus areas across a variety of vertical software applications and end markets. For more information on the Technology Group and its recent transactions, visit the Technology Groups section of the Harris Williams website. Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschftsfhrer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business. Answer:

Harris Williams Advises Learn on Demand Systems on its Investment from Shamrock Capital

RICHMOND, Va.--(BUSINESS WIRE)--Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Learn on Demand Systems on its investment from Shamrock Capital (Shamrock). The transaction was led by Derek Lewis and Bryce Walker of the Harris Williams Business Services Group and Andy Leed of the firms Technology Group. Learn on Demand Systems is a leading provider of cloud-based virtual lab environments, content, and tools that enable organizations to create and deliver hands-on learning experiences for various use cases, including IT and cybersecurity training, sales enablement and demos, and customer support, among others. Learn on Demand Systems was founded by its CEO, Corey Hynes, and recently received an investment from Quad Partners. Learn on Demand Systems is a trusted and vital partner to its clients, and its diverse suite of solutions provides engaging labs, workshops and courses to companies looking to accelerate technology learning throughout their organizations, said Derek Lewis, a managing director at Harris Williams. It was a pleasure working with the team at Learn on Demand Systems, and we are excited to see what the company accomplishes in partnership with Shamrock. We continue to see significant investment activity across the broader education technology sector, specifically in IT and cybersecurity training, where a growing digital skills gap is creating a major drag on productivity across all industries. Best-in-class companies, like Learn on Demand Systems, will continue to command strong market interest despite uncertain economic conditions, added Andy Leed, a director at Harris Williams. Learn on Demand Systems, an Inc. 5000 company, empowers organizations to accelerate technology learning through hands-on experience and skills validation. Its platforms enable organizations of all sizes, including industry leaders Microsoft, AWS, Veritas, Global Knowledge, New Horizons, and Pearson VUE, to deliver hands-on challenge-based learning, learning management, performance-based testing, and badging solutions to customers, partners, and employees. Their innovative challenge labs are paving the way for the broad adoption of performance-based testing across the IT training and certification industry. Quad Partners is a private equity firm committed to creating long-term value by investing in and building high-quality education companies. Founded in 2000, Quad Partners has managed approximately $800 million over its history. Since its inception, Quad Partners has invested in more than 60 education companies, either as platforms or add-on acquisitions. Shamrock is a Los Angeles-based investment firm with approximately $3.5 billion of assets under management, investing exclusively in the media, entertainment and communications sectors. Shamrock was originally founded in 1978 as the family investment company for the late Roy E. Disney and has since evolved into an institutional money manager with a leading group of investors including endowment and pension funds. Shamrock partners with strong management teams and takes an active, collaborative approach to creating value in each investment. In addition to its diverse portfolio of Entertainment IP, Shamrocks current investments include Ad Results Media, Adweek, Appetize, Bayard Advertising, Branded Cities, Canopy Spectrum, DeCurtis, Excel Sports Management, Iyuno Media Group, Maple Media, Mobilitie, Omega Wireless, Pixellot and Wpromote. Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across industry groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC). The Harris Williams Business Services Group has experience advising companies that provide a range of commercial, industrial and professional services. For more information on the firms Business Services Group and other recent transactions, visit the Business Services Groups section of the Harris Williams website. The Harris Williams Technology Group advises leading private and public companies, founders, and private equity, growth equity and venture capital firms on mergers and acquisitions and capital-raising transactions worldwide. The Technology Group has deep domain expertise in software and technology-enabled services and dedicated focus areas across a variety of vertical software applications and end markets. For more information on the Technology Group and its recent transactions, visit the Technology Groups section of the Harris Williams website. Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschftsfhrer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

edtsum287

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BOSTON--(BUSINESS WIRE)--Cohealo, the first sharing economy company in healthcare, today announced a contract with Vizient, the nation's largest member driven health care performance improvement company. The contract will provide more than half of the healthcare organizations in the United States with access to Cohealos equipment sharing platform at contracted pricing to reduce equipment needs this capital planning season and unlock savings opportunities. We are honored to be selected by Vizient as a supplier. COVID-19 has deeply impacted health system finances. Cohealo will enable providers to immediately avoid capital purchases by sharing equipment between their owned and affiliated facilities, maximizing the utilization of existing resources. Combined with the expense reductions from fewer rentals, service contracts, preventive maintenance, and storage, a substantial tranche of savings is made available for other growth initiatives, said Todd Rothenhaus, M.D., Cohealos chief executive officer. Vizient's diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers, representing more than $100 billion in annual purchasing volume. The Cohealo platform dynamically reallocates equipment for health networks, taking on all the work of logistics, conflict management, and communication between lenders and borrowers. Deep insight into equipment usage drives capital planning that disrupts the clinical equipment replacement cycle, freeing up dollars for more strategic purchases. Cohealo has conducted more than 5,000 shares of over 100 different equipment types, with expertise in mobilizing even the most delicate of assets, including microscopes, lasers, and surgical robots. If you are a Vizient member, you can email Cohealo at vizient@cohealo.com or learn more at https://info.cohealo.com/vizient. About Cohealo Based in Boston, Cohealo finds savings for health systems by increasing the utilization of their medical equipment through proactive data analytics and equipment sharing, so health systems can re-invest those dollars into growth. With deeper insights into equipment usage, hospitals can pinpoint redundant equipment, opportunities for rental avoidance, and ways to share equipment between facilities. As the program scales within a health system, the network effect drives increasing levels of savings and improves providers access to expensive medical technology. Cohealo has been named to Fast Companys Most Innovative Companies List and CNBCs Disruptor 50 and is recognized as the first solution of its type to bring the sharing economy to healthcare. Learn more at cohealo.com. Answer:

Cohealo Announces Agreement with Vizient to Bring Equipment Sharing to Member Health Systems

BOSTON--(BUSINESS WIRE)--Cohealo, the first sharing economy company in healthcare, today announced a contract with Vizient, the nation's largest member driven health care performance improvement company. The contract will provide more than half of the healthcare organizations in the United States with access to Cohealos equipment sharing platform at contracted pricing to reduce equipment needs this capital planning season and unlock savings opportunities. We are honored to be selected by Vizient as a supplier. COVID-19 has deeply impacted health system finances. Cohealo will enable providers to immediately avoid capital purchases by sharing equipment between their owned and affiliated facilities, maximizing the utilization of existing resources. Combined with the expense reductions from fewer rentals, service contracts, preventive maintenance, and storage, a substantial tranche of savings is made available for other growth initiatives, said Todd Rothenhaus, M.D., Cohealos chief executive officer. Vizient's diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers, representing more than $100 billion in annual purchasing volume. The Cohealo platform dynamically reallocates equipment for health networks, taking on all the work of logistics, conflict management, and communication between lenders and borrowers. Deep insight into equipment usage drives capital planning that disrupts the clinical equipment replacement cycle, freeing up dollars for more strategic purchases. Cohealo has conducted more than 5,000 shares of over 100 different equipment types, with expertise in mobilizing even the most delicate of assets, including microscopes, lasers, and surgical robots. If you are a Vizient member, you can email Cohealo at vizient@cohealo.com or learn more at https://info.cohealo.com/vizient. About Cohealo Based in Boston, Cohealo finds savings for health systems by increasing the utilization of their medical equipment through proactive data analytics and equipment sharing, so health systems can re-invest those dollars into growth. With deeper insights into equipment usage, hospitals can pinpoint redundant equipment, opportunities for rental avoidance, and ways to share equipment between facilities. As the program scales within a health system, the network effect drives increasing levels of savings and improves providers access to expensive medical technology. Cohealo has been named to Fast Companys Most Innovative Companies List and CNBCs Disruptor 50 and is recognized as the first solution of its type to bring the sharing economy to healthcare. Learn more at cohealo.com.

edtsum290

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Neptune Wellness Solutions Inc. (Neptune or the Company) (NASDAQ: NEPT) securities between July 24, 2019 and February 16, 2021, inclusive (the Class Period). Neptune investors have until May 17, 2021 to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. In June 2019, Neptune acquired SugarLeaf Labs, LLC and Forest Remedies LLC (collectively, "SugarLeaf"), a registered North Carolina-based commercial hemp company providing extraction services and formulated products. On February 15, 2021, Neptune announced net loss of CA$73.8 million for third quarter 2021 due in part to a CA$35.6 million impairment of goodwill and a CA$2.1 million impairment of property, plant and equipment and right-of-use assets related to the acquisition of SugarLeaf in July 2019, as well as accelerated amortization of CA$13.95 million also related to the SugarLeaf acquisition. On this news, Neptunes stock price fell $0.86 per share, or 30.71%, to close at $1.94 per share on February 16, 2021, thereby injuring investors. Then, on February 17, 2021, before the market opened, Neptune issued a press release announcing the termination of an at-the-market offering conducted by the Company, which would have raised $18.6 million in gross proceeds. Immediately after, Neptune issued a second press release announcing that the Company was conducting a $55 million registered direct offering. On this news, Neptunes stock price fell $0.21 per share, or 10.82%, to close at $1.73 per share on February 17, 2021, thereby injuring investors further. The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (2) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased Neptune securities during the Class Period, you may move the Court no later than May 17, 2021 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased Neptune securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Answer:

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Neptune Wellness Solutions Inc. (NEPT) Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Neptune Wellness Solutions Inc. (Neptune or the Company) (NASDAQ: NEPT) securities between July 24, 2019 and February 16, 2021, inclusive (the Class Period). Neptune investors have until May 17, 2021 to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. In June 2019, Neptune acquired SugarLeaf Labs, LLC and Forest Remedies LLC (collectively, "SugarLeaf"), a registered North Carolina-based commercial hemp company providing extraction services and formulated products. On February 15, 2021, Neptune announced net loss of CA$73.8 million for third quarter 2021 due in part to a CA$35.6 million impairment of goodwill and a CA$2.1 million impairment of property, plant and equipment and right-of-use assets related to the acquisition of SugarLeaf in July 2019, as well as accelerated amortization of CA$13.95 million also related to the SugarLeaf acquisition. On this news, Neptunes stock price fell $0.86 per share, or 30.71%, to close at $1.94 per share on February 16, 2021, thereby injuring investors. Then, on February 17, 2021, before the market opened, Neptune issued a press release announcing the termination of an at-the-market offering conducted by the Company, which would have raised $18.6 million in gross proceeds. Immediately after, Neptune issued a second press release announcing that the Company was conducting a $55 million registered direct offering. On this news, Neptunes stock price fell $0.21 per share, or 10.82%, to close at $1.73 per share on February 17, 2021, thereby injuring investors further. The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (2) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased Neptune securities during the Class Period, you may move the Court no later than May 17, 2021 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased Neptune securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

edtsum292

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: MILWAUKEE, Aug. 11, 2020 /PRNewswire/ --Mortgage Guaranty Insurance Corporation (MGIC), the principal subsidiary of MGIC Investment Corporation (NYSE: MTG), today announced the promotion of Danny Garcia-Velez to Vice President, Business Development. Danny Garcia-Velez Mr. Garcia-Velez has served MGIC since 2017 as Marketing Program Manager, Sr. and Marketing Program Director. Prior to this role he was a Vice President at the Homeownership Preservation Foundation where he led the program and counseling efforts. He received his education from Metropolitan State University in Saint Paul, Minn., where he studied urban planning, non-profit management and Spanish. "Danny's reputation is that of a problem-solver, a creative and critical thinker, and a leader in his relatively short tenure with MGIC," said Jay Hughes, Executive Vice President, Sales & Business Development. "His diverse skill set is a valuable asset for MGIC as we continue to transform our business and we are excited to work with him in his new role." About MGICMortgage Guaranty Insurance Corporation "MGIC" (www.mgic.com), the principal subsidiary of MGIC Investment Corporation, serves lenders throughout the United States, Puerto Rico, and other locations helping families achieve homeownership sooner by making affordable low-down-payment mortgages a reality. From time to time MGIC Investment Corporation releases important information via postings on its corporate website, and via postings on MGIC's website for information related to underwriting and pricing and intends to continue to do so in the future. Such postings include corrections of previous disclosures and may be made without any other disclosure. Investors and other interested parties are encouraged to enroll to receive automatic email alerts and Really Simple Syndication (RSS) feeds regarding new postings. Enrollment information for MGIC Investment Corporation alerts can be found at https://mtg.mgic.com/shareholder-services/email-alerts. For information about our underwriting and rates, see https://www.mgic.com/underwriting.SOURCE MGIC Investment Corporation Related Links http://www.mgic.com Answer:

MGIC promotes Danny Garcia-Velez to Vice President, Business Development

MILWAUKEE, Aug. 11, 2020 /PRNewswire/ --Mortgage Guaranty Insurance Corporation (MGIC), the principal subsidiary of MGIC Investment Corporation (NYSE: MTG), today announced the promotion of Danny Garcia-Velez to Vice President, Business Development. Danny Garcia-Velez Mr. Garcia-Velez has served MGIC since 2017 as Marketing Program Manager, Sr. and Marketing Program Director. Prior to this role he was a Vice President at the Homeownership Preservation Foundation where he led the program and counseling efforts. He received his education from Metropolitan State University in Saint Paul, Minn., where he studied urban planning, non-profit management and Spanish. "Danny's reputation is that of a problem-solver, a creative and critical thinker, and a leader in his relatively short tenure with MGIC," said Jay Hughes, Executive Vice President, Sales & Business Development. "His diverse skill set is a valuable asset for MGIC as we continue to transform our business and we are excited to work with him in his new role." About MGICMortgage Guaranty Insurance Corporation "MGIC" (www.mgic.com), the principal subsidiary of MGIC Investment Corporation, serves lenders throughout the United States, Puerto Rico, and other locations helping families achieve homeownership sooner by making affordable low-down-payment mortgages a reality. From time to time MGIC Investment Corporation releases important information via postings on its corporate website, and via postings on MGIC's website for information related to underwriting and pricing and intends to continue to do so in the future. Such postings include corrections of previous disclosures and may be made without any other disclosure. Investors and other interested parties are encouraged to enroll to receive automatic email alerts and Really Simple Syndication (RSS) feeds regarding new postings. Enrollment information for MGIC Investment Corporation alerts can be found at https://mtg.mgic.com/shareholder-services/email-alerts. For information about our underwriting and rates, see https://www.mgic.com/underwriting.SOURCE MGIC Investment Corporation Related Links http://www.mgic.com

edtsum293

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WASHINGTON, Nov. 9, 2020 /PRNewswire/ --NASA has selected 17U.S. companies for 20 partnerships to mature industry-developed space technologies for the Moon and beyond. The NASA and industry teams will design a 3D printing system for NASA's Artemis lunar exploration program, test a simple method for removing dust from planetary solar arrays, mature a first-stage rocket recovery system for a small satellite launch provider, and more. Various NASA centers will work with the companies, ranging from small businesses and large aerospace companies to a previous NASA challenge winner, to provide expertise and access to the agency's unique testing facilities. The partnerships aim to accelerate the development of emerging space capabilities. "Space technology development doesn't happen in a vacuum," said Jim Reuter, the associate administrator for NASA's Space Technology Mission Directorate (STMD), which made the selections and will manage the partnerships. "Whether companies are pursuing space ventures of their own or maturing cutting-edge systems to one day offer a new service to NASA, the agency is dedicated to helping bring new capabilities to market for our mutual benefit." NASA made the following selections through the 2020Announcement of Collaboration Opportunity(ACO). The selected proposals are relevant to technology topic areas outlined in the solicitation, including cryogenic fluid management and propulsion; advanced propulsion; sustainable power; in-situ propellant and consumable production; intelligent/resilient systems and advanced robotics; advanced materials and structures; entry, descent, and landing; and small spacecraft technologies. The selected companies are: Aerojet Rocketdyne Inc. of Redmond, Washington Ahmic Aerospace LLC of Oakwood, Ohio AI SpaceFactory Inc. of Secaucus, New Jersey Blue Origin LLC of Kent, Washington (two selections) Box Elder Innovations LLC of Corinne, Utah Cornerstone Research Group Inc. of Miamisburg, Ohio Elementum 3D Inc. of Erie, Colorado Gloyer-Taylor Laboratories LLC of Tullahoma, Tennessee IN Space LLC of West Lafayette, Indiana Orbital Sciences Corporation (Northrop Grumman Space Systems Inc.) of Dulles, Virginia pH Matter LLC of Columbus, Ohio Phase Four Inc. of El Segundo, California Rocket Lab USA Inc. of Long Beach, California Sensuron LLC of Austin, Texas Space Exploration Technologies Corp. (SpaceX) of Hawthorne, California Space Systems Loral Inc. (Maxar Technologies) of Palo Alto, California (three selections) Stellar Exploration Inc. of San Luis Obispo, California The selections will result in unfunded Space Act Agreements between the companies and NASA. The period of performance will be negotiated for each agreement, with an expected duration of between 12 and 24 months. The total estimated value of agency resources to support the agreements is approximately $15.5 million. A proposal under the advanced materials and structures topic has potential benefits on the Moon, Mars, and even Earth. AI SpaceFactory, an architectural and technology design firm and winner of NASA's 3D Printed Habitat Challenge, will develop a new material that mimics lunar regolith, or dirt. Working with NASA's Kennedy Space Center in Florida, the company will 3D print a test structure in a vacuum chamber that mimics environmental conditions on the Moon. The research could inform a 3D printing system for constructing large surface structures from in-situ materials on other worlds. On Earth, a locally sourced, high-performance 3D print material could benefit the construction industry by simplifying supply chains and reducing material waste. SpaceX will partner with NASA's Langley Research Center in Hampton, Virginia, to capture imagery and thermal measurements of its Starship vehicle during orbital re-entry over the Pacific Ocean. With the data, the company plans to advance a reusable thermal protection system, which protects the vehicle from aerodynamic heating, for missions returning from low-Earth orbit, the Moon, and Mars. The Ohio-based small business Ahmic Aerospace will also mature new thermal protection systems by partnering with NASA's Ames Research Center in California's Silicon Valley. Ahmic will use Ames' Arc Jet Complexto test hardware and collect data about how materials behave under ablative conditions. For more information about NASA's 2020 ACO selections, visit: https://go.nasa.gov/35cxYdv Through ACO, NASA helps reduce the development cost of technologies and accelerate the infusion of emerging commercial capabilities into space missions. These partnerships complement NASA's Artemis program and help prepare the agency for its future exploration endeavors. With these agreements and NASA's 2020 Tipping Point partnerships, STMD supports technology development needed to establish a sustainable presence on the Moon and for future crewed missions to Mars. For more information about NASA space tech public-private partnership opportunities, visit: https://go.nasa.gov/36NebCx SOURCE NASA Related Links http://www.nasa.gov Answer:

New NASA Partnerships to Mature Commercial Space Technologies, Capabilities

WASHINGTON, Nov. 9, 2020 /PRNewswire/ --NASA has selected 17U.S. companies for 20 partnerships to mature industry-developed space technologies for the Moon and beyond. The NASA and industry teams will design a 3D printing system for NASA's Artemis lunar exploration program, test a simple method for removing dust from planetary solar arrays, mature a first-stage rocket recovery system for a small satellite launch provider, and more. Various NASA centers will work with the companies, ranging from small businesses and large aerospace companies to a previous NASA challenge winner, to provide expertise and access to the agency's unique testing facilities. The partnerships aim to accelerate the development of emerging space capabilities. "Space technology development doesn't happen in a vacuum," said Jim Reuter, the associate administrator for NASA's Space Technology Mission Directorate (STMD), which made the selections and will manage the partnerships. "Whether companies are pursuing space ventures of their own or maturing cutting-edge systems to one day offer a new service to NASA, the agency is dedicated to helping bring new capabilities to market for our mutual benefit." NASA made the following selections through the 2020Announcement of Collaboration Opportunity(ACO). The selected proposals are relevant to technology topic areas outlined in the solicitation, including cryogenic fluid management and propulsion; advanced propulsion; sustainable power; in-situ propellant and consumable production; intelligent/resilient systems and advanced robotics; advanced materials and structures; entry, descent, and landing; and small spacecraft technologies. The selected companies are: Aerojet Rocketdyne Inc. of Redmond, Washington Ahmic Aerospace LLC of Oakwood, Ohio AI SpaceFactory Inc. of Secaucus, New Jersey Blue Origin LLC of Kent, Washington (two selections) Box Elder Innovations LLC of Corinne, Utah Cornerstone Research Group Inc. of Miamisburg, Ohio Elementum 3D Inc. of Erie, Colorado Gloyer-Taylor Laboratories LLC of Tullahoma, Tennessee IN Space LLC of West Lafayette, Indiana Orbital Sciences Corporation (Northrop Grumman Space Systems Inc.) of Dulles, Virginia pH Matter LLC of Columbus, Ohio Phase Four Inc. of El Segundo, California Rocket Lab USA Inc. of Long Beach, California Sensuron LLC of Austin, Texas Space Exploration Technologies Corp. (SpaceX) of Hawthorne, California Space Systems Loral Inc. (Maxar Technologies) of Palo Alto, California (three selections) Stellar Exploration Inc. of San Luis Obispo, California The selections will result in unfunded Space Act Agreements between the companies and NASA. The period of performance will be negotiated for each agreement, with an expected duration of between 12 and 24 months. The total estimated value of agency resources to support the agreements is approximately $15.5 million. A proposal under the advanced materials and structures topic has potential benefits on the Moon, Mars, and even Earth. AI SpaceFactory, an architectural and technology design firm and winner of NASA's 3D Printed Habitat Challenge, will develop a new material that mimics lunar regolith, or dirt. Working with NASA's Kennedy Space Center in Florida, the company will 3D print a test structure in a vacuum chamber that mimics environmental conditions on the Moon. The research could inform a 3D printing system for constructing large surface structures from in-situ materials on other worlds. On Earth, a locally sourced, high-performance 3D print material could benefit the construction industry by simplifying supply chains and reducing material waste. SpaceX will partner with NASA's Langley Research Center in Hampton, Virginia, to capture imagery and thermal measurements of its Starship vehicle during orbital re-entry over the Pacific Ocean. With the data, the company plans to advance a reusable thermal protection system, which protects the vehicle from aerodynamic heating, for missions returning from low-Earth orbit, the Moon, and Mars. The Ohio-based small business Ahmic Aerospace will also mature new thermal protection systems by partnering with NASA's Ames Research Center in California's Silicon Valley. Ahmic will use Ames' Arc Jet Complexto test hardware and collect data about how materials behave under ablative conditions. For more information about NASA's 2020 ACO selections, visit: https://go.nasa.gov/35cxYdv Through ACO, NASA helps reduce the development cost of technologies and accelerate the infusion of emerging commercial capabilities into space missions. These partnerships complement NASA's Artemis program and help prepare the agency for its future exploration endeavors. With these agreements and NASA's 2020 Tipping Point partnerships, STMD supports technology development needed to establish a sustainable presence on the Moon and for future crewed missions to Mars. For more information about NASA space tech public-private partnership opportunities, visit: https://go.nasa.gov/36NebCx SOURCE NASA Related Links http://www.nasa.gov

edtsum310

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: FISHKILL, N.Y., Jan. 12, 2021 /PRNewswire/ -- Lead Marvels, a content-syndication and lead generation solutions provider, is now servicing the Banks and Credit Unions industry with its turn-key Digital Content Hub solution.Lead Marvels first launch into this industry was the "CU Knowledge Hub" (www.cuknowledgehub.com) in partnership with CUBroadcast, an online talk show that offers insights from the industry's leading innovators, ambassadors, and game-changers, to an audience of more than 14,000 CU leaders.The CU Knowledge Hub, which is updated regularly, provides thought-leadership content such as white papers, guides, industry reports, and more from the most progressive bank and credit union vendors and suppliers.The site has generated more than 1,000 leads since September 2020. "The CU Knowledge Hub is an innovative way to provide current and relevant information and opportunities to my audience of credit union professionals," said Mike Lawson, creator, and host of CUBroadcast. "Specifically, during this pandemic, it is more important than ever to constantly communicate with your customers, members, and peers and this online solution by Lead Marvels helps to do just that without investing much time or effort." "We're excited to work with CUBroadcast and bring our Digital Content Hub solution to the credit union industry," added Michael Palacios, President of Lead Marvels. "We see a significant and growing opportunity to generate new business development and sales leads for banks and credit union suppliers and we're excited to be launching additional content hubs with other industry leaders in the immediate future including CU 2.0, among others," he said. Digital Content Hubs are a single, online location (sometimes referred to as a "Resource Center" or "Knowledge Hub") where the latest thought-leadership content can be shared digitally.Hubs can include webcasts, on-demand videos, podcasts, white papers, infographics, guides, case studies, industry reports, and more, providing professional audiences with an avenue to become educated and knowledgeable on what's available from the vendors and suppliers who serve them. The process to set up a Digital Content Hub is quick and easy. If you are looking to 1. engage your members, or reach new members, 2. drive new, profitable revenue without incurring cost, or a heavy lift, or 3. offer your sponsors a dynamic, direct-response advertising product, reach out to Lead Marvels for a no-obligation demo or visit:www.leadmarvels.com. Media Contact:Michael PalaciosPresident, Lead Marvels845.445.7210[emailprotected] SOURCE Lead Marvels, Inc. Answer:

Lead Marvels Launches Digital Content Hubs in Banks and Credit Unions Industry

FISHKILL, N.Y., Jan. 12, 2021 /PRNewswire/ -- Lead Marvels, a content-syndication and lead generation solutions provider, is now servicing the Banks and Credit Unions industry with its turn-key Digital Content Hub solution.Lead Marvels first launch into this industry was the "CU Knowledge Hub" (www.cuknowledgehub.com) in partnership with CUBroadcast, an online talk show that offers insights from the industry's leading innovators, ambassadors, and game-changers, to an audience of more than 14,000 CU leaders.The CU Knowledge Hub, which is updated regularly, provides thought-leadership content such as white papers, guides, industry reports, and more from the most progressive bank and credit union vendors and suppliers.The site has generated more than 1,000 leads since September 2020. "The CU Knowledge Hub is an innovative way to provide current and relevant information and opportunities to my audience of credit union professionals," said Mike Lawson, creator, and host of CUBroadcast. "Specifically, during this pandemic, it is more important than ever to constantly communicate with your customers, members, and peers and this online solution by Lead Marvels helps to do just that without investing much time or effort." "We're excited to work with CUBroadcast and bring our Digital Content Hub solution to the credit union industry," added Michael Palacios, President of Lead Marvels. "We see a significant and growing opportunity to generate new business development and sales leads for banks and credit union suppliers and we're excited to be launching additional content hubs with other industry leaders in the immediate future including CU 2.0, among others," he said. Digital Content Hubs are a single, online location (sometimes referred to as a "Resource Center" or "Knowledge Hub") where the latest thought-leadership content can be shared digitally.Hubs can include webcasts, on-demand videos, podcasts, white papers, infographics, guides, case studies, industry reports, and more, providing professional audiences with an avenue to become educated and knowledgeable on what's available from the vendors and suppliers who serve them. The process to set up a Digital Content Hub is quick and easy. If you are looking to 1. engage your members, or reach new members, 2. drive new, profitable revenue without incurring cost, or a heavy lift, or 3. offer your sponsors a dynamic, direct-response advertising product, reach out to Lead Marvels for a no-obligation demo or visit:www.leadmarvels.com. Media Contact:Michael PalaciosPresident, Lead Marvels845.445.7210[emailprotected] SOURCE Lead Marvels, Inc.

edtsum312

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BURLINGTON, Mass., June 10, 2020 /PRNewswire/ -- Arcadia(arcadia.io),a widely-recognized leader in population health management,announced today that over a dozen health system customers have successfully leveraged Arcadia's COVID-19 Surveillance and Engagement Toolkitand the Arcadia Analytics platform to enable their responses to the current pandemic.The company also announced the release of a COVID-19 Recovery Toolkit to support business continuity for its Accountable Care Organization (ACO) customers and other customers in value-based payment arrangements. Arcadia's Rapid Response: COVID-19 Surveillance and Engagement Toolkit As the curve from the number of infections related to COVID-19 was beginning to quickly rise in mid-March, Arcadia quickly developed a COVID-19 Surveillance and Engagement Toolkit with data and resources to help health systems in value-based payment arrangements meet the demands of the pandemic. Those resources include: stratification models to identify patients with the highest need and risk; interactive content in multiple languages for patient outreach and engagement via mobile devices; trusted information for patient access to care including hotlines, mental health programs and e-visit capabilities; and surveilling systems and data from electronic health records, information exchanges, labs, claims and directly from patients. Since the introduction of Arcadia's COVID-19 Surveillance and Engagement Toolkit, more than a dozen health systems have used Arcadia Analytics to reach patients via text message outreach and symptom screening tools, an increase of more than 400% compared to historical activity. "In a very short amount of time, we developed and deployed our toolkit to enable those grappling with the immediate crisis to use innovative methods for engaging patients remotely, extending care manager efficacy, and applying important data and insights to guide decision-making," said Michael Gleeson, Arcadia's Chief Innovation and Strategy Officer. "This accelerated adoption of virtual and telehealth care will remain, and it will become more instrumental to how population health is managed." COVID-19 Recovery: Economic Stability in Uncertain Times Arcadia maintains longitudinal health data on over 93 million patients and a robust research data asset. The company developed the following insights and predictions that show how health systems, ACOs, and those in value-based payment models should focus their non-COVID-19 resources during the next phase of the pandemic: Identifying Deferred Elective Care:As states begin to open and more activities are deemed safe, healthcare systems will need to identify patients that have deferred known elective care as well as patients likely to need elective care over the next 3-9 months. Appointment Volume Recovery & Management: Healthcare systems will want to prioritize missed or cancelled appointments based on clinical complexity, revenue considerations, or risk and quality gaps. Maximize Value from Telehealth Tools:Healthcare systems will need to stratify appointment needs by patients that would benefit from in-person care versus those that can be covered through a remote telehealth encounter. Provider organizations should engage patients with notifications that educate them about available telehealth options. Supporting Vulnerable Patient Populations: Healthcare systems will need to support patients with pre-existing medical or mental health conditions, who are likely to face colliding exacerbations due to a loss of support networks, reduced supply chain and access to necessities, and reduced access to the health care delivery system. Quality and Risk in Remote Care Delivery: Healthcare systems should use data to maximize each resource available to work with patients by supporting prioritization and enabling patient-reported outcomes. Organizations should help each care team member engage with more patients for a greater impact on overall contract success. Care Team Extenders: Healthcare systems must improve the efficiency with which care teams can engage patients and manage resource-intensive patients. One effective strategy may be to replace long data collection phone calls with patient screeners that patients complete over text. "Fundamental shifts back to patient care are already occurringdoctors are relying on telemedicine to care for patients from their homes, and hospital systems are redeploying clinicians in unique ways," Gleeson says. "Utilization is starting to bounce back and volumes are recovering from the lowest point, which occurred in April. We are seeing growth of about 30% across our data asset." Arcadia's COVID-19 Recovery Toolkit provides resources to help healthcare organizations navigate the long road back to normalcy, from extending their care teams to managing appointment volume. Arcadia offering industry-wide webinar on 6/18 highlighting customer stories, insights about recovery, and an introduction to the company's new COVID-19 Recovery Toolkit On June 18, 2020 at 1:00 PM ET, Arcadia will share successes from customers using its COVID-19 Surveillance and Engagement Toolkit and insights into the next set of challenges facing the healthcare system. Arcadia will introduce its COVID-19 Recovery Toolkit capabilities and share its analysis of the impact of COVID-19 on risk-adjusted premiums along with actions ACOs can take to protect their revenue. For more information, please visit arcadia.io. About Arcadia Arcadia(arcadia.io)is the only healthcare data and software company dedicated to healthcare organizations achieving financial success in value-based care.We work with health systems, providers, payers, and life science companies positioning themselves to win in value-based care, including some of the largest, most complex, and influential health systems and health plans in the country. Our purpose-built population health platform enables our customers to consistently overperform industry average outcomes by reducing medical expenses, improving risk coding accuracy,andimproving quality and patient health outcomes. Our software continuously aggregates and curatesthe highest quality, most complete and up-to-date data foundation,provides relevant, timely and predictive analytics,and enables action through care management tools and in-workflow insights that present at the point of care. Arcadia has off-the-shelf integration technology for more than 50 different physical and behavioral health EHR vendors, powered by machine learning that combs through variations in over 93 million longitudinal patient records across clinical, claims, social determinants of health, and operational data sources. Founded in 2002, Arcadia is headquartered outside Boston in Burlington, MA, with offices in Seattle, Pittsburgh, Chicago, and Rockford, IL.Arcadia has been recognized as a leading vendor by analysts Chilmark, Frost & Sullivan, IDC,andKLAS, and we have beenawarded Best in KLAS for Value-Based Care Managed Servicesin 2019 and 2020. Media Contacts: Alyssa Drew Director, Strategic Marketing Arcadia 781.202.3775 [emailprotected] Christopher Currington Senior Account Director Amendola Communications for Arcadia 314.799.1987 [emailprotected] SOURCE Arcadia.io Related Links https://www.arcadia.io Answer:

Arcadia Launches New COVID-19 Recovery Toolkit to Tackle Looming Challenges for Healthcare System Market leader was the first to develop a population health toolkit for COVID-19; now releases new capabilities to help with healthcare's next challenges after the pandemic's initial wave

BURLINGTON, Mass., June 10, 2020 /PRNewswire/ -- Arcadia(arcadia.io),a widely-recognized leader in population health management,announced today that over a dozen health system customers have successfully leveraged Arcadia's COVID-19 Surveillance and Engagement Toolkitand the Arcadia Analytics platform to enable their responses to the current pandemic.The company also announced the release of a COVID-19 Recovery Toolkit to support business continuity for its Accountable Care Organization (ACO) customers and other customers in value-based payment arrangements. Arcadia's Rapid Response: COVID-19 Surveillance and Engagement Toolkit As the curve from the number of infections related to COVID-19 was beginning to quickly rise in mid-March, Arcadia quickly developed a COVID-19 Surveillance and Engagement Toolkit with data and resources to help health systems in value-based payment arrangements meet the demands of the pandemic. Those resources include: stratification models to identify patients with the highest need and risk; interactive content in multiple languages for patient outreach and engagement via mobile devices; trusted information for patient access to care including hotlines, mental health programs and e-visit capabilities; and surveilling systems and data from electronic health records, information exchanges, labs, claims and directly from patients. Since the introduction of Arcadia's COVID-19 Surveillance and Engagement Toolkit, more than a dozen health systems have used Arcadia Analytics to reach patients via text message outreach and symptom screening tools, an increase of more than 400% compared to historical activity. "In a very short amount of time, we developed and deployed our toolkit to enable those grappling with the immediate crisis to use innovative methods for engaging patients remotely, extending care manager efficacy, and applying important data and insights to guide decision-making," said Michael Gleeson, Arcadia's Chief Innovation and Strategy Officer. "This accelerated adoption of virtual and telehealth care will remain, and it will become more instrumental to how population health is managed." COVID-19 Recovery: Economic Stability in Uncertain Times Arcadia maintains longitudinal health data on over 93 million patients and a robust research data asset. The company developed the following insights and predictions that show how health systems, ACOs, and those in value-based payment models should focus their non-COVID-19 resources during the next phase of the pandemic: Identifying Deferred Elective Care:As states begin to open and more activities are deemed safe, healthcare systems will need to identify patients that have deferred known elective care as well as patients likely to need elective care over the next 3-9 months. Appointment Volume Recovery & Management: Healthcare systems will want to prioritize missed or cancelled appointments based on clinical complexity, revenue considerations, or risk and quality gaps. Maximize Value from Telehealth Tools:Healthcare systems will need to stratify appointment needs by patients that would benefit from in-person care versus those that can be covered through a remote telehealth encounter. Provider organizations should engage patients with notifications that educate them about available telehealth options. Supporting Vulnerable Patient Populations: Healthcare systems will need to support patients with pre-existing medical or mental health conditions, who are likely to face colliding exacerbations due to a loss of support networks, reduced supply chain and access to necessities, and reduced access to the health care delivery system. Quality and Risk in Remote Care Delivery: Healthcare systems should use data to maximize each resource available to work with patients by supporting prioritization and enabling patient-reported outcomes. Organizations should help each care team member engage with more patients for a greater impact on overall contract success. Care Team Extenders: Healthcare systems must improve the efficiency with which care teams can engage patients and manage resource-intensive patients. One effective strategy may be to replace long data collection phone calls with patient screeners that patients complete over text. "Fundamental shifts back to patient care are already occurringdoctors are relying on telemedicine to care for patients from their homes, and hospital systems are redeploying clinicians in unique ways," Gleeson says. "Utilization is starting to bounce back and volumes are recovering from the lowest point, which occurred in April. We are seeing growth of about 30% across our data asset." Arcadia's COVID-19 Recovery Toolkit provides resources to help healthcare organizations navigate the long road back to normalcy, from extending their care teams to managing appointment volume. Arcadia offering industry-wide webinar on 6/18 highlighting customer stories, insights about recovery, and an introduction to the company's new COVID-19 Recovery Toolkit On June 18, 2020 at 1:00 PM ET, Arcadia will share successes from customers using its COVID-19 Surveillance and Engagement Toolkit and insights into the next set of challenges facing the healthcare system. Arcadia will introduce its COVID-19 Recovery Toolkit capabilities and share its analysis of the impact of COVID-19 on risk-adjusted premiums along with actions ACOs can take to protect their revenue. For more information, please visit arcadia.io. About Arcadia Arcadia(arcadia.io)is the only healthcare data and software company dedicated to healthcare organizations achieving financial success in value-based care.We work with health systems, providers, payers, and life science companies positioning themselves to win in value-based care, including some of the largest, most complex, and influential health systems and health plans in the country. Our purpose-built population health platform enables our customers to consistently overperform industry average outcomes by reducing medical expenses, improving risk coding accuracy,andimproving quality and patient health outcomes. Our software continuously aggregates and curatesthe highest quality, most complete and up-to-date data foundation,provides relevant, timely and predictive analytics,and enables action through care management tools and in-workflow insights that present at the point of care. Arcadia has off-the-shelf integration technology for more than 50 different physical and behavioral health EHR vendors, powered by machine learning that combs through variations in over 93 million longitudinal patient records across clinical, claims, social determinants of health, and operational data sources. Founded in 2002, Arcadia is headquartered outside Boston in Burlington, MA, with offices in Seattle, Pittsburgh, Chicago, and Rockford, IL.Arcadia has been recognized as a leading vendor by analysts Chilmark, Frost & Sullivan, IDC,andKLAS, and we have beenawarded Best in KLAS for Value-Based Care Managed Servicesin 2019 and 2020. Media Contacts: Alyssa Drew Director, Strategic Marketing Arcadia 781.202.3775 [emailprotected] Christopher Currington Senior Account Director Amendola Communications for Arcadia 314.799.1987 [emailprotected] SOURCE Arcadia.io Related Links https://www.arcadia.io

edtsum314

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SILVER SPRING, Md., June 7, 2020 /PRNewswire/ -- In response to public health and safety concerns about the appropriateness of decontaminating certain respirators, the agency is reissuing certain emergency use authorizations (EUAs) to specify which respirators are appropriate for decontamination. Based on the FDA's increased understanding of the performance and design of these respirators, the FDA has decided that certain respirators should not be decontaminated for reuse by health care personnel. For example, the FDA has learned from the Centers for Disease Control and Prevention's (CDC) National Institute for Occupational Safety and Health (NIOSH) testing that authorized respirators manufactured in China may vary in their design and performance. As such, the FDA has determined that the available information does not support the decontamination of these respirators and has accordingly revised the relevant EUAs. In addition, the FDA is also revising relevant EUAs to no longer authorize decontamination or reuse of respirators that have exhalation valves. "During this unprecedented global pandemic, the FDA continues to provide flexibility and adapt to the evolving needs of Americans based on data and science. We are committed to carefully evaluating available information and will continue to take action when there is a need to do so to protect the public health," said Anand Shah, M.D., FDA Deputy Commissioner for Medical and Scientific Affairs. "While we continue to support efforts to meet the urgent need for respirators, we are also doing everything in our authority to ensure health care personnel are adequately protected. As part of those efforts, we are announcing that we have revised and reissued a number of EUAs to amend which respirators are authorized to be decontaminated." Among other things, the FDA has reissued the EUAs for: Non-NIOSH-Approved Disposable Filtering Facepiece Respirators Manufactured in Chinaby revising the Scope of Authorization such that authorized respirators listed in Appendix Awill no longer be authorized if decontaminated. Multiple decontamination systems so that they 1) are no longer authorized to decontaminate respirators manufactured in China, where applicable,and 2) only authorize decontamination of non-cellulose respirators that do not have an exhalation valve that are either authorized in the NIOSH-Approved Air Purifying Respirators for Use in Health Care Settings During Response to the COVID-19 Public Health EmergencyEUA or that are authorized and identified in Exhibit 1 of the EUA for Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators to be decontaminated. According to CDC's recommendations, decontaminated respirators should only be used when new FDA-cleared N95 respirators, NIOSH-approved N95 respirators, or other FDA authorized respirators are not available. The decontamination systems are only authorized to decontaminate non-cellulose compatible N95 respirators. As such, health care personnel should not reuse a respirator that is incompatible with an authorized decontamination system but has nonetheless been decontaminated. Users of any respirator (whether or not decontaminated) should always assessfor proper fit after placement. Respirators with poor fit, visible soiling, or damage should not be used. The FDA continues to be vigilant and take prompt action on imported, non-NIOSH-approved respirators to ensure health care personnel receive adequate protection. For instance, the FDA is also reissuing the two EUAs covering imported respirators by tightening criteria in theNon-NIOSH-Approved Disposable Filtering Facepiece Respirators Manufactured in China as well as in the Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respiratorsto not only include new language related to decontamination as noted above, but also to revise the Scope of Authorization with respect to which jurisdictions are included in the criteria for eligibility in both EUAs, among other revisions. Additional Resources: Novel Coronavirus Emergency Use Authorization: Coronavirus FAQs on Shortages of Surgical Masks and Gowns During the COVID-19 Pandemic FAQs on the EUAs for Non-NIOSH Approved Respirators During the COVID-19 Pandemic Certain Filtering Facepiece Respirators from China May Not Provide Adequate Respiratory Protection - Letter to Health Care Providers Media Contact:Megan McSeveney, 202-380-7748Consumer Inquiries: 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov Answer:

Coronavirus (COVID-19) Update: FDA Reissues Emergency Use Authorizations Revising Which Types of Respirators Can Be Decontaminated for Reuse

SILVER SPRING, Md., June 7, 2020 /PRNewswire/ -- In response to public health and safety concerns about the appropriateness of decontaminating certain respirators, the agency is reissuing certain emergency use authorizations (EUAs) to specify which respirators are appropriate for decontamination. Based on the FDA's increased understanding of the performance and design of these respirators, the FDA has decided that certain respirators should not be decontaminated for reuse by health care personnel. For example, the FDA has learned from the Centers for Disease Control and Prevention's (CDC) National Institute for Occupational Safety and Health (NIOSH) testing that authorized respirators manufactured in China may vary in their design and performance. As such, the FDA has determined that the available information does not support the decontamination of these respirators and has accordingly revised the relevant EUAs. In addition, the FDA is also revising relevant EUAs to no longer authorize decontamination or reuse of respirators that have exhalation valves. "During this unprecedented global pandemic, the FDA continues to provide flexibility and adapt to the evolving needs of Americans based on data and science. We are committed to carefully evaluating available information and will continue to take action when there is a need to do so to protect the public health," said Anand Shah, M.D., FDA Deputy Commissioner for Medical and Scientific Affairs. "While we continue to support efforts to meet the urgent need for respirators, we are also doing everything in our authority to ensure health care personnel are adequately protected. As part of those efforts, we are announcing that we have revised and reissued a number of EUAs to amend which respirators are authorized to be decontaminated." Among other things, the FDA has reissued the EUAs for: Non-NIOSH-Approved Disposable Filtering Facepiece Respirators Manufactured in Chinaby revising the Scope of Authorization such that authorized respirators listed in Appendix Awill no longer be authorized if decontaminated. Multiple decontamination systems so that they 1) are no longer authorized to decontaminate respirators manufactured in China, where applicable,and 2) only authorize decontamination of non-cellulose respirators that do not have an exhalation valve that are either authorized in the NIOSH-Approved Air Purifying Respirators for Use in Health Care Settings During Response to the COVID-19 Public Health EmergencyEUA or that are authorized and identified in Exhibit 1 of the EUA for Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators to be decontaminated. According to CDC's recommendations, decontaminated respirators should only be used when new FDA-cleared N95 respirators, NIOSH-approved N95 respirators, or other FDA authorized respirators are not available. The decontamination systems are only authorized to decontaminate non-cellulose compatible N95 respirators. As such, health care personnel should not reuse a respirator that is incompatible with an authorized decontamination system but has nonetheless been decontaminated. Users of any respirator (whether or not decontaminated) should always assessfor proper fit after placement. Respirators with poor fit, visible soiling, or damage should not be used. The FDA continues to be vigilant and take prompt action on imported, non-NIOSH-approved respirators to ensure health care personnel receive adequate protection. For instance, the FDA is also reissuing the two EUAs covering imported respirators by tightening criteria in theNon-NIOSH-Approved Disposable Filtering Facepiece Respirators Manufactured in China as well as in the Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respiratorsto not only include new language related to decontamination as noted above, but also to revise the Scope of Authorization with respect to which jurisdictions are included in the criteria for eligibility in both EUAs, among other revisions. Additional Resources: Novel Coronavirus Emergency Use Authorization: Coronavirus FAQs on Shortages of Surgical Masks and Gowns During the COVID-19 Pandemic FAQs on the EUAs for Non-NIOSH Approved Respirators During the COVID-19 Pandemic Certain Filtering Facepiece Respirators from China May Not Provide Adequate Respiratory Protection - Letter to Health Care Providers Media Contact:Megan McSeveney, 202-380-7748Consumer Inquiries: 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov

edtsum316

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: FRAMINGHAM, Mass. & KEFALONIA, Greece--(BUSINESS WIRE)--Ameresco, Inc., (NYSE: AMRC), a leading cleantech integrator specializing in energy efficiency and renewable energy, today announced that its wind turbine project at Xerakia Dilinata of the Municipality of Kefalonia, Greece has completed construction and is in operation. The project is Amerescos first international wind project completed on continental Europe and expands the companys presence as a leader in renewable energy. It was secured as part of a design, build, operate and maintain contract (DBOM) contract awarded to Ameresco in 2019 by PPC Renewables SA (PPCR), a wholly owned subsidiary of Public Power Corporation SA, Greeces largest power generation company. Located against the picturesque backdrop of Kefalonia Island, the Kefalonia Wind Project tasked Ameresco with the design and construction of four 2.3 MW wind turbines that will be operated and maintained under an additional 14-year fixed price contract. The 9.8 million renewable energy project will supply clean energy to the area, ensuring that the islands natural beauty and resources are preserved for future generations. In benefitting our local communities with enhanced renewable energy solutions, we contribute to Greeces standing as a notable international player in the renewable energy space, said Konstantinos Mavros, ceo of PPCR. We have been pleased to work together in partnership with the Ameresco team and are proud to be a part of such a meaningful initiative. The Kefalonia Wind Project will advance Greeces environmental sustainability goals by improving the countrys overall environmental footprint and reducing carbon dioxide emissions by 22,000 tons each year. That figure results in savings equivalent to 4,753 passenger cars not driven, 2,475,526 gallons of gasoline not burned or 28,731 acres of pine forest conserved. PPCR will also return 3% of revenues received from the project to local governments and communities as an added cost savings benefit from the project. The beauty of Kefalonia is unmatched and were thrilled to be contributing to the preservation and betterment of the municipality and its residents both fiscally and environmentally, said Britta MacIntosh, senior vice president at Ameresco. This project demonstrates our commitment at Ameresco to providing renewable energy solutions that advance sustainability goals globally. To learn more about the energy efficiency solutions offered by Ameresco, visit www.ameresco.com/energy-efficiency/. About Ameresco, Inc. Founded in 2000, Ameresco, Inc. (NYSE:AMRC) is a leading cleantech integrator and renewable energy asset developer, owner and operator. Our comprehensive portfolio includes energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions delivered to clients throughout North America and the United Kingdom. Amerescos sustainability services in support of clients pursuit of Net Zero include upgrades to a facilitys energy infrastructure and the development, construction, and operation of distributed energy resources. Ameresco has successfully completed energy saving, environmentally responsible projects with Federal, state and local governments, healthcare and educational institutions, housing authorities, and commercial and industrial customers. With its corporate headquarters in Framingham, MA, Ameresco has more than 1,000 employees providing local expertise in the United States, Canada, and the United Kingdom. For more information, visit www.ameresco.com. About Public Power Corporation Renewables SA PPC Renewables SA (PPCR), is a wholly-owned subsidiary of the Public Power Corporation SA, Greeces largest power generation company. In 2006, PPCR inherited all Renewable Energy Source (RES) related activities (wind, small hydroelectric, solar and geothermal) from PPC, including all its technological innovation, know-how and expertise in the field of power generation. The company owns 32 Wind Farms, 18 Small Hydro and 28 Photovoltaic Power Plants with its total installed capacity reaching 250MW. For more information, visit www.ppcr.gr The announcement of a customers entry into, or completion of, a construction project contract is not necessarily indicative of the timing or amount of revenue from such contract, of the companys overall revenue for any particular period or of trends in the companys overall total project backlog. This project was included in our previously reported contracted backlog as of March 31, 2021. Answer:

Amerescos 9.2MW Wind Project for PPC Renewables Completes Construction in Kefalonia, Greece Ameresco expands international presence through partnership with renewables subsidiary of Greeces largest power generation company, Public Power Corporation

FRAMINGHAM, Mass. & KEFALONIA, Greece--(BUSINESS WIRE)--Ameresco, Inc., (NYSE: AMRC), a leading cleantech integrator specializing in energy efficiency and renewable energy, today announced that its wind turbine project at Xerakia Dilinata of the Municipality of Kefalonia, Greece has completed construction and is in operation. The project is Amerescos first international wind project completed on continental Europe and expands the companys presence as a leader in renewable energy. It was secured as part of a design, build, operate and maintain contract (DBOM) contract awarded to Ameresco in 2019 by PPC Renewables SA (PPCR), a wholly owned subsidiary of Public Power Corporation SA, Greeces largest power generation company. Located against the picturesque backdrop of Kefalonia Island, the Kefalonia Wind Project tasked Ameresco with the design and construction of four 2.3 MW wind turbines that will be operated and maintained under an additional 14-year fixed price contract. The 9.8 million renewable energy project will supply clean energy to the area, ensuring that the islands natural beauty and resources are preserved for future generations. In benefitting our local communities with enhanced renewable energy solutions, we contribute to Greeces standing as a notable international player in the renewable energy space, said Konstantinos Mavros, ceo of PPCR. We have been pleased to work together in partnership with the Ameresco team and are proud to be a part of such a meaningful initiative. The Kefalonia Wind Project will advance Greeces environmental sustainability goals by improving the countrys overall environmental footprint and reducing carbon dioxide emissions by 22,000 tons each year. That figure results in savings equivalent to 4,753 passenger cars not driven, 2,475,526 gallons of gasoline not burned or 28,731 acres of pine forest conserved. PPCR will also return 3% of revenues received from the project to local governments and communities as an added cost savings benefit from the project. The beauty of Kefalonia is unmatched and were thrilled to be contributing to the preservation and betterment of the municipality and its residents both fiscally and environmentally, said Britta MacIntosh, senior vice president at Ameresco. This project demonstrates our commitment at Ameresco to providing renewable energy solutions that advance sustainability goals globally. To learn more about the energy efficiency solutions offered by Ameresco, visit www.ameresco.com/energy-efficiency/. About Ameresco, Inc. Founded in 2000, Ameresco, Inc. (NYSE:AMRC) is a leading cleantech integrator and renewable energy asset developer, owner and operator. Our comprehensive portfolio includes energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions delivered to clients throughout North America and the United Kingdom. Amerescos sustainability services in support of clients pursuit of Net Zero include upgrades to a facilitys energy infrastructure and the development, construction, and operation of distributed energy resources. Ameresco has successfully completed energy saving, environmentally responsible projects with Federal, state and local governments, healthcare and educational institutions, housing authorities, and commercial and industrial customers. With its corporate headquarters in Framingham, MA, Ameresco has more than 1,000 employees providing local expertise in the United States, Canada, and the United Kingdom. For more information, visit www.ameresco.com. About Public Power Corporation Renewables SA PPC Renewables SA (PPCR), is a wholly-owned subsidiary of the Public Power Corporation SA, Greeces largest power generation company. In 2006, PPCR inherited all Renewable Energy Source (RES) related activities (wind, small hydroelectric, solar and geothermal) from PPC, including all its technological innovation, know-how and expertise in the field of power generation. The company owns 32 Wind Farms, 18 Small Hydro and 28 Photovoltaic Power Plants with its total installed capacity reaching 250MW. For more information, visit www.ppcr.gr The announcement of a customers entry into, or completion of, a construction project contract is not necessarily indicative of the timing or amount of revenue from such contract, of the companys overall revenue for any particular period or of trends in the companys overall total project backlog. This project was included in our previously reported contracted backlog as of March 31, 2021.

edtsum321

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SPRINGVILLE, Utah, Aug. 18, 2020 /PRNewswire/ --Patri, the leader in cloud software powering data-backed opportunity qualification and intelligent resource investments, is pleased to introduce a new Board of Advisors.Patri's Advisors include nine accomplished leaders in capture and proposal management, sales, solutions engineering, and executive leadership positions at top companies in multiple countries. The newly-formed Advisory Board is comprised of the following individuals: Sunil Agrawal, Vice President and Head of Commercial Excellence (APAC) at ISS A/S; Jeremy Brim, Managing Director at Growth Ignition; Larissa Cornelius, Managing Director at nFold; Naquan Ishman, Director of Solutions Engineering at Decision Lens; Ashley Kayes, Senior Proposal Consultant at AOC Key Solutions (KSI); Mike Mattson, Vice President of Sales and CS at OpenGov; Mike Maxwell, National Director of State & Local Government and Education (SLED) Sales at Databricks; Jennifer Namvar, Capture Director in the federal government contracting industry; and Jessie Yu, CEO at EcoInteractive. Patri CEO Josh Ellars said, "Patri's Advisors include some of the best practitioners in sales, capture management, bid and proposal management, solutions engineering, and executive leadership in India, South Africa, the U.K., and the U.S. Our collective mission is to elevate the bid and proposal, capture, solutions engineering, sales, and executive leadership professions by providing innovative data-powered solutions to pursue the right opportunities and make smarter resource investments." Patri also recently announced a partnership with AOC Key Solutions (KSI)that combines innovative bid analytics and productivity technology with the market's leading capture and proposal consulting services to help government contractors win more business in the U.S. federal, state, and local government market that spends over $7 trillion annually. To learn more about the new Capture and Bid Score Service, please visit https://info.aockeysolutions.com/capture-bid-score-service. About Patri: Patri is a software and consulting firm based in Springville, Utah, dedicated to helping companies of all industries win more business through data-powered solutions and expert services. Patri's Bid Score is an innovative SaaS solution powering data-backed qualification, intelligent resource investments, and improved win rates for top companies in multiple countries. For more information, please visit https://gopatri.com. SOURCE Patri Related Links https://gopatri.com Answer:

Patri Announces New Board of Advisors SaaS company welcomes nine advisors to guide product development and global growth

SPRINGVILLE, Utah, Aug. 18, 2020 /PRNewswire/ --Patri, the leader in cloud software powering data-backed opportunity qualification and intelligent resource investments, is pleased to introduce a new Board of Advisors.Patri's Advisors include nine accomplished leaders in capture and proposal management, sales, solutions engineering, and executive leadership positions at top companies in multiple countries. The newly-formed Advisory Board is comprised of the following individuals: Sunil Agrawal, Vice President and Head of Commercial Excellence (APAC) at ISS A/S; Jeremy Brim, Managing Director at Growth Ignition; Larissa Cornelius, Managing Director at nFold; Naquan Ishman, Director of Solutions Engineering at Decision Lens; Ashley Kayes, Senior Proposal Consultant at AOC Key Solutions (KSI); Mike Mattson, Vice President of Sales and CS at OpenGov; Mike Maxwell, National Director of State & Local Government and Education (SLED) Sales at Databricks; Jennifer Namvar, Capture Director in the federal government contracting industry; and Jessie Yu, CEO at EcoInteractive. Patri CEO Josh Ellars said, "Patri's Advisors include some of the best practitioners in sales, capture management, bid and proposal management, solutions engineering, and executive leadership in India, South Africa, the U.K., and the U.S. Our collective mission is to elevate the bid and proposal, capture, solutions engineering, sales, and executive leadership professions by providing innovative data-powered solutions to pursue the right opportunities and make smarter resource investments." Patri also recently announced a partnership with AOC Key Solutions (KSI)that combines innovative bid analytics and productivity technology with the market's leading capture and proposal consulting services to help government contractors win more business in the U.S. federal, state, and local government market that spends over $7 trillion annually. To learn more about the new Capture and Bid Score Service, please visit https://info.aockeysolutions.com/capture-bid-score-service. About Patri: Patri is a software and consulting firm based in Springville, Utah, dedicated to helping companies of all industries win more business through data-powered solutions and expert services. Patri's Bid Score is an innovative SaaS solution powering data-backed qualification, intelligent resource investments, and improved win rates for top companies in multiple countries. For more information, please visit https://gopatri.com. SOURCE Patri Related Links https://gopatri.com

edtsum324

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SILVER SPRING, Md., Feb. 4, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration has scheduled ameeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021,to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Janssen Biotech Inc. "A public discussion by the advisory committee members about the data submitted in support of safety and effectiveness of Janssen Biotech Inc.'s COVID-19 vaccine will help ensure that the public has a clear understanding of the scientific data and information that FDA will evaluate in order to make a decision about whether to authorize this vaccine," said Acting FDA Commissioner Janet Woodcock, M.D. "The FDA remains committed to keeping the public informed about our evaluation of the data for COVID-19 vaccines, so that the American public and medical community have trust and confidence in FDA-authorized vaccines." The FDA intends to make background materials available to the public, including the meeting agenda and committee roster, no later than two business days prior to the meeting. In general, advisory committees include a chair, members with scientific and public health expertise, and a consumer and industry representative. Additional members with specific expertise may be added for individual meetings as needed. The members of the VRBPAC are independent, scientific and public health experts from around the country who provide advice to the agency, which may include advice on the safety and effectiveness data submitted in the EUA request. However, final decisions on whether to authorize the vaccine for emergency use are made by the FDA. In terms of timing for convening the VRBPAC meeting following the submission of the EUA request, this amount of time will allow the FDA to thoroughly evaluate the data and information submitted in the EUA request before the meeting and to be prepared for a robust public discussion with the advisory committee members. While the FDA cannot predict how long its ongoing evaluation of the data and manufacturing information will take following the VRBPAC meeting to make a decision on the request for an EUA, the agency will review the request as expeditiously as possible, taking into consideration the discussion by the advisory committee, while still doing so in a thorough and science-based manner. The FDA intends to issue a Federal Register notice as soon as possible with details of the meeting, which will include information about a public docket for comments. At that time, public comments can be submitted. These comments will be reviewed by the FDA. The FDA intends to livestream the VRBPAC meeting on the agency's YouTube, Facebook and Twitter channels; the meeting will also be webcast from the FDA website. Additional Resources: COVID-19 Vaccines Emergency Use Authorization for Vaccines Explained Emergency Use Authorization for Vaccines to Prevent COVID-19; Guidance for Industry Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry # # # Media Contact:FDA Office of Media Affairs, 301-796-4540Consumer Inquiries: Emailor 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov Answer:

Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.'s COVID-19 Vaccine Candidate

SILVER SPRING, Md., Feb. 4, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration has scheduled ameeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021,to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Janssen Biotech Inc. "A public discussion by the advisory committee members about the data submitted in support of safety and effectiveness of Janssen Biotech Inc.'s COVID-19 vaccine will help ensure that the public has a clear understanding of the scientific data and information that FDA will evaluate in order to make a decision about whether to authorize this vaccine," said Acting FDA Commissioner Janet Woodcock, M.D. "The FDA remains committed to keeping the public informed about our evaluation of the data for COVID-19 vaccines, so that the American public and medical community have trust and confidence in FDA-authorized vaccines." The FDA intends to make background materials available to the public, including the meeting agenda and committee roster, no later than two business days prior to the meeting. In general, advisory committees include a chair, members with scientific and public health expertise, and a consumer and industry representative. Additional members with specific expertise may be added for individual meetings as needed. The members of the VRBPAC are independent, scientific and public health experts from around the country who provide advice to the agency, which may include advice on the safety and effectiveness data submitted in the EUA request. However, final decisions on whether to authorize the vaccine for emergency use are made by the FDA. In terms of timing for convening the VRBPAC meeting following the submission of the EUA request, this amount of time will allow the FDA to thoroughly evaluate the data and information submitted in the EUA request before the meeting and to be prepared for a robust public discussion with the advisory committee members. While the FDA cannot predict how long its ongoing evaluation of the data and manufacturing information will take following the VRBPAC meeting to make a decision on the request for an EUA, the agency will review the request as expeditiously as possible, taking into consideration the discussion by the advisory committee, while still doing so in a thorough and science-based manner. The FDA intends to issue a Federal Register notice as soon as possible with details of the meeting, which will include information about a public docket for comments. At that time, public comments can be submitted. These comments will be reviewed by the FDA. The FDA intends to livestream the VRBPAC meeting on the agency's YouTube, Facebook and Twitter channels; the meeting will also be webcast from the FDA website. Additional Resources: COVID-19 Vaccines Emergency Use Authorization for Vaccines Explained Emergency Use Authorization for Vaccines to Prevent COVID-19; Guidance for Industry Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry # # # Media Contact:FDA Office of Media Affairs, 301-796-4540Consumer Inquiries: Emailor 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov

edtsum328

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PALO ALTO, Calif., Jan. 19, 2021 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as the leader in the annual IMV ServiceTrak Radiation Oncology Systems report, ranking first in all nine of the tracked categories. Additionally, Varian's Net Promotor Score (NPS) improved from 78 in 2019 to 85 in 2020the highest NPS among industry competitors. NPS represents the likelihood a customer would recommend a manufacturer to a colleague. "This annual survey is very important to us because we are laser-focused on providing value to our customers, and this gives us direct feedback about how we're doing. It is a sign we are meeting and exceeding our customers' needs, which is what we strive to dobecause we never forget that our customers are helping cancer patientsthe ultimate beneficiaries when we're successful," said Kevin O'Reilly, president of Varian's Oncology Systems business. "In addition to these rankings, we are pleased at the accelerated trajectory of improvement in NPS score, year-over-year, during an especially difficult year, when our service teams really had to go the extra mile to be able to provide service safely during a pandemic. A score of 85 puts us in the top quartile of NPS scoresacross all industries," O'Reilly added. For the fourth year in a row, Varian achieved the top ratings for Best Customer Satisfaction, Best System Performance, and Best Service. In the current, 2020 report, the nine categories for which Varian ranked first included: System Uptime Meets Expectations Technology Leadership Reliability of Hardware Competence of Service Engineer Overall OEM Applications Training Program System Software Ease of Use Ease of Integration Treatment Planning Overall Service Performance Service Follow-up The IMV ServiceTrak Radiation Oncology Systems report is a survey of U.S. hospital oncology professionals who perform therapeutic radiation oncology treatments using external beam radiation therapy systems. The survey results from interviews with 345 unique radiation therapy sites representing 533 systems. Respondents participated in online data collection between April 28, 2020 August 31, 2020 and during phone interviews from July 14, 2020 September 1, 2020. About VarianAt Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visithttp://www.varian.comand follow @VarianMedSys on Twitter. About IMVIMV Medical Information Division, part of Science and Medicine Group, specializes in researching the medical imaging and other advanced healthcare technology markets. IMV's ServiceTrak annual series of reports benchmark and monitor customer satisfaction with equipment manufacturers, system performance by product type, and service providers. For more information, please visit www.imvinfo.com. Investor Relations Contact Global Anshul Maheshwari VP, Treasurer and Investor Relations 1 (650) 424-6081 [emailprotected] Press Contacts Aimee Corso Health + Commerce on behalf of Varian +1 (310) 780-2661 [emailprotected] SOURCE Varian Related Links www.varian.com Answer:

Varian Ranked Highest in Survey of US Radiation Oncology Professionals

PALO ALTO, Calif., Jan. 19, 2021 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as the leader in the annual IMV ServiceTrak Radiation Oncology Systems report, ranking first in all nine of the tracked categories. Additionally, Varian's Net Promotor Score (NPS) improved from 78 in 2019 to 85 in 2020the highest NPS among industry competitors. NPS represents the likelihood a customer would recommend a manufacturer to a colleague. "This annual survey is very important to us because we are laser-focused on providing value to our customers, and this gives us direct feedback about how we're doing. It is a sign we are meeting and exceeding our customers' needs, which is what we strive to dobecause we never forget that our customers are helping cancer patientsthe ultimate beneficiaries when we're successful," said Kevin O'Reilly, president of Varian's Oncology Systems business. "In addition to these rankings, we are pleased at the accelerated trajectory of improvement in NPS score, year-over-year, during an especially difficult year, when our service teams really had to go the extra mile to be able to provide service safely during a pandemic. A score of 85 puts us in the top quartile of NPS scoresacross all industries," O'Reilly added. For the fourth year in a row, Varian achieved the top ratings for Best Customer Satisfaction, Best System Performance, and Best Service. In the current, 2020 report, the nine categories for which Varian ranked first included: System Uptime Meets Expectations Technology Leadership Reliability of Hardware Competence of Service Engineer Overall OEM Applications Training Program System Software Ease of Use Ease of Integration Treatment Planning Overall Service Performance Service Follow-up The IMV ServiceTrak Radiation Oncology Systems report is a survey of U.S. hospital oncology professionals who perform therapeutic radiation oncology treatments using external beam radiation therapy systems. The survey results from interviews with 345 unique radiation therapy sites representing 533 systems. Respondents participated in online data collection between April 28, 2020 August 31, 2020 and during phone interviews from July 14, 2020 September 1, 2020. About VarianAt Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visithttp://www.varian.comand follow @VarianMedSys on Twitter. About IMVIMV Medical Information Division, part of Science and Medicine Group, specializes in researching the medical imaging and other advanced healthcare technology markets. IMV's ServiceTrak annual series of reports benchmark and monitor customer satisfaction with equipment manufacturers, system performance by product type, and service providers. For more information, please visit www.imvinfo.com. Investor Relations Contact Global Anshul Maheshwari VP, Treasurer and Investor Relations 1 (650) 424-6081 [emailprotected] Press Contacts Aimee Corso Health + Commerce on behalf of Varian +1 (310) 780-2661 [emailprotected] SOURCE Varian Related Links www.varian.com

edtsum330

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SILVER SPRING, Md., April 23, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremityor hand, wrist and armdisability. "Thousands of stroke survivors require rehabilitation each year. Today's authorization offers certain chronic stroke patients undergoing stroke rehabilitation an additional treatment option to help them move their hands and arms again and fills an unmet need for patients who may not have access to home-based stroke rehabilitation technologies," said Christopher M. Loftus, M.D., acting director of the Office of Neurological and Physical Medicine Devices in the FDA's Center for Devices and Radiological Health. A strokeoccurs when normal blood flow to the brain is interrupted. Brain cells obtain oxygen and nutrients from regular blood circulation, so when there is a blockage of blood flow to the brain caused by a clot (an ischemic stroke) or excessive bleeding in the brain due to a ruptured blood vessel (a hemorrhagic stroke), the brain cells can die from a lack of blood and oxygen. Although stroke is a brain disease, it can affect the entire body and sometimes causes long-term disability such as complete paralysis of one side of the body (hemiplegia) or one-sided weakness (hemiparesis) of the body. Stroke survivors may have problems with the simplest of daily activities, including speaking, walking, dressing, eating and using the bathroom. According to the Centers for Disease Control and Prevention, someone in the United States has a stroke every 40 seconds. About 795,000 people in the U.S. have a stroke each year. Post-stroke rehabilitation helps individuals overcome disabilities that result from stroke damage. The IpsiHand System uses non-invasive electroencephalography (EEG) electrodes instead of using an implanted electrode or other invasive feature to record brain activity. The EEG data is then wirelessly conveyed to a tablet for analysis of the intended muscle movement (intended motor function) and a signal is sent to a wireless electronic hand brace, which in turn moves the patient's hand. The device aims to help stroke patients improve grasping. The device is prescription-only and may be used as part of rehabilitation therapy. The FDA assessed the safety and effectiveness of the IpsiHand System device through clinical data submitted by the company, including an unblinded study of 40 patients over a 12-week trial. All participants demonstrated motor function improvement with the device over the trial. Adverse events reported included minor fatigue and discomfort and temporary skin redness. The IpsiHand System device should not be used by patients with severe spasticity or rigid contractures in the wrist and/or fingers that would prevent the electronic hand brace from being properly fit or positioned for use or those with skull defects due to craniotomy or craniectomy. The IpsiHand System device was grantedBreakthrough Devicedesignation, which is a process designed to expedite the development and review of devices that may provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The FDA reviewed the IpsiHand System device through the De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk devices of a new type. Along with this authorization, the FDA is establishing special controls for devices of this type, including requirements related to labeling and performance testing. When met, the special controls, along with general controls, provide reasonable assurance of safety and effectiveness for devices of this type. This action creates a new regulatory classification, which means that subsequent devices of the same type with the same intended use may go through the FDA's 510(k) premarket process, whereby devices can obtain clearance by demonstrating substantial equivalence to a predicate device. The FDA granted marketing authorization of the Neurolutions IpsiHand Upper Extremity Rehabilitation System to Neurolutions, Inc. Additional Resources: FDA: Breakthrough Devices Program FDA: De Novo Classification Request CDC: Stroke Facts National Institute of Neurological Disorders and Stroke: Stroke Information Page Media Contact:Shirley Simson, 202-597-4230 Consumer Inquiries: Emailor 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov Answer:

FDA Authorizes Marketing of Device to Facilitate Muscle Rehabilitation in Stroke Patients

SILVER SPRING, Md., April 23, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremityor hand, wrist and armdisability. "Thousands of stroke survivors require rehabilitation each year. Today's authorization offers certain chronic stroke patients undergoing stroke rehabilitation an additional treatment option to help them move their hands and arms again and fills an unmet need for patients who may not have access to home-based stroke rehabilitation technologies," said Christopher M. Loftus, M.D., acting director of the Office of Neurological and Physical Medicine Devices in the FDA's Center for Devices and Radiological Health. A strokeoccurs when normal blood flow to the brain is interrupted. Brain cells obtain oxygen and nutrients from regular blood circulation, so when there is a blockage of blood flow to the brain caused by a clot (an ischemic stroke) or excessive bleeding in the brain due to a ruptured blood vessel (a hemorrhagic stroke), the brain cells can die from a lack of blood and oxygen. Although stroke is a brain disease, it can affect the entire body and sometimes causes long-term disability such as complete paralysis of one side of the body (hemiplegia) or one-sided weakness (hemiparesis) of the body. Stroke survivors may have problems with the simplest of daily activities, including speaking, walking, dressing, eating and using the bathroom. According to the Centers for Disease Control and Prevention, someone in the United States has a stroke every 40 seconds. About 795,000 people in the U.S. have a stroke each year. Post-stroke rehabilitation helps individuals overcome disabilities that result from stroke damage. The IpsiHand System uses non-invasive electroencephalography (EEG) electrodes instead of using an implanted electrode or other invasive feature to record brain activity. The EEG data is then wirelessly conveyed to a tablet for analysis of the intended muscle movement (intended motor function) and a signal is sent to a wireless electronic hand brace, which in turn moves the patient's hand. The device aims to help stroke patients improve grasping. The device is prescription-only and may be used as part of rehabilitation therapy. The FDA assessed the safety and effectiveness of the IpsiHand System device through clinical data submitted by the company, including an unblinded study of 40 patients over a 12-week trial. All participants demonstrated motor function improvement with the device over the trial. Adverse events reported included minor fatigue and discomfort and temporary skin redness. The IpsiHand System device should not be used by patients with severe spasticity or rigid contractures in the wrist and/or fingers that would prevent the electronic hand brace from being properly fit or positioned for use or those with skull defects due to craniotomy or craniectomy. The IpsiHand System device was grantedBreakthrough Devicedesignation, which is a process designed to expedite the development and review of devices that may provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The FDA reviewed the IpsiHand System device through the De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk devices of a new type. Along with this authorization, the FDA is establishing special controls for devices of this type, including requirements related to labeling and performance testing. When met, the special controls, along with general controls, provide reasonable assurance of safety and effectiveness for devices of this type. This action creates a new regulatory classification, which means that subsequent devices of the same type with the same intended use may go through the FDA's 510(k) premarket process, whereby devices can obtain clearance by demonstrating substantial equivalence to a predicate device. The FDA granted marketing authorization of the Neurolutions IpsiHand Upper Extremity Rehabilitation System to Neurolutions, Inc. Additional Resources: FDA: Breakthrough Devices Program FDA: De Novo Classification Request CDC: Stroke Facts National Institute of Neurological Disorders and Stroke: Stroke Information Page Media Contact:Shirley Simson, 202-597-4230 Consumer Inquiries: Emailor 888-INFO-FDA The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. SOURCE U.S. Food and Drug Administration Related Links http://www.fda.gov

edtsum332

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SHANGHAI, April 3, 2020 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM) ("Trip.com Group" or the "Company"), a leading provider of online travel and related services, including accommodation reservation, transportation ticketing, packaged tours and in-destination services, corporate travel management, and other travel-related services, today announced that it has entered into, as borrower, a facility agreement (the "Facility Agreement") datedApril 3, 2020with certain financial institutions specified therein, for up to US$1 billion transferrable term and revolving loan facility with an incremental facility of up to US$500 million (the "Facilities"). The Facilities have a 3-yeartranche and a 5-year tranche. The proceeds borrowed under the Facilities may be used for the general working capital requirements of the Trip.com Group, including repayment of any existing financial indebtedness. About Trip.com Group Limited Trip.com Group Limited (Nasdaq: TCOM) is a leading one-stop travel service provider consisting of Trip.com, Ctrip, Skyscanner, and Qunar. Across its platforms, Trip.com Group enables local partners and travelers around the world to make informed and cost-effective bookings for travel products and services, through aggregation of comprehensive travel-related information and resources, and an advanced transaction platform consisting of mobile apps, Internet websites, and 24/7 customer service centers. Founded in 1999 and listed on Nasdaq in 2003, Trip.com Group has become one of the largest travel companies in the world in terms of gross merchandise value. For further information, please contact: Investor Relations Trip.com Group Limited Tel: +86 (21) 3406-4880 X 12229 Email: [emailprotected] SOURCE Trip.com Group Limited Answer:

Trip.com Group Announces Entry into Facility Agreement

SHANGHAI, April 3, 2020 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM) ("Trip.com Group" or the "Company"), a leading provider of online travel and related services, including accommodation reservation, transportation ticketing, packaged tours and in-destination services, corporate travel management, and other travel-related services, today announced that it has entered into, as borrower, a facility agreement (the "Facility Agreement") datedApril 3, 2020with certain financial institutions specified therein, for up to US$1 billion transferrable term and revolving loan facility with an incremental facility of up to US$500 million (the "Facilities"). The Facilities have a 3-yeartranche and a 5-year tranche. The proceeds borrowed under the Facilities may be used for the general working capital requirements of the Trip.com Group, including repayment of any existing financial indebtedness. About Trip.com Group Limited Trip.com Group Limited (Nasdaq: TCOM) is a leading one-stop travel service provider consisting of Trip.com, Ctrip, Skyscanner, and Qunar. Across its platforms, Trip.com Group enables local partners and travelers around the world to make informed and cost-effective bookings for travel products and services, through aggregation of comprehensive travel-related information and resources, and an advanced transaction platform consisting of mobile apps, Internet websites, and 24/7 customer service centers. Founded in 1999 and listed on Nasdaq in 2003, Trip.com Group has become one of the largest travel companies in the world in terms of gross merchandise value. For further information, please contact: Investor Relations Trip.com Group Limited Tel: +86 (21) 3406-4880 X 12229 Email: [emailprotected] SOURCE Trip.com Group Limited

edtsum333

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN FRANCISCO, April 27, 2020 /PRNewswire/ -- The global exoskeleton marketsize is anticipated to reach USD 4.2 billionby 2027, expanding at a CAGRof 26.3%over the forecast period, according to a new report by Grand View Research, Inc. Growing adoption of exoskeletons in healthcare and non-healthcare settings, reimbursement coverage offered on these systems, and increasing prevalence of spinal cord injuries (SCIs) are the key factors driving the market. Moreover, development in robotics and growing demand for customized exoskeleton that addresses the specific needs of the patients is anticipated to fuel the growth over the forecast period. Key suggestions from the report: The global exoskeleton market size is anticipated to reach USD 4.2 billion by 2027 owing to rising applications of these products in healthcare and non-healthcare settings Based on technology type, mobile exoskeleton accounted for a major share of 61.8% in 2019 owing to introduction of innovative mobile systems for various industrial applications On the basis of technology drive type, electric actuators dominated the global market with a revenue share of 32.1% as they are cost-effective than other drive types North America dominated the market with a value of USD 297.8 million in 2019 owing to availability of favorable reimbursement policies and increasing investments in robotics Some of the key players operating in this market are Ekso Bionics, Cyberdyne, ReWalk Laboratories, REX Bionics, and Suit X. Read 120 page research report with ToC on "Exoskeleton Market Size, Share & Trends Analysis Report By Technology Type (Mobile, Stationary), By Technology Drive Type, By End User, By Region, And Segment Forecasts, 2020 - 2027'' at:https://www.grandviewresearch.com/industry-analysis/exoskeleton-market Based on technology type, in 2019, mobile exoskeleton dominated the global market, accounting for a revenue share of 61.8%. Introduction of innovative mobile exoskeleton by manufacturers for the aging and disabled population is a key factor driving the market. However, mobile systems are complicated and expensive to design, which increases their cost. This is compelling the patients to switch to the stationary systems, thus making stationary systems the fastest growing segment in the market. On the basis of technology drive type, in 2019, electric actuators dominated the global exoskeleton market with a share of 32.1% in terms of revenue, as they are cost-effective in comparison with the other drive types. Moreover, presence of a wide variety of commercialized electric actuators is fueling the growth of this electric actuators segment. Usage of fuel cell-powered exoskeleton is increasing in military applications as they provide longer operation hours. This is anticipated to drive the fuel cell segment over the forecast period. North America dominated the global market in 2019, generating a revenue of USD 297.8 million. Increasing investments in robotics, growing geriatric population, favorable reimbursement policies, and availability of funding for various projects are anticipated to drive the regional market over the forecast period. Asia Pacific is expected to exhibit the fastest CAGR owing to growing geriatric population, improvement in the healthcare infrastructure, and increasing investments in robotics in countries, such as Japan, China, and India. Grand View Research has segmented the global exoskeleton market based on technology type, technology drive type, end user, and region: Exoskeleton Technology Type Outlook (Revenue, USD Million, 2016 - 2027) Mobile Exoskeleton Active Passive Stationary Exoskeleton Active Passive Exoskeleton Technology Drive Type Outlook (Revenue, USD Million, 2016 - 2027) Pneumatic Actuator Hydraulic Electric Servo Electric Actuator Fully Mechanical Shape Memory Alloy Actuator Fuel Cell Exoskeleton End-user Outlook (Revenue, USD Million, 2016 - 2027) Healthcare Rehabilitation Centers Elderly Care Assisted Living Facilities Military Industrial Production Construction Logistics Exoskeleton Regional Outlook (Revenue, USD Million, 2016 - 2027) North America U.S. Canada Europe U.K. Germany France Italy Spain Switzerland Asia Pacific Japan China Latin America Brazil Mexico Middle East & Africa South Africa Find more research reports on Medical Devices Industry, by Grand View Research: Patient Temperature Management Market The global patient temperature management market size was valued at USD 2.64 billion in 2018 and is expected to witness attractive CAGR of 8.5% over the forecast period. Personalized LASIK Surgery Market The global personalized LASIK surgery market size was valued at USD 1.43 billion in 2014. Growing popularity of corrective eye surgery is expected to support market growth. 3D Printed Surgical Models Market The global 3D printed surgical models market size was valued at USD 500.0 million in 2018 and is expected to exhibit a CAGR of 10.3% over the forecast period. Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry JamesCorporate Sales Specialist, USAGrand View Research, Inc.Phone: +1-415-349-0058Toll Free: 1-888-202-9519Email: [emailprotected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn| Twitter SOURCE Grand View Research, Inc. Answer:

Exoskeleton Market Size Worth $4.2 Billion by 2027 | CAGR: 26.3%: Grand View Research, Inc.

SAN FRANCISCO, April 27, 2020 /PRNewswire/ -- The global exoskeleton marketsize is anticipated to reach USD 4.2 billionby 2027, expanding at a CAGRof 26.3%over the forecast period, according to a new report by Grand View Research, Inc. Growing adoption of exoskeletons in healthcare and non-healthcare settings, reimbursement coverage offered on these systems, and increasing prevalence of spinal cord injuries (SCIs) are the key factors driving the market. Moreover, development in robotics and growing demand for customized exoskeleton that addresses the specific needs of the patients is anticipated to fuel the growth over the forecast period. Key suggestions from the report: The global exoskeleton market size is anticipated to reach USD 4.2 billion by 2027 owing to rising applications of these products in healthcare and non-healthcare settings Based on technology type, mobile exoskeleton accounted for a major share of 61.8% in 2019 owing to introduction of innovative mobile systems for various industrial applications On the basis of technology drive type, electric actuators dominated the global market with a revenue share of 32.1% as they are cost-effective than other drive types North America dominated the market with a value of USD 297.8 million in 2019 owing to availability of favorable reimbursement policies and increasing investments in robotics Some of the key players operating in this market are Ekso Bionics, Cyberdyne, ReWalk Laboratories, REX Bionics, and Suit X. Read 120 page research report with ToC on "Exoskeleton Market Size, Share & Trends Analysis Report By Technology Type (Mobile, Stationary), By Technology Drive Type, By End User, By Region, And Segment Forecasts, 2020 - 2027'' at:https://www.grandviewresearch.com/industry-analysis/exoskeleton-market Based on technology type, in 2019, mobile exoskeleton dominated the global market, accounting for a revenue share of 61.8%. Introduction of innovative mobile exoskeleton by manufacturers for the aging and disabled population is a key factor driving the market. However, mobile systems are complicated and expensive to design, which increases their cost. This is compelling the patients to switch to the stationary systems, thus making stationary systems the fastest growing segment in the market. On the basis of technology drive type, in 2019, electric actuators dominated the global exoskeleton market with a share of 32.1% in terms of revenue, as they are cost-effective in comparison with the other drive types. Moreover, presence of a wide variety of commercialized electric actuators is fueling the growth of this electric actuators segment. Usage of fuel cell-powered exoskeleton is increasing in military applications as they provide longer operation hours. This is anticipated to drive the fuel cell segment over the forecast period. North America dominated the global market in 2019, generating a revenue of USD 297.8 million. Increasing investments in robotics, growing geriatric population, favorable reimbursement policies, and availability of funding for various projects are anticipated to drive the regional market over the forecast period. Asia Pacific is expected to exhibit the fastest CAGR owing to growing geriatric population, improvement in the healthcare infrastructure, and increasing investments in robotics in countries, such as Japan, China, and India. Grand View Research has segmented the global exoskeleton market based on technology type, technology drive type, end user, and region: Exoskeleton Technology Type Outlook (Revenue, USD Million, 2016 - 2027) Mobile Exoskeleton Active Passive Stationary Exoskeleton Active Passive Exoskeleton Technology Drive Type Outlook (Revenue, USD Million, 2016 - 2027) Pneumatic Actuator Hydraulic Electric Servo Electric Actuator Fully Mechanical Shape Memory Alloy Actuator Fuel Cell Exoskeleton End-user Outlook (Revenue, USD Million, 2016 - 2027) Healthcare Rehabilitation Centers Elderly Care Assisted Living Facilities Military Industrial Production Construction Logistics Exoskeleton Regional Outlook (Revenue, USD Million, 2016 - 2027) North America U.S. Canada Europe U.K. Germany France Italy Spain Switzerland Asia Pacific Japan China Latin America Brazil Mexico Middle East & Africa South Africa Find more research reports on Medical Devices Industry, by Grand View Research: Patient Temperature Management Market The global patient temperature management market size was valued at USD 2.64 billion in 2018 and is expected to witness attractive CAGR of 8.5% over the forecast period. Personalized LASIK Surgery Market The global personalized LASIK surgery market size was valued at USD 1.43 billion in 2014. Growing popularity of corrective eye surgery is expected to support market growth. 3D Printed Surgical Models Market The global 3D printed surgical models market size was valued at USD 500.0 million in 2018 and is expected to exhibit a CAGR of 10.3% over the forecast period. Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry JamesCorporate Sales Specialist, USAGrand View Research, Inc.Phone: +1-415-349-0058Toll Free: 1-888-202-9519Email: [emailprotected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn| Twitter SOURCE Grand View Research, Inc.

edtsum338

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BERKELEY, Calif., Nov. 11, 2020 /PRNewswire/ -- Honeit, a leading interview technology software provider, today announced thatSteve Cadigan, a highly sought-after talent advisor to leaders and organizations across the globe, will join its Advisory Board. "Honeit is thrilled to welcome Steve Cadigan to our Advisory Board. We couldn't be more excited to work with Steve. His experience scaling LinkedIn, while transforming the recruitment industry is an incredible combination," saidNick Livingston, Co-founder and CEO. Based in Berkeley, CA, the Honeit interview platform combines scheduling automation, conversation intelligence and interview collaboration to help remote recruiting, hiring and research teamsscreen and assess talent faster, together. Honeit improves the interview experience and simplifies the hiring process through better conversations and unbiased interview data. The platform streamlines four critical steps in the hiring process attracting, scheduling, screening and assessing candidates. Honeit was designed by recruiters to play nice with any ATS or CRM through light-weight scheduling links, secure share links and API integrations. "We believe conversations with candidates and hiring managers are full of (talent) insights and are excited to help companies capture, search and share interview intelligence," saidJames Craft,Co-founder and CTO. "Recruiting is the most important muscle a company needs to develop if they want to win in today's dynamic digital economy. Every company is looking for a competitive advantage in how they hire top talent and Honeit not only delivers a big advantage, but it also enables companies to be more strategic, efficient and effective in their recruiting flow. I could not be more excited to be part of this team," saidSteve Cadigan, Founder of Cadigan Talent Ventures. Steve Cadigan speaks regularly at conferences and major Universities and is retained by Silicon Valley's top VC's for his talent expertise. He is a regular guest on Bloomberg West and CNBC. Prior to launching his own firm, Steve worked as an HR executive for over 25 years at a wide range of top-tier companies including: ESPRIT, Allianz, Cisco Systems, Electronic Arts and capped by serving as the first CHRO for LinkedIn from 2009 through 2012. His culture work at LinkedIn led Stanford to build a case study for their business school. Today, Steve serves on the Board of Directors to three companies and on the Advisory Board of several others. He holds a BA in History from Wesleyan and an MA in HROD from the University of San Francisco. For more information, visit https://www.honeit.com/. Contacts for media inquiries: Beatriz Arana, 34 634 691 473 [emailprotected] SOURCE Honeit Related Links https://www.honeit.com/ Answer:

Steve Cadigan Joins the Honeit Advisory Board

BERKELEY, Calif., Nov. 11, 2020 /PRNewswire/ -- Honeit, a leading interview technology software provider, today announced thatSteve Cadigan, a highly sought-after talent advisor to leaders and organizations across the globe, will join its Advisory Board. "Honeit is thrilled to welcome Steve Cadigan to our Advisory Board. We couldn't be more excited to work with Steve. His experience scaling LinkedIn, while transforming the recruitment industry is an incredible combination," saidNick Livingston, Co-founder and CEO. Based in Berkeley, CA, the Honeit interview platform combines scheduling automation, conversation intelligence and interview collaboration to help remote recruiting, hiring and research teamsscreen and assess talent faster, together. Honeit improves the interview experience and simplifies the hiring process through better conversations and unbiased interview data. The platform streamlines four critical steps in the hiring process attracting, scheduling, screening and assessing candidates. Honeit was designed by recruiters to play nice with any ATS or CRM through light-weight scheduling links, secure share links and API integrations. "We believe conversations with candidates and hiring managers are full of (talent) insights and are excited to help companies capture, search and share interview intelligence," saidJames Craft,Co-founder and CTO. "Recruiting is the most important muscle a company needs to develop if they want to win in today's dynamic digital economy. Every company is looking for a competitive advantage in how they hire top talent and Honeit not only delivers a big advantage, but it also enables companies to be more strategic, efficient and effective in their recruiting flow. I could not be more excited to be part of this team," saidSteve Cadigan, Founder of Cadigan Talent Ventures. Steve Cadigan speaks regularly at conferences and major Universities and is retained by Silicon Valley's top VC's for his talent expertise. He is a regular guest on Bloomberg West and CNBC. Prior to launching his own firm, Steve worked as an HR executive for over 25 years at a wide range of top-tier companies including: ESPRIT, Allianz, Cisco Systems, Electronic Arts and capped by serving as the first CHRO for LinkedIn from 2009 through 2012. His culture work at LinkedIn led Stanford to build a case study for their business school. Today, Steve serves on the Board of Directors to three companies and on the Advisory Board of several others. He holds a BA in History from Wesleyan and an MA in HROD from the University of San Francisco. For more information, visit https://www.honeit.com/. Contacts for media inquiries: Beatriz Arana, 34 634 691 473 [emailprotected] SOURCE Honeit Related Links https://www.honeit.com/

edtsum339

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "United States Gutters & Downspouts Market 2021" report has been added to ResearchAndMarkets.com's offering. This study analyzes US demand for gutter and downspout products (also referred to as rainware) by product, market, material, and region. Historical data for 2010, 2015, and 2020 and forecasts for 2025 and 2030 are presented in dollars and in linear feet (excluding hardware and accessories). Gutter and downspout demand is segmented into the following product categories: For the purposes of this report, gutter guards that are part of one-piece gutter systems are counted as gutters. The gutter and downspout market segments analyzed are: Excluded from the definition of residential buildings are housing units located in a structure whose primary purpose is something other than habitation. Thus, a small living space contained in a larger retail facility would be classified as part of a retail building and not a residential building. The gutter and downspout materials addressed in the study are: Additionally, demand for gutter and downspout products is broken out for the following US geographic regions and subregions: Key Topics Covered: 1. Executive Summary 2. COVID-19 Pandemic 3. Overview 4. Gutters 5. Downspouts 6. Gutter Guards 7. Hardware & Accessories 8. Aluminum Gutters & Downspouts 9. Steel Gutters & Downspouts 10. Plastic Gutters & Downspouts 11. Copper, Zinc, & Other Gutter & Downspout Materials 12. Residential Gutters & Downspouts 13. Commercial Gutters & Downspouts 14. Regional Trends 15. Key Suppliers & Market Share 16. Appendix For more information about this report visit https://www.researchandmarkets.com/r/6j6fnt Answer:

United States Gutters & Downspouts Market Report 2021: Historical Data for 2010, 2015, and 2020 and Forecasts for 2025 and 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Gutters & Downspouts Market 2021" report has been added to ResearchAndMarkets.com's offering. This study analyzes US demand for gutter and downspout products (also referred to as rainware) by product, market, material, and region. Historical data for 2010, 2015, and 2020 and forecasts for 2025 and 2030 are presented in dollars and in linear feet (excluding hardware and accessories). Gutter and downspout demand is segmented into the following product categories: For the purposes of this report, gutter guards that are part of one-piece gutter systems are counted as gutters. The gutter and downspout market segments analyzed are: Excluded from the definition of residential buildings are housing units located in a structure whose primary purpose is something other than habitation. Thus, a small living space contained in a larger retail facility would be classified as part of a retail building and not a residential building. The gutter and downspout materials addressed in the study are: Additionally, demand for gutter and downspout products is broken out for the following US geographic regions and subregions: Key Topics Covered: 1. Executive Summary 2. COVID-19 Pandemic 3. Overview 4. Gutters 5. Downspouts 6. Gutter Guards 7. Hardware & Accessories 8. Aluminum Gutters & Downspouts 9. Steel Gutters & Downspouts 10. Plastic Gutters & Downspouts 11. Copper, Zinc, & Other Gutter & Downspout Materials 12. Residential Gutters & Downspouts 13. Commercial Gutters & Downspouts 14. Regional Trends 15. Key Suppliers & Market Share 16. Appendix For more information about this report visit https://www.researchandmarkets.com/r/6j6fnt

edtsum345

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ISSOIRE, France & GRENOBLE, France--(BUSINESS WIRE)--Regulatory News: BIOCORP (FR0012788065 ALCOR / Eligible PEA PME) (Paris:ALCOR), a French company specialized in the development and manufacturing of medical devices and connected solutions in the health sector and Diabeloop, a young company, pioneer in therapeutic artificial intelligence with personalized and automated solutions for the management of diabetes treatment, announce today a cooperation agreement. This collaboration aims to unite the expertise of both companies to offer new, simple and personalized treatment options to people living with diabetes. Diabeloop has developed Automated Insulin Delivery (AID) systems including a self-learning algorithm hosted in a dedicated handset and connected to a Continuous Glucose Monitoring (CGM) solution and an insulin pump. The artificial intelligence developed by Diabeloop analyzes glucose data, calculates the right dose of insulin to be administered and automatically administers it. For its part, BIOCORP has developed and markets Mallya, an intelligent sensor for insulin injection pens, and the first in its class to receive CE marking (class IIb). Compatible with any disposable insulin pens, it enables reliable monitoring of doses selected for injection and offers patients with diabetes better compliance with their treatment. Through this agreement and the integration of Mallya into Diabeloop's technological environment, patients equipped with insulin pens will benefit from a unique, easy-to-use and personalized solution to improve their quality of care and life on a daily basis. Eric Dessertenne, CEO of BIOCORP, explained: "We are very pleased to combine our R&D capabilities with the common ambition to improve the quality of care for patients with diabetes. The technological platform developed by Diabeloop in the field of insulin pumps, which reproduces the functioning of the pancreas thanks to AI, has real potential in the insulin pen market. Insulin-dependent people, users of these pens, are indeed looking for digital services that are increasingly rich in information and advice for better compliance with their insulin intake". Marc Julien, co-CEO of Diabeloop, added: "We are delighted with this agreement with Biocorp, a partner with great expertise. This cooperation opens up new opportunities to bring Diabeloop's simple and personalized interoperable technology to people living with diabetes who use insulin pens to perform their multiple insulin injections every day. The disposable insulin pen market is estimated to be worth more than $9 billion by 2022 in the top 10 markets (United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil)1. References: 1Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 2022 - WiseGuyReports ABOUT DIABELOOP Diabeloops mission: to relieve people living with Type 1 diabetes from dozens of therapeutic decisions and reduce their heavy mental burden. Initially conceived from a medical research project, Diabeloop was created in 2015 by Dr. Guillaume Charpentier, now Chief Medical Officer, and Erik Huneker who has co-managed the company with Marc Julien since 2016. This complementary management team works with experienced partners, CEA-Leti (a research laboratory) and CERITD (a French research team of diabetologists). In 2018, DBLG1 System, Diabeloops first medical device for automated diabetes management, obtained CE marking, followed by DBL-hu, its solution for highly unstable Type 1 diabetes management in 2020. A second round of financing of 31 million euros concluded in November 2019 to speed up the international commercial rollout of the DBLG1 iController and support an ambitious R&D program. The company is supported by several investors and industrial groups in the healthcare sector, including CERITD, Aliad, Cemag Invest, Sofimac Innovation, Supernova Invest, Kreaxi, Crdit Agricole, Odysse Venture, Agiradom, as well as business angels. Today, Diabeloop gathers the personality, the passion and the skills of close to 100 talented individuals who work hard to improve the quality of life for every person living with Type 1 diabetes. ABOUT BIOCORP Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This smart sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of patients with diabetes. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 70 employees. BIOCORP is listed on Euronext since July 2015 (FR0012788065 ALCOR). For more information, please visit www.biocorpsys.com. Answer:

BIOCORP and Diabeloop Announce Co-Development Agreement in Personalized Diabetes Management Integration of automated solutions into the insulin smart pen market

ISSOIRE, France & GRENOBLE, France--(BUSINESS WIRE)--Regulatory News: BIOCORP (FR0012788065 ALCOR / Eligible PEA PME) (Paris:ALCOR), a French company specialized in the development and manufacturing of medical devices and connected solutions in the health sector and Diabeloop, a young company, pioneer in therapeutic artificial intelligence with personalized and automated solutions for the management of diabetes treatment, announce today a cooperation agreement. This collaboration aims to unite the expertise of both companies to offer new, simple and personalized treatment options to people living with diabetes. Diabeloop has developed Automated Insulin Delivery (AID) systems including a self-learning algorithm hosted in a dedicated handset and connected to a Continuous Glucose Monitoring (CGM) solution and an insulin pump. The artificial intelligence developed by Diabeloop analyzes glucose data, calculates the right dose of insulin to be administered and automatically administers it. For its part, BIOCORP has developed and markets Mallya, an intelligent sensor for insulin injection pens, and the first in its class to receive CE marking (class IIb). Compatible with any disposable insulin pens, it enables reliable monitoring of doses selected for injection and offers patients with diabetes better compliance with their treatment. Through this agreement and the integration of Mallya into Diabeloop's technological environment, patients equipped with insulin pens will benefit from a unique, easy-to-use and personalized solution to improve their quality of care and life on a daily basis. Eric Dessertenne, CEO of BIOCORP, explained: "We are very pleased to combine our R&D capabilities with the common ambition to improve the quality of care for patients with diabetes. The technological platform developed by Diabeloop in the field of insulin pumps, which reproduces the functioning of the pancreas thanks to AI, has real potential in the insulin pen market. Insulin-dependent people, users of these pens, are indeed looking for digital services that are increasingly rich in information and advice for better compliance with their insulin intake". Marc Julien, co-CEO of Diabeloop, added: "We are delighted with this agreement with Biocorp, a partner with great expertise. This cooperation opens up new opportunities to bring Diabeloop's simple and personalized interoperable technology to people living with diabetes who use insulin pens to perform their multiple insulin injections every day. The disposable insulin pen market is estimated to be worth more than $9 billion by 2022 in the top 10 markets (United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil)1. References: 1Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 2022 - WiseGuyReports ABOUT DIABELOOP Diabeloops mission: to relieve people living with Type 1 diabetes from dozens of therapeutic decisions and reduce their heavy mental burden. Initially conceived from a medical research project, Diabeloop was created in 2015 by Dr. Guillaume Charpentier, now Chief Medical Officer, and Erik Huneker who has co-managed the company with Marc Julien since 2016. This complementary management team works with experienced partners, CEA-Leti (a research laboratory) and CERITD (a French research team of diabetologists). In 2018, DBLG1 System, Diabeloops first medical device for automated diabetes management, obtained CE marking, followed by DBL-hu, its solution for highly unstable Type 1 diabetes management in 2020. A second round of financing of 31 million euros concluded in November 2019 to speed up the international commercial rollout of the DBLG1 iController and support an ambitious R&D program. The company is supported by several investors and industrial groups in the healthcare sector, including CERITD, Aliad, Cemag Invest, Sofimac Innovation, Supernova Invest, Kreaxi, Crdit Agricole, Odysse Venture, Agiradom, as well as business angels. Today, Diabeloop gathers the personality, the passion and the skills of close to 100 talented individuals who work hard to improve the quality of life for every person living with Type 1 diabetes. ABOUT BIOCORP Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This smart sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of patients with diabetes. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 70 employees. BIOCORP is listed on Euronext since July 2015 (FR0012788065 ALCOR). For more information, please visit www.biocorpsys.com.

edtsum350

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PITTSBURGH, July 2, 2020 /PRNewswire/ -- F.N.B. Corporation (NYSE: FNB) announced today that it plans to issue financial results for the second quarter of 2020, at 6:00 PM ET Thursday, July 16, 2020. Chairman, President and Chief Executive Officer, Vincent J. Delie, Jr., Chief Financial Officer, Vincent J. Calabrese, Jr., and Chief Credit Officer, Gary L. Guerrieri, plan to host a conference call to discuss the Company's financial results on Friday, July 17, 2020, 8:15 AM ET. Participants are encouraged to pre-register for the conference call at:http://dpregister.com/10145866.Callers who pre-register will be provided a conference passcode and unique PIN to bypass the live operator and gain immediate access to the call. Participants may pre-register at any time, including up to and after the call start time. Dial-in Access: The conference call may be accessed by dialing 844-802-2440 (for domestic callers) or 412-317-5133 (for international callers). Participants should ask to be joined into the F.N.B. Corporation call. Webcast Access: The audio-only call and related presentation materials may be accessed via webcast through the "Investor Relations" section of the Corporation's website at www.fnbcorporation.com. Access to the live webcast will begin approximately 30 minutes prior to the start of the call. Presentation Materials: Presentation slides and the earnings release will also be available on the Corporation's website at www.fnbcorporation.com, by accessing the "About Us" tab and clicking on "Investor Relations" then "Investor Conference Calls." A replay of the call will be available shortly after the completion of the call until midnight ET on Friday, July 24, 2020. The replay can be accessed by dialing 877-344-7529 (for domestic callers) or 412-317-0088 (for international callers); the conference replay access code is 10145866. Following the call, a link to the webcast and the related presentation materials will be posted to the "Shareholder and Investor Relations" section of F.N.B. Corporation's website at www.fnbcorporation.com. About F.N.B. CorporationF.N.B. Corporation (NYSE: FNB), headquartered in Pittsburgh, Pennsylvania, is a diversified financial services company operating in seven states and the District of Columbia. FNB's market coverage spans several major metropolitan areas including: Pittsburgh, Pennsylvania; Baltimore, Maryland; Cleveland, Ohio; Washington, D.C.; and Charlotte, Raleigh, Durham and the Piedmont Triad (Winston-Salem, Greensboro and High Point) in North Carolina. The Company has total assets of more than $35 billion and approximately 350 banking offices throughout Pennsylvania, Ohio, Maryland, West Virginia, North Carolina, South Carolina and Virginia. FNB provides a full range of commercial banking, consumer banking and wealth management solutions through its subsidiary network which is led by its largest affiliate, First National Bank of Pennsylvania, founded in 1864. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, government banking, business credit, capital markets and lease financing. The consumer banking segment provides a full line of consumer banking products and services, including deposit products, mortgage lending, consumer lending and a complete suite of mobile and online banking services. FNB's wealth management services include asset management, private banking and insurance. The common stock of F.N.B. Corporation trades on the New York Stock Exchange under the symbol "FNB" and is included in Standard & Poor's MidCap 400 Index with the Global Industry Classification Standard (GICS) Regional Banks Sub-Industry Index. Customers, shareholders and investors can learn more about this regional financial institution by visiting the F.N.B. Corporation website at www.fnbcorporation.com. SOURCE F.N.B. Corporation Related Links http://www.fnbcorporation.com Answer:

F.N.B. Corporation Schedules Second Quarter 2020 Earnings Report and Conference Call

PITTSBURGH, July 2, 2020 /PRNewswire/ -- F.N.B. Corporation (NYSE: FNB) announced today that it plans to issue financial results for the second quarter of 2020, at 6:00 PM ET Thursday, July 16, 2020. Chairman, President and Chief Executive Officer, Vincent J. Delie, Jr., Chief Financial Officer, Vincent J. Calabrese, Jr., and Chief Credit Officer, Gary L. Guerrieri, plan to host a conference call to discuss the Company's financial results on Friday, July 17, 2020, 8:15 AM ET. Participants are encouraged to pre-register for the conference call at:http://dpregister.com/10145866.Callers who pre-register will be provided a conference passcode and unique PIN to bypass the live operator and gain immediate access to the call. Participants may pre-register at any time, including up to and after the call start time. Dial-in Access: The conference call may be accessed by dialing 844-802-2440 (for domestic callers) or 412-317-5133 (for international callers). Participants should ask to be joined into the F.N.B. Corporation call. Webcast Access: The audio-only call and related presentation materials may be accessed via webcast through the "Investor Relations" section of the Corporation's website at www.fnbcorporation.com. Access to the live webcast will begin approximately 30 minutes prior to the start of the call. Presentation Materials: Presentation slides and the earnings release will also be available on the Corporation's website at www.fnbcorporation.com, by accessing the "About Us" tab and clicking on "Investor Relations" then "Investor Conference Calls." A replay of the call will be available shortly after the completion of the call until midnight ET on Friday, July 24, 2020. The replay can be accessed by dialing 877-344-7529 (for domestic callers) or 412-317-0088 (for international callers); the conference replay access code is 10145866. Following the call, a link to the webcast and the related presentation materials will be posted to the "Shareholder and Investor Relations" section of F.N.B. Corporation's website at www.fnbcorporation.com. About F.N.B. CorporationF.N.B. Corporation (NYSE: FNB), headquartered in Pittsburgh, Pennsylvania, is a diversified financial services company operating in seven states and the District of Columbia. FNB's market coverage spans several major metropolitan areas including: Pittsburgh, Pennsylvania; Baltimore, Maryland; Cleveland, Ohio; Washington, D.C.; and Charlotte, Raleigh, Durham and the Piedmont Triad (Winston-Salem, Greensboro and High Point) in North Carolina. The Company has total assets of more than $35 billion and approximately 350 banking offices throughout Pennsylvania, Ohio, Maryland, West Virginia, North Carolina, South Carolina and Virginia. FNB provides a full range of commercial banking, consumer banking and wealth management solutions through its subsidiary network which is led by its largest affiliate, First National Bank of Pennsylvania, founded in 1864. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, government banking, business credit, capital markets and lease financing. The consumer banking segment provides a full line of consumer banking products and services, including deposit products, mortgage lending, consumer lending and a complete suite of mobile and online banking services. FNB's wealth management services include asset management, private banking and insurance. The common stock of F.N.B. Corporation trades on the New York Stock Exchange under the symbol "FNB" and is included in Standard & Poor's MidCap 400 Index with the Global Industry Classification Standard (GICS) Regional Banks Sub-Industry Index. Customers, shareholders and investors can learn more about this regional financial institution by visiting the F.N.B. Corporation website at www.fnbcorporation.com. SOURCE F.N.B. Corporation Related Links http://www.fnbcorporation.com

edtsum352

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WASHINGTON, April 29, 2021 /PRNewswire/ -- The pandemic has pushed three million women out of the workforce, over 1.5 million mothers, amounting to $64 billion dollars in lost wages, according to the U.S. Bureau of Labor Statistics. Former news reporter and columnist, Leslie Yeransian-Dolsak, recognizes mothers for stepping up to the plate during the pandemic with her new children's book, "My Important Girl." Continue Reading Book Cover These natural caretakers have had to lean-out of the workforce during the COVID-19 public health crisis. With school closures, a shortage of childcare resources, and grandparents unable to turn to, women and mothers have been no longer able to outsource many essential caretaking roles and are experiencing a she-cession. "My Important Girl" spotlights the many roles a mother has, no matter how mundane or minor. From cook to historian to teacher to cheerleader, mothers have been the backbone of children's lives during this public health crisis. On this Mother's Day there is no better time to celebrate mothers than now. The past 13 months has hit caretakers hard, with half of mothers who left the workforce during the pandemic stating they will not return anytime soon. Three out of four mothers indicate levels of depression, anxiety or toxic stress. Hardest hit by the pandemic, single mothers Asian and Hispanic, nearing levels of 10% unemployment, having to leave their jobs to care for their children, mainly because their jobs didn't offer remote options."While we openly talk about 'leaning into' the workforce, we really need to take a moment to praise the women, the mothers who have had to pick up the rubble of this public health crisis," said author Yeransian-Dolsak. "They were given no choice other than to hunker down and pull their families through this. They are the silent who need to be celebrated.""Mothers need to be praised right now more than ever. Children need to look at their mothers' roles through a lens of gratitude. This book does both," said illustrator Kate Filyakova.6000 Sunsets is always looking to support mothers in need. Currently, partnering with Sanctuary Project an organization that empowers and employs survivors of trafficking, violence, and addiction to provide "My Important Girl" as encouragement for mothers at this most challenging time.Contact: Leslie Yeransian [emailprotected] 617.733.1225SOURCE Leslie Yeransian-Dolsak Answer:

Book Praises Mothers for Role During Pandemic Author Tells Why Leaning Out of Workforce Deserves Thanks

WASHINGTON, April 29, 2021 /PRNewswire/ -- The pandemic has pushed three million women out of the workforce, over 1.5 million mothers, amounting to $64 billion dollars in lost wages, according to the U.S. Bureau of Labor Statistics. Former news reporter and columnist, Leslie Yeransian-Dolsak, recognizes mothers for stepping up to the plate during the pandemic with her new children's book, "My Important Girl." Continue Reading Book Cover These natural caretakers have had to lean-out of the workforce during the COVID-19 public health crisis. With school closures, a shortage of childcare resources, and grandparents unable to turn to, women and mothers have been no longer able to outsource many essential caretaking roles and are experiencing a she-cession. "My Important Girl" spotlights the many roles a mother has, no matter how mundane or minor. From cook to historian to teacher to cheerleader, mothers have been the backbone of children's lives during this public health crisis. On this Mother's Day there is no better time to celebrate mothers than now. The past 13 months has hit caretakers hard, with half of mothers who left the workforce during the pandemic stating they will not return anytime soon. Three out of four mothers indicate levels of depression, anxiety or toxic stress. Hardest hit by the pandemic, single mothers Asian and Hispanic, nearing levels of 10% unemployment, having to leave their jobs to care for their children, mainly because their jobs didn't offer remote options."While we openly talk about 'leaning into' the workforce, we really need to take a moment to praise the women, the mothers who have had to pick up the rubble of this public health crisis," said author Yeransian-Dolsak. "They were given no choice other than to hunker down and pull their families through this. They are the silent who need to be celebrated.""Mothers need to be praised right now more than ever. Children need to look at their mothers' roles through a lens of gratitude. This book does both," said illustrator Kate Filyakova.6000 Sunsets is always looking to support mothers in need. Currently, partnering with Sanctuary Project an organization that empowers and employs survivors of trafficking, violence, and addiction to provide "My Important Girl" as encouragement for mothers at this most challenging time.Contact: Leslie Yeransian [emailprotected] 617.733.1225SOURCE Leslie Yeransian-Dolsak

edtsum367

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BENSALEM, Pa., April 1, 2021 /PRNewswire/ --Law Offices of Howard G. Smith reminds investors of the upcoming May 17, 2021deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Lordstown Motors Corp. ("Lordstown" or the "Company") (NASDAQ: RIDE) securities between August 3, 2020 and March 17, 2021, inclusive (the "Class Period"). Investors suffering losses on their Lordstown investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [emailprotected]. On March 12, 2021, Hindenburg Research published a report alleging that Lordstown has "no revenue and no sellable product." Though the Company has "consistently pointed to its book of 100,000 pre-orders as proof of deep demand of its proposed EV truck," the report alleged that these "orders are largely fictitious" and merely formed a "marketing relationship" with no obligation to purchase products. On this news, the Company's share price fell $2.93, or 16.5%, to close at $14.78 on March 12, 2021, thereby injuring investors. Then on March 17, 2021, after trading had closed, the Company held an earnings call disclosing that Lordstown had received an inquiry from the Securities & Exchange Commission ("SEC"). On this news, the stock fell approximately another 9% in aftermarket trading. The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company's purported pre-orders were non-binding; (2) many of the would-be customers who made these purported pre-orders lacked the means to make such purchases and/or would not have credible demand for Lordstown's Endurance; (3) Lordstown is not and has not been "on track" to commence production of the Endurance in September 2021; (4) the first test run of the Endurance led to the vehicle bursting into flames within 10 minutes; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Lordstown securities during the Class Period, you may move the Court no later thanMay 17, 2021 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish tolearn moreabout this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to[emailprotected], or visit our website at www.howardsmithlaw.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts Law Offices of Howard G. SmithHoward G. Smith, Esquire215-638-4847888-638-4847[emailprotected]www.howardsmithlaw.com SOURCE Law Offices of Howard G. Smith Related Links http://www.howardsmithlaw.com/ Answer:

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lordstown Motors Corp. (RIDE)

BENSALEM, Pa., April 1, 2021 /PRNewswire/ --Law Offices of Howard G. Smith reminds investors of the upcoming May 17, 2021deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Lordstown Motors Corp. ("Lordstown" or the "Company") (NASDAQ: RIDE) securities between August 3, 2020 and March 17, 2021, inclusive (the "Class Period"). Investors suffering losses on their Lordstown investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [emailprotected]. On March 12, 2021, Hindenburg Research published a report alleging that Lordstown has "no revenue and no sellable product." Though the Company has "consistently pointed to its book of 100,000 pre-orders as proof of deep demand of its proposed EV truck," the report alleged that these "orders are largely fictitious" and merely formed a "marketing relationship" with no obligation to purchase products. On this news, the Company's share price fell $2.93, or 16.5%, to close at $14.78 on March 12, 2021, thereby injuring investors. Then on March 17, 2021, after trading had closed, the Company held an earnings call disclosing that Lordstown had received an inquiry from the Securities & Exchange Commission ("SEC"). On this news, the stock fell approximately another 9% in aftermarket trading. The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company's purported pre-orders were non-binding; (2) many of the would-be customers who made these purported pre-orders lacked the means to make such purchases and/or would not have credible demand for Lordstown's Endurance; (3) Lordstown is not and has not been "on track" to commence production of the Endurance in September 2021; (4) the first test run of the Endurance led to the vehicle bursting into flames within 10 minutes; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. If you purchased or otherwise acquired Lordstown securities during the Class Period, you may move the Court no later thanMay 17, 2021 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish tolearn moreabout this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to[emailprotected], or visit our website at www.howardsmithlaw.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts Law Offices of Howard G. SmithHoward G. Smith, Esquire215-638-4847888-638-4847[emailprotected]www.howardsmithlaw.com SOURCE Law Offices of Howard G. Smith Related Links http://www.howardsmithlaw.com/

edtsum377

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: VALLEY FORGE, Pa., July 9, 2020 /PRNewswire/ --Vanguard today filed a preliminary registration statement with the Securities and Exchange Commission to launch Vanguard ESG U.S. Corporate Bond ETF. The low-cost, broadly diversified ETF will be Vanguard's first ESG-focused fixed income product for U.S. investors and complements Vanguard's existing equity ESG ETFs and mutual funds. The fund is expected to launch in September and Vanguard's Fixed Income Group will serve as the fund's advisor. "Vanguard's new U.S. ESG bond fund illustrates our commitment to providing investors with quality investment products and the ability to construct a portfolio that reflects their values," said Kaitlyn Caughlin, head of Vanguard's Portfolio Review Department. "Investors in this fund will benefit from our leading fixed income indexing capabilities, a low expense ratio, and robust screening process, all in an accessible and diversified manner." ESG investing continues to gain traction around the world. U.S. investors hold more than $321 billion in assets in ESG mutual funds and ETFs and industry-wide assets for the fixed income indexed market doubled in 2019 to approximately $1.3 billion.1,2 Vanguard ESG U.S. Corporate Bond ETF will complement Vanguard's existing $10.6 billion U.S. equity ESG product suite and offer a diverse fixed income option for investors. May 2000 Vanguard launches its first ESG offering, Vanguard FTSE Social Index Fund (VFTAX), the largest ESG index fund in the U.S with $7.9 billion in assets. September 2018 Two U.S.-domiciled ESG ETFs are launched, Vanguard ESG U.S. Stock ETF (ESGV) and Vanguard ESG International Stock ETF (VSGX) with $1.6 billion and $995.5 million in assets respectively. April 2019 Vanguard introduces an actively-managed equity ESG fund, Vanguard Global ESG Select Stock Fund (VESGX), managed by Wellington Management Company LLP with $130.9 million in assets. A focus on corporate bond exposure Vanguard ESG U.S. Corporate Bond ETF will have an estimated expense ratio of 0.12% and seek to track the Bloomberg Barclays MSCI US Corporate SRI Select Index, a rules-based index that captures a broad cross-section of the U.S. corporate bond market and screens out the bonds of companies whose activities that do not meet specific ESG criteria. Bloomberg L.P. and MSCI have partnered in managing bond ESG indexes for over eight years, and MSCI has managed ESG data for nearly 50 years. Importantly, there are consistent and established methods for screening corporate bonds in accordance with ESG criteriaother areas of the bond market, such as government-backed or mortgage-backed debt securities do not have such procedures in place. The index methodology includes using the parent Bloomberg Barclays U.S. Corporate Index as a baseline, with Bloomberg and MSCI applying robust exclusion screens for the bonds of companies that the Index provider determines are involved in, and/or derive threshold amounts of revenue from certain activities or business segments related to: adult entertainment, alcohol, gambling, tobacco, nuclear weapons, controversial weapons, conventional weapons, civilian firearms, nuclear power, genetically modified organisms, or thermal coal, oil, or gas. The Index also excludes the bonds of any company that, as determined by the Index provider, does not meet certain standards defined by the index provider's ESG controversies assessment, including the United Nations Global Compact Principles, as well as companies that fail to have at least one woman on their boards or do not report board diversity. Additionally, the ESG screens are continually assessed and applied to the investible corporate bond market to determine appropriate, diverse representation and select highly liquid bonds to promote a more liquid ETF for investors to trade in the market. Managed by Vanguard's leading Fixed Income Group Vanguard's Fixed Income Group, which oversees more than $1.8 trillion in global assets, will serve as the advisor for Vanguard ESG U.S. Corporate Bond ETF.3 The team has managed fixed income funds for more than 34 years, marked by the launch of the first bond index fund, Vanguard Total Bond Market Index Fund (VBTLX), in 1986. Using their deep investment capabilities, disciplined security selection process, and rigorous risk management techniques, the team has delivered consistent, long-term performance to Vanguard clients95% of Vanguard's bond funds outperformed their peers over a ten-year period.4 Vanguard offers 18 U.S.-domiciled fixed income ETFs with more than $228 billion in assets.5 The firm launched its first ETF in 2001 and today offers 80 ETFs to U.S. investors totaling more than $1 trillion in client assets. Investing in ESG funds Vanguard believes ESG investing is an enduring option for investors wishing to align their values with that of their investment portfolio. ESG products may perform differently, and may have different returns, than that of the broad market because they are excluding or including certain securities, resulting in overweights or underweights to some sectors. Vanguard investment strategists Jan-Carl Plagge and Doug Grim in their paper, "Have Investors Paid a Performance Price? Examining the Behavior of ESG Equity Funds," found that while differences in industry allocations relative to the broad market exist for ESG funds, there is no significant positive or negative return correlation driven by ESG factors. Investors should continue to assess their investment risk-reward appetite on a fund-by-fund basis. About VanguardVanguard is one of the world's largest investment management companies. As of May 31, 2020, Vanguard managed $5.9 trillion in global assets. The firm, headquartered in Valley Forge, Pennsylvania, offers more than 425 funds to its more than 30 million investors worldwide. For more information, visit vanguard.com. All data as of June 30, 2020 unless otherwise noted. 1US ESG assets (https://www.icifactbook.org/ch2/20_fb_ch2#esg)2Morningstar, data as of June 20203Vanguard data as ofMay 31, 20204Lipper, a Thomson Reuters Company, as of March 31, 2020. For the ten-year period, 74 of 78 Vanguard bond funds outperformed their peer group averages. Results for other time periods will vary. Only funds with a minimum ten-year history were included in the comparison. Note that the competitive performance data shown represent past performance, which is not a guarantee of future results, and that all investments are subject to risks. For the most recent performance, visit our website at www.vanguard.com/performance.5Vanguard data as ofMay 31, 2020 A registration statement relating to the Vanguard ETF Shares has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state. For more information about Vanguard funds, visit institutional.vanguard.com or call 800-523-1036 to obtain a prospectus or, if available, a summary prospectus. Investment objectives, risks, charges, expenses, and other important information about a fund are contained in the prospectus; read and consider it carefully before investing. Copies of the final prospectus can be obtained from Vanguard. Please note that a preliminary prospectus is subject to change. Vanguard ETF Shares are not redeemable with the issuing fund other than in very large aggregations worth millions of dollars. Instead, investors must buy and sell Vanguard ETF Shares in the secondary market and hold those shares in a brokerage account. In doing so, the investor may incur brokerage commissions and may pay more than net asset value when buying and receive less than net asset value when selling. All investing is subject to risk, including the possible loss of the money you invest. Investments in bonds are subject to interest rate, credit, and inflation risk. ESG funds are subject to ESG investment risk, which is the chance that the stocks or bonds screened by the index sponsor for ESG criteria generally will underperform the market as a whole or that the particular stocks or bonds selected will, in the aggregate, trail returns of other funds screened for ESG criteria. BLOOMBERG is a trademark of Bloomberg Finance LP. or its affiliates. BARCLAYS is a trademark and service mark of Barclays Bank Plc (collectively with its affiliates, "Barclays"). MSCI is a trademark and service mark of MSCI, Inc. (collectively with its affiliates, including MSCI ESG Research LLC ("MSCI ESG"), "MSCI"). These marks are used under license. Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited ("BISL") (collectively, "Bloomberg"), or Bloomberg's licensors own all proprietary rights in the Bloomberg Barclays MSCI US Corporate SRI Select IndexSM("Index") which Index is determined, composed and calculated by BISL, or any successor thereto, based on environmental, social and governance research provided by MSCI ESG.Neither Bloomberg, Barclays nor MSCI is affiliated with Vanguard as Issuer of the Vanguard ESG U.S. Corporate Bond ETF, and neither Bloomberg, Barclays nor MSCI approves, endorses, reviews or recommends Vanguard ESG U.S. Corporate Bond ETF. Bloomberg, Barclays and MSCI do not guarantee the timeliness, accurateness or completeness of any data or information relating to the Index, and none shall be liable in any way to the Issuer, investors in Vanguard ESG U.S. Corporate Bond ETFor other third parties in respect of the use or accuracy of the Index or any data included therein. Vanguard Marketing Corporation, Distributor. SOURCE Vanguard Related Links http://www.vanguard.com Answer:

Vanguard Expands ESG Suite With Launch Of First Fixed Income ESG ETF For U.S. Investors Vanguard ESG U.S. Corporate Bond ETF is expected to launch in September

VALLEY FORGE, Pa., July 9, 2020 /PRNewswire/ --Vanguard today filed a preliminary registration statement with the Securities and Exchange Commission to launch Vanguard ESG U.S. Corporate Bond ETF. The low-cost, broadly diversified ETF will be Vanguard's first ESG-focused fixed income product for U.S. investors and complements Vanguard's existing equity ESG ETFs and mutual funds. The fund is expected to launch in September and Vanguard's Fixed Income Group will serve as the fund's advisor. "Vanguard's new U.S. ESG bond fund illustrates our commitment to providing investors with quality investment products and the ability to construct a portfolio that reflects their values," said Kaitlyn Caughlin, head of Vanguard's Portfolio Review Department. "Investors in this fund will benefit from our leading fixed income indexing capabilities, a low expense ratio, and robust screening process, all in an accessible and diversified manner." ESG investing continues to gain traction around the world. U.S. investors hold more than $321 billion in assets in ESG mutual funds and ETFs and industry-wide assets for the fixed income indexed market doubled in 2019 to approximately $1.3 billion.1,2 Vanguard ESG U.S. Corporate Bond ETF will complement Vanguard's existing $10.6 billion U.S. equity ESG product suite and offer a diverse fixed income option for investors. May 2000 Vanguard launches its first ESG offering, Vanguard FTSE Social Index Fund (VFTAX), the largest ESG index fund in the U.S with $7.9 billion in assets. September 2018 Two U.S.-domiciled ESG ETFs are launched, Vanguard ESG U.S. Stock ETF (ESGV) and Vanguard ESG International Stock ETF (VSGX) with $1.6 billion and $995.5 million in assets respectively. April 2019 Vanguard introduces an actively-managed equity ESG fund, Vanguard Global ESG Select Stock Fund (VESGX), managed by Wellington Management Company LLP with $130.9 million in assets. A focus on corporate bond exposure Vanguard ESG U.S. Corporate Bond ETF will have an estimated expense ratio of 0.12% and seek to track the Bloomberg Barclays MSCI US Corporate SRI Select Index, a rules-based index that captures a broad cross-section of the U.S. corporate bond market and screens out the bonds of companies whose activities that do not meet specific ESG criteria. Bloomberg L.P. and MSCI have partnered in managing bond ESG indexes for over eight years, and MSCI has managed ESG data for nearly 50 years. Importantly, there are consistent and established methods for screening corporate bonds in accordance with ESG criteriaother areas of the bond market, such as government-backed or mortgage-backed debt securities do not have such procedures in place. The index methodology includes using the parent Bloomberg Barclays U.S. Corporate Index as a baseline, with Bloomberg and MSCI applying robust exclusion screens for the bonds of companies that the Index provider determines are involved in, and/or derive threshold amounts of revenue from certain activities or business segments related to: adult entertainment, alcohol, gambling, tobacco, nuclear weapons, controversial weapons, conventional weapons, civilian firearms, nuclear power, genetically modified organisms, or thermal coal, oil, or gas. The Index also excludes the bonds of any company that, as determined by the Index provider, does not meet certain standards defined by the index provider's ESG controversies assessment, including the United Nations Global Compact Principles, as well as companies that fail to have at least one woman on their boards or do not report board diversity. Additionally, the ESG screens are continually assessed and applied to the investible corporate bond market to determine appropriate, diverse representation and select highly liquid bonds to promote a more liquid ETF for investors to trade in the market. Managed by Vanguard's leading Fixed Income Group Vanguard's Fixed Income Group, which oversees more than $1.8 trillion in global assets, will serve as the advisor for Vanguard ESG U.S. Corporate Bond ETF.3 The team has managed fixed income funds for more than 34 years, marked by the launch of the first bond index fund, Vanguard Total Bond Market Index Fund (VBTLX), in 1986. Using their deep investment capabilities, disciplined security selection process, and rigorous risk management techniques, the team has delivered consistent, long-term performance to Vanguard clients95% of Vanguard's bond funds outperformed their peers over a ten-year period.4 Vanguard offers 18 U.S.-domiciled fixed income ETFs with more than $228 billion in assets.5 The firm launched its first ETF in 2001 and today offers 80 ETFs to U.S. investors totaling more than $1 trillion in client assets. Investing in ESG funds Vanguard believes ESG investing is an enduring option for investors wishing to align their values with that of their investment portfolio. ESG products may perform differently, and may have different returns, than that of the broad market because they are excluding or including certain securities, resulting in overweights or underweights to some sectors. Vanguard investment strategists Jan-Carl Plagge and Doug Grim in their paper, "Have Investors Paid a Performance Price? Examining the Behavior of ESG Equity Funds," found that while differences in industry allocations relative to the broad market exist for ESG funds, there is no significant positive or negative return correlation driven by ESG factors. Investors should continue to assess their investment risk-reward appetite on a fund-by-fund basis. About VanguardVanguard is one of the world's largest investment management companies. As of May 31, 2020, Vanguard managed $5.9 trillion in global assets. The firm, headquartered in Valley Forge, Pennsylvania, offers more than 425 funds to its more than 30 million investors worldwide. For more information, visit vanguard.com. All data as of June 30, 2020 unless otherwise noted. 1US ESG assets (https://www.icifactbook.org/ch2/20_fb_ch2#esg)2Morningstar, data as of June 20203Vanguard data as ofMay 31, 20204Lipper, a Thomson Reuters Company, as of March 31, 2020. For the ten-year period, 74 of 78 Vanguard bond funds outperformed their peer group averages. Results for other time periods will vary. Only funds with a minimum ten-year history were included in the comparison. Note that the competitive performance data shown represent past performance, which is not a guarantee of future results, and that all investments are subject to risks. For the most recent performance, visit our website at www.vanguard.com/performance.5Vanguard data as ofMay 31, 2020 A registration statement relating to the Vanguard ETF Shares has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state. For more information about Vanguard funds, visit institutional.vanguard.com or call 800-523-1036 to obtain a prospectus or, if available, a summary prospectus. Investment objectives, risks, charges, expenses, and other important information about a fund are contained in the prospectus; read and consider it carefully before investing. Copies of the final prospectus can be obtained from Vanguard. Please note that a preliminary prospectus is subject to change. Vanguard ETF Shares are not redeemable with the issuing fund other than in very large aggregations worth millions of dollars. Instead, investors must buy and sell Vanguard ETF Shares in the secondary market and hold those shares in a brokerage account. In doing so, the investor may incur brokerage commissions and may pay more than net asset value when buying and receive less than net asset value when selling. All investing is subject to risk, including the possible loss of the money you invest. Investments in bonds are subject to interest rate, credit, and inflation risk. ESG funds are subject to ESG investment risk, which is the chance that the stocks or bonds screened by the index sponsor for ESG criteria generally will underperform the market as a whole or that the particular stocks or bonds selected will, in the aggregate, trail returns of other funds screened for ESG criteria. BLOOMBERG is a trademark of Bloomberg Finance LP. or its affiliates. BARCLAYS is a trademark and service mark of Barclays Bank Plc (collectively with its affiliates, "Barclays"). MSCI is a trademark and service mark of MSCI, Inc. (collectively with its affiliates, including MSCI ESG Research LLC ("MSCI ESG"), "MSCI"). These marks are used under license. Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited ("BISL") (collectively, "Bloomberg"), or Bloomberg's licensors own all proprietary rights in the Bloomberg Barclays MSCI US Corporate SRI Select IndexSM("Index") which Index is determined, composed and calculated by BISL, or any successor thereto, based on environmental, social and governance research provided by MSCI ESG.Neither Bloomberg, Barclays nor MSCI is affiliated with Vanguard as Issuer of the Vanguard ESG U.S. Corporate Bond ETF, and neither Bloomberg, Barclays nor MSCI approves, endorses, reviews or recommends Vanguard ESG U.S. Corporate Bond ETF. Bloomberg, Barclays and MSCI do not guarantee the timeliness, accurateness or completeness of any data or information relating to the Index, and none shall be liable in any way to the Issuer, investors in Vanguard ESG U.S. Corporate Bond ETFor other third parties in respect of the use or accuracy of the Index or any data included therein. Vanguard Marketing Corporation, Distributor. SOURCE Vanguard Related Links http://www.vanguard.com

edtsum379

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SALT LAKE CITY, Jan. 7, 2021 /PRNewswire/ --CleanSpark, Inc. (Nasdaq: CLSK), ("CleanSpark, or the Company"), an advanced software and controls technology solutions company focused on solving modern energy challenges, and Bay Area Energy Solutions, Inc. today announced they are jointly developing the first pilot microgrid solution for an estate residence in Healdsburg, CA. The companies are pleased to have secured the first contract under a previously announced partnership agreement. This initial project is anticipated to be the first of a joint initiative formed with a number of domestic energy developers, including Bay Area Energy Solutions. Luxury and estate homes offer a targeted niche with unique requirements for which CleanSpark and its partners can provide strategic solutions. Properties of this size often require significant power for one or more building structures and can even include business operations on site. There are thousands of homes greater than 10,000 square feet in the state of California alone, where incentives and tax benefits, along with well-documented utility challenges support the implementation of new, renewable, and resilient energy sources. CleanSpark expects to develop a significant pipeline of projects within this sector. CleanSpark Launches Luxury Estate Energy Program Following Successful Bitcoin Deployment Tweet this The first deployment is a 14,000 square foot estate currently under construction. When completed, the luxury residence will be operated fully grid-disconnected, utilizing on site generation, solar, and storage managed by CleanSpark's mPulse Controller for system optimization. The goal of the project is to provide self-sufficient off-grid energy for locations frequently experiencing grid disruptions from events including wildfires and public safety grid shutdowns. The California Energy Commission anticipates increasing volatility in areas prone to disruptions. Kilowatt Labs, Inc.'s supercapacitor-based energy storage which will be installed with photovoltaic solar panels during the first phase of the project in order to power construction of the home. Additional solar and stand-by generators will be added once the homeowner takes residence.Amer Tadayon CRO of CleanSpark commented, "We are seeing increasing investments being made by estate homeowners integrating sustainable energy technology into construction projects of this magnitude, and we believe this trend will continue. This is the first foray directly into this market segment for CleanSpark. With our development partners, we can help solve critical energy and resiliency challenges for these types of residences." Adding, "We are pleased to continue building our pipeline of microgrid projects with partners like Bay Area Energy Solutions, where we expect to deploy multiple mPulse controlled residential microgrids in 2021." Joel Ware, owner of Bay Area Energy Solutions said, "Because this is an off-grid project, we worked with a number of energy providers including Kilowatt Labs to procure the proper electrical generation and storage for the construction phase, as well as the permanent occupancy of the home. CleanSpark's Controller will enable our customer to power their home and property efficiently, with self-sufficient, sustainable energy that is not reliant on the increasingly volatile utility grid." Zach Bradford CEO of CleanSpark said of the project, "We are excited to participate on this project with Bay Area Energy. CleanSpark's proprietary mPulse system, paired with solar, storage, and generators will provide complete resiliency as well as significant cost savings. It will also allow their microgrid to be 'future-proof' should they wish to add additional solar or other resources at a later date. We believe that the sustainable energy management opportunities presented within the higher end residential real estate market will parallel the successes we've begun to experience in our Bitcoin mining operations."Parties interested in learning more about CleanSpark products and services are encouraged to inquire by contacting the Company directly at [emailprotected] or visiting the Company's website at www.cleanspark.com. Investors are encouraged to contact the Company at[emailprotected], or visiting the Company's website at https://ir.cleanspark.com/ About CleanSpark:CleanSpark, Inc., a Nevada corporation, is in the business of providing advanced software and controls technology solutions to solve modern energy challenges. We have a suite of software solutions that provide end-to-end microgrid energy modeling, energy market communications, and energy management solutions. Our offerings consist of intelligent energy monitoring and controls, intelligent microgrid design software, middleware communications protocols for the energy industry, energy system engineering, and software consulting services. Through its wholly owned subsidiary ATL Data Centers LLC, CleanSpark owns and operates a data center that provides customers with traditional on-site and cloud-based data center services. The Company also owns and operates a fleet of over 3,400 ASIC (application-specific integrated circuit) Bitcoin miners producing over 200 PH/s in mining capacity. Capacity is expected to increase to over 5,900 ASIC and 300 PH/s in mining capacity by early 2021. CleanSpark plans to apply its technologies with a goal of mining bitcoins at the lowest energy prices in the United States. For more information, visit https://ATL-DATA.comAbout Bay Area Energy Solutions, Inc.:Bay Area Energy Solutions, Inc. provides custom solar design and installation services for residential and commercial properties in the Greater California Bay Area. Bay Area Energy Solutions, Inc. is proud to be a certified Sunpower dealer, and a Tesla PowerWall authorized installer. Forward-Looking Statements:CleanSpark cautions you that statements in this press release that are not a description of historical facts are forward-looking statements. These statements are based on CleanSpark's current beliefs and expectations. The inclusion of forward-looking statements should not be regarded as a representation by CleanSpark that any of our plans will be achieved. Actual results may differ from those set forth in this press release due to the risk and uncertainties inherent in our business, including, without limitation: the successful deployment energy solution on the project, the fitness of our energy software and solutions for this particular application or market, the expectations of future revenue growth may not be realized, ongoing demand for our software products and related services, the impact of global pandemics (including COVID-19) on the demand for our products and services; and other risks described in our prior press releases and in our filings with the Securities and Exchange Commission (SEC), including under the heading "Risk Factors" in our Annual Report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and we undertake no obligation to revise or update this press release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.Contact - Investor Relations:CleanSpark Inc. Investor Relations(801)-244-4405SOURCE CleanSpark, Inc. Related Links http://www.cleanspark.com Answer:

CleanSpark, Inc. Commences Residential Estate Program with Bay Area Energy Solutions, Inc. Companies Launch Initiative with First Luxury Deployment

SALT LAKE CITY, Jan. 7, 2021 /PRNewswire/ --CleanSpark, Inc. (Nasdaq: CLSK), ("CleanSpark, or the Company"), an advanced software and controls technology solutions company focused on solving modern energy challenges, and Bay Area Energy Solutions, Inc. today announced they are jointly developing the first pilot microgrid solution for an estate residence in Healdsburg, CA. The companies are pleased to have secured the first contract under a previously announced partnership agreement. This initial project is anticipated to be the first of a joint initiative formed with a number of domestic energy developers, including Bay Area Energy Solutions. Luxury and estate homes offer a targeted niche with unique requirements for which CleanSpark and its partners can provide strategic solutions. Properties of this size often require significant power for one or more building structures and can even include business operations on site. There are thousands of homes greater than 10,000 square feet in the state of California alone, where incentives and tax benefits, along with well-documented utility challenges support the implementation of new, renewable, and resilient energy sources. CleanSpark expects to develop a significant pipeline of projects within this sector. CleanSpark Launches Luxury Estate Energy Program Following Successful Bitcoin Deployment Tweet this The first deployment is a 14,000 square foot estate currently under construction. When completed, the luxury residence will be operated fully grid-disconnected, utilizing on site generation, solar, and storage managed by CleanSpark's mPulse Controller for system optimization. The goal of the project is to provide self-sufficient off-grid energy for locations frequently experiencing grid disruptions from events including wildfires and public safety grid shutdowns. The California Energy Commission anticipates increasing volatility in areas prone to disruptions. Kilowatt Labs, Inc.'s supercapacitor-based energy storage which will be installed with photovoltaic solar panels during the first phase of the project in order to power construction of the home. Additional solar and stand-by generators will be added once the homeowner takes residence.Amer Tadayon CRO of CleanSpark commented, "We are seeing increasing investments being made by estate homeowners integrating sustainable energy technology into construction projects of this magnitude, and we believe this trend will continue. This is the first foray directly into this market segment for CleanSpark. With our development partners, we can help solve critical energy and resiliency challenges for these types of residences." Adding, "We are pleased to continue building our pipeline of microgrid projects with partners like Bay Area Energy Solutions, where we expect to deploy multiple mPulse controlled residential microgrids in 2021." Joel Ware, owner of Bay Area Energy Solutions said, "Because this is an off-grid project, we worked with a number of energy providers including Kilowatt Labs to procure the proper electrical generation and storage for the construction phase, as well as the permanent occupancy of the home. CleanSpark's Controller will enable our customer to power their home and property efficiently, with self-sufficient, sustainable energy that is not reliant on the increasingly volatile utility grid." Zach Bradford CEO of CleanSpark said of the project, "We are excited to participate on this project with Bay Area Energy. CleanSpark's proprietary mPulse system, paired with solar, storage, and generators will provide complete resiliency as well as significant cost savings. It will also allow their microgrid to be 'future-proof' should they wish to add additional solar or other resources at a later date. We believe that the sustainable energy management opportunities presented within the higher end residential real estate market will parallel the successes we've begun to experience in our Bitcoin mining operations."Parties interested in learning more about CleanSpark products and services are encouraged to inquire by contacting the Company directly at [emailprotected] or visiting the Company's website at www.cleanspark.com. Investors are encouraged to contact the Company at[emailprotected], or visiting the Company's website at https://ir.cleanspark.com/ About CleanSpark:CleanSpark, Inc., a Nevada corporation, is in the business of providing advanced software and controls technology solutions to solve modern energy challenges. We have a suite of software solutions that provide end-to-end microgrid energy modeling, energy market communications, and energy management solutions. Our offerings consist of intelligent energy monitoring and controls, intelligent microgrid design software, middleware communications protocols for the energy industry, energy system engineering, and software consulting services. Through its wholly owned subsidiary ATL Data Centers LLC, CleanSpark owns and operates a data center that provides customers with traditional on-site and cloud-based data center services. The Company also owns and operates a fleet of over 3,400 ASIC (application-specific integrated circuit) Bitcoin miners producing over 200 PH/s in mining capacity. Capacity is expected to increase to over 5,900 ASIC and 300 PH/s in mining capacity by early 2021. CleanSpark plans to apply its technologies with a goal of mining bitcoins at the lowest energy prices in the United States. For more information, visit https://ATL-DATA.comAbout Bay Area Energy Solutions, Inc.:Bay Area Energy Solutions, Inc. provides custom solar design and installation services for residential and commercial properties in the Greater California Bay Area. Bay Area Energy Solutions, Inc. is proud to be a certified Sunpower dealer, and a Tesla PowerWall authorized installer. Forward-Looking Statements:CleanSpark cautions you that statements in this press release that are not a description of historical facts are forward-looking statements. These statements are based on CleanSpark's current beliefs and expectations. The inclusion of forward-looking statements should not be regarded as a representation by CleanSpark that any of our plans will be achieved. Actual results may differ from those set forth in this press release due to the risk and uncertainties inherent in our business, including, without limitation: the successful deployment energy solution on the project, the fitness of our energy software and solutions for this particular application or market, the expectations of future revenue growth may not be realized, ongoing demand for our software products and related services, the impact of global pandemics (including COVID-19) on the demand for our products and services; and other risks described in our prior press releases and in our filings with the Securities and Exchange Commission (SEC), including under the heading "Risk Factors" in our Annual Report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and we undertake no obligation to revise or update this press release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.Contact - Investor Relations:CleanSpark Inc. Investor Relations(801)-244-4405SOURCE CleanSpark, Inc. Related Links http://www.cleanspark.com

edtsum382

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NATICK, Mass.--(BUSINESS WIRE)--Cognex Corporation (NASDAQ: CGNX) today announced that the company's Board of Directors declared a quarterly cash dividend of $0.06 per share. This dividend is payable on March 12, 2021 to all shareholders of record at the close of business on February 26, 2021. About Cognex Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors. Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com. Answer:

Cognex Declares Quarterly Cash Dividend

NATICK, Mass.--(BUSINESS WIRE)--Cognex Corporation (NASDAQ: CGNX) today announced that the company's Board of Directors declared a quarterly cash dividend of $0.06 per share. This dividend is payable on March 12, 2021 to all shareholders of record at the close of business on February 26, 2021. About Cognex Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors. Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.

edtsum388

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ALBUQUERQUE, N.M., Aug. 25, 2020 /PRNewswire/ --"Ryon's debut novel is a magical page-turner. A must read for those who love family and friendship, ache at their loss, and yearn to find a way to help and heal. Parents' Choice Gold Award Local NM author, mother and nurse, Loriel Ryon is proud to release her first children's book, INTO THE TALL, TALL GRASS, published by Margaret K. McElderry (S&S) on 4/7/20. Set in the New Mexico desert, it tells the tale of a twelve-year-old girl, Yolanda, unraveling the mystery behind the secret family trait that has plagued her family for generations. Into the Tall, Tall Grass book cover by Loriel Ryon Loriel Ryon: author of Into the Tall, Tall Grass When a strange grass emerges in the desert behind their home, Yolanda's grandmother wakes up from a coma, begging Yolanda to take her to the lone pecan tree left on their land. Determined not to lose her, Yolanda sets out on this journey with her sister, her ex-best friend, a boy who has a crush on her and her naughty dog. Along the way, Yolanda discovers long-buried secrets that have made their family trait a family curse. But she also finds the healing power of the magic all around her, which just might promise a new beginning. This story blends wondrous elements from the magical desert setting to STEM to sisterhood and first crushes. It explores themes of grief and loss, the complex struggles of finding one's place in their family. It is a perfect read for ages 10 and up. Reviews and Awards:"A must-have tale, perfect for fans of emotionally resonant magical realism" School Library Journal, starred reviewAmerican Booksellers Association Indies Introduce and Indie Next Spring 2020 Top Title Pick: "Into the Tall, Tall Grassis a magical story with a charming cast of characters and emotional life lessons." Jackie Jou, Mysterious Galaxy Books"This heartfelt tale weaves together science and magic believably and sensitively."-Kirkus"This engaging read pulls on the heartstrings, but gently." -Booklist"Yolanda's struggles are complex, and the narrative of family legacies and intergenerational trauma is ultimately compellinguplifting" -Publisher's WeeklyLoriel is available for interviews and features. SOURCE Loriel Ryon Related Links https://www.lorielryon.com/ Answer:

Local New Mexico Author, Mother and Nurse, Loriel Ryon, releases her debut middle grade novel, "Into the Tall, Tall Grass" to high praise

ALBUQUERQUE, N.M., Aug. 25, 2020 /PRNewswire/ --"Ryon's debut novel is a magical page-turner. A must read for those who love family and friendship, ache at their loss, and yearn to find a way to help and heal. Parents' Choice Gold Award Local NM author, mother and nurse, Loriel Ryon is proud to release her first children's book, INTO THE TALL, TALL GRASS, published by Margaret K. McElderry (S&S) on 4/7/20. Set in the New Mexico desert, it tells the tale of a twelve-year-old girl, Yolanda, unraveling the mystery behind the secret family trait that has plagued her family for generations. Into the Tall, Tall Grass book cover by Loriel Ryon Loriel Ryon: author of Into the Tall, Tall Grass When a strange grass emerges in the desert behind their home, Yolanda's grandmother wakes up from a coma, begging Yolanda to take her to the lone pecan tree left on their land. Determined not to lose her, Yolanda sets out on this journey with her sister, her ex-best friend, a boy who has a crush on her and her naughty dog. Along the way, Yolanda discovers long-buried secrets that have made their family trait a family curse. But she also finds the healing power of the magic all around her, which just might promise a new beginning. This story blends wondrous elements from the magical desert setting to STEM to sisterhood and first crushes. It explores themes of grief and loss, the complex struggles of finding one's place in their family. It is a perfect read for ages 10 and up. Reviews and Awards:"A must-have tale, perfect for fans of emotionally resonant magical realism" School Library Journal, starred reviewAmerican Booksellers Association Indies Introduce and Indie Next Spring 2020 Top Title Pick: "Into the Tall, Tall Grassis a magical story with a charming cast of characters and emotional life lessons." Jackie Jou, Mysterious Galaxy Books"This heartfelt tale weaves together science and magic believably and sensitively."-Kirkus"This engaging read pulls on the heartstrings, but gently." -Booklist"Yolanda's struggles are complex, and the narrative of family legacies and intergenerational trauma is ultimately compellinguplifting" -Publisher's WeeklyLoriel is available for interviews and features. SOURCE Loriel Ryon Related Links https://www.lorielryon.com/